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II. Abstract: 
In this thesis (chapter 2), some multi-component reactions (MCRs) of aryl aldehydes 
incorporating the azide functional group were investigated to produce heterocyclic and other 
MCR products in order to investigate post-MCR azide cycloadditions. Although the MCRs 
were often successful, post-MCR reactions did not occur and, occasionally, cycloaddition 
occurred before the MCR. 
In chapter 3, the synthesis of novel tetra- and triazolo-analogues of the 
pyrrolobenzothiadiazepines and benzothiadiazepines are described. These compounds are of 
great interest as synthetic targets due to their potential medicinal properties. The key 
processes are the intramolecular 1,3-dipolar cycloaddition between the azide and the nitrile 
present in precursors (I), or the azide and the alkyne present in precursors (II) to form the 
novel final compounds of type (III), as shown below. The synthesis of these precursors from 
readily available starting materials is discussed. 
 
In chapter 4 of this thesis, some azide chemistry of 2-azido aryl compounds is investigated. In 
chapter 4.1, it was found that attempted N-alkylation of 2-azidobenzamide with alkyl halides 
gave mixtures of benzotriazinones and quinazolinones, as shown below:  
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V 
 
In chapter 4.2 of this thesis other functionalised 2-azido aryl compounds were studied in order 
to produce 1,2,4-oxadiazoles as a potential new ligand system in supramolecular chemistry. 
For example, 1,2,4-oxadiazoles were synthesised  when  an amidoxime reacted with an acid 
chloride and then reaction of the azide moiety with an alkyne furnished 1,2,3-triazoles:  
 
 
In chapter 4.3 of this thesis, some simple heterocycles and some macrocycles were 
synthesised by aza-Wittig reaction and Staudinger reaction of a further series of 2-azido aryl 
compounds, for example: 
 
In the final chapter of this thesis, the attempted synthesis of sulfur analogues of the 
circumdatins and fuligocandins was attempted. These two pyrrolobenzodiazepine natural 
products and their analogues have interesting biological activities.  
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III. Abbreviations: 
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1. Introduction 
1.1. Multicomponent reactions (MCRs). 
1.1.1. General aspects of multicomponent reactions (MCRs). 
 
The ideal synthesis should lead to the desired product in as few steps as possible
1,2
 
 
(Figure 
1.1), in good overall yield and by using environmentally acceptable reagents. The variables 
that have to be optimized are overall yield, cost, time, environmental acceptability, simplicity 
of performance and safety. Purification and isolation steps such as extraction, distillation, 
crystallization or chromatography must also be considered. 
 
A good and efficient way of gaining the product is a one pot reaction of three or more starting 
compounds, i.e. by using multicomponent reactions (MCRs). Multicomponent reactions 
(MCRs) are one of the most valuable tools in making chemical structures. MCRs are methods 
in which three or more starting materials are converted in one chemical step to form a specific 
product
3
 . 
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 Mechanistic study for a number of MCRs has shown three different types as shown in Figure 
1.2. Type (1) MCRs are combinations of equilibria between all participating starting 
materials, including the last step that forms the desired product. Type (2) MCRs are 
collections of equilibria where just the final step which is irreversible and drives the process 
towards the desired product. MCRs of type (3) create of a sequence of irreversible starting 
materials that all proceed towards the main product.  
 
The result of an MCR is dependent on the nature of the starting materials in addition to the 
reaction conditions
4
. For an MCR to be efficient and feasible, the compatibility of all the 
possible pairs of reagents must be looked at during the planning stages.
5
 Having in mind this 
general principle, it is obvious that this task increases when the number of reagents increases, 
as there will be more combinations. MCRs have emerged as a useful tool for the formation of 
chemical libraries of drug-like compounds with high levels of molecular complexity and 
diversity in drug discovery programs. 
 
                             
 
 
 
Chaper 1                                                                                                                                               Introduction 
3 
 
1.1.2. The history of multicomponent reactions (MCRs). 
 
The historical development of multicomponent reactions is outlined in Figure 1.3, and will be 
discussed below. 
 
 
1.1.2.1. Reaction of Laurent and Gerhardt. 
The first examples of MCRs appeared in the mid-19
th
 century. The first was discovered by 
Laurent and Gerhardt in 1838. In this, benzoylazotide was prepared from ammonia and bitter 
almond oil.
6,7 
In chemistry terms, this was a four component condensation of benzaldehyde 
with hydrogen cyanide and ammonia to form an intermediate α–amino cyanide (1) which 
underwent condensation with another benzaldehyde molecule to prepare a Schiff base 
(benzoylazotide (2))
7
 , as shown below: 
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1.1.2.2. Multicomponent Strecker reaction. 
1850 is the year that the chemistry of MCRs is considered to have officially started, with the 
introduction by Strecker
8
 of a methodology for producing α–amino acids (5) via the synthesis 
of α–amino cyanides from aldehydes followed by a post MCR hydrolysis of the cyanide 
functionality
9-11
. An example is given in Scheme 1.2. 
 
α-Amino acids are a particularly important class because they have difunctional groups, and 
are the building blocks from which proteins are constructed.
12
  They are widely utilized as 
components of medicinally active molecules and as chiral catalysts.
13-17
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1.1.2.3. Multicomponent Hantzsch reaction. 
 
The Hantzsch dihydropyridine synthesis was introduced
4
 in 1882. This is a four component 
process involving ammonia, two molecules of an acetoacid ester (6) and an aldehyde to form 
dihydropyridines (7) (see Scheme 1.3).
18-20
  
1,4-Dihydropyridines, the products of the Hantzch reaction, are  an important class of  
calcium channel blockers and have been commercialized in, for example, nifedipine
21
, 
amlodipine
22
 and nimodipine
23
. 
 
1.1.2.4. Multicomponent Biginelli reaction. 
 
In 1893 the Biginelli three component reaction was shown to yield 3,4-dihydropyrimidin-
2(1H)-ones (10), another medicinally interesting heterocycle
24
. In this process benzaldehyde 
condenses with an acetoacid ester (8) and urea (9) in the presence of HCl as catalyst. The 
product usually precipitates out upon cooling making this method very useful and very 
practical. 
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The scope of this reaction has been extended by changes of the components used, allowing 
access to a large number of functionalized dihydropyrimidinone analogues,
25,26
 a field of very 
active research due to the important biological properties they show,
27-31
 including the first 
enzymatic example.
32
 
 
1.1.2.5. Multicomponent Mannich reaction. 
 
The next big advance after the Biginelli reaction, the Mannich reaction
33
 was discovered by 
Mannich in 1912. This process is one of the most cited and used reactions in organic 
synthesis
34
. The Mannich reaction is a three compound condensation between an enolizable 
CH-acidic carbonyl compound (11), a non-enolizable aldehyde (often formaldehyde) and an 
amine to produce a β-aminocarbonyl compound (12), as shown below: 
 
The mechanism
19
 for the Mannich reaction is shown below in Figure 1.4.  
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Mannich reactions are widely used in medicinal chemistry, for example, in the synthesis of 
fluoxetine (antidepressant), tolmetin (anti-inflammatory drug), rolitetracycline (Mannich base 
of tetracycline), azacyclophanes and tramadol.
35,36
 The Mannich reaction is also employed in 
the synthesis of natural compounds such as antibiotics, peptides, alkaloids (e.g. tropinone) and 
nucleotides.
37 
 
1.1.2.6. Asinger synthesis of thiazolines. 
 
In 1959, Asinger introduced an MCR process for thiazolines
38
. Two types of the reaction have 
been discovered. The first one is a three component condensation between ammonia, sulfur 
and an oxo compound while the second involves four components, namely sodium hydrogen 
sulfide,  an oxo compound,  ammonia and  an  α-halo oxo compound39, as shown in Scheme 
1.6 below: 
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1.1.2.7. Multicomponent Bucherer-Bergs reaction. 
 
The Bucherer-Bergs reaction, a method to make hydantoins was discovered
40,41
 in 1934
 
. 
 
This method used four components being concerned with the condensation between hydrogen 
cyanide, a carbonyl compound, ammonia and carbon dioxide
42
. The reaction is performed by 
the use of KCN and (NH4)2CO3 (besides the carbonyl component) which in the course of the 
reaction generates the NH3 and CO2 units in-situ that eventually get incorporated in the 
hydantoin (15) skeleton. 
The hydantoins have many applications. They are an important heterocyclic scaffolds in 
biology and have pharmacological activity, for example, 5,5-diphenylhydantoin (also  called 
Dilantin). The also have useful applications in carbohydrate chemistry.
43-45 
 
 
 
1.1.2.8. Isocyanide-based multicomponent reactions (IMCRs). 
1.1.2.8.1. Synthesis of isocyanides 
 
Another class of MCRs began with the development of the chemistry of the isocyanides
46-48
. 
Isocyanides, also known as isonitriles, are compounds with an interesting functional group. 
They are one of the few classes of organic compounds with a divalent carbon (C
2+
) and their 
chemical reactions change the divalent (C
2+
) into the tetravalent carbon atom (C
4+
). 
Isocyanides have the ability to react with both nucleophiles and electrophiles at the same 
position, the carbon atom leading to the so called α-adduct49. Isocyanide chemistry started in 
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1859 when allyl isocyanide (17) was prepared from allyl iodide (16) and silver cyanide
50-53
, as 
shown in Scheme 1.8. 
 
Their wider use in synthesis was started after a more general method for the production of 
isocyanides (19) by dehydration of formylamines (18) appeared in 1958
53
, as shown in 
Scheme 1.9 and 1.10 below. This eventually led to the development of the isocyanide-based 
MCRs (IMCRs) which compose the most well-known and versatile class of MCRs
54
. 
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1.1.2.8.2. Multicomponent Passerini reaction. 
The first IMCRs were developed by Passerini
55
 in 1921 shortly after the reactivity of 
isocyanides was recognized. The Passerini condensation is a three component reaction 
between a carbonyl compound, an isocyanide (20) and a carboxylic acid to form α–
acyloxycarboxamides (21), as shown in Scheme 1.11 below: 
 
A mechanism has been proposed
55-57
, based on the large amount experimental data gained and 
on the mechanistic studies performed. It concerns the formation of a hydrogen-bonded adduct 
from the acid and the carbonyl component, thus activating both components, which 
subsequently react with the isocyanide to form an α–adduct. This α-adduct is unstable, cannot 
be isolated, and rearranges to the stable α-acyloxycarboxamide, as shown below (Figure 1.5): 
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The Passerini reaction has been used by the pharmaceutical industry for the synthesis of drug-
like compounds, and for the synthesis of heterocycles, polycyclics and the total synthesis of 
natural products.
58,59
 
 
1.1.2.8.3. Multicomponent Ugi reaction. 
 
In 1959, a major advance in MCRs was set by Ugi by using four compounds.
60,61
 In the Ugi 
reaction a carbonyl component, isocyanide, a carboxylic acid and an amine are reacted to 
form α–acylamido amides (22), as shown in the Scheme 1.12.   
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The Ugi reaction is similar to the Passerini reaction but the fourth component (the amine) 
adds one more point of diversity giving a higher number of molecules that can potentially be 
synthesized
62
. The proposed mechanism
63
 for the Ugi condensation concerns the production 
of an imine from the carbonyl and the amine which in the presence of the isocyanide and the 
carboxylic acid reacts in a similar fashion to the Passerini reaction, yielding the α-adduct 
which then undergoes a rearrangement, yielding the final product.  
 
The use of bifunctional components can lead to cyclic structures through intramolecular 
condensation. The number of Ugi-derived products can be developed even more by the 
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incorporation of post-MCR modifications
5,9
. Figure 1.7 gives a list of types of structures made 
using Ugi-type MCRs.
64
 
  
 The Ugi reaction is used in pharmaceutical products  such as Crixivan
65
, and for many of the 
caine-type anesthetics including bupivacaine
66
 and lidocaine.
67
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1.1.2.9. Multicomponent Gewald reaction. 
 
In 1961 Gewald reported
68
 the production of poly-substituted thiophenes (33) from the 
reaction between a carbonyl compound (ketone, aldehyde or 1,3-dicarbonyl) with elemental 
sulfur and activated nitriles in the presence of an amine base
69
. 
 
 
1.1.2.10. Multicomponent Pauson and Khand. 
 
In 1971 another well-known MCR was developed by Pauson and Khand
70,71
. The 
transformation yields cyclopentenones (34) and involves the [2+2+1] cycloaddition reaction 
between an alkyne, an alkene and CO, in the presence of Co2(CO)8  as catalyst. It has found 
application in producing prostaglandin analogues. 
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1.2. Quinazolinones: 
1.2.1. An introduction to quinazolinones: 
Later in this thesis an unexpected synthesis of quinazolinones will be discussed. A brief 
introduction to these heterocycles is hence included here. 
Quinazolinones are an important class of heterocycle with a wide range of pharmacological 
and biological activities such as antiviral, anticancer, antidiabetes, antiobesity, anti-
inflammatory, anti-tubercular
72
, antiulcer, insecticidal, anticonvulsant, hypolipidemic activity 
and antimicrobial properties. They are also potent and selective ALK5 inhibitors
73
. 
Quinazolines also have tranquilizer, sedative, analgesic, diuretic, antihypertensive, anesthetic, 
and muscle relaxant properties
74-76
. Some examples, compounds (40-44), are shown in Figure 
1.8. 
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Figure 1.8: Pharmaceutical compounds containing the quinazolinone moiety
74
. 
The quinazoline moiety is present in approximately 150 naturally occurring alkaloids isolated 
to date from a number of families of the plant kingdom, animals and microorganisms.
77-81
 An 
example is febrifugine, from the Asian plant dichroa ferifuga
82
 and the garden plant 
Hydrangea
83
, used as a chinese herbal remedy effective against malaria (Fig. 1.9). 
 
Chaper 1                                                                                                                                               Introduction 
17 
 
 
Figure 1.9 
 
1.2.2. Synthesis of quinazolinones. 
2-Methyl-4(3H)-quinazolinone (48) was synthesized via the reaction of anthranilic acid with 
various imidates in methanol (Scheme 1.15)
84
.  
 
Quinazolinones (50)  were efficiently synthesized in good to excellent yields via reaction of 
aromatic benzoyl chlorides (49) with 2-aminobenzamide using SBA-Pr-SO3H as a nano solid 
acid catalyst  under solvent-free conditions
85
 as shown in Scheme 1.16. 
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The quinazolin-4-ones  (52) were synthesized in high to excellent yield (75-99 %)  via the 
reaction of anthranilic acid, amines, and esters (or formic acid) under solvent-free conditions 
using Yb(OTf)3 as a catalyst
86
, as shown in Scheme 1.17. 
 
Another approach describes a novel reaction to provide 3-substituted-4(3H)-quinazolinones 
(53) or (54) in high yield by the reaction of the Vilsmeier reagent with 5-substituted-2-
aminobenzoic acid derivatives (Scheme 1.18)
87
. The reaction was found to be temperature 
dependent with compound (53) formed at room temperature and compound (54) formed at 90 
o
C.  
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Finally, quinazolinones (56) can be made by reaction of aldehyde with 2-aminobenzamides 
(55) via a p-toluene sulfonic acid catalysed cyclocondensation followed by oxidative 
dehydrogenation mediated by  phenyliodine diacetate (PIDA) as shown in Scheme 1.19.
88
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1.3. Benzotriazinones. 
1.3.1. An introduction to benzotriazinones. 
Benzotriazinones will also feature later in this thesis (see discussion) and so are briefly 
introduced here. 
 Benzotriazinones are an important class of heterocycle and have attracted attention in 
medicinal and bioorganic chemistry
89-91
.  For example, benzotriazinones have been reported 
having diuretic
92
, sedative
93
, antiarthritic
94
, antitumor
95
, anesthetic
96
 and antitubercular 
activities
97
.  
Traditionally
98-100
,  methyl anthranilate (60) (Scheme 1.20) was reacted with NaNO2 and HCl 
at 0 
o
C to form a diazonium (61) as an intermediate and then reaction between the diazonium 
intermediate and  aliphatic amines gave 3-substituted 1,2,3-benzotriazine-4-ones (63). 
 
Alternatively, the parent 1,2,3-benzotriazin-4-one (65) can be prepared as shown in Scheme 
1.21
101
 and can then be substituted at the 3-position. 
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bis-1,2,3-Benzotriazin-4(3H)-ones (68), shown in Scheme 1.22, were prepared by reaction of 
isotoic anhydride (66) with an alkanediamine in the presence of DMF at 50 
o
C under mild 
conditions.
102
 The diazotization of the intermediate bis-[(2-aminobenzoyl-)amino]alkanes (67) 
in aqueous solution afforded good yields of the bis-1,2,3-benzotrizine-4-ones (68). 
 
 
 
1.3.2. Reactivity of 1,2,3-benzotriazinones. 
The 1,2,3-benzotrizin-4-ones (70) were alkylated at the N3 position with dibromoalkane in 
the presence of K2CO3  as  a weak base to afford  3-(3-bromoalkyl)-1,2,3,-benzotriazin-4(3H)-
ones (71)
103
, using 1,4-dibromobutane and 1,3-dibromopropane (Scheme 1.23). 
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3-Benzyl-1,2,3-benzotriazin-4(3H)-ones
104,105
 (72)  have been prepared by alkylation of the  
1,2,3-benzotriazin-4(3H)-one (65) with benzyl halides in  anhydrous DMF in the presence of  
potassium carbonate. Compound (74) was prepared by alkylation  of 1,2,3-benzotriazin-
4(3H)-one (65) with compound (73) under the same conditions, as shown in Scheme 1.24. 
 
Another method for the preparation of 3-substituted 1,2,3-benzotriazin-4(3H)ones involves 
the intermediate salt (76) which  was reacted with haloalkanes  to afford  3-substituted 1,2,3-
benzotriazin-4(3H)-ones (77)
106
 (Scheme 1.25). 
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3-aryl-1,2,3-benzotriazin-4(3H)-ones (78) were prepared from 1,2,3-benzotriazin-4(3)-one 
(65) and aryl halides
107
 in the  presence  of 10 mol % of various copper catalysts (CuI, CuBr, 
Cu2O, CuBr2, Cu) and K2CO3 (used to neutralize the released acid, HX) in DMF (Scheme 
1.26). 
 
1,2,3-Benzotriazin-4(3)-ones (63) react with alkynes such as diphenyl ethyne in the presence 
of a nickel (0)/phosphine catalyst to give substituted 1(2H)-isoquinolones (79)
108
(Scheme 
1.27). 
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1.4.1. Pyrrolobenzodiazepines. 
 
These heterocycles will also appear in the later discussion section. The pyrrolo[2-1-c][1,4] 
benzodiazepine (PBD) group of natural products includes tomaymycin
109
 (90), 
prothracarcin
110
 (91), sibanomicin
111
 (92), sibiromycin
109,112
 (89),  chicamycin
113
 A (96), 
neothramycins
114
 A (93) and B (94), DC-81
115
 (95), anthramycin
116 
(86), mazethramycin
117
 
(87) and  porothramycin
118 
(88),  as shown in Figure 1.10. 
 
 The PBDs are of interest because of their biological activity. The minor groove of DNA is 
the biological target, by interaction with an electrophilic carbinolamine or imine functionality 
at N10-C11 of the PBD. The resulting DNA adduct inhibits DNA replication and gives the 
PBDs potent antitumour antibiotic activity (see Figure 1.11)
118-122
. 
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1.4.2. Preparation of pyrrolobenzodiazepines (PBDs). 
 
Synthesise of compounds in the PBD class was involved: 1) seven membered cyclic dilactam 
reduction;
123-125
 2) reductive cyclization of an acyclic nitro aldehyde;
126,127
 3) cyclic 
iminothioether reduction;
124
 4) expansion of N-pentenylphthalimides by photochemical
128,129
 
means; 5) amino acetal cyclization;
130
 6) carbonylation of o-haloanilides catalyzed by 
palladium,
131-133
 and 7) azide based routes.
120
 
Azide based routes are relevant to the work in this thesis. In an azide based literature synthesis 
(Scheme 1.28), reaction of 2-azidobenzoyl chloride
134
 with L-prolinol gave the o-
azidobenzamide derivative (100). Oxidation of compound (100) with pyridinium 
chlorochromate (PCC) at room temperature gave aldehyde (101) in 81% yield. The 
iminophosphorane (102a) was prepared via the reaction between triphenylphosphine and 
compound (101) at 0 
o
C. Compound (102a) was converted to PBD (103) at room temperature 
in 1 hour. The formation of the alternative iminophosphorane (102b) was also used as the 
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more reactive tributylphosphine could be used at -10 
o
C with a short reaction time (30 min). 
This resulted in a more efficient cyclisation to give PBD (103).
120
 
An alternative route for the preparation of compound (103) used L-proline. Reaction of o-
azidobenzoyl chloride and L-proline gave the azidobenzamide (104) in 82% yield. The 
compound (104) was esterified into the methyl ester drivative (105) by methanol in 96% 
yield. Reaction of compound (105) with triphenylphosphine or tributylphosphine gave the 
iminophosphoranes (106) at ambient temperature. Reduction to the aldehyde with DIBAL and 
aza-Wittig cyclisation gave the PBD (103) in 57 % yield
120
. Alternatively, aza-Wittig 
cyclisation of (106a or b) gave iminoether (107) which was hydrolysed to the lactam (108a) 
[Scheme 1.28].
120
 
 
Chaper 1                                                                                                                                               Introduction 
28 
 
 
 
 
Chaper 1                                                                                                                                               Introduction 
29 
 
1.4.3. The Circumdatins. 
There is a large class of quinazolinobenzodiazepine natural products.
135,136
 Examples are 
circumdatins F and C (110 and 111), benzomavin A (112) and sclerotigenin (113). 
Circumdatins D-J (114-117) which have an additional tetrahydropyrrole ring as shown in 
Figure 1.12 below
137,138
, and are of great relevance to the pyrrolobenzodiazepine derivatives 
targeted in this thesis.  
 
 
1.4.4. Synthesis of Circumdatins. 
 
Circumdatin F (110)
139
 was obtained by treating precursor (120) with Sc(OTf)3 in DMF. 
Compound (120) was prepared by direct coupling of anthranilic acid with isatoic anhydride in 
heated water to make (119) in 87 % yield, which was converted to the methyl ester with a 
high isolated yield (80 %) in hot acidic methanol. Coupling with a Cbz-L-amino acid in the 
presence of EDC in DCM, and  hydrogenation  by catalytic Pd(OH)2 gave compound (120), 
as shown in Scheme 1.29. 
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In another route, shown in Scheme 1.30, reaction of the isatoic anhydride (66a) with L-
proline
140
 in DMSO at 140 
o
C afforded the corresponding the PBD (108a) with a high yield of 
91 %.  The PBD (108a) was treated with acid chloride (123a)
141
  in DMAC in the presence of 
DMAP and NEt3 to give the desired 2-nitrobenzamide (124a) in a yield of 82 %.  The 2-
nitrobenzamide (124a) was treated with excess acetic acid and zinc to give the desired 
circumdatin
142
 H (116) in high yield 72 %. The same approach was used to synthesise 
circumdatin J (117), also shown in Scheme 1.30. 
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1.4.5. The Fuligocandins 
Several new PBD compounds were isolated from the extract of the fruiting bodies of the 
myxomycete Fuligocandida. These compounds were the known cycloanthranilylproline 
(108a) and three unknown derivatives (126-128), which were named as fuligocandin A-C 
(Figure 1.13). 
 
Compound (126) was unstable and easily converted into compound (128). Compound (127) 
(Fuligocandin B) was isolated as a yellow pigment, which was found to be derived from 
condensation of an acetone and a cycloanthranilic acid and indole-3-carbaldehyde. 
 
1.4.6. Synthesis of Fuligocandins 
 
The synthesis of fuligocandins A and B has been reported, as shown in Schemes 1.31 and 
1.32. Thus, 1,3-dichloroacetone was reacted
143 
with triphenylphosphine and the product 
intermediate phosphonium salt was neutralized with a base to provide the desired ylidic 
product (130). Indole-3-carbaldehyde was coupled with benzensulfonyl chloride to give 
(132a) and with 4-nitrobenzenesulfonyl chloride to give (132b). The aldehydes (132a and 
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132b) were reacted with the phosphorus ylide via Wittig reaction to give indole derivatives 
(133a and 133b), as shown in Scheme 1.31. 
 
The synthesis continued as shown in Scheme 1.32. The reaction of isatoic anhydride with L-
proline in DMSO gave the pyrrolo-1,4-benzodiazepine derivative (108a). Compound (108a) 
was selectively thionated using the P2S5-Py2 complex to provide the known monothione 
(134). In the final reaction in this process, the monothione (134) was reacted with 
chloroacetone to give Fuligocandin A (128) via episulfide contraction. Fuligocandin B (127) 
was prepared by one–pot alkylation of the monothione with 133a or 133b and subsequent 
sulfur extrusion and deprotection. 
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In this final key step using sulfur extrusion, there is an episulfide contraction reaction driven 
by alkylation. The process begins by alkylation of thioamide (A) (Figure 1.14) with the 
enolizable halocarbonyl compound (B). Enolisation followed by electrocyclic  closure of  the 
enolate thiocarbonyl ylide of (C) gave the episulfide, which was converted to vinylogous 
amide (E), after desulfurisation  with trimethyl phosphite.
143
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1.5. Benzothiadiazepines. 
1.5.1. An introduction to benzothiadiazepines. 
Sultams of the benzothiadiazepines type are a key target in this thesis. The sultam moiety is 
the backbone of many heterocyclic compounds of pharmaceutical and synthetic 
importance.
144-146
 The sultam derivatives display potent activities such as antiblastic, 
apoptotic, antitumor and antihypertensive activities,
147-151
 and sulfonamides are well known in 
medicinal chemistry in general. This made us look at sulfonamide analogues of the 
pyrrolobenzodiazepines as potential biologically active molecules, and a brief introduction 
follows. 
Pyrrolo[1,2,5]benzothiadiazepine (140) was prepared by Artico as a non-nucleoside reverse 
transcriptase inhibitor, but did not display appreciable activity against HIV-1. Compound 
(141), however, was a useful inhibitor of reverse transcriptase.
152-154
 The same research group
 
have reported that compounds (142) and (143) have shown activity that is of interest in the 
potential treatment of chronic myelogenous leukemia.
155,156
  
 
Some typical published routes to these PBD thia analogues will now be reviewed as they are 
of interest in this thesis. For example, precursor (144) was obtained by reacting an aryl 
sulfonyl chloride with a pyrrolo ester analogue. Reduction of the nitro ester (144) with iron in 
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acetic acid gave the corresponding amino ester (145). Compound (146) was synthesized by 
intramolecular cyclisation of the amino ester in the presence of 2-hydroxypyridine as a 
bifunctional catalyst. Alkylation of compound (146) in the presence of potassium carbonate
152 
(shown in Scheme 1.33) gave a wide range of pyrrolobenzothiadiazepines (147a). 
 
The benzyl and cyclopropyl analogues (151) (Scheme 1.34) were obtained by 
intramolecular
152 
cyclization of the 1-(2-fluorobenzene-1-sulfonyl)-1H-pyrrole-2-(N-
cyclopropyl)carboxyamide (150) in the presence of sodium hydride (NaH) and cuprous 
iodide. The amide compound (150) was prepared by treating the acid (149) with 
cyclopropylamine in the presence of N-(3-dimethylaminopropyl)-N’-ethylcarbodiimide 
hydrochloride (EDC) and 4-dimethylaminopyridine (DMAP). Compound (149) in turn was 
prepared by alkaline hydrolysis of ester (148), which was prepared by reacting 2-
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fluorobenzenesulfonyl chloride with 2-ethoxycarbonyl-1H-pyrrole (as shown in Scheme 
1.34). 
 
 In another route, pyrrolidino derivatives (147b) were synthesized
152 
from 2-ethoxycarbonyl-
1-(2-nitrobenzenesulfonyl) pyrrolidine (152), which was reduced to the amino ester (153) 
with iron powder in glacial acetic acid. Intramolecular cyclization of compound (153) was 
done by heating in the presence of 2-hydroxypyridine. Alkylation with alkyl halides in the 
presence of potassium carbonate gave the saturated pyrrolidino derivatives (147b), as shown 
in Scheme 1.35.   
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1.5.2. Tetracyclic (PBDs) and (PBTDs). 
 
Another of the aims of this thesis is to make pyrrolobenzothiadiazepines with additional fused 
rings
120,157
. The analogous pyrrolobenzodiazepines have attracted interest in the literature as 
potential antitumour compounds (see above), neurological agents and protease 
inhibitors.
137,158,159 
 
The specific targets in this thesis are those formed by intramolecular azide 1,3-cycloaddition 
reaction, as shown in the Figure 1.16, and this work builds upon previous work in our 
research group.
160,161
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In the group previously
162
, 2-azidobenzenesulfonic acid or 2-azidobenzoic acid was converted 
to the corresponding acid chloride (as shown in Scheme 1.36) and coupled with L-prolinol  to 
give the alcohols (156a) and (100) in yields of 96 and 79 %, respectively. The alcohols were 
oxidised into the aldehydes (157a, 157b) by Swern oxidation or Dess-Martin periodinane. 
The conversion of the aldehydes (157a and 157b) into the alkynes (159a) and (159b) was 
achieved using the Bestmann-Ohira reagent (158). The alkynes (159a and 159b) could not be 
isolated, as they underwent cyclisation to form the triazoles (160a) and (160b)
163
, as shown in 
Scheme 1.36. 
 
It is relevant to note that Broginni
164,165 
showed that the (S)-N-Boc protected proline 
derivative  was reduced in the presence of DIBAL-H to give alkene (161) which was coupled 
to   2-nitrobenzoyl chloride to give the nitro compound (162).  Reduction of the nitro (162) 
with iron powder in acetic acid gave the corresponding amino compound (163).  Diazotisation 
with sodium nitrite and HCl followed by reaction with sodium azide afforded compound 
(164). The azide (164) gave stable triazoline (165) in carbon tetrachloride or toluene at 80 
o
C, 
as per Scheme 1.37.  
One of the aims of this thesis (see figure 1.16 and also Chapter 3) was to attempt the synthesis 
of the nitrile systems (Y = CN) and to explore the use of azide-nitrile reactions to make 
tetrazolo-fuzed systems. 
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Chapter 2: 
2. Results and Discussion: Multicomponent reactions (MCRs). 
2.1. Introduction. 
Multicomponent reactions (MCRs) are chemical methods in which three or more starting 
materials are converted in one chemical step to form a specific product.
166
 Nowadays MCRs 
are considered as a powerful tool for making target molecules of biological relevance 
efficiently, especially in drug discovery
167
. We decided to use o-azidobenzaldehyde (203) as a 
starting material in multicomponent reactions. The azide product was available from 2-amino 
benzyl alcohol. 
The azide groups offers extra reactivity, as azides have a lot of chemistry open to them. We 
looked to use 2-azidobenzaldehyde in MCR processes involving nitriles in the hope that, as 
the group had seen previously
168
, some interesting post-MCR azide-nitrile reactions would 
occur. The use of o-azidobenzaldehyde in multicomponent reactions has been explored by  
Ying Zhong, where reaction of o-azidobenzaldehyde, amine, isocyanide and carboxylic acid 
give the azide product (166) through the Ugi-four component condensation (Ugi-4CC).
169
 
Staudinger reaction and intramolecular aza-Wittig reaction gave 3,4-dihydroquinazolines 
(168) via diphenylmethyliminophosphorane (167) (Scheme 2.1 ). 
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The same group used 2-azidobenzaldehyde in a Ugi-three component reaction (U-3CR) with 
aniline, tert-butyl isocyanide and silica gel to make α-amino amidine azides (169). The azides 
could undergo an intramolecular cyclization with the secondary amine in which the α-amino 
amidine azide was converted into an amidino substituted indazole (170) (Scheme 2.2).
170
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2-Azidobenzaldehyde has also been used in the Passerini reaction
171 
with isocyanides and 
carboxylic acids by the same group to make α-acyloxy-carboxamide azides (171) as shown in 
Scheme 2.3. Using the Staudinger and intermolecular aza-Wittig reaction, the azides were 
reacted with triphenylphosphine to give 4H-1,3-benzoxazines (173) (Scheme 2.3).
171
  
Again using the Staudinger reaction, the de-acetylated product (174) was reacted with 
triphenyl phosphine to give iminophosphorane (175). The iminophosphorane (175) was 
reacted with isocyanate to give the diimide (176) which cyclised to give 2-amino-4-
aminocarbonyl substituted 4H-3,1-benzoxazines (177) (also shown in Scheme 2.3). 
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2-Azidobenzaldehyde has been also used in the Biginelli-three component reaction with ethyl 
accetoacetate and urea (or thiourea) in the presence of trimethylsilyl chloride as catalyst to 
make dihydropyrimidinone azide (178) (Scheme 2.4) which was reacted with 
triphenylphosphine to give iminophosphorane (179) via Staudinger reaction which was then 
treated with aromatic isocyanates or acid chlorides  in the presence of K2CO3 or Et3N to 
synthesise pyrimido[1,6-c]quinazolin-4-ones (180 and 181), via aza-Wittig reaction and 
cyclisation.
172
 
 
In our work, we selected known MCRs incorporating a nitrile and benzaldehyde and looked to 
replace benzaldehyde with o-azidobenzaldehyde to look, for the first time, at post-MCR azide 
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to nitrile cycloaddition. Some of the reactions investigated with o-azidobenzaldehyde gave the 
desired MCR and a new product with an azide and a nitrile but the azide did not react with the 
nitrile. Some of the attempted reactions resulted in the MCR stopping after one reaction 
between just two of the components. These processes are discussed in detail below, as either 3 
or 4 component MCRs. 
 
2.2. The use of three component MCRs 
2.2.1. Knoevenagel Condensation of Malononitrile with o-
Azidobenzaldehyde. 
 
 
Compound (206) was needed as a precursor for another MCR reaction (see next section). 
2-Azidobenzaldehyde (203) was condensed with malononitrile (205) in the presence of 
piperidine as an organic base. The mixture was heated at reflux for 1 hour.  Instead of the 
desired product (206), the tetrazoloquinoline (207) was isolated in 68 % yield. 
The structure of product (207) was confirmed by IR spectroscopy, and by its 
1
H NMR 
spectrum, 
13
C NMR spectrum, mass spectrometry and melting point. 
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The 
1
H NMR spectrum indicated the absence of the aldehyde (CHO) proton at 10.37 ppm 
with the appearance of the alkenyl (CH=C-CN) proton at 8.08 ppm.  
The 
13
C NMR spectrum showed the disappearance of the aldehyde carbon signal at 188.63 
ppm with the presence of the nitrile (CN) carbon signal at 114.04 ppm and the alkenyl 
(CH=C-CN) signal at 145.73 ppm. It was further determined that the compound contained a 
CN group from the peak at ʋmax 2200.0 cm
-1
 while IR also showed the absence of the azide 
absorption peak at ʋmax 2127.0 cm
-1
, in addition to the disappearance of the aldehyde (CHO) 
group at ʋmax 1735.0 cm
-1
. The correct measured mass of 196.0627 for the ion [M+H
+
] gave 
further evidence for the structure. This is a known molecule, although it is formed by a 
different route in the literature.
173
 
 
2.2.2. 3-(2-Morpholinoethylamino)-4-nitro-2,5-diphenylcyclopent-3-ene-1,1-
dicarbonitrile derivatives. 
This MCR (Scheme 2.6) was based on a previous reaction by Knight
174
 who had shown the 
reaction to work with β-nitrostyrene (X=H)175, 2-morpholinoethyl isocyanide and a range of 
easily synthesised benzylidenemalononitriles
176,177
. 
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182 X R
1
 R
2
 Yield Notes 
1 H H Cyclohexyl 0% No reaction 
2 H H CH2CH2-morpholino 45% Successful 
3 H o-N3 CH2CH2-morpholino 30% o-N3-pre-cyclised 
4 H p-Cl CH2CH2-morpholino 42% Successful 
5 N3 H CH2CH2-morpholino 89% Successful 
6 N3 p-Cl CH2CH2-morpholino 78% Successful 
7 N3 p-NO2 CH2CH2-morpholino 67% Successful 
8 N3 p-OCH3 CH2CH2-morpholino 20% Successful 
Table 2.1: Synthesis of cyclopentene Derivative (182) 
 
We repeated the Knight
174
 reaction successfully with the morpholino system (entries 2 and 4 
in Table 2.1) and then attempted it with the o-azido derivative of β-nitrostyrene in the hope 
that the product (182, X=N3)
162
 could undergo a post-MCR azide to nitrile 1,3-dipolar 
cycloaddition and hence form some novel highly functionalied tetrazolo systems. The 2-azido 
nitrostyrene was easily made from 2-azidobenzaldehyde and nitromethane as described 
previously
161
. Arylidene-malononitriles came from simple Knoevenagel condensation
176,177
. 
The formation of the desired (X = N3) 3-component MCR products was successfully achieved 
(see Table 2.1 entries 5-8) but none of the azido products (182) could be made to undergo 
tetrazole formation. When the azido group was on the malononitrile component (R
1
=o-N3) the 
system cyclised to give compound (207) before any MCR could occur as discussed above 
(Scheme 2.5).                                                                                                                 
 IR spectra, 
1
H NMR spectra, 
13
C NMR spectra, mass spectrometry and physical 
characteristics identified the new products (182, X = N3). In the IR-spectra, azido absorptions 
showed at around 2123.0-2128.5 cm
-1
 and strong nitro absorptions arose at around 1626.1-
1638.9 cm
-1
, in addition to cyano absorptions at around 2190-2251.5 cm
-1
, as well as the 
absorption band at 3300 cm
-1
 indicating the formation of the new NH group in the product. In 
the 
1
H-NMR spectra, the proton on the NH group appeared in the region of 9.72-9.86 ppm as 
a singlet and the protons of the cyclopentene ring appeared at around 4.76-5.76 ppm. As for 
13
C-NMR spectra, the most deshielded absorptions were observed for cyclopentene ring 
alkene carbons at around 156.58-158.13 ppm. The compounds synthesised previously (entries 
2 and 4 in Table 2.1) had data identical to that reported by Knight
174
 and other compounds 
gave fully consistent data (see experimental). 
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2.2.3. 5-Amino-2,3,7,7a-tetrahydro-1,3-dioxo-7-phenyl-1H-pyrrolo[1,2-
e]imidazole-6-carbonitrile derivatives. 
 
A. R=H (literature reaction) 
 
Reaction of hydantoin, benzaldehyde and malononitrile in water gave a product which was 
isolated from the reaction mixture by filtration and washed with PE/EtOAc (60 %). The 
structure of the product (231, R=H) was confirmed by IR, 
1
H-NMR spectroscopy, 
13
C-NMR 
spectroscopy, mass spectrometry and physical characteristics. With benzaldehyde (R=H) this 
is a known  literature 3-component MCR
178
, and data was fully consistent with that reported 
in the literature
178
.  
B. R=N3 (new reaction) 
 
Reaction of hydantoin, 2-azidobenzaldehyde and malononitrile in water under the same 
conditions gave a new product. After completion of the reaction which was monitored by 
TLC at regular intervals, a different product was identified to that predicted from the model 
reaction with benzaldehyde. Instead of the expected poly-substituted cyclopentene (232), the 
tricyclic tetrazole (233) was isolated.  
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In this case, it is assumed that reaction of o-azidobenzaldehyde and malononitrile formed a 
product before any reaction involving the hydantoin could occur. Compound (233) was 
formed in 34 % yield. 
 
The structure of compound (233) was deduced from its IR spectrum, 
1
H NMR spectrum, 
13
C 
NMR spectrum and mass spectrometry. IR spectroscopy showed the presence of a peak at 
1703.0 cm
-1 
(C=O) and an amide NH2 at 3385.4 cm
-1
. IR confirmed that both the azide and 
the nitrile were not present. 
1
HNMR spectroscopy also confirmed the structure of the product 
(233). A broad singlet at 8.33-8.49 ppm showed the 2 protons of the NH2 group and a 
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multiplet at 8.67-7.89 ppm appeared for the 4 protons of the aryl group and at 8.96 ppm one 
proton confirmed the alkene CH group. 
13
C NMR spectroscopy also confirmed the structure 
of the product (233) with the correct number of C, CH plus the carbonyl group at 162.44ppm. 
The structure of the product (233) was confirmed by mass spectrometry. 
Compound (233) did not react with hydantoin (confirmed by a test reaction) and hence the 
reaction stopped at this point. The product forms due to condensation, 1,3-dipolar 
cycloaddition [to give compound (207) again] and then hydrolysis of the remaining nitrile 
under the aqueous reaction conditions. 
It was thought that water as solvent had hydrolysed the nitrile to the amide. Thus, this reaction 
also was attempted with dry ethanol and acetonitrile as solvents. This was successful and gave 
the non-hydrolysed compound (207) this time in 76 % yield. The absence of water meant that 
hydrolysis did not occur, allowing the nitrile to be isolated. The data for compound (207) was 
identical to that in section 2.2.1, above. 
 
Reaction of 2-azidobenzaldehyde and malononitrile in water also gave the hydrolysed product 
(233), showing that the hydantoin is not required. The nitrile (207) underwent easy hydrolysis 
to give the amide (233).  
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2.2.4. 2-Phenyl-2-(phenylamino)acetonitrile derivative. 
 
 
Three component reactions of benzaldehyde, amines and trimethylsilyl cyanide (TMSCN) in 
the biphasic system (toluene/H2O = 10/1) tetrabutylammonium bromide (TBAB), sodium 
bicarbonate and Oxone was claimed in the literature to allow oxidation of the aminonitrile to 
the iminonitrile.
179
 With aniline and benzaldehyde, however, we could only isolate the 
“Strecker” product-aminonitrile (240), a well-known product.180  
When these conditions were applied to 2-azidobenzaldehyde and aniline (Scheme 2.12), we 
also isolated the “non-oxidised” aminonitrile (242). 
 
 
 
In the IR spectrum, the nitrile group was seen at 2190.4 the azido group absorption band 
appeared at 2121.9 cm
-1
. The structure of the product (242) was confirmed by its 
1
H NMR 
spectrum, in which the NH group showed at 8.70 ppm and the CH was seen at 4.06 ppm. In 
the 
13
C NMR spectrum, the same non-aromatic CH group was seen at 45.99 ppm. The 
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structure of the product was confirmed by mass spectrometry, in which the molecular mass of 
the compound was equal to 250.1092 g/mol (M+H
+
).  
When heated in toluene for 4 days at reflux, compound (242) was stable, but in xylene at 
reflux for 4 days, the compound unexpectedly gave the known
181
 indazole (250) in 50 % 
yield. Similar indazoles, formed by azides reacting with imines, were also reported by 
Sagar
170
 (see Scheme 2.2, above) 
 
As shown above in Scheme 2.13, this reaction might occur by loss of HCN, loss of N2 and 
then nitrene formation and then nitrene insertion into the imine and to give compound 
(250)
181
. As this reaction looked to be interesting two other precursors were synthesised as 
shown below (Scheme 2.14 and Scheme 2.15): 
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The structure of these products was confirmed by IR spectroscopy, 
1
H NMR spectroscopy, 
13
C NMR spectroscopy and mass spectrometry. The effects of heat on compounds (248) and 
(245) were investigated but neither of them formed an indazole or any other recognisable 
product. 
 
2.2.5. 3,3-Dicyano-N-alkyl-2-arylpropanamide derivatives. 
 
 
 
The Ugi reaction of isocyanide, aldehyde, acetic acid, and malononitrile gave 3,3-dicyano-N-
alkyl-2-arylpropanamide derivatives in good yield in ethanol as a solvent at 70
o
C. Two 
carbon-carbon bonds and one amide group were formed by this reaction. In the literature
182
, 
the role of the carboxylic acid in this reaction is to trap the nitrilium intermediate, and to 
activate the aldehyde and intermediate alkene toward nucleophilic attack as shown in Figure 
2.1. The literature reaction (R=H) was repeated to make sure that the chemistry worked before 
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trying it with the azide (R=N3). Compound (252a) was successfully synthesised in  71 % yield 
with data identical to that reported in the literature.
182
  
 
 
This reaction was repeated with 2-azidobenzaldehyde but was unsuccessful. The reaction was 
monitored by TLC at regular intervals and a different product (253) was identified, along with 
the aldehyde condensation then cycloaddition product (207)  (see Scheme 2.17). 
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It was also found that compound (253) could be formed by leaving out the aldehyde. The 
structure of compound (253) was deduced from its IR spectrum, 
1
H NMR spectrum, 
13
C NMR 
spectrum, and mass spectrometry. Molecular ion peak at 198.1008 g/mol (M+Na
+
) was 
displayed by the mass spectrum of this compound as expected. In the 
1
H NMR spectrum, 
there was a singlet for the alkene proton (7.41 ppm), a multiplet for the C-NH (6.99-7.05 
ppm) and a multiplet for the cyclohexyl ring protons at around 1.13-1.95 ppm. In the 
13
C 
NMR spectrum, the most deshielded peak was observed for the alkene carbon at 158.88 ppm. 
In the IR spectrum, the absorption band at 3277.2 cm
-1
 indicated the formation of the new NH 
group in the product and the CN group appeared at 2204.4 cm
-1
. Product (253) can be formed 
from attack of the anion of (205) on the isocyanide, protonation and then tautomerism to the 
conjugated (253). 
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2.2.6. Synthesis of 4-(cyclohexylamino)-2,5-diphenylcyclopentane-1,1,3,3-
tetracarbonitrile. 
 
 
The three component reaction of benzaldehyde, isocyanocyclohexane and malononitrile with  
DABCO as a catalyst proceeded as reported in the literature and gave the reported product 
(257) in 56 % yield, with melting point, IR spectrum, 
1
H NMR spectrum, 
13
C NMR spectrum 
and mass spectrometry all in agreement with that reported in the literature
183
 and entirely 
consistent with the structure.  
We attempted the same reaction with o-azidobenzadehyde. The desired product (258, Scheme 
2.19) could  not be identified, and no other products could be identified. 
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2.3. The use of four component MCRs 
2.3.1. Dihydropyridine derivative. 
 
The reaction of benzaldehyde (Scheme 2.20, R=H), aniline, dimethyl acetylene dicarboxylate 
and malononitrile gave dimethyl-6-amino-5-cyano-1,4-diphenyl-1,4-dihydropyridine-2,3-
dicarboxylate  in good yield. This was a literature reaction
184
 that was repeated to confirm the 
chemistry before it was attempted with o-azidobenzaldehyde (R=N3). 
 
When the reaction was attempted with 2-azidobenzaldehyde, it was unsuccessful. The 
reaction was monitored by TLC at regular intervals and a new product was identified, but was 
found (again) to be compound (207) which caused the reaction to stop before any MCR could 
take place, a reaction observed several times already in this chapter. 
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Compound (207) did not react with aniline and dimethylacetylene dicarboxylate, the other 
components present in this reaction mixture. 
 
2.4. Conclusions. 
The formation of compound (207) proved to be a problem with respect to MCRs and this 
along with other priorities brought this part of the work to an end. The fact that azide to cyano 
cycloaddition to form (207) did occur was a good result, although other cyano-azides (when 
the MCR did work) did not cyclise. The unexpected indazole formation is being explored 
further. With these two exceptions, and despite having made some new azides using MCRs, 
the chemistry explored in this chapter proved unsuccessful in terms of post-MCR azide to 
nitrile cycloadditions. 
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Chapter 3: 
3. Results and Discussion: Triazolo and tetrazolobenzothiadiazepines and 
benzodiazepines. 
 
In this section of the research the aim was to synthesise triazolo- and tetrazolo- benzothiadia-
zepines. These compounds were of great interest as synthetic targets due to their potential 
biological activity.  
Our project investigated preparing triazolo and tetrazolo analogues via the intramolecular 1,3-
dipolar cycloaddition between an azide moiety and an alkyne or nitrile. 
 Schemes 3.1- 3.3 summarises the chemistry that will be presented in this chapter, with 
Section 3.1.1 looking at triazoles and Section 3.1.2 at tetrazoles.  
In Scheme 3.1, the aldehydes (184) are to be converted to alkynes (185) using the Bestmann – 
Ohira reagent and then cyclised to the triazoles (186). 
 
In Scheme 3.2, aldehydes (184) are to be converted into oximes (187) and then are to be 
converted into nitrile compounds (188) via dehydration. 1,3-Dipolar cycloaddition of the 
azide group and nitriles could then be explored. 
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The convertion of the alcohols (183) into tosylates and then into nitriles (191) by reaction 
with sodium cyanide, allowing further azide to nitrile reactions, as shown in Scheme 3.3. will 
also be discussed. 
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3.1. The synthesis of triazolobenzothiadiazepines. 
3.1.1. Synthesis of  triazolopyrrolobenzothiadiazepine. 
3.1.1.1. (S)-[1-(2´-Azidobenzenesulfonyl)pyrrolidin-2-yl] methanol. 
 
 
This route started by the reaction of L-prolinol with the 2-azidobenzenesulfonyl chloride. The 
sulfonic acid
185
 (155a) was synthesised and converted to the sulfonyl chloride by heating at 
reflux with (COCl2) in DCM and DMF.
186
 The sulfonyl chloride was coupled with prolinol in 
an aqueous solution of potassium carbonate as the base giving the alcohol (156a) in good 
yield (72 %). 
The structure of the product (156a) was confirmed by its IR spectrum, 
1
H NMR (400 MHz) 
spectrum, 
13
C NMR (100 MHz) spectrum and mass spectrometry, and was identical to that 
synthesised by this same route in the group previously.
160
 A sample of compound (156a) was 
required in order to compare it to the same alcohol made by another (novel) route as discussed 
in the next section.  
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3.1.1.2. An Alternative Method for the Synthesis of Alcohol (298). 
3.1.1.2.1. Synthesis of 2-azido-N-(pent-4-en-1-yl)benzenesulfon-amide. 
 
 
The sulfonamide
161
 (301) was treated with 5-bromo-1-pentene in MeCN in the presence of 
pyridine. The mixture was heated to reflux under a nitrogen atmosphere for 72 hours. The 
desired product was isolated in a low 8 % yield as a light yellow oil. Attempts to improve the 
reaction yield were unsuccessful (MeCN, DMSO, Et3N, DMAP in many combinations). 
The structure of the product (303) was confirmed by spectroscopic analysis. The 
1
H NMR 
spectrum showed the presence of the proton on the NH group in the compound at 4.88-4.96 
ppm. The appearance of four downfield signals for four aromatic protons as a multiplet at 
7.18-7.24 (2H) ppm, a triplet of doublets at 7.53 (1H) ppm and a doublet of doublets at 7.91 
(1H) ppm indicated the presence of the aromatic ring. The six aliphatic protons were seen 
upfield as a quintet at 1.52 (2H), a quartet at 2.00 (2H) and a quartet at 2.83 ppm (2H). The 
alkene protons appeared downfield at 4.88-4.96 ppm for (=CH2) and 5.59-5.70 ppm for 
(CH=). 
The 
13
C NMR (100 MHz) spectrum showed the three aliphatic CH2 carbons at 28.66 (CH2), 
30.67 (CH2) and 42.79 (CH2) ppm. The appearance of five CH signals at 119.36, 124.91 
130.76, 133.96 and 137.19 ppm and the sp
2 
CH2 carbon at 115.62 ppm confirmed the 
structural assignment. 
It was determined that the product contained the NH stretching absorption peak at ʋmax 3299.5 
cm
-1
  in the infrared spectrum and the presence of the absorption peak at ʋmax 2133.4 cm
-1
 for 
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N3 group confirmed that the azide was still present. Mass spectrometry further supported the 
structure of product with measured mass of 289.0730 for the ion [M+Na]
+
 for required mass 
of 289.0730. 
 
3.1.1.2.2. Synthesis of {1-[(2-azidophenyl)sulfonyl]pyrrolidin-2-yl}methanol. 
 
 
The aim of this section was to investigate a new route to the alcohol (156a) using 
intramolecular aminohydroxylation of the N-alkenylsulfonamide via an inorganic oxidant 
under heavy metal-free conditions, a reaction that was reported in the recent literature with 
non-azide compounds.
187
  
The N-alkenylsulfonamide was treated with Oxone (KHSO5) in a mixture of MeCN and H2O 
in the presence of TsOH-H2O as Brønsted acid at room temperature. The desired product was 
obtained in excellent yield (95 %) as a yellow oil. 
The structure of the product was confirmed by its IR spectrum, 
1
H NMR (400 MHz) 
spectrum, 
13
C NMR (100 MHz) spectrum and mass spectrometry, and the data was identical 
to that obtained from L-prolinol in the section above. The L-prolinol derived sample above is 
a single enantiomer. This sample is racemic. 
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3.1.1.2.3. Synthesis of 2-azido-N-(but-3-en-1-yl)benzenesulfonamide. 
 
The reaction of 2-azidobenzenesulfonic acid with (COCl)2 in DCM in the presence of DMF 
gave the sulfonyl chloride. The sulfonyl chloride was coupled with 3-buten-1-amine in a 
mixed phase reaction using K2CO3 as the base. The desired product (304) was isolated in 78 
% as a pale yellow oil. The structure of the product was deduced from its IR spectrum, 
1
H 
NMR spectrum, 
13
C NMR spectrum and mass spectrometry, which were fully consistent  with 
the assigned structure.  
 
3.1.1.2.4. Attempted synthesis of {1-[(2-azidophenyl)sulfonyl]-azetidin-2-
yl}methanol. 
 
 
The N-alkenylsulfonamide was treated with Oxone (KHSO5) in a mixture of MeCN and H2O 
in the presence of TsOH-H2O as Brønsted acid at room temperature. The reaction was 
unsuccessful and no significant or identifiable product was obtained.  
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3.1.1.2.5. Synthesis of  2-azido-N-(pent-4-en-1-yl)benzamide. 
 
The reaction of 2-azidobenzenesulfonic acid with (COCl)2 in DCM in the presence of DMF 
gave the acid chloride. The acid chloride was coupled with 5-amino-1-pentene
188
 in a mixed 
phase reaction using K2CO3 as the base. The desired product (310) was isolated in 72 % as a 
yellow oil.  
The structure of the product was deduced from its IR spectrum, 
1
HNMR spectrum, 
13
CNMR 
spectrum and mass spectrometry. In the 
1
H NMR spectrum, the four aromatic protons showed 
as a doublet of doublets at 7.10 (1H) ppm, a triplet of doublets at 7.14 (1H) ppm and a triplet 
of doublets at 7.40 (1H) ppm which confirmed the 1,2-disubstitution pattern on the benzene 
ring system. The NH was found at 8.04 ppm. The six aliphatic protons appeared upfield as a 
quintet at 1.66 (CH2), quartet at 2.09 (CH2) and a multiplet at 3.37-3.42 (2H). The alkene 
protons were seen downfield at 4.92 ppm for (=CHH), 4.99 ppm for (=CHH) and 5.70-5.82 
ppm for (CH=). 
In the 
13
C NMR (100 MHz) spectrum, the three aliphatic CH2s carbons showed at 28.64 
(CH2), 31.25 (CH2) and 39.54 (CH2) ppm and showed the appearance of the carbonyl carbon 
at 164.58 ppm. The appearance of five CH signals at 118.37 (CH), 125.17 (CH), 132.17 (CH), 
132.19 (CH) and 137.79 (CH) ppm and the sp
2
 CH2 at 115.22 ppm completed the assignment. 
It was determined that the product contained the NH stretching absorption peak at ʋmax 3293.9 
cm
-1
, a peak at ʋmax 1712.4 cm
-1
 for C=O  and a peak at ʋmax 2124.9 cm
-1
 for the N3 group in 
the IR spectrum. Mass spectrometry further supported the structure of product with a 
measured mass of 231.1238 for the ion [M+H]
+
 for a required mass of 231.1240. 
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3.1.1.2.6. Attempted synthesis of (2-azidophenyl)(2-(hydroxymethyl) 
pyrrolidin-1-yl)methanone. 
 
 
The N-alkenylcarbonamide (310) was treated with Oxone (KHSO5) in a mixture of MeCN 
and H2O in the presence of TsOH-H2O as Brønsted acid at room temperature.  
The reaction mixture was purified by using column chromatography. Instead of the desired 
product (100), compound (306b) was isolated in reasonable yield (60 %) as a yellow oil. This 
is the product of alkene reaction with oxone and not aminohydroxylation. 
The structure of the product (306b) was implied by its IR spectrum, 
1
H NMR spectrum, 
13
C 
NMR spectrum and mass spectrometry. The 
1
H NMR spectrum showed the eight upfield 
aliphatic CH2 protons at 1.50-1.99 (4H) and 3.32-3.56 (4H) and the single CH at 3.76-3.83 
ppm. The presence of the proton on NH was noted at 7.51 ppm.  The aromatic protons were 
downfield at 7.12 (1H), 7.16 (1H), 7.42 (1H) and 8.03 (1H) giving a pattern of d, dd, dd and d 
consistent with a 1,2-disubstituted benzene ring system. The disappearance of the alkene 
protons present in compound (310) was also noted. 
The 
13
C NMR spectrum showed the four (CH) aromatic carbons downfield at 118.42, 125.22, 
132.17 and 132.37 ppm. The presence of four aliphatic CH2 at 25.93, 32.12, 50.24 and 67.04 
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(O-CH2) together with the CH at 58.24 ppm supported the structural assignment. The IR 
spectrum showed a peak at ʋmax 2125.8 cm
-1
 for N3 stretch. The NH stretching absorption 
peak appeared at ʋmax 3360.0 cm
-1
. The correct measured mass 326.0378 for the ion [M]
+
 
gives further evidence for the structure. 
It should be noted that a genuine sample of compound (100) was made from 2-azidobenzoyl 
chloride and proline and this give very different spectroscopic data to that seen for compound 
(306b) 
 
3.1.1.3. (S)-[1-(2´-Azidobenzenesulfonyl)pyrrolidin-2yl]carbaldehyde. 
Chambers
160,163
 had already converted enantiopure (156a) into (157a) and then into the alkyne 
and triazole. We repeated this with the racemic sample in order that both were available for 
biological testing. 
 
The alkyl alcohol was converted to the aldehyde by oxidation reaction under nitrogen to yield 
the aldehyde. This reaction worked in 96 % yield. 
This method was that of the Swern oxidation
189
 which uses (COCl)2 and DMSO, for which 
the mechanism is  given below. 
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The structure of compound (157a) was deduced from its IR spectrum, 
1
H NMR (400 MHz) 
spectrum, 
13
C NMR (100 MHz) spectrum and mass spectrometry, and was identical to that 
reported previously in the group by Chambers
160
.  
 
3.1.1.4. Pyrrolo[1,2-b][1,2,3]triazolo[5,1-d][1,2,5]benzothiadiazepine 8,8-
dioxide. 
 
 
 The next reaction in the synthesis was to convert the aldehyde (157a) into the triazole (160a). 
This reaction was performed using the Bestmann-Ohira reagent which was prepared freshly in 
two steps. 
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To make the Bestmann-Ohira reagent tosyl chloride was reacted with sodium azide (forming 
in-situ the sulfonyl azide) and then reacted with dimethyl (2-oxopropyl) phosphonate to give 
the Bestmann-Ohira reagent as shown in Scheme 3.14. All spectroscopic data for this reagent 
agreed with the literature
190
. 
 
The reagent was reacted with the aldehyde and converted it into the alkyne by reaction in a 
basic solution of potassium carbonate in methanol. 
The proposed mechanism for the formation of the alkyne
191
 moiety is shown in Figure 3.2. 
 
In our case, as with Chambers,
160,163
 the alkyne product (159a) was not isolated. The alkyne 
reacted with the azide and underwent a 1,3-dipolar cycloaddition to form the desired triazole 
product (160a) in 70 % yield. 
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The structure of compound (160a) was deduced from its IR spectrum, 
1
H NMR (400 MHz) 
spectrum, 
13
C NMR (100 MHz) spectrum and mass spectrometry, and was identical to that 
reported by Chambers in the group previously. 
Again, it is worth noting that the Chambers sample was derived from L-proline and was 
enantiopure. Triazole (160a) here is racemic. The synthesis of this was useful for biological 
testing and was useful as a test reaction before looking at some new molecules. 
 
 
3.1.2. The synthesis of other triazolobenzothiadiazepines. 
3.1.2.1. Coupling of the sulfonic acid with secondary amine alcohols. 
 
Having successfully repeated Chambers’ work, the scope of the intramolecular azide – alkyne 
1,3-dipolar cycloaddition was next explored. This started with some other secondary amino 
alcohols. Chambers had only looked at other naturally occurring amino acid derived 
systems.
160,163
 
 
The reaction of 2-azidobenzenesulfonic acid (155a) with oxalyl chloride in DCM in the 
presence of a drop of DMF gave a sulfonyl chloride which was coupled with the 2-piperidine 
methanol in a mixed phase reaction using potassium carbonate as the base. The isolated 
product was the alcohol (262) in 85 % yield. 
The structure of compound (262) was deduced from its IR spectrum, 
1
H NMR (400 MHz) 
spectrum, 
13
C NMR (100 MHz) spectrum and mass spectrometry. 
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It was determined that the compound contained a hydroxyl group from the peak at ʋmax 3521.2 
cm
-1
 and a peak at ʋmax 2097.7 cm
-1
 confirmed the azide group  in the IR spectrum.  
The 
1
H NMR spectrum showed a multiplet at 4.04-4.09 ppm for the hydroxyl group and the 
alcohol methylene was found at 3.77-3.88 ppm. The four aromatic protons were downfield at 
7.22 (1H), 7.29 (1H), 7.57 (1H) and 7.99 (1H) ppm giving a pattern of dd, d, dd and d 
consistent with a 1,2-disubstituted benzene ring system. The eight aliphatic CH2 protons were 
upfield at 1.69-1.59 (5H), 1.69 (1H), 3.10 (1H) and 3.55-3.61 (1H) and the single CH  was 
seen at 2.41 ppm. 
The 
13
C NMR (100 MHz) spectrum showed the six aromatic carbons at 119.95 (CH), 124.63 
(CH), 130.90 (qC), 131.48 (CH), 133.87 (CH) and 137.83 (qC) and the four CH2 and single 
CH in piperidine ring system were upfield at 18.95 (CH2), 24.91 (CH2), 25.29 (CH2), 41.30 
(CH2) and 54.38 (CH). 
The correct measured mass 297.1024 for the ion [M+H]
+
 gives further proof for the structure. 
The same strategy was next applied to other secondary amino alcohol derivatives, and the 
structures and yields are summarised in Table 3.1 with spectroscopic data summarised in 
Table 3.2. 
 
No 
Secondary 
amine alcohol 
Products Appearance %, Yield 
1 
 
2-piperidinemethanol 
 
yellow oil 85 
2 
 
2-(benzylamino)ethanol 
 
brown solid, 
(93-95 
o
C) 
88 
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3  
2-(methylamino)ethanol 
 
yellow oil 90 
4 
 
2-piperidineethanol 
 
orange oil 82 
5  
4-(ethylamino)-1-butanol 
 
brown oil 75 
6 
 
3-(benzylamino)-1-propanol 
 
dark brown oil 86 
7 
 
 
4-piperidinemethanol 
 
brown oil 
 
70 
Table 3.1: Synthesis of sulfonamides with primary alcohol substituents. 
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No. Products 
NMR (400 MHz, CDCl3, ppm) 
IR (cm
-1
) 
HRMS 
1
H NMR
 13
CNMR
 
OH CH2OH CH2OH N3 OH 
1 
 
2.41 
3.77-
3.88 (m) 
60.53 2097.7 
3521.2 
(bs) 
297.1024 
[M+H]
+ 
[Calc.= 
297.1016] 
2 
 
2.22 
(bs) 
3.49 
(br.s) 
60.74 2101.1 
3359.0 
(bs) 
333.1016 
[M+H]
+ 
[Calc.= 
333.1016] 
3 
 
2.19 
(br.s) 
3.71 (t) 60.43 2099.4 3516.1 
257.0703 
[M+H]
+ 
[Calc.= 
257.0703] 
4 
 
2.84 
(br.s) 
3.63-
3.73 (m) 
58.58 2097.4 3537.1 
311.1167 
[M+H]
+ 
[Calc.= 
311.1172] 
5 
 
2.23-
2.33 
(m) 
3.56-
3.58 (m) 
60.07 2098.4 3527.0 
299.1166 
[M+H]
+ 
[Calc.= 
299.1172] 
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6 
 
2.18 
(bs) 
3.55-
3.57 (m) 
58.75 2101.2 3542.4 
347.1166 
[M+H]
+ 
[Calc.= 
347.1172] 
7 
 
2.68 
(bs) 
3.81 (d) 66.83 2127.6 3517.0 
297.1026 
[M+H]
+ 
[Calc.= 
297.1016] 
Table 3.2: Charateristic spectroscopic data for the primary alcohols. 
 
 
3.1.2.2. Synthesis of the aldehydes. 
 
 
The alcohols in Tables 3.1 and 3.2 were converted into the aldehydes by oxidation reaction 
under nitrogen. Although many oxidation methods are known, our attempts used the Dess-
Martin periodinane reagent
192
 and the Swern oxidation. 
All oxidation reactions were successful and yields and key spectroscopic data are recorded in 
Table 3.3 and 3.4, respectively. The mechanism
193
 of the Dess-Martin process is given  in 
Figure 3.3. The Swern mechanism was done above in Figure 3.1. 
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No Starting material Products Appearance 
%, 
Yield 
1 
  
Orange oil 76 
2 
  
White solid, 
(m.p.=111-113 
o
C) 
83 
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3 
  
deep brown  
oil 
76 
4 
 
 
Light yellow 
oil 
81 
5 
  
 
light yellow oil 
 
76 
6 
 
 
light yellow oil 77 
7 
  
Yellow oil 
 
92 
Table 3.3: Yield and appearance of the aldehydes. 
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No. Products 
NMR (400 MHz, 
ppm) IR 
HRMS 1
HNMR
 13
CNMR
 
CHO CHO N3 CHO 
1 
 
9.66 (s) 
(CDCl3) 
200.94 
(CDCl3) 
2098.8 1731.8 
317.0680 
[M+H]
+ 
[Calc.= 
317.0679] 
2 
 
9.34 (s) 
(CDCl3) 
197.87 
(CDCl3) 
2102.1 1715.6 
369.0420 
[M+K]
+ 
[Calc.= 
369.0418] 
3 
 
9.61 (s) 
(CDCl3)  
197.73 
(CDCl3) 
2100.3 1731.1 
277.0373 
[M+Na]
+ 
[Calc.= 
277.0366] 
4 
 
9.62 (t) 
(CDCl3) 
199.87 
(CDCl3) 
2099.4 1721.0 
331.0832 
[M+Na]
+ 
[Calc.= 
331.0825] 
5 
 
9.79 (s) 
(CDCl3) 
201.42 
(CDCl3)  
2098.1 1720.1 
297.1009 
[M+H]
+ 
[Calc.= 
297.1016] 
6 
 
9.53 (s) 
(CDCl3) 
200.12 
(DMSO-
d6) 
2100.0  1722.0 
345.1012 
[M+H]
+ 
[Calc.= 
345.1016] 
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7 
 
9.58 (s) 
(CDCl3) 
202.44 
(CDCl3) 
2098.6 1723.0 
295.0856 
[M+H]
+ 
[Calc.= 
295.0859] 
Table 3.4: Spectroscopic data summary for the aldehydes. 
 
 
 
 
3.1.2.3. Reaction of the aldehydes with Bestmann-Ohira reagent and 
attempted  triazole formation. 
The next set of reactions conducted was to convert the aldehyde moiety into the triazole via 
the alkyne. These reactions were performed using the Bestmann-Ohira reagent.  
In the case of aldehyde (263), the alkyne product was not isolated as the intermediate alkyne 
(269) underwent a spontaneous 1,3-dipolar cycloaddition to form the desired triazole product 
(270) in 71 % yield. 
 
The structure of compound (270) was deduced from its IR spectrum, 
1
H NMR (400 MHz) 
spectrum, 
13
C NMR (100 MHz) spectrum and mass spectrometry. 
The 
1
H NMR spectrum showed the disappearance of the CHO proton at 9.66 ppm. The 
piperidine ring CH2 protons showed upfield at 1.33-1.45 (1H), 1.60-1.79 (2H), 1.87-1.92 
(1H), 2.02-2.15 (2H), 3.73 (1H) and 3.86-3.89 (1H). The aromatic protons appeared as a 
Chaper 3                                                                                                                            Results and Discussion 
80 
 
triplet of doublets (td) at 7.58 (1H) ppm, a broad signal (br.s) at 7.68 (1H) ppm, a doublet of 
doublets (dd) at 7.75 (1H) ppm and a doublet of doublets (dd) at 7.93 (1 H) ppm which 
showed the 1,2-substitution pattern on the aromatic ring system. The appearance of a new 
aromatic proton was seen downfield as a doublet (d) at 9.97 (1H) ppm and consistent with 
triazole formation. 
The 
13
C NMR spectrum showed no carbon for the aldehyde carbonyl at 200.94 ppm. The 
appearance of five aromatic CH signals confirmed an extra aromatic CH carbon from the 
triazole formation with peaks at 125.02 (CH), 127.96 (CH), 129.70 (CH), 132.86 (CH) and 
134.48 (CH) ppm. The four CH2 and the CH of the piperidine ring system appeared upfield at 
23.67 (CH2), 25.07 (CH2), 29.42 (CH2), 48.80 (CH2), 52.25 (CH) ppm. Infrared spectral data 
proved that the azide was absent and also confirmed the disappearance of the carbonyl group 
peak at ʋmax 1731.8 cm
-1
. 
Further evidence for the structure was given by the HRMS for the measured ion [M+H]
+
 was 
consistent at 291.0910. 
The reaction of aldehydes (272) and (276) with the Bestmann-Ohira reagent gave the alkynes 
and again these reacted with the azide. The isolated products were the desired triazole 
products (274) and (278) (Table 3.5, below) in good yields of 73 % and 68 %, respectively. 
However, the reaction of aldehydes (280), (285) and (294) with Bestmann-Ohira reagent gave 
the three alkynes (281), (286) and (295) showing in these cases that the alkynes did not react 
with the azide to form the desired triazole product. The aldehyde (290) did not react with 
Bestmann-Ohira reagent and did not give the alkyne. Table 3.5 summaries the syntheses of 
triazolobenzothiadiazepines attempted in this thesis, and Table 3.6 summaries the 
spectroscopic data for compound (270), (274) and (278).  
 
No Starting material Intermediate products Desired products % 
1 
 
 
 
71 
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2 
  
 
73 
3 
  
 
68 
4 
  
No 0 
5 
  
No 0 
6 
 
No No 0 
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7 
 
 
No 0 
Table 3.5: Summary of Triazolobenzothisdiazepine reaction. 
 
 
 
Entry Desired Products 
NMR (400 MHz, CDCl3, ppm) 
HRMS 
1
H NMR
 13
C NMR
 
N-CH=C N-CH=C 
1 
 
7.68 (br.s) 136.53 
291.0909 
[M+H]
+ 
[Calc.= 
291.0910] 
2 
 
7.54 (m) 134.41 
327.0905 
[M+H]
+ 
[Calc.= 
327.1091] 
3 
 
7.68 (s) 133.15 
251.0612 
[M+H]
+ 
[Calc.= 
251.0597]
 
 
Table 3.6: Summary of Triazolobenzothiazepine data. 
 
 
Table 3.7 summarises the data obtained for the alkynes (281), (286) and (295). It is interesting 
that azide to alkyne cycloadditions only occurred in cases where 7-membered rings could 
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result. Alkynes (281) and (286) would give 8- and 9-membered rings and (295) would give a 
bridged 9-membered ring. It is possible that spontaneous 8- and 9- membered ring formation 
is not as favoured as 7-membered ring formation. 
No Products 
NMR (400 MHz, CDCl3, ppm) 
IR (cm
-1
) 
HRMS 
1
H NMR
 13
C NMR
 
-CCH -CCH -CCH N3 -CCH 
4 
 
1.84 (bs) 70.44 80.81 2099.6 
3307.
6 
305.1062 
[M+H]
+ 
[Calc.= 
305.1067] 
5 
 
1.87 (bs) 68.98 83.18 2101.1 
3281.
9 
293.1064 
[M+H]
+ 
[Calc.= 
293.1067] 
7 
 
2.03(bs) 70.23 85.55 2099.1 
3270.
0 
291.0910 
[M+H]
+ 
[Calc.= 
291.0910] 
Table 3.7: Summary of spectroscopic data for compounds 281, 286 and 295. 
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3.1.2.4. Attempted cyclization reaction with heating. 
 
 
In a further attempt to perform intramolecular cyclization of the alkynes (281), (286) and 
(295), compound (286) was heated to reflux in anhydrous chloroform for 3 days under a 
nitrogen atmosphere whilst being monitored by TLC which showed no change. The solvent 
was replaced with dry toluene and heated to reflux for 3 days. A different product was 
identified. Instead of the desired triazole product (287) the amine (288) (Scheme 3.18) was 
isolated: this is the product of azide reduction. 
The structure of compound (288) was deduced by its infrared spectrum, 
1
H NMR (400 MHz) 
spectrum, 
13
C NMR spectrum and mass spectrometry. 
The 
1
H NMR spectrum showed the presence of the characteristic amine NH2 proton signal as 
a broad singlet at 4.95 ppm while the alkyne CH proton was seen at 1.87 ppm.  
The 
13
C NMR (100 NMR) spectrum showed the presence of the alkyne carbons at 68.97 
(CCH) and 83.28 (CCH) ppm.  
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The infrared spectrum showed the disappearance of the azide stretch at ʋmax 2101.1 cm
-1 
and 
also showed the appearance of the NH2 group at ʋmax 3375.7-3485.8 cm
-1
. The alkyne (CH) 
absorption was present at ʋmax 2304.1 cm
-1
. 
Mass spectrometry further supported the structure of product with measured mass of 
267.1167 for the ion [M+H]
+
 for required mass of 267.1162. 
Attempts to thermally cyclise alkynyl azides (281) and (295) were also attempted but were 
unsuccessful. 
 
3.1.2.5. Cyclisation reaction under “click” conditions. 
 
 
One final attempt was made to cyclise the alkynyl azides (281), (286) and (295).   
In this attempt, the alkyne azides were treated with a solution of CuSO4.5H2O in the biphasic 
system t-BuOH/H2O as a solvent in the presence of sodium ascorbate.
194
 This method is that 
used for copper catalysed alkyne-azide cycloaddition (CuAAC) for which the mechanism
195
 is 
given below. This reaction is the well-known azide-alkyne “click” process. 
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The reaction was successful with compound (281) and gave the benzothiazocine (282) in 80 
% yield. Alkynylazides (286) and (295) did not react. 
The structure of the product (282) was confirmed by IR spectroscopy, its 
1
H NMR (400 MHz) 
spectrum, and 
13
C NMR (100MHz) spectrum and by mass spectrometry.  
The 
1
H NMR (400 MHz) spectrum showed the disappearance of the alkyne proton at 1.84 
ppm. The appearance of five aromatic protons confirmed an extra aromatic proton from the 
triazole with peaks as a multiplet at 7.55-7.59 (2H), a doublet at 7.63 (1H), a triplet of 
doublets at 7.68 (1H) and a doublet at 8.03 (1H) ppm. The piperidine ring CH2 protons 
showed upfield at 1.18-1.69 (6H, 3 x CH2), 3.51 (1H, NCHH) and 4.03-4.12 (1H, NCHH) 
and the CH in the piperidine ring system appeared at 2.68-2.71 ppm. The remaining 
(diazocine) CH2 was seen as two signals at 1.87/2.28 ppm. 
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The 
13
C NMR (100 MHz) spectrum showed the disappearance of the two alkyne carbons at 
70.44 (CCH) and 80.81 (CCH) ppm. The presence of five aromatic CH signals confirmed an 
extra aromatic (CH) carbon from the triazole formation in the 
13
C NMR spectrum with peaks 
at 127.65 (CH), 130.01 (CH), 130.30 (CH), 131.70 (CH) and 133.87 (CH) ppm. The extra 
aromatic quaternary carbon was seen at 133.93 ppm. The five CH2 and the CH signal were 
upfield at 18.32 (CH2), 23.07 (CH2), 24.79 (CH2) 32.38 (CH2), 41.22 (CH2) and 54.68 (CH) 
ppm. The infrared spectrum data proved that the azide absorption peak was absent and also 
confirmed the disappearance of the alkyne group absorption. 
Further evidence for the structure was given by the HRMS for the measured ion [M+H]
+
 at 
305.1063. 
 
 
 
 
 
 
Chaper 3                                                                                                                            Results and Discussion 
88 
 
3.2. The Synthesis of tetrazolobenzothiadiazepines. 
3.2.1. Synthesis of tetrazolopyrrolobenzothiadiazepine. 
3.2.1.1. (S)-Pyrrolobenzo[1,2-b]tetrazolo[5,1-d][1,2,5]thiadiazepine 9,9-
dioxide. 
 
The nitrile
186
 (337) was synthesised as described by Chambers
160
 in the group previously and 
was cyclised to give the tetrazole as also shown by Chambers. The synthesis and cyclisation 
of compound (337) were repeated to establish the process before moving onto new systems. 
Compound (338) was successfully formed in 60 % yield. 
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3.2.2. The synthesis of new tetrazolobenzothiadiazepines. 
The nitriles were made by oxime dehydration where the oximes came, in turn, from the 
aldehydes we had already synthesised, as discussed above. 
3.2.2.1. Conversion of the aldehydes into the oximes. 
 
 
Scheme 3.21 shows a typical example of this reaction. Oximes can exist as two stereo 
isomers, syn (Z) and anti (E) as shown
196
 
 
in Figure 3.5. 
 
Scheme 3.21 shows a typical example of this reaction. The mechanism
197
 is illustrated below 
(Figure 3.6),
 
and involves first addition of the aldehyde or ketone to hydroxylamine to form 
an unstable intermediate
198
. In the second step, the intermediate decomposes by loss of H2O 
giving the oxime. 
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The oximes synthesised in our work by reaction of aldehydes with hydroxylamine are 
summarised in Table 3.8.
 
No Starting material Products Appearance/m.p 
Yield  
% 
1 
  
Light yellow oil 68 
2 
  
White solid 
(m.p.=129-131 
o
C) 
96 
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3 
 
 
Light yellow  oil 78 
4 
  
Light yellow oil 88 
5 
 
 
 
light yellow oil 
 
92 
6 
 
 
yellow oil 93 
7 
 
 
White solid 
(m.p.= 151-153 
o
C) 
85 
Table 3.8: Oximes synthesis in this work 
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The structures of all oxime products were confirmed by spectroscopic means. The 
1
H NMR 
(400 NMR) spectrum of compound (314), for example, showed the absence of the 
characteristic aldehyde CH proton signal. The presence of the broad signal OH proton 
downfield at 9.01 ppm gave further evidence for the success of the conversion of the aldehyde 
to the oxime and also seen was the appearance of the CH=N proton as a doublet at 6.84 ppm. 
The appearance of four aromatic protons downfield as a doublet of doublets at 7.21(1H) ppm, 
a doublet at 7.28 (1H) ppm, a doublet of doublet of doublets at 7.57 (1H) and doublet of 
doublets at 7.96 (1H) ppm showed the expected pattern of a 1,2-disubstituted benzene ring 
system. The eight upfield aliphatic CH2 protons showed at 1.26 (1H), 1.36-1.42 (1H), 1.54-
1.62 (1H), 1.66-1.74 (3H), 2.12 (1H) and 3.16 (1H) ppm and the single CH proton in the ring 
system appeared at 3.93 (1H) ppm. 
The 
13
C NMR spectrum confirmed that the carbonyl carbon had disappeared from 200.94 
ppm and the new CHN signal appeared at 149.71 ppm. The presence of four aromatic CH 
signals at 119.85, 124.57, 131.42 and 134.02 ppm confirmed the structural assignment. 
The infrared spectrum showed the presence of the broad OH stretch at ʋmax 3244.5 cm
-1
 and 
showed the presence of the CH=N group at ʋmax 1471.5 cm
-1
. The azide was present at ʋmax 
2100.3 cm
-1
 and also noted was the disappearance of the carbonyl group peak at ʋmax 1731.8 
cm
-1
. 
Further evidence for the structure was given by the HRMS for the measured ion [M+Na]
+
 
which was consistent at 332.0788. 
The data for the oximes produced is shown in Table 3.9 in summary form. 
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No Products 
NMR (400 MHz, ppm) 
IR (cm
-1
) 
Mass 
1
H NMR
 13
C NMR
 
CH=N OH CHN N3 OH 
1 
 
6.84 
(d), 
(CDCl3) 
9.01 
(bs) 
149.71 
(CDCl3)  
2100.
3 
3244.5 
(br.) 
332.0788 
[M+H]
+ 
[Calc.= 
332.0788] 
2 
 
6.43 
(dd) 
(DMSO
-d6) 
11.1
4 
147.42, 
(DMSO-
d6) 
2098.
5 
3213.7 
346.0970 
[M+H]
+ 
[Calc.= 
346.0968] 
3 
 
7.31 (t), 
(CDCl3) 
8.77 
147.22 
(CDCl3)  
2129.
7 
3427.0 
270.0659 
[M+H]
+ 
[Calc.= 
270.0655] 
4 
 
6.55 (t), 
(CDCl3) 
8.75 
148.79 
(CDCl3) 
2098.
7 
3247.6 
324.1120 
[M+H]
+ 
[Calc.= 
324.0625] 
5 
 
7.34 (t), 
(CDCl3)  
8.26 
150.30 
(CDCl3) 
2098.
5 
3446.4 
312.1124 
[M+H]
+ 
[Calc.= 
312.1125] 
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6 
 
7.02 (t), 
(CDCl3)  
9.41 
148.49 
(CDCl3) 
2101.
2 
3258.9 
360.1120 
[M+H]
+ 
[Calc.= 
360.01125] 
7 
 
7.27 
(d), 
(CDCl3) 
9.58 
153.69 
(CDCl3) 
2097.
8 
3255.6 
310.0967 
[M+H]
+ 
[Calc.= 
310.0968] 
Table 3.9: Summary of oxime spectroscopic data. 
 
3.2.2.2. Conversion of the oximes into the nitriles. 
 
 
In the next reaction, nitriles were synthesised by the dehydration of the oximes. Many 
reagents are available for this process and an example is the use of BOP in combination with 
DBU.
199,200
 
In our work,  the oxime was reacted with (COCl)2 in the DCM in the presence of 1,8-
diazabicyclo[5.4.0]undec-7-ene (DBU) as the base. The mixture was heated to reflux while 
monitoring by TLC and the nitrile was isolated from the reaction by extraction with DCM. 
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The reaction was performed using diphenylcyclopropenone as a catalyst, and is based on 
interest in our group and others
201
 in the development of diphenylcyclopropenone as a reagent 
and catalyst. 
In this case, the nitriles (315), (318), (321), (324), (328), (331) and (334) were synthesised 
with yields shown in Table 3.10. 
No Starting material Products Appearance-m.p. 
Yield
% 
1 
  
Dark brown oil 86 
2 
  
Light yellow solid 
(m.p.=107-109 
o
C) 
 
84 
3 
 
 
Yellow  oil 71 
4 
 
 
Light yellow oil 81 
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5 
 
 
 
light yellow oil 
 
 
 
92 
6 
 
 
Bronze coloured 
solid 
(m.p.=78-80 
o
C) 
77 
7 
  
Light yellow oil 
 
85 
Table 3.10: Synthesis of nitriles from oximes. 
 
All the nitriles gave consistent spectroscopic data. With compound (315), for example, the 
1
H 
NMR spectrum showed the absence of the characteristic oxime hydroxyl OH proton and the 
disappearance of the CH=N proton. The eight upfield aliphatic CH2 protons showed at 1.46-
1.59 (1H), 1.61-1.71 (2H), 1.78-1.87 (2H), 1.91-1.96 (1H), 2.91 (1H) and 3.77 (1H) ppm and 
the single CH proton in the ring system appeared at 5.09 ppm. The presence of four aromatic 
protons downfield as a doublet of doublet of doublets at 7.18 (1H) ppm, a doublet at 7.25 
(1H) ppm, a doublet of doublet of doublets at 7.54 (1H) and a doublet at 7.87 (1H) ppm 
confirmed that the 1,2-disubstituted benzene ring system was still present.  
The 
13
C NMR spectrum showed the presence of the (CN) as a new quaternary carbon at 
116.35 ppm and confirmed that the CH=N signal had disappeared. The presence of four 
aromatic CH signals at 120.05, 124.05, 131.55 and 134.70 ppm and four aliphatic CH2 
carbons and the CH carbon at 20.01 (CH2), 24.93 (CH2), 29.63 (CH2), 43.49 (CH2) and 46.16 
(CH) ppm confirmed the assignment. 
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The infrared spectrum showed the disappearance of the broad OH stretch at ʋmax 3244.5 cm
-1
 
and showed the absence of the CH=N group at ʋmax 1471.5 cm
-1
. The azide absorption was 
present at ʋmax 2100.4 cm
-1
 and further proof came from a ʋmax of 2257.0 cm
-1 
for (CN). 
Mass spectrometry further supported the structure of the product with a measured mass of 
309.1140 for the ion [M+NH4]
+
 for required mass of 309.1128. 
The IR spectra, 
1
H NMR spectra, 
13
C NMR spectra, and mass spectrometry identified the 
other products, and the data obtained is summarised in Table 3.11. 
No Products 
13
C NMR 
(400 MHz, 
CDCl3, ppm) 
IR (cm
-1
) 
HRMS 
CN N3 CN 
1 
 
116.35 2100.4 2257.0 
309.1140 
[M+NH4]
+ 
[Calc.= 
309.1128] 
2 
 
114.29 2104.9 2248.8 
350.0685 
[M+Na]
+ 
[Calc.= 
350.0682] 
3 
 
114.50 2125.2 2261.1 
269.0812 
[M+NH4]
+ 
[Calc.= 
269.0815] 
4 
 
117.34 2098.5 2253.7 
323.1294 
[M+NH4]
+ 
[Calc.= 
323.1284] 
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5 
 
119.21 2099.0 2246.5 
311.1286 
[M+NH4]
+ 
[Calc.= 
311.1285] 
6 
 
117.34 2102.2 2250.7 
364.0836 
[M+Na]
+ 
[Calc.= 
364.0839] 
7 
 
120.58 2098.6 2254.0 
292.0857 
[M+H]
+ 
[Calc.= 
292.0863] 
Table 3.11: Summary of spectroscopic data for nitriles. 
 
 
 
3.2.2.3. Cycloaddition of the nitriles with azides. 
 
The intramolecular azide to nitrile reaction is shown in the following example: 
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This method is one of the most important synthesis routes to tetrazoles, as shown in figure 
3.7. 
 
The reaction mechanism is a straightforward [2+3] cycloaddition of nitrile to form a five 
membered tetrazole ring. 
With the azides (315), (318) and (321) expected benzothiazepine products (316, 319 and 322) 
were isolated in 68 %, 78 % and 89 %, respectively. However, none of the desired products 
could be identified and only starting material (324, 328, 331 and 334) could be identified in 
the other reactions attempted, as summarised in Table 3.12. 
No Starting material Products Appearance/m.p. % 
1 
  
White solid 
(m.p.= 179-181 
o
C) 
68 
2 
 
 
Light yellow oil 78 
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3 
  
Yellow  oil 89 
4 
 
No 
No 
 
0 
5 
 
No No 
 
0 
6 
 
No No 0 
7 
 
No 
No 
 
 
0 
Table 3.12: Synthesis of Tetrazoles. 
 
The structures of the products (316), (319) and (322) were confirmed through spectroscopic 
analysis. 
The 
1
H NMR spectrum of compound (316), for example, showed the eight upfield CH2 
protons at 1.43-1.50 (1H), 1.66-1.85 (3H), 2.24-2.32 (1H), 2.71-2.82 (2H) and 3.35-3.39 (1H) 
ppm and the single CH proton in the thiadiazepine ring system at 5.23 (1H) ppm. The 
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presence of four aromatic protons at 7.67 (1H) ppm, 7.84 (1H) ppm, 8.16 (1H) and 8.47 (1H) 
ppm confirmed the 1,2-disubstituted benzene ring system.  
The 
13
C NMR spectrum showed the absence of the (CN) carbon at 116.35 ppm and the 
appearance of seven aromatic carbon signals confirmed the extra sp
2
 carbon of the tetrazole 
ring with signals at 124.48 (CH), 129.46 (CH) 129.74 (CH), 130.37 (qC), 130.67 (qC), 134.64 
(CH) and 154.24 (qC) ppm while the four aliphatic CH2 carbon signals and CH carbon signal 
of the piperidine ring system appeared at 20.62 (CH2), 24.27 (CH2), 28.97 (CH2), 45.37 (CH2) 
and 51.81 (CH) ppm. 
The IR spectrum confirmed the loss of the azide group at ʋmax 2100.4 cm
-1
 and the absence of 
the nitrile group at ʋmax 2257.0 cm
-1
. 
Mass spectrometry further supported the structure of product with a measured mass of 
292.0866 for the ion [M+H]
+
 for a required mass of 292.0863. 
The other structures were confirmed in the same manner with IR spectroscopy, 
1
H NMR 
spectra, 
13
C NMR spectra and mass spectrometry all being consistent (Table 3.13). 
 
No. Products 
13
C NMR 
(400 MHz, CDCl3, ppm) Mass 
C=N 
1 
 
154.24 
292.0866 [M+H]
+ 
[Calc.= 292.0863] 
2 
 
151.75 
328.0866 [M+H]
+ 
[Calc.= 328.0863] 
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3 
 
151.72 
252.0555 [M+H]
+ 
[Calc.= 252.0550] 
Table 3.13: Summary of the Tetrazole Data. 
 
All attempts to cyclise compound, (324), (328), (331) and (334) were unsuccessful, again 
showing that the formation of 8- and 9-membered rings, this time using azide to nitrile 
cycloadditon, is not favoured. Compound (324) gave the amine (326) when heated in xylene 
for 3 days, but no other reactions gave any products. 
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3.2.3. Attempted synthesis of tetrazolobenzothiadiazepine analogues via 
tosylates. 
3.2.3.1. Tosylation of the alcohol. 
 
 
As well as making nitriles by oxime dehydration, we also made them by nucleophilic 
substitution  of tosyl by cyanide. The tosylates were made from the alcohols made above. 
Thus the alcohols were converted into tosylates using p-toluenesulfonyl chloride and base.
202
 
The alcohol was treated with p-toluenesulfonyl chloride in the presence of Et3N as a base in 
DCM and the mixture stirred for 5 hours at room temperature. The desired products (339, 
350, 354, 357, 361, 364, 368 and 346) were synthesised with the yields and appearance shown 
in Table 3.14. 
No. Starting material Desired products Appearance 
Yield
% 
1 
  
Yellow oil 98 
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2 
  
Light yellow 
solid 
(m.p.=92-94 
o
C) 
98 
3 
  
Yellow  oil 88 
4 
  
Light yellow oil 84 
5 
 
 
 
Deep brown oil 
 
97 
6 
 
 
Brown oil 89 
7 
  
Brown oil 
 
89 
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8 
  
Light yellow oil 
94 
 
Table 3.14: Sythesis of tosylates. 
 
The structures of the tosylates were confirmed by IR spectroscopy, 
1
H NMR spectrum, 
13
C 
NMR spectrum and mass spectrometry. 
The 
1
H NMR spectrum of compound (339), for example, showed the three CH3 protons from 
the tosylate group as a singlet at 2.34 (3H) ppm while the absence of the OH proton signal 
gave further evidence for the success of the tosylation. The distinct signals of the p-tosyl 
aromatic ring protons confirmed the tosylation.  
The 
13
C NMR spectrum showed the aromatic CH carbons downfield at 120.10, 124.44, 
127.83, 129.97, 131.05 and 133.89 ppm and the four aliphatic CH2 carbons and CH in the 
piperidine ring system were found at 18.24 (CH2), 24.89 (CH2), 24.92 (CH2), 41.97 (CH2) and 
50.58 (CH) ppm. The p-totyl methyl was seen at 21.63 ppm. 
IR spectroscopy showed the azide group at ʋmax 2099.0 cm
-1
 and the disappearance of the 
broad peak at ʋmax 3359.0 cm
-1
 for OH stretching.  
Mass spectrometry further supported the structure of the product with a measured mass of 
468.1365 for the ion [M+NH4]
+
 for a required mass of 468.1370. 
The structures of the other tosylates were confirmed in the same manner with IR 
spectroscopy, 
1
H NMR spectra, 
13
C NMR spectra, mass spectrometry and the key data is 
shown in Table 3.15. 
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No. Tosylate 
NMR (400 MHz, 
CDCl3, ppm) IR (cm
-1
) 
HRMS 
1
H NMR
 13
C NMR
 
CH3 CH3 N3 C-O 
1 
 
2.34 (bs) 21.63 2099.0 1159.2 
468.1365 
[M+NH4]
+ 
[Calc.= 
468.1370] 
2 
 
2.47 (bs) 21.68 2129.5 1159.4 
509.0910 
[M+Na]
+ 
[Calc.= 
509.0924] 
3 
 
2.42 (s) 21.65 2100.5 1157.7 
428.1063 
[M+NH4]
+ 
[Calc.= 
428.1057] 
4 
 
2.36 (bs) 21.65 2098.1 1157.0 
465.1269 
[M+H]
+ 
[Calc.= 
465.1261] 
5 
 
2.46 (bs) 21.66 2129.0 1155.9 
453.1264 
[M+H]
+ 
[Calc.= 
453.1261] 
6 
 
2.45 (s) 21.66 2128.0 1157.0 
501.1266 
[M+H]
+ 
[Calc.= 
501.1261] 
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7 
 
 
2.35 (s) 21.64 2130.6 1173.8 
451.1108 
[M+H]+ 
[Calc.= 
451.1104] 
8 
 
 
2.26 (bs) 21.46 2120.5 1147.4 
437.1237 
[M+Na]
+ 
[Calc.= 
437.1254] 
Table 3.15: Summary of spectroscopic Data for the Tosylates. 
 
 
3.2.3.2. Reactivity of tosylate with sodium cyanide. 
The next step was the displacement of the tosylate with cyanide anion. 
203
 The tosylates were 
treated with NaCN in dry DMSO. The mixture was heated at 70 
o
C under a nitrogen 
atmosphere for 12 h. Under these conditions, the expected nitriles  were never isolated. 
Instead a mixture of saturated 7, 8- and 9-membered rings were formed [product (1) in Table 
3.16] together with some additional cyanide addition products [product (2) in Table 3.16]. 
 
      
No. Tosylate 
Desired 
product 
Product obtained 
(1) 
Product obtained 
(2) 
1 
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2 
  
 
 
3 
 
  
None 
4 
 
   
5 
   
None 
6 
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7 
 
 
 
None 
8 
 
   
Table 3.16: The results of attempted nitrile to azide cycloadditions. 
                                          
The structures of these products were confirmed by their infrared spectra, 
1
H NMR spectra, 
13
C NMR spectra, mass spectrometry and (in the case of (342)) by X-ray crystallography. 
The 
1
H NMR spectrum of compound (356), for example, showed the presence of the 
secondary amine NH proton signal as a broad singlet at 4.38 ppm and the appearance of the 
three CH3 protons as a singlet at 2.82 (3H) ppm. The presence of four aromatic protons at 
6.89 (1H) ppm, 7.01 (1H) ppm, 7.33 (1H) and 7.85 (1H) ppm confirmed the 1,2-disubstituted 
benzene ring system.  
The 
13
C NMR spectrum showed the 2CH2 carbons and the CH3 carbon upfield at 35.73 (CH3), 
42.64 (CH2) and 52.41 (CH2) ppm. The four aromatic CH signals were found at 120.97 (CH), 
121.10 (CH), 130.33 (CH) and 133.35 (CH) ppm. 
The IR spectrum showed the presence of the NH stretch at ʋmax 3370.5 cm
-1
. The azide 
absorption peak had disappeared from ʋmax 2100.5 cm
-1
 and the C-N stretch peak at ʋmax 
1148.7 cm
-1
 was also seen. No nitrile was present. 
Further evidence for the structure was given by the HRMS for the measured ion [M+H]
+
 was 
which consistent at 213.0694. 
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For the other cyclised examples (341, 352, 359, 363 and 366), the structures were confirmed 
in the same manner with IR spectroscopy, 
1
H NMR spectra, 
13
C NMR spectra and mass 
spectrometry. The data for these compounds is summarised in Table 3.17. 
No. Product (1) 
1
H NMR (400 MHz, 
CDCl3, ppm) 
IR (cm
-1
) 
HRMS 
N-H N-H C-N 
1 
 
4.47 (bs) 3348.1 1153.2 
252.0931 [M]
+ 
[Calc.= 
252.0932] 
2 
 
4.32 (bs) 3370.8 1152.8 
289.1007 
[M+H]
+ 
[Calc.= 
289.1005] 
3 
 
4.38 (bs) 3370.5 1148.7 
213.0694 
[M+H]
+ 
[Calc.= 
213.0692] 
4 
 
4.20 (bs) 3365.0 1150.0 
267.1167 
[M+H]
+ 
[Calc.= 
267.1162 
5 
 
4.79 (bs) 3409.9 1146.1 
255.1165 
[M+H]
+ 
[Calc.= 
255.1162] 
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6 
 
5.07 (bs) 3368.7 1150.1 
303.1157  
[M+H]
+ 
[Calc.= 
303.1162] 
Table 3.17: Summary of spectroscopic data for products formed from amine                                                           
displacement of tosyl. 
 
The structure of compound (342) was established by X-ray crystallography and also gave 
fully consistent spectroscopic data. This allowed the structures of the other products (353, 360 
and 367) to be confirmed with IR spectroscopy, 
1
H NMR spectra, 
13
C NMR spectra and mass 
spectrometry, as all showed similar features to those noted for compound (342), summarised 
in Table 3.18.  
 
Figure 3.9: Crystal structure of the compound (342) 
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No Product (2) 
NMR (400 MHz, CDCl3, 
ppm) IR (cm
-1
) 
HRMS 
1
H NMR
 13
C NMR
 
NH C=N CN NH CN 
1 
 
8.22 (bs) 141.06 110.36 3346.4 2252.6 
304.0998 
[M]
+ 
[Calc.= 
304.0994] 
2 
 
8.20 (bs) 146.20 110.37 3378.1 2248.7 
341.1065 
[M+H]
+ 
[Calc.= 
341.1067] 
3 
 
8.09 (bs) 158.19 110.76 3314.0 2255.2 
319.1228 
[M+H]
+ 
[Calc.= 
319.1223] 
4 
 
No No 114.73 No 2216.5 
327.1040 
[M]
+ 
[Calc.= 
327.1041] 
Table 3.18: Summary of data for nitriles (342), (353), (360) and (367). 
 
The mechanism for the reaction is proposed (Scheme 3.10, below) to be nitrene formation and 
conversion of the nitrene to an amine or attack of the azide by cyanide
204-208
 followed by 
nitrogen loss. The amine could then displace tosylate to give products (341), (352), (350), 
(359), (363) and (366) [Table 3.17] or the cyano substituted amine anion could displace tosyl 
and then be further attacked by more cyanide  to form compounds (342), (353) and (360) 
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[Table 3.18] or stop (no extra cyanide addition) to form compound  (367) [Table 3.18]. 
Compound (370) [entry 7, Table 3.16] results from azide reduction and tosyl displacement by 
cyanide. 
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3.2.3.3. Reactivity of compound (346) with sodium cyanide. 
 
  
As implied in Table 3.16, tosylate (346) behaved differently when reacted with NaCN in the 
presence of dry DMSO. The mixture was heated at 70 
o
C under a nitrogen atmosphere for 12 
h. Instead of the tetrazolo-product or other compounds just discussed above,  products (348 
and 349) were formed with yields of 31 % and 35 %, respectively. These unusual products 
were only seen with this one amide example (those above are all sulfonamides). 
Spectroscopic analysis implied of the formation of product (348). The 
1
H NMR spectrum 
showed the appearance of nine aromatic protons including the distinct tosyl doublets at 7.63 
(2H) and 7.95 (2H) ppm. The eight upfield aliphatic CH2 protons showed at 1.18-1.64 (6H), 
3.73 (1H), and 4.22-4.29 (1H) ppm and the single CH proton in the ring system appeared at 
3.05 (1H) ppm. The presence of three upfield CH3 protons on the toluene was seen as a singlet  
at 2.28 (3H) ppm. 
The 
13
C NMR spectrum showed the aromatic CH carbons downfield at 126.91 (2 x CH), 
128.36 (2 x CH), 129.65 (2 x CH), 129.79 (2 x CH), and 133.07 ppm and the four aliphatic 
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CH2 carbons and CH in the piperidine ring system were found at 18.96 (CH2), 24.42 (CH2), 
25.36 (CH2), 41.30 (CH2) and 51.11 (CH) ppm. There were three aromatic quaternary carbons 
plus one carbonyl. IR spectroscopy showed the presence of the carbonyl group at ʋmax 1719.5 
cm
-1
 and the disappearance of the broad peak at ʋmax 2120.5 cm
-1
 for azide stretching. Mass 
spectrometry further supported the structure of the product with a measured mass of 396.1242 
for the ion [M+Na]
+
 for a required mass of 396.1240. 
The structure of the product (349) was implied by its IR spectrum, 
1
H NMR spectrum, 
13
C 
NMR spectrum and mass spectrometry. The 
1
H NMR spectrum showed the eight aliphatic 
CH2 protons at 1.18-1.53 (6H), 2.17 (1H), and 3.02 (1H) ppm and the single CH in the 
piperidine ring system was seen at 3.50 ppm. The four aromatic protons were downfield  as a 
doublet at 7.22 ppm (2H) and as a doublet at 7.67 ppm (2H). 
The 
13
CNMR spectrum showed the CH aromatic carbons downfield at 126.99 (2 x CH) and 
129.79 (2 x CH) ppm and and the four aliphatic CH2 carbons and CH in the piperidine ring 
system were found at 19.15 (CH2), 24.19 (CH2), 24.77 (CH2), 41.41 (CH2) and 54.68 (CH) 
ppm. The CH3 carbon on the tosylate appeared as a singlet  at 21.53 ppm. 
IR spectroscopy showed the absence of the carbonyl group seen in compound (346) at ʋmax 
1720.8 cm
-1
 and the disappearance of the broad peak at ʋmax 2120.5 cm
-1
 for azide stretching.  
The correct measured mass 270.1164 for the ion [M+H]
+
 gives further evidence for the 
structure. 
Compound (349) can be formed from cleavage of the amide bond present in starting material 
(346). Compound (348) is more difficult to explain but would arise from the de-azideation of 
the starting material (346)- a reaction never seen in our research group in many years of azide 
chemistry, and for which precedent could not be found in the literature. 
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Chapter 4: 
4. Results and Discussion: 1. Reactivity of 2-azidobenzamide. 
This short section brings together some results that were obtained as part of an investigation 
into the reactivity of 2-azidobenzoic acid derivatives and of compounds derived from 2-
azidobenzaldehyde. 
4.1. Reactivity of 2-azidobenzamide 
4.1.1. Summary. 
2-Aminobenzamide (376) was reacted with sodium nitrite and HCl at 0 
o
C to form the 
diazonium salt as an intermediate. Reaction between the diazonium intermediate and sodium 
azide by the displacement of nitrogen by the azide anion gave 2-azidobenzamide (377). The 
2-azidobenzamide (377) was treated with alkyl bromides in the presence of sodium carbonate 
as a base in anhydrous DMSO to give benzotriazinones (195) and quinazolinones (169) as 
shown in Scheme 4.1. This investigation came about as a result of a wider investigation of the 
attempted aminohydroxylation reactions discussed previously in this thesis. 
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4.1.2. Reactivity of 2-azidobenzamide. 
4.1.2.1. Reactivity of 2-azidobenzamide with alkyl bromides. 
 
 
The aim of this reaction was to alkylate the amide in order to provide a precursor for the 
aminohydroxylation discussed in an earlier chapter. 
Compound (377) was treated with 5-bromo-1-pentene (378) in the presence of sodium 
carbonate as a base in anhydrous DMSO and heated at 95 
o
C for 48 hours under a nitrogen 
atmosphere and the reaction mixture was purified by column chromatography in order to 
investigate  two new products. 
It was immediately obvious that the expected product was not formed. Spectroscopic analysis 
confirmed the identity of the first compound as compound (379) [see Scheme 4.2].  The 
1
H 
NMR spectrum showed four aromatic protons with signals at 7.72 ppm as a doublet of 
doublets, 7.86 ppm as a doublet of doublets, 8.07 ppm as a doublet and 8.27 ppm as a doublet. 
The six CH2 protons appeared as a triplet of doublets at 1.95 ppm, an apparent quintet at 2.12 
ppm and a triplet at 4.41 ppm as well as the alkenic CH2 protons and CH proton which 
appeared at 4.92 (CHH), 5.00 (CHH) and 5.71-5.82 (CH) ppm, respectively.  In the 
13
C 
NMR, the 3 alkyl CH2s appeared at 27.93, 30.74 and 49.40 ppm whilst the sp
2
 CH2 signal 
appeared at 115.58 ppm. The appearance of five sp
2
 CH signals at 125.06, 128.22, 132.26, 
134.72 and 137.14 as well as the C=O signal confirmed the assignment. 
It was further determined that the compound contained a carbonyl group from a peak at ʋmax 
1679.5 cm
-1 
in the infrared spectrum which also showed no peak for the azide group and also 
the absence of the amide NH2 absorption peak. Mass spectrometry further supported the 
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structure of product with a measured mass of 215.1059 for the ion [M]
+
 for a required mass of 
215.1059. 
The identity of the second product (380) was confirmed by IR spectroscopy, 
1
H NMR 
spectrum, 
13
C NMR spectrum and mass spectrometry. 
The 
1
H NMR spectrum showed a signal at 12.11 ppm indicating the NH group. Two signals at 
2.59 and 2.84 ppm confirmed the presence of the four protons of the butenyl as well as the 
three protons of the ethylene which showed at 4.97 ppm (CHH) as a doublet, at 5.08 ppm 
(CHH) as a doublet of doublets and 5.82-5.92 ppm (CH) as a multiplet. The four aromatic 
protons at 7.40, 7.63, 7.70, and 8.21 ppm with the multiplicity of dd, d, dd, d indicated the 
1,2-disubstitution pattern of the benzene ring. The 
13
C NMR spectrum showed the four 
quaternary carbons at 120.53, 149.45, 156.07 and 164.39 ppm. The two upfield CH2s 
appeared at 31.31 and 35.19 ppm whilst the presence of the four aromatic proton CH signals 
was seen at 126.44, 127.26, 134.82 and 136.43 ppm in addition to the characteristic signals of 
the alkene  downfield at 116.29 ppm (CH=CH2) and 126.24 ppm (CH=CH2). Furthermore, 
the IR spectrum displayed a broad NH absorption peak at ʋmax  3168.3 cm
-1
 while no peak 
appeared for the azide group. A sharp peak at ʋmax 1673.1 cm
-1
 showed the carbonyl group. 
Mass spectrometry further supported the structure of the product with a measured mass of 
201.1023 for the ion [M+H]
+
 for a required mass of 201.1022. 
This process was explored further by investigating the reaction of 4-bromo-1-butene, 1-
bromobutane, 1-bromopropane, 2-bromopropane, bromocyclohexane, 3-bromo-2-
methylpropene, benzyl bromide, 2-bromo-2-methylpropane, bromodiphenylmethane and 
triphenylmethyl bromide with 2-azidobenzamide. 
Each of 4-bromo-1-butene (391), 1-bromobutane (384) and 1-bromo propane (381) gave two 
products whilst each of 2-bromopropane (395), bromocyclohexane (389), 3-bromo-2-
methylpropene (387), benzyl bromide (397) and  2-bromo-2-methylpropane (405) gave a 
single product. In addition bromodiphenylmethane (399) and triphenylmethyl bromide (402) 
did not react with 2-azidobenzamide but gave a benzophenone (401) and triphenylmethanol 
(404), respectively. The yields and physical properties of the products are shown in the Table 
4.1. 
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No. 
Starting 
material (1) 
Starting 
material (2) 
Compound (1) Compound (2) 
1 
 
  
Colour=dark orange oil 
% = 39 % 
 
 
Colour= light yellow 
m.p=167-169 
o
C 
% = 33 % 
 
2 
 
  
Colour= yellow oil 
% = 35 % 
 
 
Colour= Yellow solid 
m.p=148-150 
o
C 
% = 29 % 
 
3 
 
 
 
Colour=Light yellow oil 
% = 37 % 
 
 
 
Colour=light yellow 
oil 
% = estimated 20 % 
 
4 
 
 
 
Colour=Light yellow 
solid 
m.p = 49-51
o
C 
% = 37 % 
 
 
Colour=light yellow 
solid 
m.p=209-211 
o
C 
% = 23 % 
 
5 
 
 
 
Colour=Light yellow 
solid 
m.p = 47-49 
o
C 
% = 34 % 
 
 
 
No 
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6 
  
 
Colour=light yellow solid 
m.p = 137-139 
o
C 
% = 30 % 
 
 
 
No 
7 
 
 
 
 
Colour=light yellow solid 
m.p = 69-71 
o
C 
% = 36 % 
 
 
 
No 
8 
  
 
Colour=yellow solid 
m.p = 110-112 
o
C 
% = 33 % 
 
 
 
No 
 
9 
 
  
Colour= light yellow oil 
% = 20 % 
No 
10 
 
  
No 
11 
 
  
No 
Table 4.1: Synthesis and Appearance of Benzotriazinones and Quinazolinones. 
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The structures of the triazinone products were confirmed by IR spectroscopy, 
1
H NMR 
spectra, 
13
C NMR spectra, mass spectrometry, and the results are summarised in Table 4.2. 
Typically in these compounds, the 
1
H NMR spectra showed the presence of four aromatic 
protons downfield at around 7.00-8.00 ppm in a 1,2-disubstituted pattern with the alkyl 
neighbouring the N-C=O seen at around 4.37 – 5.65 ppm. All samples gave signals consistent 
with their alkyl sidechain, and also showed the absence of the starting material amide protons. 
All the 
13
C NMR spectra showed the presence of a carbonyl (C=O) upfield at around 155.09-
155.52 ppm and the appearance of four aromatic CH signals downfield at around 120.0 -130.0 
ppm. All compounds gave other 
13
C data that was fully consistent with the assigned 
structures.  
Further proof for the structures was given by the infrared spectra, with the presence of the 
carbonyl (C=O) stretching peak at around ʋmax 1640.6-1683.8 cm
-1
 and the loss of the azide 
group and absence of the NH2 group. 
For all the examples, the correct accurate masses were observed by high resolution mass 
spectrometry. 
Two alkyl halides (387) and (405), gave the same triazinone product (378). In the second 
case, the product might arise as a result of a free-radical mechanism. A suggested mechanism 
for these reactions is discussed in full later. 
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No. Compound (1) 
13
C NMR
 
(400 MHz, 
CDCl3, ppm) 
IR (cm
-1
) 
HRMS 
C=O C=O 
1 
 
155.52 1679.5 
215.1059 [M]
+
, 
 
[Calc.=215.1059]
 
2 
 
155.50 1681.0 
202.0970 
[M+H]
+
, 
 
[Calc.=202.0975] 
3 
 
155.50 1678.4 
204.1127 
[M+H]
+
, 
 
[Calc.=204.1131] 
4 
 
155.52 1640.6 
190.0973 [M+H]
+ 
 
[Calc.=190.0975] 
5 
 
155.09 1676.5 
190.0970 
[M+H]
+
, 
 
[Calc.=190.0975] 
6 
 
155.12 1681.1 
230.1285 
[M+H]
+
, 
 
[Calc.=230.1288] 
 
7 
 
155.43 1683.8 
202.0975 
[M+H]
+
, 
 
[Calc.=202.0975] 
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8 
 
155.39 1681.8 
238.0977 
[M+H]
+
, 
 
[Calc.=238.0975] 
9 
 
155.43 1683.8 
202.0982 
[M+H]
+
, 
 
[Calc.=202.0975] 
Table 4.2: Characteristic spectroscopic data for the benzotriazinone derivatives. 
 
The structures of the second series of products (380, 393, 386 and 383) were confirmed as the 
quinazolinones by IR spectroscopy, 
1
H NMR, 
13
C NMR spectra and mass spectrometry, and 
the data is summarised in Table 4.3. 
The 
1
H NMR spectra showed the disappearance of the two broad singlets for the amide proton 
and the appearance of a new NH signal at around 11.12-12.17 ppm confirming the NH group 
as well as the four aromatic protons at around 7.00 – 8.30 ppm characteristic of the 1,2-
disubstitution pattern of the benzene ring. The alkyls neighbouring the N=C were seen at 
around 2.68-6.40 ppm. 
The 
13
C NMR spectra of these products showed the carbonyl signal at 164.12-164.57 ppm 
with the appearance of the C=N signal at around 150.89-157.17 ppm as well as the presence 
of four aromatic proton CH signals at 123.46-136.43 ppm. 
The infrared spectra displayed a broad NH absorption peak at around ʋmax 3163.1- 3182.1 cm
-
1
 while no peak was observed for the azide group. A sharp peak at ʋmax 1650.0-1674.3 cm
-1
 
showed the carbonyl group in addition to the disappearance of the NH2 group at ʋmax 3362 cm
-
1
. For all the examples, the correct accurate masses were observed by high resolution mass 
spectrometry giving further proof for the structures, and all showed 
1
H and 
13
C spectra 
consistent with their particular side chain. Compound (393) presumably arises from the 
rearrangement of the initial non-conjugated product into the more conjugated (393). 
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No Compound (2) 
NMR (400 MHz, 
CDCl3, ppm) IR (cm
-1
) 
HRMS 1
HNMR
 13
C NMR
 
NH C=O C=N C=O NH 
 
 
12.11 
164.3
9 
156.0
7 
1673.1 3168.3 
201.1023 
[M+H]
+ 
 
[Calc.=201.1022] 
 
 
11.98 
164.1
2 
150.8
9 
1658.7 3182.1 
187.0860 
[M+H]
+ 
 
[Calc.=187.0793] 
 
 
11.12 
164.2
5 
157.1
7 
1650.0 3173.6 
189.1023 
[M+H]
+ 
 
[Calc.=189.1022] 
 
 
12.17 
164.5
7 
156.7
8 
1674.3 3163.1 
175.0869 [M+H]
+ 
 
[Calc.=175.0866] 
Table 4.3: Characteristic spectroscopic data for the quinazolinone derivatives. 
 
 
The mechanism for the formation of the benzotriazinone and quinazolinones is not clear but 
Figure (4.1) shows how the quinazolinones might form and Figure (4.2) attempts to account 
for triazinones. Path A (Figure 4.1) gives the nitrene of 2-azidobenzamide which then picks 
up the alkyl halide, loses hydrogen, cyclises and loses more hydrogen to give the 
quinazolinone. Evidence for the nitrene comes from the presence of 2-aminobenzamide as a 
product. The alternative (Path B, Figure 4.1) is less likely as the alkylation (first step) is not 
known and no azide or amine intermediate could be detected. For the benzotriazinone (Figure 
4.2) path B (initial alkylation) is unlikely so path C is proposed. Here, the azide reacts with a 
nucleophile and then eliminates a single nitrogen (picked up by the nucleophile) to give a 
diazonium which cyclises to the parent unsubstituted benzotriazinone which then alkylates. It 
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is possible that the nucleophile could be dimethyl sulfide formed by interaction of DMSO 
with the alkyl halide (see Figure 4.2) 
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4.1.2.2. Reactivity of 2-azidobenzamide with 1-bromobutane. 
4.1.2.2.1. Synthesis of 2-azido-N,N-dibutylbenzamide with 2-bromopropane. 
 
 
The reaction
209
 of 2-azidobenzamide (377) with bromobutane (407) was used to produce the 
N,N-dialkyl amide (408), with the idea of exploring the reactivity of this material. 
2-Azido-N,N-dibutylbenzamide (408) was heated with sodium carbonate as a base in 
anhydrous DMSO in the presence and absence of 2-bromopropane. The mixture was heated to 
95 
o
C for 48 hours (no reaction) and then to 120 
o
C for 48 hours. After the completion of the 
reaction, the mixture was purified by column chromatography. Compound (410) was isolated 
in good yield as a yellow oil as shown in Scheme 4.4, below. In this reaction, the unsaturated 
(C=N) compound was not seen.  
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The structure of compound (410) was confirmed IR spectroscopy, NMR spectra and mass 
spectrometry. The 
1
H NMR spectrum showed the signals of the alkyl chain CH2s and the 
critical sp
3
 CH at 1.15-1.24 (1H), 1.29-1.36 (3H), 1.50-1.59 (3H), 1.84 (1H), 2.72-2.79 (1H) 
and 4.48-4.50 (2H) ppm. The NH was seen at 4.00-4.07 ppm. 
 
The 
13
C NMR spectrum showed the presence of the carbonyl signal at 164.34 ppm. The 
terminal methyl signals (carbons d and h) appeared at 13.68 ppm and 13.89 ppm and the 
signals of the alkyl chain sp
3
 carbons appeared at 18.64 (CH2), 20.15 (CH2), 30.48 (CH2), 
35.48 (CH2), 44.88 (CH2) and 69.25 (CH) ppm whilst the four aromatic CH signals were at 
114.81, 118.41, 128.41 and 133.06 ppm. 
Further proof for the structure was given by the infrared spectrum which displayed a broad 
NH absorption peak at ʋmax 3284.2 cm
-1 
and showed a sharp peak at ʋmax 1610.1 cm
-1
 for the 
carbonyl group. There was no sharp peak at ʋmax 2097.8 cm
-1
 for the azide group. Mass 
spectrometry further supported the structure of product with a measured mass of 247.1802 for 
the ion [M+H]
+
 for a required mass of 247.1805. 
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4.1.3. Attempted reaction of 3-propylbenzo[d][1,2,3]triazin-4(3H)-one with  
cyclopropenones. 
 
 
Following a literature report
210
 that some triazines react with cyclopropenone, the reactivity of 
triazines towards cyclopropenone (412) was investigated. 
The reactivity of compound (382) was investigated by mixing with diphenylcyclopropenone. 
Compound (382) was treated with diphenylcyclopropenone in toluene. The reaction mixture 
was heated at 80 
o
C for 48 hours whilst being monitored by TLC which showed no reaction. 
The reaction mixture also was heated to reflux for 3 days. None of the desired product (413) 
could be identified and only starting material (382) could be isolated. 
Attempted reaction of benzotriazinone (398) with diphenylcyclopropenone was also 
unsuccessful. 
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4.2. Reactivity of 2-azidobenzaldoxime and 2-azidobenzaldehyde. 
 
In this section, some reactions of 2-azidobenzaldehyde, oxime (416), its amidoxime derivative 
(421), and the 2-azidobenzonitrile (420) and alkyne (419) are explored. This work formed part 
of a group-wide project looking at the synthesis and reactivity of bifunctional arylazides and 
especially their use in the synthesis of potential ligands in organometallic chemistry, a 
collaboration with an inorganic group. 
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4.2.1. Synthesis of 2-azidobenzonitrile. 
 
 
The oxime (416) was synthesised in our work by reaction of the aldehyde with 
hydroxylamine. The reaction
173
 proceeded easily and gave the product in 89 % yield and was 
identical to that reported previously in the group
211
. 
The oxime (416) was dehydrated to form a nitrile in the presence of diphenylcyclopropenone, 
(COCl)2 and DBU, a reaction developed in our laboratories as part of another project on 
diphenylcyclopropenone.
201
 A product was isolated from the reaction mixture by extraction 
with DCM and washed with water and purified by using silica column chromatography to 
give the desired product as a yellow oil in 87% yield. This is a new route to this known 
azide.
212,213
 The structure of the product (420) was confirmed by comparison to literature 
data
213 
and by spectroscopic analysis. IR spectroscopy showed the presence of a peak at ʋmax 
2227.9 cm
-1
 for the CN group and a sharp peak for azide group which displayed at ʋmax 2109.8 
cm
-1
. It was also seen that the peak for OH group was absent. The 
1
H NMR spectrum also 
indicated the absence of the hydroxyl proton. 
The 
13
C NMR spectrum also confirmed the structure with the correct number of carbons with 
the nitrile signal appearing at 104.22 ppm. The absence of the oxime signal (CH=N), 
previously seen at 146.15 ppm was also noted. In mass spectrometry, the molecular mass of 
the nitrile (420) was equal to 233.0790 which was as expected for ion [2M-2N2+H]
+
. 
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4.2.2. Reactivity of 2-azidobenzonitrile. 
In an attempt to perform cycloaddition of the nitrile and the azide present in compound (420), 
it was heated in a variety of solvents with no success. Compound (420) was also treated with 
a solution of CuSO4.5H2O in the biphasic system t-BuOH/H2O as a solvent in the presence of 
sodium ascorbate. Instead of the desired tetrazole dimer product (423), a compound assigned 
as structure (424) was isolated in  10 % yield as shown in Scheme 4.8, below. 
 
The proposed structure of the product (424) was suggested by IR spectroscopy, 
1
H NMR 
spectrum, 
13
C NMR spectrum and mass spectrometry.  
The 
1
H NMR spectrum showed the presence of ten CH signals at 6.29 (1H), 6.62 (1H), 6.69 
(1H), 7.02 (1H), 7.22-7.41 (3H), 7.53-.7.55 (2H), and 7.67 (1H) ppm.  
The IR spectrum showed the disappearance of the peaks ʋmax 2227.9 cm
-1
 and ʋmax 2109.8 cm
-
1
 for nitrile and azide, respectively. 
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In the 
13
C NMR spectrum for (424), the ten CH carbons from the aromatic ring appeared at 
125.43, 126.71, 128.30, 128.36, 128.98, 129.09, 130.42, 130.52, 143.39 and 143.56 ppm. The 
absence of the CN group previously seen at 104.22 ppm was also noted. 
Further evidence for the structure was given by the HRMS for the measured ion [M]
+
 which 
was consistent at 234.0905. 
 
4.2.3. Synthesis of (Z)-2-azido-N'-hydroxybenzimidamide. 
 
 
The nitrile (420) was converted into the amidoxime (425) in 67 % yield by reaction with 
hydroxylamine hydrochloride in the presence of base.
214
 Amidoximes are useful precursors in 
heterocyclic synthesis
214
, as will be shown later.  
The structure of compound (425) was deduced by its IR spectroscopy, NMR spectroscopy and 
mass spectrometry. 
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4.2.3.1. Synthesis of 3-(2´-azidophenyl)-1,2,4-oxadiazole. 
We aimed to use the amidoxime in (425) to make a 1,2,4-oxadiazole and then use the azide to 
make a 1,2,3-triazole, hence producing a potentially interesting ligand system. 
 
The synthesis of 1,2,4-oxadiazole (427) was achieved in 93 % yield by treating amidoxime 
(425) with 2-chloro-2-oxoacetate in THF. A second product, compound (428) was isolated in 
5 % yield. A mechanism is shown in Figure 4.4, based upon the known reactivity of 
amidoximes with acid chlorides.
215
 Once compound (427) is formed, reduction of the azide to 
the amine and reaction of the amine with the acid chloride would form compound (428). Both 
compounds gave fully consistent and very distinct spectroscopic data, including HRMS data.  
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4.2.3.2. Synthesis of Ethyl 2-[(1H-indazol-3-yl)amino]-2-oxoacetate. 
 
The azide (427) was reacted with triphenylphosphine  in anhydrous toluene. At room 
temperature, no reaction occurred. When the mixture was heated at reflux, a new product was 
isolated and was found to be the unexpected indazole (430) in 61 % yield, as shown in 
Scheme 4.11, below: 
 
Spectroscopic analysis confirmed the structure as compound (430). The infrared spectrum 
confirmed the loss of the azide group from ʋmax 2097.1 cm
-1 
and the characteristic carbonyl 
groups were found at ʋmax 1701.8 cm
-1
 and ʋmax 1732.1 cm
-1
 . The presence of two NH peaks 
was seen at ʋmax 3158.5 and 3376.7 cm
-1
. 
The 
1
H NMR spectrum showed a triplet at 1.34 ppm and a quartet at 4.33 ppm that 
correspond to the CH3 and OCH2 of the ethoxy unit, respectively. The two NH protons in the 
product appeared at 11.19 ppm and 12.94 ppm. 
The 
13
C NMR spectrum indicated the terminal methyl of the ethoxy group at 14.30 and the 
methylene at 62.82 ppm. The two carbonyl signals appeared at 156.89 and 160.97 ppm while 
the imine peak (C=N) appeared at 141.40 ppm. The four signals for the aromatic (CH) 
carbons were seen at 110.81, 120.48, 121.72 and 127.01 ppm 
The structure of the product (430) was further confirmed by HRMS analysis with an accurate 
measured mass for [M]
+
 of  233.0799  for a required of 233.0800. 
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Figure 4.5 (above) shows a possible mechanism. The starting material forms either the nitrene 
or the amine. N-O cleavage is then followed by N-N bond formation to give the indazole. 
Protonation or H
. 
abstraction and then tautomerisation gives the final product. Indazole 
formation from a similar compound, 5-methyl-3-(2-aminophenyl)-1,2,4-oxadiazole- is known 
in the literature
216
. The structure of compound (430) was confirmed by X-ray crystallography. 
The crystal structure shows the methyl ester rather than the ethyl ester due to the solvent of 
crystallisation being methanol and transesterification, as shown in Figure 4.6.  
 
Figure 4.6: Crystal structure of the compound (430) 
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4.2.3.3. Synthesis of dimethyl 1-{2-[5-(ethoxycarbonyl)-1,2,4-
oxadiazol-3-yl]phenyl}-1H-1,2,3-triazole-4,5-dicarboxylate. 
 
As mentioned above, this type of compound was of interest in a collaborative project that our 
group has in order to find 1,2,4-oxadiazole ligands. The reaction of compound (427) with 
DMAD was performed in toluene at reflux for 24 hours to give the desired product in 75 % 
yield. The product (427) is substituted with an oxadiazole ring and a triazole ring. The triazole 
was formed via [3+2] cycloaddition based upon the use of DMAD as an excellent 
dipolarophile.
217
 
The structure of the product (431) was confirmed by spectroscopic analysis. The 
1
H NMR 
spectrum was consistent with the presence the ethoxy methyl protons as a triplet at 1.43 ppm 
and the methylene protons as a quartet at 4.50 ppm. The methyls of the two methyl esters 
appeared as singlets at 3.76 ppm and 4.02 ppm. Three signals integrating to four protons were 
seen in the aromatic region. 
The 
13
C NMR spectrum showed the presence of two oxadiazole C=N carbons at 153.62  and 
158.16 ppm, two quaternary benzene ring carbons at 123.73 and 132.93 ppm, two quaternary 
carbons at 134.00 and 139.31 ppm for the triazole ring as well as three signals at 160.30, 
166.37 and 166.43 ppm for the three carbonyls. The four aromatic CHs appeared at 128.80, 
130.72, 131.61 and 132.29 ppm whilst three signals at 13.90, 52.78 and 53.39 ppm appeared 
for the three methyl carbons with a signal at 64.01 ppm for the methylene carbon. 
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In the IR spectrum a strong absorption band at ʋmax 1731. 8 cm
-1 
was seen for the carbonyl 
groups while the absence of the azide absorption band supported successful cycloaddition. 
The correct measured mass of 402.0975 for the ion [M+H]
+
 in the mass spectrum confirmed 
that the reaction was successful. 
 
4.2.3.4. Attempted Synthesis of 3,5-bis(2-azidophenyl)-1,2,4-oxadiazole. 
 
 
The amidoxime (425) was treated with 2-azidobenzoyl chloride in the presence of pyridine as 
a base in THF at reflux. The mixture was heated for 3 days in toluene whilst monitored by 
TLC which showed no product. Replacement of the toluene with THF similarly gave no 
reaction. Product (432) could not be formed. However, after 24 hours in THF, it was noted 
that the O-acyl-amidoxime (433) [or its N-acyl-equivalent (433a)] could be isolated. 
 
 
The intermediate was isolated in 44 % yield. 
Chaper 4                                                                                                                            Results and Discussion 
142 
 
Spectroscopic analysis confirmed the structure as compound (433). The infrared spectrum 
confirmed the presence of the azide group at ʋmax 2118.3 cm
-1 
and the characteristic carbonyl 
group found at ʋmax 1721.8 cm
-1
. The presence of the NH2 peaks were at ʋmax 3341.7 and 
3465.7 cm
-1
. 
The 
1
H NMR spectrum showed the eight aromatic (CH) protons downfield at 7.15-7.22 (2H), 
7.25 (2H), 7.47 (1H), 7.57 (1H), 7.77 (1H), 8.00 (1H) giving a pattern of m, dd, dd, dd, d and 
d consistent with two 1,2-disubstituted benzene ring system. The primary amine protons 
(NH2) were present at 5.90 (2H, bs), implying (433) and not (433a) had formed. 
The 
13
C NMR spectrum indicated the presence of the carbonyl signal at 163.26 whilst the 
imine peak (C=N) was found at 156.49 ppm. The presence of eight signals for the aromatic 
(CH) carbons at 118.71, 119.25, 124.91, 125.04, 131.21, 131.89, 132.77 and 133.45 ppm in 
the 
13
C NMR spectrum, together with four quaternary carbons at 121.85, 122.11, 138.10 and 
139.27 ppm confirmed the assignment. 
The structure of the product (433) was further confirmed by HRMS analysis with an accurate 
measured mass for [M+H]
+
 of  323.0990  for a required of 323.0999. 
It should be noted that O-acyl-amidoximes are well known intermediates in 1,2,4-oxadiazole 
synthesis.
218
 
 
4.2.3.5. Synthesis of 3,5-bis(2-azidophenyl)-1,2,4-oxadiazole. 
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In this reaction, the carbonyl group was reacted with the amine and converted to the 1,2,4-
oxadiazole by the catalytic
219
 use of  tetrabutylammonium fluoride as a mild and efficient 
catalyst in THF. The mixture was heated at reflux for 72 h. The reaction mixture was 
monitored by TLC, which showed the disappearance of the starting material.  A product was 
isolated from the reaction mixture by purification with silica column chromatography to 
afford the desired product (432) in 90 % yield. 
The structure of the compound (432) was confirmed by its IR spectroscopy NMR 
spectroscopy and mass spectrometry. 
The mechanism for conversion of acylamidoximes to 1,2,4-oxadiazole  and the  role of 
fluoride is shown in Figure 4.8, below.
219
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4.2.3.6. Synthesis of tetramethyl 1,1'-[(1,2,4-oxadiazole-3,5-diyl)bis(2,1-
phenylene)]bis(1H-1,2,3-triazole-4,5-dicarboxylate). 
 
The reaction of the 1,2,4-oxadiazole (432) with DMAD was performed in toluene at reflux for 
24 hours. A product was purified from the reaction mixture by silica column chromatography 
to give the desired product in 95 % yield. The product (434) is substituted with an oxadiazole 
ring and two triazole rings. 
The structure of the product (434) was confirmed by spectroscopic analysis. The 
1
H NMR 
spectrum was consistent with the methyls of the four methyl esters at 3.64 ppm (6H, bs), 3.94 
ppm (3H, s) and 3.98 ppm (3H, s) as well seven signals integrating to eight protons in the 
aromatic region. 
The 
13
C NMR spectrum showed the presence of two oxadiazole C=N carbons at 165.65 and 
171.56 ppm, four quaternary aromatic benzene carbons at 121.14, 123.99, 139.22 and 139.57 
ppm, four quaternary carbons at 132.74, 133.04, 133.71 and 134.11 ppm for the two triazole 
rings as well as four signals at 157.88, 158.06, 160.38 and 160.44 ppm for the four carbonyls. 
The eight aromatic CHs appeared at 128.60, 129.07, 130.40, 130.64, 131.56, 131.78, 131.85 
and 133.58 ppm whilst four signals at 52.79, 52.95, 53.38 and 53.49 ppm appeared for the 
four methyl carbons. 
In the IR spectrum a strong absorption band at ʋmax 1731.5 cm
-1 
was seen for the carbonyl 
groups while the absence of the azide absorption band supported successful cycloaddition. 
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The correct measured mass of 589.1422 for the ion [M+H]
+
 in the mass spectrum confirmed 
that the reaction was successful. 
 
4.2.3.7. Attempted synthesis of bis-[3-(2-azidophenyl)-1,2,4-oxadiazole] 
(436). 
 
The amidoxime (425) was treated with oxalyl chloride (435) in the presence of pyridine as a 
base in DCM. The mixture was stirred at room temperature for 24 hours whilst monitored by 
TLC which showed the disappearance of the starting material. A product was obtained from 
the reaction mixture by purification with silica column chromatography and identified as the 
desired product (436), in 80 % yield. This same reaction failed when attempted in THF. 
The structure of the compound (436) was confirmed by its IR spectrum, 
1
HNMR spectrum, 
13
C NMR spectrum and mass spectrometry. 
The 
1
H NMR spectrum showed the presence of four signals integrating to eight aromatic 
protons downfield at 7.14 (2H), 7.17-7.20 (2H), 7.53 (2H) and 7.93 (2H) ppm giving a pattern 
of dd, m, ddd and dd consistent with the two 1,2-disubstituted benzene ring systems.  
The 
13
C NMR showed the presence of eight quaternary carbons at 138.93 (2 x qC), 143.37 (2 
x qC), 164.28 (2 x qC(C-C)), and 165.76 (2 x qC (C=N)) ppm. The presence of  eight signals 
of the aromatic (CH) carbons appeared at 118.81 (2 x CH), 125.02 (2 x CH), 133.91 (2 x CH) 
and 134.08 (2 x CH) ppm. 
The infrared spectrum confirmed the presence of the azide group at ʋmax 2111.7 cm
-1
. The 
absence of the OH previously seen at ʋmax 3371.0 cm
-1
 as well as the absence of the NH2 
peaks at ʋmax  3151.7 and 3483.3 cm
-1 
was also noted. 
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Mass spectrometry further supported the structure of the product (436) with a measured mass 
of 395.0727 for ion [M+Na]
+
 for a required mass of 395.0724. 
 
4.2.4. Dimerisation of 2-azidobenzonitrile oxime. 
A further diazide made was the dimer (418) resulting from the chlorination and 
dehydrochlorination of the oxime (416) as show in Scheme 4.16.  This reaction procedure 
involves the formation of an intermediate nitrile oxide which forms when the o-
azidobenzaldoxime (416) was treated with N-chlorosuccinimide in anhydrous DCM in the 
presence pyridine as a base. Compound (418) was isolated in 78 % yield and its chemistry 
along with that of compound (436) is being explored by another member of the group. 
 
The proposed mechanism for the formation of the dimer (418) is shown in Figure 4.9, and is 
based upon the known behaviour of nitrile oxides.
220-222
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The structure of the o-azidobenzaldoxime dimer was confirmed by IR spectroscopy, 
1
H NMR 
spectrum, 
13
C NMR spectrum and mass spectrometry. 
The 
1
H NMR spectrum showed the presence of eight signals of aromatic protons at 7.06 (1H), 
7.09-7.14 (2H), 7.18 (1H), 7.27 (1H), 7.38-7.50 (3H) and the loss of the two (OH and CH) 
oxime proton signals. The 
13
C NMR spectrum indicated the presence of six quaternary 
carbons at 113.61, 115.23, 118.79, 118.83, 138.54 and 139.28 ppm and the presence of eight 
signals for the aromatic (CH) carbons at 118.90, 118.96, 125.21, 125.27, 130.88, 130.99, 
132.12 and 132.30 ppm.  
The IR spectrum showed the presence of the azide group at ʋmax 2091.3 cm
-1
 while showing 
no peak for the OH group of the oxime that previously appeared at ʋmax 3162.3 cm
-1
. 
The HRMS spectrum showed the theoretical mass for the [M-2N2+H]
+
 ion to be 265.0720, 
which compared well with the measured accurate mass of 265.0717. 
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4.2.5. Synthesis of 1-azido-2-ethynylbenzene.  
Having looked at some reactions of 2-azidobenzonitrile, we also made the alkyne (419). This 
reaction (Scheme 4.18) was successful but lack of time meant that the chemistry of the alkyne 
was not explored. 
 
The o-azidobenzaldehyde was treated with freshly prepared Bestmann-Ohira reagent in dry 
methanol in the presence of potassium carbonate as a base. The mixture was stirred at room 
temperature for 24 hours. A product was isolated from the reaction mixture by extraction into 
dichloromethane and purified to give the desired product in 90 % yield as a brown oil. 
The structure of compound (419) was confirmed from its IR spectrum, 
1
H NMR  spectrum, 
13
C NMR spectrum and mass spectrometry, and by comparison to the published data of this 
known compound,
223
 which was previously made by a different route. 
In the 
1
H NMR spectrum, for example the terminal CH of the alkyne proton appeared at 3.30 
ppm as a singlet whilst the absence of the aldehyde proton previously at 10.37 ppm was also 
noted. The terminal CH signal of the alkyne was seen at 79.33 ppm and the presence of four 
signals for the aromatic (CH) carbons was seen at 114.05, 124.62, 130.13 and 134.28 ppm in 
the 
13
C NMR spectrum. 
It was confirmed in the infrared spectrum that the compound contained the alkyne group from 
the peak at ʋmax 3290.5 cm
-1
 while the presence of the azide group was seen at ʋmax 2102.8 cm
-
1
. The loss of the  broad peak at ʋmax 1733.3 cm
-1
 for the carbonyl provided further evidence. 
The correct mass of 286.0958 for the measured ion [2M]
+
 further supported the structural 
assignment for the compound (419). 
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4.3. Further azide reactions. 
The final section of this chapter will explore reactions based around the following general 
process: 
 
The aim was to then conduct aza-Wittig reactions and Staudinger reactions and make some 
simple heterocycles and some macrocycles as shown in the examples below. The diazide 
could also be reacted to form triazoles as seen with other azides in this chapter, above. 
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4.3.1. Synthesis of 2-azidobenzyl benzoate. 
 
 
The benzoyl chloride was coupled with o-azidobenzyl alcohol in anhydrous DCM in the 
presence of pyridine and DMF giving the product (479) in good yield (77 %). 
The structure of the product (479) was confirmed by its IR spectrum, 
1
H NMR spectrum, 
13
C 
NMR spectrum and mass spectrometry. 
 
4.3.2. Synthesis of 2-[(triphenyl-λ5-phosphanylidene)amino]benzyl benzoate.  
 
The azide (479) was treated with triphenylphosphine in anhydrous toluene giving the desired 
product of a successful Staudinger reaction in 75%. 
The structure of the product (480) was confirmed by its IR spectrum, 
1
H NMR spectrum, 
13
C 
NMR spectrum and mass spectrometry. 
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In the 
1
H NMR spectrum, the presence of the aliphatic CH2 protons were seen as a singlet at 
5.65 ppm. The twenty four aromatic downfield protons showed as a doublet at 6.39 (1H), a 
triplet at 6.59 (1H), a triplet at 6.79 (1H), a multiplet at 7.24-7.33 (8H), a multiplet at 7.38-
7.45 (4H), a doublet at 7.65 (3H), a doublet at 7.67 (3H) and a doublet at 7.96 (3H) ppm. 
In the 
13
C NMR spectrum, the aliphatic CH2 signal appeared at 65.69 ppm. The twenty four 
aromatic CHs appeared between 117.11-132.60 ppm and six quaternary carbons were seen at 
128.60 (qC), 129.90 (3 x qC), 130.98 (qC) and149.80 (qC) ppm. The carbonyl signal was 
found at 167.02 ppm. 
Infrared spectrum showed the carbonyl absorption group at ʋmax 1715.9 cm
-1
 and the loss of 
the azide absorption peak previously seen at ʋmax 2117.6 cm
-1
. 
Further evidence for the structure was given by the HRMS for the measured ion [M+Na]
+
 was 
consistent at 488.1777. 
4.3.3. Synthesis of 2-phenyl-4H-benzo[d][1,3]oxazine. 
 
The iminophosphorane (480) was heated to reflux in dry toluene for 24 hours under a nitrogen 
atmosphere whilst being monitored by TLC which showed no product formation. The solvent 
was replaced with anhydrous xylene and the mixture heated to reflux for 24 hours. The 
mixture was purified by silica column chromatography giving the desired product (481) in an 
excellent yield of 93 %.    
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The structure of the product (481) was confirmed by its IR spectrum, 
1
H NMR spectrum, 
13
C 
NMR spectrum and mass spectrometry, and comparison to known data. 
224
 
The azide (479) was also reacted with tributylphosphine in anhydrous toluene in order to 
compare the reactivity of triphenyl and tributyl phosphine. The mixture was stirred at room 
temperature for 12 hours. After completion of the reaction, the amine (483) was isolated in 60 
% yield as a yellow oil. 
 
The structure of the compound (483) was confirmed using spectroscopic analysis. 
In the 
1
H NMR spectrum, the protons of the NH2 group appeared at 4.70 ppm as a singlet, and 
the IR spectrum indicated the appearance of the NH2 group with a signal at ʋmax 3376.9 cm
-1
 
and also showed the disappearance of the peak at ʋmax 2117.6 cm
-1
 for azide group, in addition 
to the presence of the (C=O) peak at ʋmax 1705.1 cm
-1
. 
The reaction of azide (479) with PBu3 was repeated without attempting to isolate the 
iminophosphorane. This formed the expected oxazine (481) in 69 % yield togther with a 
second product, compound (484), as shown in Scheme 4.24: 
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The structure of product (484) was deduced from its IR spectroscopy, 
1
H NMR spectrum, 
13
C 
NMR spectrum and mass spectrometry. 
The 
1
H NMR spectrum confirmed the presence of fourteen aromatic protons which indicates 
the presence of the three aryl groups. The proton of the NH group in the product was seen as a 
broad singlet at 9.69 ppm. The methylene CH2 protons were seen as a singlet at 5.31 ppm.  
The 
13
C NMR spectrum indicated the presence of fourteen CH peaks in the three aromatic 
rings at 124.71 (CH), 125.24 (CH), 127.45 (2 x CH), 128.53 (2 x CH), 128.73 (2 x CH) 
129.88 (2 x CH), 130.01 (CH), 131.75 (CH), 131.91 (CH) and 133.60 (CH) ppm whilst the 
two carbonyl peaks were seen at 165.82 and 167.47 ppm with the methylene CH2 peak found 
at 66.12 ppm. 
The infrared spectrum showed the disappearance of azide group. The NH peak was found at 
ʋmax 3317.1 cm
-1
 and the carbonyl group was seen at ʋmax 1696.1 cm
-1
.  
Mass spectrometry further supported the structure of product (484) with a measured mass of 
331.1205 for the ion [M]
+
 for a required mass of 331.1195. 
Compound (484) could arise from the reaction of the arylamine (483) with the ester (479), a 
process that should eliminate 2-azidobenzyl alcohol, which was not, however, seen in the 
reaction mixture. 
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4.3.4. Synthesis and reactivity of 2-azidobenzyl 2-azidobenzenesulfonate. 
 
 The sulfonic acid was converted to the sulfonyl chloride by heating at reflux as a suspension 
in 2M (COCl2) in DCM and DMF. The sulfonyl chloride was treated with o-azidobenzyl 
alcohol in an aqueous solution of potassium carbonate as the base. The mixture was stirred at 
room temperature and monitored by TLC which showed no product. The same reaction was 
repeated using triethylamine and different amounts of DMF. All attempted reactions were 
unsuccessful at room temperature. The reaction was repeated by heating at 80 
o
C for 72 hours. 
A new product was formed. The mixture was purified to give the desired product (475) in 
good yield (72%). 
Compound (475) was reacted with triphenylphosphine (PPh3) in dry toluene. The mixture was 
stirred at room temperature for 24 hours, after which time the azide had disappeared. The 
desired product (476) was isolated in 71 % yield. 
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The formation of compound (476) was implied from IR spectroscopy, 
1
H NMR and 
13
C NMR 
spectroscopy.  
The 
1
H NMR spectrum showed the presence of four signals integrating to thirty eight 
aromatic protons in the aromatic range between 6.32-8.10 ppm and showed the methylene 
(CH2) as a singlet at 5.15 ppm. The 
13
C NMR spectrum showed the presence of ten quaternary 
carbons and thirty eight aromatic (CH) carbons and the presence of the methylene (CH2) at 
26.73 ppm. The infrared spectrum showed the disappearance of the azide stretch at ʋmax 
2125.7 cm.
-1 
The iminophosphorane (476) was treated with diethyl malonate in anhydrous toluene. The 
mixture was heated to reflux for 24 hours. The desired product (477, Scheme 4.27) could not 
be identified, and no other identifiable products were found. 
Compound (476) also failed to undergo aza-Wittig reaction with benzaldehyde. 
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4.3.5. Synthesis and reactivity of 2-azidobenzyl 2-azidobenzoate. 
 
2-Azidobenzoic acid was converted into the 2-azidobenzoyl chloride by heating at reflux with 
(COCl)2 in dichloromethane and DMF. The o-azidobenzoyl chloride was treated with o-
azidobenzoyl alcohol, triethylamine and DMF in DCM. The mixture was stirred at room 
temperature for 72 hours whilst being monitored by TLC which showed no product. The 
solvents were removed and replaced with pyridine and the mixture heated for 48 hours whilst 
being monitored by TLC. A new product was observed and the desired product (485) was 
isolated in good yield (74%), and its structure confirmed by spectroscopic analysis. 
The diazido compound was treated with triphenylphosphine in toluene. A single new product 
was isolated and was identified the arylamino iminophosphorane (487) rather that the di-
iminophosphorane (486), as shown in Scheme 4.29. Compound (487) was formed in 50 % 
yield. 
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The 
1
H NMR spectrum of the product showed the presence of the methylene CH2 protons and 
the NH2 group as a broad singlet at 5.72 ppm. The aromatic protons appeared as a doublet at 
6.51 (1H), a triplet at 6.56 (1H), a doublet at 6.62 (1H), a triplet at 6.70 (1H), a triplet at 6.90 
(1H), a triplet at 7.23 (1H), a doublet at 7.39 (1H), a multiplet at 7.44-7.47 (6H), a multiplet at 
7.51-7.55 (3H), a multiplet at 7.76-7.80 (6H) and a doublet at 7.93 (1H) ppm, and confirmed 
that only one PPh3 had reacted. 
The 
13
C NMR spectra displayed the quaternary carbons at 111.76, 129.95, 130.17, 130.79, 
131.78, 149.92 and 150.21 ppm whilst the expected number of aromatic CH carbons appeared 
between 116.13 –133.67 ppm. The methylene CH2 carbon appeared at 65.14 ppm and the 
carbonyl carbon was seen at 168.52 ppm. The infrared spectrum showed that the azide was 
absent and also showed the presence of the carbonyl group peak at  ʋmax 1684.0 cm
-1
 in 
addition to the appearance of the amine absorption group at ʋmax 3369.8 and 3473.7 cm
-1
. 
Mass spectrometry further supported the structure of product with a measured mass of 
503.1883 for ion [M+H]
+
 for a required mass of 503.1884. 
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The arylamino iminophosphorane (487) was treated at reflux with diethyl malonate in 
anhydrous toluene giving the product (488) in 65 % yield, the structure of which was deduced 
from its IR spectroscopy, 
1
H NMR spectrum, 
13
C NMR spectrum and mass spectrometry. 
 
The 
1
H NMR spectrum showed a triplet at 1.20 ppm and a quartet at 4.17 ppm that 
correspond to the CH3 and OCH2 of the ethoxy unit, respectively. The proton of the NH group 
in the product appeared as a singlet at 13.27 ppm. The eight protons of the two aromatic rings 
appeared as a doublet at 6.97 (1H), a doublet of doublets at 7.04 (1H), a multiplet at 7.14-7.22 
(2H), a doublet of doublets at 7.27 (1H), a doublet of doublets at 7.41 (1H), a doublet at 7.95 
(1H) and a doublet at 8.64 (1H) ppm. The methylene CH2 protons between the ethoxy and 
amide groups were seen at 3.50 ppm while the protons of the methylene (CH2) group of the 
benzyl ester were seen at 5.34 ppm. 
The 
13
C NMR spectrum indicated the terminal methyl of the ethoxy group at 14.15 and the 
methylene at 61.63 ppm. The two carbonyl signals appeared at 163.94 and 167.46 ppm while 
the imine peak (C=N) appeared at 158.94 ppm. The eight signals for the aromatic (CH) 
carbons were seen at 120.40, 122.74, 124.01, 124.12, 127.23, 128.94, 129.23 and 132.71 ppm. 
In the infrared spectrum, it was determined that the product contained the NH stretching 
absorption with a peak at ʋmax 3161.4 cm
-1
 and a carbonyl group at ʋmax 1737.5 cm
-1
. 
The HRMS spectrum showed the theoretical mass for the [M]
+
 ion to be 338.1267, which 
compared well with the measured accurate mass of 338.1278. 
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4.4. Conclusion 
This chapter has shown that a range of simple aryl azides are potentially useful building 
blocks for the synthesis of benzotriazinones, quinazolines, ligand-like oxadiazolyl substituted 
1,2,3-triazolyl benzenes, various diazides and  one example of a 12-membered ring 
macrocyclic oxadiazacyclododecine. 
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Chapter 5: 
5. Results and Discussion: Attempted Synthesis of circumdatin and 
fuligocandin analogues. 
5.1. Introduction and Aims. 
Circumdatins D, E, H and J are examples of pyrrolobenzodiazepine alkaloids that were 
extracted  from a terrestrial strain of the fungus Aspergillus as reported by Rahbeak et al. in 
1999, and shown in figure 5.1 below. 
 
This chapter will deal with the attempted synthesis of sulfonamide analogues of these 
circumdatins. 
The circumdatins are targets because of the wide range of biological activities they process 
such as inhibition of mitochondrial NADH oxidase, antifungal, antitumor and antibiotic 
activity.
135,137,225-227
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This aims of this work are summarised below, and this chapter will look at the synthesis of 
known
161
 compound (441) and its reactivity towards 2-azidobenzoyl chloride and 2-
azidobenzenesulfonyl chloride to give intermediates (450) and (453) as shown in Scheme 5.1. 
Aza-Wittig reaction would then give the circumdatin analogues (451) and (454). This is 
discussed in Section 5.2. 
 
 
Attempts were also made to convert known
161
 compound (441) into fuligocandin analogues. 
The fuligocandins are pyrrolobenzodiazepine natural products that have attracted interest due 
to anti-leukemia, antitumor activity.
143,228-230
 The fuligocandins themselves have been 
synthesised
143
 (see introduction) and again, the aim of this section of the work was to produce 
sulfonamide analogues based on this route. This is summarised in Scheme 5.2 and is 
discussed in Section 5.3 
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5.2. Attempted synthesis of Circumdatin analogues. 
5.2.1. Methoxycarbonyl-1-(2'-azidobenzenesulfonyl)pyrrolidine. 
The first step on the way to precursor (441) [see aims] was to couple 2-azidobenzenesulfonic 
acid and L-proline as per Scheme 5.3: 
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Thus, 2-azidobenzenesulfonic acid
231
 was converted into the sulfonyl chloride by heating at 
reflux in thionyl chloride and DMF. Coupling of the 2-azidobenzenesulfonyl chloride with L-
proline methyl ester was performed in a mixed phase process with aqueous potassium 
carbonate as the base to give the desired product (440) in 58 % yield.  
Evidence for the successful coupling was given by the 
1
H NMR spectrum which showed the 
three protons of the methyl ester at 3.59 ppm. The four aromatic protons were located at 7.16 
(1H), 7.22 (1H), 7.51 (1H) and 7.93 ppm (1H) and the pyrrolidine ring CH2 protons showed at 
1.79-1.88 (1H), 1.99-2.04 (2H), 2.08-2.18 (1H), 3.34-3.40 (1H) and 3.56-3.61 (1H) ppm with 
the CH of the pyrrolidine ring at 4.60-4.63 ppm. The 
13
CNMR spectrum, infrared and mass 
spectrum were fully consistent, and the data was identical to that for this compound produced 
elsewhere in the group for another project
161
.  
 
5.2.2. Attempted synthesis of 10,10-dioxo-2,3,3a,5-tetrahydro-1H-
pyrrolo[1,2-b][1,2,5]benzothiadiazepin-4-one. 
 
 
Following a procedure used by Bergman with the corresponding amide
143
, reaction of the 
ester (440) and triphenylphosphine in dry THF was attempted at room temperature. After 
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completion of the reaction by TLC, water was added. The mixture was heated at reflux 
overnight. The mixture was purified by using column chromatography. Instead of the desired 
product (441), the amine (442) was isolated (39 %), a compound that is known in the 
literature.
232
 
It was possible that triphenylphosphine was the wrong choice of phosphine in this reaction. 
Thus, the reaction also was attempted with tributylphosphine (PBu3).
143
 After completion of 
the reaction which was monitored by TLC at regular intervals, a mixture of products (442) 
and (443) was isolated. Compound (442) was identical to that isolated before. The structure of 
the compound (443) was confirmed by spectroscopic analysis. 
 
The 
1
H NMR spectrum indicated the seven pyrrolidine protons at 1.62-1.71 (1H), 1.76-1.95 
(2H), 2.21-2.30 (1H), 2.80-2.86 (1H), 3.27-3.32 (1H) and 4.50 (1H) ppm while the methyl 
protons (CH3) appeared at 3.71 ppm. The four aromatic protons were observed as a doublet of 
doublets at 7.02, a doublet at 7.12, a doublet of doublets at 7.39 and a doublet at 7.69 ppm. 
The 
13
C NMR spectrum indicated the three quaternary carbons at 131.69, 140.48 and 164.49 
ppm while the methyl carbon appeared at 63.75 ppm. 
Infrared spectral data confirmed the disappearance of the azide group and confirmed the 
absence of the carbonyl group peak previously seen at ʋmax 1736.7 cm
-1
. 
All attempts to convert azide (440), amine (442) or imine (443) into the desired compound 
(441) were unsuccessful. Thus, other routes towards compound (441) were explored. 
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5.2.3. 2-Methoxycarbonyl-1-(2'-nitrobenzenesulfonyl)pyrrolidine. 
With the azide (440) proving to be an unsuccessful precursor, we looked instead at the 
corresponding nitro compound (Scheme 5.5): 
 
In the first step, the sulfonyl chloride was coupled with L-proline methyl ester in an aqueous 
solution of potassium carbonate
231
 giving the product (445) in good 84% yield.  
The structure of compound (445) was deduced from its IR spectrum, 
1
H NMR (400 MHz) 
spectrum, 
13
C NMR (100 MHz) spectrum and mass spectrometry, and is a known 
compound.
161
 
 
The next step was reduction of the nitro ester to amino ester. The nitro ester was reacted with 
iron powder in glacial acetic acid
161
 and afforded the amino ester (442), identical to that 
formed above, in 74 % yield.  
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We had hoped that the amino ester would cyclise under these conditions to give the desired 
product (441). As this did not happen, it became critical to find a method to cyclise compound 
(442). After many efforts, a method was found (next section).  
 
 
5.2.4. Successful synthesis of 10,10-dioxo-2,3,3a,5-tetrahydro-1H-
pyrrolo[1,2-b][1,2,5]benzothiadiazepin-4-one. 
The route chosen was a literature route
233
 that had proven very difficult to repeat for a 
previous worker in the group.
161
 
 
The aminoester (442) and 2-hydroxy pyridine were mixed in diphenyl ether and heated under 
reflux at 205 
o
C while monitoring via TLC overnight. A new product was identified. The 
structure of compound (441) was confirmed by its IR spectrum, 
1
H NMR spectrum, 
13
C NMR 
spectrum and mass spectrometry, and was identical to that in the literature
232,233
, and to that 
reported by João from our research group.
161
  
Unfortunately, and as reported by João, the reaction was low yielding, often did not work and 
was not a reliable way of getting the quantity of compound (441) needed. Thus, another route 
to (441) was investigated, as summarised in Scheme 5.8: 
Chaper 5                                                                                                                           Results and Discussion 
167 
 
 
Thus, 2-nitrobenzenesulfonyl chloride was coupled with L-proline in sodium hydroxide to 
give the carboxylic acid (446) in excellent yield and purity. 
Reduction
137
 of the nitro carboxylic acid (446) to the amino carboxylic acid (448) was 
achieved in 71 % yield with iron powder in glacial acetic acid.  
The structure of the amino carboxylic acid (448) was confirmed from its IR spectrum and 
from 
1
H and 
13
C NMR spectroscopy and mass spectrometry.   
The amide bond forming reaction was achieved by the addition of N,N’-
dicyclohexylcarbodiimide (DCC) in DCM to the amino carboxylic acid (448).
137
 The mixture 
was stirred overnight, and a new product was isolated from the reaction mixture, and found to 
be (441) in  63 % yield. 
The structure of the product (441) was confirmed by IR spectroscopy, 
1
H NMR spectrum, 
13
C 
NMR spectroscopy and mass spectrometry, and was identical to that formed by the unreliable 
methods discussed above. 
This was found to be the most reliable procedure for the synthesis of known compound (441). 
With a reliable route established, we could at last start to look at routes towards the 
circumdatin analogues all based on Scheme 5.1 in the aims, above.  
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5.2.5. Attempted Synthesis of Circumdatin Analogues from Compound 
(441). 
 
This followed the method Bergman used for the actual circumdatins. The amide (441) was 
treated with 2-azidobenzoyl chloride in the presence of Et3N and DMAP and the mixture 
stirred for 2 hours at room temperature.
137
 TLC showed starting material and a new product. 
This was assumed to be intermediate (450). This crude reaction mixture was dissolved in dry 
benzene and (n-Bu)3P was added. The mixture was heated for 1 hour at 60 
o
C. None of the 
desired product (451) or intermediate (450) could be identified and only starting material 
(441) could be identified, and was recovered in 75 % yield. All attempts to isolate the 
intermediate (450) were unsuccessful under a wide variety of conditions. 
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This was a very disappointing results as we knew that Bergman had performed this reaction 
with the amide analogue of (441) [ie C=O in place of SO2]. 
5.2.6. Attempted synthesis the double sulfonamide.  
 
 
This time, amide (441) was treated with DMAP, Et3N and 2-azidobenzenesulfonyl chloride. 
No product was formed with only starting material being recovered. The conditions followed 
were those that had previously been successful for Bergman
137 
for the synthesis of the 
circumdatin diamide system. A wide variety of modified conditions also failed to give (453). 
For completion, we also attempted to form compound (453) in-situ and react it with tri-n-
butyl phosphine. This was also unsuccessful. The difficulty we had in making compound 
(441) and its failure to react was a major problem for the direction of this project, and we had 
no choice but to stop investigation into the synthesis of sulfonamide analogues of 
circumdatins. 
Previous work in the group
161
 had attempted to use the pyrrolobenzothiadiazepine (441) to 
make fuligocandin analogues. This work had revealed several steps that needed to be 
explored. The rest of this chapter explores the efforts made in this thesis towards completing 
the group’s route to sulfonamide analogues of fuligocandin. 
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5.3. The Attempted synthesis of Fuligocandin analogues. 
Scheme 5.2, above, Summarised the aims of this section of the work. 
5.3.1. Synthesis of 1,2,3,11a-tetrahydrobenzo[f]pyrrolo[1,2-
b][1,2,5]thiadiazepine-11(10H)-thione 5,5-dioxide. 
 
 
The amide (441) was reacted with Lawesson’s reagent143 in MeCN. A product was isolated 
from the reaction mixture by silica column chromatography and was identified as the desired 
product in yielded (11 %). 
João had previously
161
 made compound (455) in 37 % yield. However, there were other steps 
to investigate so we moved on with the fuligocandin analogue synthesis. 
 
5.3.2.  Synthesis of phosphorus ylide for the fuligocandin B analogue. 
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This was prepared from 1,3-dichloroacetone and triphenylphosphine as per Scheme 5.12. The 
mixture was refluxed for 24 hours, filtered and treated with Na2CO3/MeOH-H2O. The identify 
of compound (130) was deduced from its melting point=179-182 
o
C (Lit. m.p.= 178-180 
o
C)
234
, and  it was formed in 60 % yield. 
 
5.3.3. Synthesis of the Precursor for Fuligocandin B. 
Before attempted to make fuligocandin analogues, the indole needed for fuligocandin needed 
to be protected. In the literature Bergman
143
 used 2-nitrophenylsulfonyl chloride when the 
actual fuligocandins were made. 
 
Indole-3-carbaldehyde was successfully reacted with 2-nitrophenylsulfonyl chloride. 
The structure of compound (467) was deduced from its IR spectrum, 
1
H NMR spectroscopy, 
13
C NMR spectroscopy and mass spectrometry, and was identical to that synthesised in the  
previously literature.
143
 The 4-nitro analogue was successfully synthesised in the same 
fashion, again as described previously
161,143
. We also made the previously unreported 2-
azidophenylsulfonyl analogue of (467). 
All attempts to react the 2-nitro compound
143
 or its 4-nitro analogue with phosphorus ylide 
(130) were unsuccessful. This is a well-established literature process and its failure is still 
being explored in the group. It should be noted that João
161
 succeeded with this step but failed 
to react compound (468) with compound (455).  
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Due to being unable to make the indole needed for the fuligocandin B indole
143
 based system 
we completed this section of the work by attempting the synthesis of the more simple 
fuligocandin A SO2 analogue. Reaction of the compound (455) with chloroacetone under the 
Eschenmoser conditions described by Bergman
143
 with the corresponding amide was 
unsuccessful. This confirmed the earlier findings of João, and also implied, in conclusion to 
this section, that this route to sulfonamide analogues of the fuligocandins was not viable. 
 
The routes explored towards the synthesis of sulfonamide analogues of the circumdatins and 
fuligocandins were both unsuccessful and this concludes the discussion of this thesis. 
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Experimental 
General Techniques: 
For all reactions conducted under anhydrous conditions, the glassware was oven dried and the 
reaction was carried out under a nitrogen atmosphere, unless otherwise stated. 
 
Solvents and Reagents: 
Bulk solutions were evaporated under reduced pressure using a Büchi rotary evaporator. 
Reagents and solvents used were obtained from commercial suppliers or purified according to 
standard procedures. Pet ether refers to distilled light petroleum of fraction (40–60 °C). 
THF was distilled over sodium wires (1‐2%, w/v) with benzophenone as the indicator. 
Dichloromethane and toluene were distilled over calcium hydride (5% w/v) for ~5 h. All other 
anhydrous solvents and commercially available starting materials were purchased from the 
following suppliers. Acros, Fisher Scientific and Sigma Aldrich. Deuterated solvents were 
purchased from Goss Scientific. 
All reactions monitored and analysed by thin layer chromatography (TLC)  were done so 
using Macherey-Nagel 0.2 mm pre-coated Alugram® N/UV254 silica gel or alumina gel 
plates.  
Column chromatography was conducted using 60 Å, 70-230 mesh, 63-200 μm silica gel 
supplied by Sigma-Aldrich. Where necessary, 60 Å, 50-200 μm, basic alumina gel was used 
and was supplied by Acros. 
NMR Spectroscopy: 
1
H NMR, 
13
CNMR, DEPT, COSY and HSQC NMR spectra were recorded on Bruker DPX, 
Bruker AVIII 400 MHz NMR and Bruker AV500 NMR spectrometers. Chemical shifts (δH) 
are quoted in parts per million relative to the residual protiosolvent (δH (CHCl3) = 7.24 ppm) 
against an internal deuterium lock. Coupling constants (J) are given in Hertz. 
The 
1H NMR spectra are reported as follows: δ / ppm (number of protons, multiplicity, 
coupling constants J /Hz, assignment). DEPT and two‐dimensional NMR spectroscopy 
(COSY, HSQC) were used where appropriate to assist the assignment of the signals in the 
1
H 
NMR and 
13
C NMR spectra. 
 
Mass Spectrometry: 
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High resolution mass spectra (accurate mass) were recorded on a 6210-Time-of-Flight 
LC/LM. 
Melting Points: 
Melting point determinations were recorded on a Stuart SMP 10 digital melting point 
apparatus. 
Infra‐Red Spectroscopy: 
Infrared spectra were recorded on a Nicolet 380 FT‐IR instrument as a thin film for oils and 
neat for solids. 
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6. Chapter 6: Experimental for chapter 2: multicomponent reactions 
(MCRs). 
6.1. Synthesis of Tetrazolo[1,5-a] quinoline-4-carbonitrile. 
 
 
o-Azidobenzaldehyde
168
 (2.00 g, 13.6 mmol), piperidine (1 drop), malononitrile (1.08 g, 
16.31 mmol, 1.2 eq) and ethanol (20 mL) were heated at reflux for 1 hour.  The solution was 
then cooled to room temperature. The solvent was evaporated to yield the product as a brown 
solid (1.1 g, yield = 68 %, m.p = 274-276 
o
C, lit. m.p = 276-278 
o
C
173
). 
IR: ʋmax (cm
-1
): 3061.2, 2980.0, 2236.5, 1614.8, 1600.6, 1579.9, 1533.1, 1235.3, 1221.2, 
1153.1, 1041.5, 936.2, 776.6. 
1
H NMR: H (400 MHz, DMSO): 9.02-9.07 (1H, m, H-C=C), 8.80 (1H, d, J=7.8 Hz, H-Ar), 
8.10-8.13 (2H, m, 2 x H-Ar), 7.88 (1H, dd, J
1
=7.8 Hz, J
2
= 1.5 Hz H-Ar). 
13
C NMR c (100 MHz, DMSO): 145.73 (qC), 143.37 (CH), 134.82 (CH), 131.41 (CH), 
130.83 (CH), 128.93 (qC), 122.66 (qC), 116.53 (CH), 114.04 (CN), 97.18 (qC). 
HRMS (m/z): [M + H
+
] for C10H6N5 calculated = 196.0618, measured = 196.0627. 
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6.2. Attempted synthesis of 2-(2-azidophenyl)-4-(cyclohexylamino)-3-nitro-
5-phenylcyclopent-3-ene-1,1-dicarbonitrile. 
 
A mixture of benzylidene malononitrile (77 mg, 0.5 mmol), cyclohexane isocyanide (54.5 
mg, 0.5 mmol), and 2-azido nitrostyrene (95 mg, 0.5 mmol) was stirred in dry THF (15 mL) 
for 24h at ambient temperature. TLC showed no reaction. 
6.3. Synthesis of 3-(2-Morpholinoethylamino)-5-(2-azidophenyl)-4-nitro-2-
phenylcyclopent-3-ene-1,1-dicarbonitrile. 
 
 
A mixture of benzylidenemalononitrile
176
 (77 mg, 0.5 mmol, 1.0 eq), 2-morpholinoethyl 
isocyanide (70 mg, 0.5 mmol, 1.0 eq), and 2-azido-β-nitrostyrene235,162 (95 mg, 0.5 mmol, 1.0 
eq) was stirred in dry THF (15 mL) for 48h at ambient temperature. After completion of the 
reaction, which was monitored by TLC, the solvent was evaporated and the residue was 
dissolved in diethyl ether (15 mL). After 10 min., the product precipitated directly from the 
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solution and was filtered and washed with diethyl ether (2 × 15 mL). Purification by silica gel 
chromatography (petroleum ether/ ethyl acetate:1/2) yielded the pure product as a light yellow 
powder (170 mg, 89 %, m.p.= 187 - 188 
o
C). 
IR: ʋmax (cm
-1
): 3196.4 (NH), 3050.0 (C=CH unsat), 2920.5 (CH o.o.p.), 2877.6 (CH sat.) 
2190.0 (CN), 2128.5 (N3), 1638.9 (NO2), 1600.9 (C=C), 1555.0 (C=Cring), 1231.0 (C-C), 
1142.3 (C-N), 737.5. 
1
H NMR: H (400 MHz, CDCl3): 9.80 (1H, s, HN), 7.56 (2H, t, J=3.2 Hz, ArH), 7.24-7.51 
(5H, m, ArH), 7.19 (1H, dd, J=7.3 Hz, ArH), 7.12 (1H, dd, J=7.3 Hz,  ArH), 5.51 (1H, s, CH-
Ar), 4.76 (1H, s, CH-Ar), 3.77 (4H, t, J=4.5 Hz, CH2-O-CH2-), 2.88 (2H, t, J=7.6 Hz, CH2-
CH2), 2.51 (4H, t, J=4.5 Hz, CH2-N-CH2-), 1.35 (2H, t, J=7.6 Hz, CH2-CH2). 
13
C NMR c (100 MHz, CDCl3): 157.79 (qC), 138.79 (qC), 133.35 (qC), 131.18 (CH), 
130.50 (CH), 130.18 (2 x CH), 129.36 (2 x CH), 128.20 (CH), 126.59 (qC), 125.74 (CH), 
125.52 (CH), 114.47 (qC), 113.99 (CN), 113.02 (CN), 66.61 (2 x CH2), 56.40  (CH2), 54.62 
(CH), 53.30 (CH), 53.25 (2 x CH2), 44.63 (qC), 42.12 (CH2). 
MS (m/z): [M + H
+
] for C25H25N8O3 calculated = 485.2044, measured = 485.2055. 
 
6.4. Synthesis of 3-(2-Morpholinoethylamino)-5-(2-azidophenyl)-2-(4-
chlorophenyl)-4-nitrophenylcyclopent-3-ene-1,1-dicarbonitrile. 
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A mixture of 4-chloro benzylidenemalononitrile
176
 (94.25 mg, 0.5 mmol, 1.0 eq), 2-
morpholinoethyl isocyanide (70 mg, 0.5 mmol, 1.0 eq) and 2-azidonitrostyrene (95 mg, 0.5 
mmol, 1.0 eq) was stirred in dry THF (15 mL) for 48h at ambient temperature. After 
completion of the reaction which was monitored by TLC, the solvent was evaporated and the 
residue was dissolved in diethyl ether (15 mL). After 10 min., the product precipitated directly 
from the solution and was filtered and washed with diethyl ether (2 × 15 mL). Purification by 
silica gel chromatography (petroleum ether/ethyl acetate: 1/2, Rf=0.3) yielded the pure 
product as a pale orange solid (160 mg, 0.218 mmol, 78 %, m.p.=148-150 
o
C). 
IR: ʋmax (cm
-1
): 3232.3 (NH), 3050.0 (C=CHunsat), 2923.2 (o.o.p.), 2819.5 (CH sat), 2195.2 
(CN), 2125.4 (N3), 1626.6 (NO2), 1583.3 (C=C), 1550.0 (C=Cring), 1231.0 (C-C), 1182.2 (C-
N), 752.7 (C-Cl), 730.0 (CH). 
1
H NMR: H (400 MHz, DMSO): 9.85 (1H, s, HN), 7.63 (2H, d, J=8.5 Hz, 2 x ArH), 7.47-
7.58 (3H, m, 3 x ArH), 7.41 (1H, dd, J=7.3 Hz, ArH), 7.27 (1H, dd, J=7.3 Hz, ArH), 7.16 
(1H, d, J=7.3 Hz, ArH), 5.35 (1H, s, CH-Ar),  5.25 (1H, s,  CH-Ar), 3.57 (4H, t, J=3.0 Hz, 
CH2-O-CH2-), 3.16 (2H, t, J=6.2 Hz, CH2-CH2), 3.01 (2H, t, J=6.2 Hz, N-CH2), 1.30-2.44 
(4H, t, J=3.0 Hz, CH2-N-CH2-). 
13
C NMR c (100 MHz, DMSO): 157.26 (qC), 139.03 (qC), 135.31 (qC), 132.26 (qC), 
131.61 (2 x CH), 130.92 (CH), 130.25 (CH), 129.72 (2 x CH), 125.72 (qC), 119.83 (CH), 
119.52 (CH), 114.48 (qC), 113.38 (CN), 112.23 (CN), 66.68 (2 x CH2), 56.40 (CH2), 54.79 
(CH), 53.89 (CH),  53.29 (2 x CH2), 44.44 (qC), 42.44 (CH2). 
HRMS (m/z): [M+H
+
] for C25H23N8O3Cl calculated = 519.1654, measured = 519.1657. 
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6.5. Synthesis of 3-(2-Morpholinoethylamino)-5-(2-azidophenyl)-4-nitro-2-
(nitrophenyl)cyclopent-3-ene-1,1-dicarbonitrile. 
 
A mixture of of 4-nitrobenzylidenemalononitrile
177
 (99.5 mg, 0.5 mmol, 1.0 eq), 2-
morpholinoethyl isocyanide (70 mg, 0.5 mmol, 1.0 eq) and 2-azidonitrostyrene (95 mg, 0.5 
mmol, 1.0 eq) was stirred in dry THF (15 mL) for 48h at ambient temperature. After 
completion of the reaction which was monitored by TLC, the solvent was evaporated and the 
residue was dissolved in diethyl ether (15 mL). After 10 min., the product precipitated directly 
from the solution and was filtered and washed with diethyl ether (2 × 15 mL). Purification by 
silica gel chromatography (petroleum ether/ethylacetate: 1/2, Rf = 0.3) yielded the pure 
product as a brown solid (140 mg, 67 %, m.p.=115-117 
o
C). 
IR: ʋmax (cm
-1
): 3239.8 (NH), 3081.6 (C=CHstr.), 2950.0 (CH (Sat)), 2250.6 (CN), 2125.6 
(N3), 1628.3 (NO2), 1600.0 (C=C), 1523.6.0 (C=Cring), 1231 (C-C), 1113.7 (C-N), 729.3 (C-
H). 
1
H NMR: H (400 MHz, DMSO): 9.72 (1H, s, HN), 8.11 (1H, d, J=8.5 Hz,  ArH), 7.73 (2H, 
d, J=8.5 Hz, 2 x ArH), 7.25-7.42 (3H, m, 3 x ArH), 7.14 (1H, dd, J=7.3 Hz, ArH), 7.03 (1H, 
dd, J=7.3 Hz, ArH), 5.62 (1H, s, CH-ArNO2), 5.15 (1H, s, CH-ArN3), 3.43 (4H, t, J=3.0 Hz, 
CH2-O-CH2-), 3.03 (2H, t, J=6.0 Hz, CH2-CH2), 2.81 (2H, t, J=6.0 Hz, CH2-CH2), 2.36 (4H, 
t, J=3.0 Hz, CH2-N-CH2-). 
13
C NMR c (100 MHz, DMSO): 170.81 (qC), 156.58 (qC), 148.87 (qC), 148.49 (qC), 
131.64 (2CH), 131.01 (CH), 128.28 (CH), 126.30 (CH), 125.76 (CH), 125.19 (2 x CH), 
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124.62 (qC), 119.88 (qC), 113.89 (CN), 113.59 (CN), 66.67 (2 x CH2), 56.28 (CH2), 54.57 
(CH), 53.83 (CH),  53.24 (2 x CH2)), 44.11 (qC), 42.62 (CH2). 
HRMS (m/z): [M + H
+
] for C25H23N9O5 calculated = 530.1895, measured = 530.1909. 
6.6. Synthesis of 3-(2-Morpholinoethylamino)-5-(2-azidophenyl)-2-(4-ethoxy 
phenyl)-4-nitrocyclopent-3-ene-1,1-dicarbonitrile. 
 
 
A mixture of of 4-methoxybenzylidenemalononitrile
176
 (92 mg, 0.5 mmol, 1.0 eq), 2-
morpholinoethyl isocyanide (70 mg, 0.5 mmol, 1.0 eq) and 2-azidonitrostyrene (95 mg, 0.5 
mmol, 1.0 eq) was stirred in dry THF (15 mL) for 48h at ambient temperature. After 
completion of the reaction which was monitored by TLC, the solvent was evaporated and the 
residue was dissolved in diethyl ether (15 mL). After 10 min., the product precipitated directly 
from the solution and was filtered and washed with diethyl ether (2 × 15 mL). Purification by 
silica gel chromatography (petroleum ether/ethyl acetate: 1/2, Rf=0.23) yielded pure product 
as a light brown powder (50 mg, 20 %, m.p.=152 - 154 
o
C). 
IR: ʋmax (cm
-1
): 3188.2 (NH), 3050.0 (C=CHstr), 2934.0 (CH (Sat)), 2251.5 (CN), 2123.0 
(N3), 1630.0 (NO2), 1611.5 (C=C), 1582.7 (C=C) ring, 1253.2(C-C), 1114.1(C-N), 752.3 (C-
H). 
1
H NMR: H (400 MHz, DMSO): 9.86 (1H, s, HN), 7.39-7.58 (3H, m, 3 x ArH), 7.27 (1H, 
dd, J=7.0 Hz, ArH), 7.16 (1H, t, J=7.0 Hz,  ArH), 7.09 (2H, d, J=8.65 Hz, 2 x ArH), 6.94 
(1H, d, J=8.5 Hz, ArH), 5.76 (1H, s, CH), 5.31 (1H, s, CH), 3.56-3.57 (4H, m, CH2-O-CH2-), 
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3.19 (2H, t, J=6.8 Hz, CH2-CH2), 2.95-3.04 (2H, t, J=6.8 Hz, CH2-CH2), 2.30 (4H, t, J=3.3 
Hz, CH2-N-CH2-). 
13
C NMR c (100 MHz, DMSO): 160.70 (qC), 158.13 (qC), 139.01 (qC), 138.79 (qC), 
131.20 (2 x CH), 130.82 (CH), 128.18 (CH), 126.66 (CH), 125.74 (CH), 125.54 (2 x CH), 
124.21 (qC), 119.81 (qC), 114.97 (CN), 114.08 (CN), 66.69 (2 x CH2-), 56.49 (CH2), 55.73 
(CH), 55.62 (CH), 54.13 (CH3), 53.30 (2 x CH2), 44.90 (qC), 42.21 (CH2). 
HRMS (m/z): [M + H
+
] for C26H26N8O4 calculated = 515.2149, measured = 515.2147. 
 
6.7. Synthesis of tetrazolo[1,5-a]quinoline-4-carboxamide 
 
A mixture of of hydantoin (300 mg, 3.0 mmol), 2-azidobenzaldehyde (441 mg, 3 mmol), 
malononitrile (198 mg, 3.0 mmol), piperidine (10 mmol %) and 25 mL of water were stirred 
for 8h at 70 
o
C. After completion of the reaction, which was monitored by TLC, the solvent 
was evaporated. The residue was purified by silica gel chromatography (petroleum ether/ethyl 
acetate: 1/1, Rf=0.25) which yielded the pure product (233) as a light yellow soild (200 mg, 
34 %, m.p.= 139 - 141 
o
C). 
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IR: ʋmax (cm
-1
): 3385.4, 3300.2, 3153.9, 3048.5, 2923.0, 2852.0, 1703.0, 1619.4, 1599.2, 
1596.0, 1213.0, 1148.0, 763.7. 
1
H NMR: H (400 MHz, DMSO): 8.96 (1H, s, CH), 8.68 (1H, d, J=8.1 Hz, ArH), 8.33-8.49 
(3H, m, (NH2 + ArH)), 8.11 (1H, dd, J
1
=7.3 Hz, J
2
= 7.1 Hz, ArH) 7.89 (1H, dd, J
1
=7.2 Hz, 
J
2
= 6.8 Hz,  ArH). 
13
C NMR c (100 MHz, DMSO): 162.44 (C=O), 146.26 (qC), 137.19 (CH), 133.74 (CH), 
131.52 (CH), 131.30 (qC), 129.03 (CH), 123.64 (qC), 118.60 (qC), 116.71 (CH). 
HRMS (m/z): [M + H
+
] for C10H7N5O calculated = 236.0543, measured = 236.0552. 
6.8. Synthesis tetrazolo[1,5-a]quinoline-4-carbonitrile. 
 
 
A mixture of hydantoin (300 mg, 3.0 mmol), benzaldehyde (441 mg, 3.0 mmol), 
malononitrile (198 mg, 3.0 mmol), piperidine (10 mmol %) and 25 mL of ethanol was stirred 
for 8h at 80 
o
C. After completion of the reaction which was monitored by TLC, solvent was 
evaporated. The residue was purified by silica gel chromatography (petroleum ether/ethyl 
acetate: 1/1, Rf=0.3) which yielded the pure product (207) as a light orange solid (150 mg, 26 
%, m.p.= 275 - 277 
o
C, lit. m.p.= 276 - 278 
o
C
173
).  
Data as reported above. 
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6.9. Synthesis of Tetrazolo[1,5-a]quinoline-4-carboxamide. 
 
 
A mixture of benzaldehyde (441 mg, 3.0 mmol), malononitrile (198 mg, 3.0 mmol), 
piperidine (10 mmol %) and 25 mL of water were stirred for 8h at 70 
o
C. After completion of 
the reaction which was monitored by TLC, the solvent was evaporated. The residue was 
purified by silica gel chromatography (petroleum ether/ethyl acetate: 1/1, Rf=0.3) which 
yielded the pure product as a light yellow solid (200 mg, 39 %, m.p.= 139 - 141 
o
C).  
Data as reported above. 
 
6.10. Synthesis of 2-Phenyl-2-(phenylamino)acetonitrile.  
 
 
Aniline (93.13 mg, 1.0 mmol, 1.0 eq.) was added to a stirring solution of benzaldehyde (106.1 
mg, 1.0 mmol, 1.0 eq.) in toluene (13 mL) at room temperature, and the mixture stirred until 
the disappearance of the starting materials. TMSCN (99 mg, 1.0 mmol, 1.0 eq.) was added. 
The mixture was stirred for 5 min before the portionwise addition of H2O (10 % by volume), 
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TBAB (322 mg, 1.0 mmol, 1.0 eq.), Oxone (307 mg, 1.0 mmole, 1.0 eq) and NaHCO3 (126 
mg, 1.5 mmol, 1.5 eq) at 0 
o
C. The biphasic mixture was then stirred vigorously at room 
temperature until the disappearance of the intermediate; the biphasic mixture was then 
partitioned between EtOAc (20 mL) and sat. aq. NaHCO3 (20 mL). The aqueous phase was 
extracted with EtOAc (2 × 20 mL) and the combined organic phases washed with brine, dried 
(Na2SO4), and concentrated in vacuum. The residue was purified by silica gel 
chromatography (petroleum ether/ethyl acetate: 10/1, Rf=0.24) which yielded the pure 
product as a brown solid (150 mg, 72 %, m.p.= 73 - 75 
o
C, lit. m.p.= 73 - 74 
o
C)
180
. 
IR: ʋmax (cm
-1
): 3335.3, 3034.4, 2960.0, 2880.0, 2180.0, 1680.0, 1598.0, 1514.5, 1279.7, 
1242.1, 748.6. 
1
H NMR: H (100 MHz, DMSO): 8.38 (1H, s, HN), 7.52 (2H, d, J=6.0 Hz, 2 x  ArH), 7.37-
7.44 (2H, m, 2 x ArH), 7.06-7.22 (3H, m, 3 x ArH), 6.82 (1H, t, J=7.5 Hz, ArH), 6.70 (2H, d, 
J=7.5 Hz, 2  x ArH)  3.97 (1H, s, CH). 
13
C NMR c (100 MHz, DMSO): 144.69 (qC), 134.47 (qC), 129.61 (2 x CH), 129.37 (2 x 
CH), 127.29 (2 x CH), 120.30 (CH), 116.72 (CN), 115.12 (CH), 114.16 (2 x CH), 50.22 
(CH). 
HRMS (m/z): [M +H
+
] for C14H12N2 calculated = 209.1072, measured = 209.1080. 
 
6.11. Synthesis of 2-(2-Azidophenyl)-2-(phenylamino)acetonitrile
 
. 
 
 
Aniline (93.13 mg, 1.0 mmol, 1.0 eq.) was added to a stirring solution of 2-
azidobenzaldehyde (147.12 mg, 1.0 mmol, 1.0 eq.) in toluene (13 mL) at room temperature, 
Chaper 6                                                                                                                                             Experimental 
185 
 
and the mixture stirred until the disappearance of the starting materials. TMSCN (99 mg, 1.0 
mmol, 1.0 eq.) was added. The mixture was stirred for 5 min before the portionwise addition 
of H2O (10 % by volume), TBAB (322 mg, 1.0 mmol, 1.0 eq.), Oxone (307 mg, 1.0 mmole, 
1.0 eq) and NaHCO3 (126 mg,1.5 mmol, 1.5 eq) at 0 
o
C. The biphasic mixture was then 
stirred vigorously at room temperature until the disappearance of the intermediate; the 
biphasic mixture was then partitioned between EtOAc (20 mL) and sat. aq. NaHCO3 (20 mL). 
The aqueous phase was extracted with EtOAc (2 × 20 mL) and the combined organic phases 
washed with brine, dried (Na2SO4), and concentrated in vacuum. The residue was purified by 
silica gel chromatography (petroleum ether/ethyl acetate: 95/5, Rf=0.2) which yielded the 
pure product as a dark orange solid (140 mg, 56 %, m.p.= 97 - 98 
o
C). 
IR: ʋmax (cm
-1
): 3350.6, 3026.3, 2970.0, 2880.0, 2190.4, 2121.9, 1599.5, 1587.4, 1240.0, 
1159.8, 748.2. 
1
H NMR: H (400 MHz, DMSO): 8.70 (1H, s, HN), 7.52 (1H, d, J=7.5 Hz, ArH), 7.39 (1H, 
dd, J=7.5 Hz, ArH), 7.12-7.20 (4H, m, 4 x ArH), 6.81 (2H, t, J=7.3 Hz, 2 x ArH), 6.70 (1H, 
d, J=7.5 Hz, ArH), 4.06 (1H, s, CH). 
13
C NMR c (100 MHz, DMSO): 144.62 (qC), 138.16 (qC), 131.10 (CH), 129.59 (2 x CH), 
129.18 (CH), 128.09 (qC), 125.52 (CH), 120.40 (CH), 118.88 (CH), 118.08 (CN), 114.39 (2 x 
CH), 45.99 (CH). 
HRMS (m/z): [M +H
+
] for C14H11N5 calculated = 250.1087, measured = 250.1092. 
6.12. Synthesis of 2-(2-Azidophenyl)-2-(cyclohexylamino)acetonitrile. 
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Cyclohexylamine (93.13 mg, 1.0 mmol, 1.0 eq.) was added to a stirring solution of 2-
azidobenzaldehyde (147.12 mg, 1.0 mmol, 1.0 eq.) in toluene (13 mL) at room temperature, 
and the mixture stirred until the disappearance of the starting materials. TMSCN (99 mg, 1.0 
mmol, 1.0 eq.) was added. The mixture was stirred for 5 min before the portionwise addition 
of H2O (10 % by volume), TBAB (322 mg, 1.0 mmol, 1.0 eq.), Oxone (307 mg, 1.0 mmole, 
1.0 eq) and NaHCO3 (126 mg, 1.5 mmol, 1.5 eq) at 0 
o
C. The biphasic mixture was then 
stirred vigorously at room temperature until the disappearance of the intermediate; the 
biphasic mixture was partitioned between EtOAc (20 mL) and sat. aq.NaHCO3 (20 mL). The 
aqueous phase was extracted with EtOAc (2 × 20 mL) and the combined organic phases 
washed with brine, dried (Na2SO4), and concentrated in vacuum. The residue was purified by 
silica gel chromatography (petroleum ether/ethyl acetate: 10/1, Rf=0.24) which yielded the 
pure product as a yellow solid (170 mg, 67 %, m.p.= 69 - 71 
o
C). 
IR: ʋmax (cm
-1
): 3306.2, 3062.4, 2923.6, 2854.1, 2187.0, 2130.3, 1600.0, 1570.4, 1286.9, 
1114.5, 739.4. 
1
H NMR: H (400 MHz, CDCl3): 8.53 (1H, s, HN), 7.43 (1H, d, J=7.7 Hz, ArH), 7.35 (2H, 
dd, J=7.7 Hz, 2 x ArH), 7.06-7.22 (2H, m, 2 x ArH), 4.89 (1H, s, CH), 1.38-1.01 (11H, m, 
cyclohexane). 
13
C NMR c (100 MHz, DMSO): 137.81 (qC), 130.50 (CH), 128.00 (qC), 125.39 (CH), 
124.93 (CH), 118.77 (CH), 118.32 (CN), 55.11 (CH), 47.09 (CH), 33.75 (CH2), 31.97 (CH2), 
25.89 (CH2), 24.79 (CH2), 24.39 (CH2). 
HRMS (m/z): [M + H
+
] for C14H17N5 calculated = 256.1557, measured = 256.1555. 
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6.13. Synthesis of 2-(2-Azidophenyl)-2-(benzylamino)acetonitrile. 
 
 
Benzylamine (107.13 mg, 1.0 mmol, 1.0 eq.) was added to a stirring solution of 2-
azidobenzaldehyde (147.12 mg, 1.0 mmol, 1.0 eq.) in toluene (13 mL) at room temperature, 
and the mixture stirred until the disappearance of the stating materials. TMSCN (99 mg, 1.0 
mmol, 1.0 eq.) was added. The mixture was stirred for 5 min before the portionwise addition 
of H2O (10 % by volume), TBAB (322 mg, 1.0 mmol, 1.0 eq.), Oxone (307 mg, 1.0 mmole, 
1.0 eq) and NaHCO3 (126 mg, 1.5 mmol, 1.5 eq) at 0 
o
C. The biphasic mixture was then 
stirred vigorously at room temperature until the disappearance of the intermediate; the 
biphasic mixture was partitioned between EtOAc (20 mL) and sat. aq. NaHCO3 (20 mL). The 
aqueous phase was extracted with EtOAc (2 × 20 mL) and the combined organic phases 
washed with brine, dried (Na2SO4), and concentrated in vacuum. The residue was purified by 
silica gel chromatography (petroleum ether/ethyl acetate: 95/5, Rf=0.28) which yielded the 
pure product as a brown oil (150 mg, 57 %). 
IR: ʋmax (cm
-1
): 3327.4, 3029.7, 2979.8, 2840.0, 2199.1, 2126.5, 1680.0, 1600.0, 1560.4, 
1287.2, 1140.0, 750.2. 
1
H NMR: H (400 MHz, CDCl3): 8.62 (1H, s, HN), 7.10-7.40 (9H, m, 9 x ArH), 4.73 (1H, s, 
CH), 1.12 (2H, s, CH2). 
13
C NMR c (100 MHz, DMSO): 138.00 (qC), 137.89 (qC), 130.63 (CH), 129.27 (CH), 
128.62 (CH), 128.52 (2 x CH), 128.04 (qC), 127.71 (CH), 125.30 (CH), 118.79 (2 x CH), 
118.40 (CN), 51.98 (CH2), 49.43 (CH). 
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HRMS (m/z): [M+H
+
] for C15H13N5 calculated = 264.1244, measured = 264.1255. 
6.14. Synthesis of 2-(2-Azidophenyl)-2-(phenylamino)acetonitrile. 
 
 
Aniline (93.13 mg, 1.0 mmol, 1.0 eq.) was added to a stirring solution of 2-
azidobenzaldehyde (147.12 mg, 1.0 mmol, 1.0 eq.) in toluene (13 mL) at room temperature, 
and the mixture stirred until the disappearance of the starting materials. TMSCN (99 mg, 1.0 
mmol, 1.0 eq.) was added. The mixture was stirred for 5 min before the portionwise addition 
of H2O (10 % by volume), TBAB (322 mg, 1.0 mmol, 1.0 eq.) and NaHCO3 (126 mg, 1.5 
mmol, 1.5 eq) at 0 
o
C. The biphasic mixture was then stirred vigorously at room temperature 
until the disappearance of the intermediate; the biphasic mixture was partitioned between 
EtOAc (20 mL) and sat. aq. NaHCO3 (20 mL). The aqueous phase was extracted with EtOAc 
(2 × 20 mL) and the combined organic phases washed with brine, dried (Na2SO4), and 
concentrated in vacuum. The residue was purified by silica gel chromatography (petroleum 
ether/ethyl acetate: 95/5, Rf=0.2) which yielded the pure product as a dark orange solid (150 
mg, 60 %, m.p.= 97 - 98 
o
C). 
IR: ʋmax (cm
-1
): 3350.6, 3026.3, 2970.0, 2880.0, 2190.4, 2121.9, 1599.5, 1587.4, 1240.0, 
1159.8, 748.2. 
1
H NMR: H (400 MHz, DMSO): 8.70 (1H, s, HN), 7.52 (1H, d, J=7.5 Hz, ArH), 7.39 (1H, 
dd, J=7.5 Hz, ArH), 7.12-7.20 (4H, m, 4 x ArH), 6.81 (2H, t, J=7.3 Hz, 2 x ArH), 6.70 (1H, 
d, J=7.5 Hz, ArH), 4.06 (1H, s, CH). 
13
C NMR c (100 MHz, DMSO): 144.62 (qC), 138.16 (qC), 131.10 (CH), 129.59 (2 x CH), 
129.18 (CH), 128.09 (qC), 125.52 (CH), 120.40 (CH), 118.88 (CH), 118.08 (CN), 114.39 (2 x 
CH), 45.99 (CH). 
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HRMS (m/z): [M +H
+
] for C14H11N5 calculated = 250.1087, measured = 250.1092. 
 
6.15. Synthesis of 2-phenyl-2H-indazole. 
 
 
[2-(2-Azidophenyl)-2-(phenylamino)acetonitrile] (50 mg) was heated to reflux temperature in 
dry xylene (10 mL) under a nitrogen atmosphere for 120 hours.  The solvent was removed in 
vacuo and the crude product was purified by silica chromatography (petroleum ether/ethyl 
acetate: 8/1, Rf = 0.28) to yield the pure product as a white solid (40 mg, 50 %, m.p.= 77 - 79 
o
C, lit. m.p.=84-85 
o
C
181
).  
IR: ʋmax (cm
-1
): 3057.2, 2979.9, 2890.0, 1630.0, 1610.8, 1519.3, 1199.0, 1150.0, 749.0. 
1
H NMR: H (400 MHz, DMSO):  8.37 (1H, s, HC=N), 7.19-7.85 (9H, m, 9 x ArH). 
13
C NMR c (100 MHz, DMSO): 129.93 (qC), 129.75 (2CH), 129.21 (qC), 127.91 (CH), 
126.83 (CH), 123.87 (CH), 121.02 (2 x CH), 120.43 (CH), 120.37 (CH), 119.24 (qC), 117.94 
(CH). 
HRMS (m/z): [M + H
+
] for C13H10N2 calculated = 195.0917, measured = 195.0922. 
The data is identical to the literature.
181
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6.16. Synthesis of 2-[(Cyclohexylamino)methylene]malononitrile. 
 
 
A solution of 2-azidobenzaldehyde (147 mg, 1.0 mmol, 1.0 eq), acetic acid (60 mg, 1.0 mmol, 
1.0 eq) and malononitrile (66 mg, 1.0 mmol, 1.0 eq) in ethanol (10 mL) was stirred at 70 
o
C. 
Cyclohexyl isocyanide (109 mg, 1.0 mmol, 1.0 eq) was added after 30 minutes and the 
mixture stirred for 12 hours at 70 
o
C. After completion of the reaction
182
 which was monitored 
by TLC, the solvent was evaporated. The residue was purified by silica gel chromatography 
(petroleum ether/ethyl acetate: 1/5, Rf=0.23) to yield the pure product as a light yellow solid 
(100 mg, 57 %, m.p.= 133 - 135 
o
C). 
IR: ʋmax (cm
-1
): 3228.4 (NH), 3035.7 (CHunsat.), 2935.2 (CHsat.), 2854.6, 2204.4 (CN), 
1644.0 (C=C), 1530.0, 1293.3 (C-C), 1183.8 (C-N), 755.4 (C-H). 
1
H NMR: H (400 MHz, CDCl3): 7.41 (1H, s, C=C-H), 6.99-7.06 (1H, m, HN), 3.17-3.25 
(1H, m, CH-NH of cyclohexyl), 1.13- 1.95 (10H, m, 5 x CH2). 
13
C NMR c (100 MHz, DMSO): 158.88 (CH), 115.96 (CN), 114.17 (CN), 59.96 (CH), 
49.61 (qC), 33.39 (2CH2), 24.72 (CH2), 24.64 (2 x CH2). 
HRMS (m/z): [M + Na
+
] for C10H13N3 calculated = 198.1002, measured = 198.1008. 
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6.17. Synthesis of 2-[(Cyclohexylamino)methylene]malononitrile. 
 
 
A solution of malononitrile (66 mg, 1.0 mmol, 1.0 eq) and acetic acid (60 mg, 1.0 mmol, 1.0 
eq) in ethanol (10 mL) was stirred at 70 
o
C.  Cyclohexyl isocyanide (109 mg, 1.0 mmol, 1.0 
eq) was added after 30 minutes and the mixture stirred for 12 hours at 70 
o
C. After completion 
of the reaction which was monitored by TLC, the solvent was evaporated. The residue was 
purified by silica gel chromatography (petroleum ether/ethyl acetate: 1/5, Rf=0.2) to yield the 
pure product as a light yellow solid (110 mg, 63 %, m.p.= 133 - 135 
o
C). 
IR: ʋmax (cm
-1
): 3224.2 (NH), 3035.4 (CH unsat.), 2934.8 (CH sat.), 2854.8, 2205.5 (CN), 
1634.0 (C=C), 1297.3 (C-C), 1183.9 (C-N), 757.9. 
1
H NMR: H (400 MHz, CDCl3): 7.33 (1H, s, C=C-H), 6.79-6.81 (1H, m, HN), 3.13-3.18 
(1H, m, CH-NH of cyclohexyl), 1.07- 1.88 (10H, m, 5 x CH2). 
13
C NMR c (100 MHz, DMSO): 158.83 (CH), 115.91 (CN), 114.12 (CN), 59.18 (CH), 
49.78 (qC), 33.42 (2 x CH2), 24.72 (CH2), 24.62 (2 x CH2). 
HRMS (m/z): [M + Na
+
] for C10H13N3 calculated = 198.1002, measured = 198.1010. 
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6.18. Synthesis of Tetrazolo[1,5-a]quinoline-4-carbonitrile. 
 
 
A mixture of 2-azidobenzaldehyde (147 mg, 1.0 mmol, 1.0 eq), malononitrile (66 mg, 1.0 
mmol, 1.0 eq) in 2.0 mL PEG-400 at room temperature was stirred  for 30 minutes. A solution 
of dimethyl acetylendicarboxylate (142 mg, 1.0 mmol, 1.0 eq) and aniline (93 mg, 1.0 mmol, 
1.0 eq) in 2.0 mL PEG was then added to the mixture. The whole solution was stirred at room 
temperature for 10 hours. After completion of the reaction which was monitored by TLC, the 
reaction mixture was extracted with diethyl ether and PEG was separated from the products. 
The combined organic layers were evaporated. The residue was purified by silica gel column 
chromatography (petroleum ether/ethyl acetate: 1/1, Rf=0.3) to yield the pure product (207) as 
a yellow solid (100 mg, 51 %, m.p.= 2273 - 275 
o
C, lit. m.p.= 276 - 278 
o
C
173
).  
Data as reported above. 
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Chapter 7: 
7. Chapter 7: Experimental for chapter 3: Triazolo and Tetrazolo-
benzothiadiazepines and benzodiazepines. 
7.1. The synthesis of Triazolobenzothiadiazepines. 
7.1.1. Synthesis of 2-azidobenzenesulfonic acid. 
 
 
To a suspension of aniline-2-sulfonic acid (5.79 g, 33.4 mmol, 1 eq) in water (22 mL) at 0 
o
C, 
was added cooled conc. H2SO4 (7.5 mL) dropwise. A solution of NaNO2 (3.0 g, 43.4 mmol, 
1.3 eq) in water (15 mL) cooled to 0 
o
C was added to the suspension dropwise and the whole 
stirred for 30 mins before a cooled solution of NaN3 (4.34 g, 66.8 mmol, 2.0 eq) in water (15 
mL) was added dropwise and the reaction was allowed to warm to room temperature. The 
resulting solution was crash cooled in an ice bath to afford the 2-azidobenzenesulfonic acid as 
a precipitate which was collected by vacuum filtration and dried in the oven at 80-100 
o
C to 
give the product as a pale grey solid (4.0 g, 60 %, m.p.=154-156 
o
C, lit. m.p.=153-155 
o
C
185
).  
IR: ʋmax (cm
-1
): 749.8, 1024.4, 1085.8, 1133.6, 1147.5, 1200.00, 1261.9, 1292.4, 1444.1, 
1471.6, 1574.2, 1584.9, 2122.7, 3477.1. 
1
H NMR: H (400 MHz, DMSO): 7.13 (1H, td, J
1
=7.6 Hz, J
2
=0.9 Hz ArH), 7.21 (1H, d, 
J=7.3 Hz, ArH), 7.38 (1H, td, J
1
=7.6 Hz, J
2
=1.3 ArH), 7.76 (1H, dd, J
1
=7.5 Hz, J
2
=1.4 Hz, 
ArH) ppm. 
13
C NMR c (100 MHz, DMSO): 120.82 (CH), 124.64 (CH), 129.01 (CH), 130.72 (CH), 
136.44 (2 qC) ppm. 
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7.1.2. Coupling of the sulfonic acid with secondary amine alcohols. 
General experimental : 
 
2-Azidobenzenesulfonic acid (437 mg, 2.2 mmol, 2.2 eq) was heated to reflux in a 2M 
solution of   (COCl)2 in dichloromethane (2.5 mL, 5.0 mmol, 5.0 eq) with a drop  of DMF  
under an inert atmosphere of nitrogen for 5 hours. The reaction was cooled to room 
temperature before the crude acid chloride was concentrated and the residue was washed with 
dichloromethane (2 x 20 mL) to give the crude sulfonyl chloride as an orange solid. 
A solution of potassium carbonate (4.0 mmol, 4.0 eq) in water (10 mL) was added in one 
portion to a stirring solution of the secondary amine alcohol (1.0 mmol, 1.0 eq) in 
dichloromethane (10 mL). The sulfonyl chloride was dissolved in dichloromethane (5 mL) 
and was added slowly to this solution. The reaction
186
 was allowed to stir at room temperature 
for 18 hours before the organic layer was separated and the aqueous layer washed with 
dichloromethane (2 x 20 mL). The combined organic phases were dried (MgSO4), filtered, 
concentrated and purified by silica column chromatography. 
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7.1.2.1. Synthesis of {1-[(2-azidophenyl)sulfonyl]piperidin-2-yl}methanol. 
 
 
[Eluent: petroleum ether/ethyl acetate: 2/1, Rf = 0.22] to yield the product as a yellow oil (85 
%). 
IR: ʋmax (cm
-1
): 744.5, 928.5, 1043.7, 1154.5, 1288.3, 1320.4, 1470.9, 1574.3, 2097.7, 
2898.5, 2940.7, 3521.2. 
1
H NMR: H (400 MHz, CDCl3): 1.22-1.59 (5H, m, CH2), 1.69 (1H, d, J=12.5 Hz, CHH), 
2.41 (1H, br.s, OH), 3.10 (1H, td, J
1
=12.7 Hz, J
2
=1.9 Hz, CH), 3.55-3.61 (1H, m, NCHH), 
3.77-3.88 (2H, m, HOCH2), 4.08-4.09 (1H, m, NCHH), 7.22 (1H, dd, J
1
=7.9 Hz, J
2
=7.6 Hz, 
ArH), 7.29 (1H, d, J= 8.0 Hz, ArH), 7.57 (1H, dd, J
1
=7.9 Hz, J
2
=7.6 Hz, ArH), 7.99 (1H, d, 
J=8.0 Hz, ArH) ppm. 
13
C NMR c (100 MHz, CDCl3): 18.95 (CH2), 24.91 (CH2), 25.29 (CH2), 41.30 (CH2), 54.38 
(CH), 60.53 (CH2), 119.95 (CH), 124.63 (CH), 130.90 (qC), 131.48 (CH), 133.87 (CH), 
137.83 (qC) ppm. 
HRMS (ESI
+
): found 297.1024 [M+H]
+
, C12H17N2O3S requires 297.1016. 
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7.1.2.2. Synthesis of 2-azido-N-benzyl-N-(2-hydroxyethyl)benzenesulfonamide. 
 
 [Eluent: petroleum ether/ethyl acetate: 2/1, Rf = 0.21] to yield the product as a brown solid 
(88 %, m.p.= 93 - 95 
o
C). 
IR: ʋmax (cm
-1
): 762.0, 934.6, 993.0, 1052.4, 1155.4, 1336.4, 1468.8, 1571.9, 2101.1, 2939.6, 
3359.0. 
1
H NMR: H (400 MHz, CDCl3): 12.22 (1H, br.s, OH), 3.41 (2H, br.s, NCH2), 3.49 (2H, 
br.s, HO-CH2), 4.58 (2H, br.s, Ph-CH2), 7.22-7.36 (7H, m, 7 x ArH), 7.62 (1H, dd, J
1
= 7.9 
Hz, J
2
=7.4 Hz, ArH), 8.05 (1H, d, J=7.8 Hz, ArH) ppm. 
13
C NMR c (100 MHz, CDCl3):  50.35 (CH2), 53.26 (CH2), 60.74 (CH2), 119.88 (CH), 
124.77 (CH), 127.98 (CH), 128.21 (2 x CH), 128.76 (2 x CH), 130.43 (qC), 131.87 (CH), 
134.09 (CH), 136.54 (qC), 138.18 (qC) ppm. 
HRMS (ESI
+
): found 333.1016 [M+H]
+
, C15H17N4O3S requires 333.1016. 
7.1.2.3. Synthesis of 2-azido-N-(2-hydroxyethyl)-N-methylbenzenesulfonamide. 
 
 
Chaper 7                                                                                                                                             Experimental 
197 
 
 [Eluent: petroleum ether/ethyl acetate: 2/1, Rf = 0.2] to yield the product as a yellow oil (90 
%). 
IR: ʋmax (cm
-1
):  759.7, 908.0, 975.4, 1059.1, 1143.6, 1265.0, 1287.5, 1323.9, 1442.0, 1470.9, 
1574.2, 2099.4, 2929.2, 3516.1. 
1
H NMR: H (400 MHz, CDCl3): 2.19 (1H, br.s, OH), 2.89 (1H, s, CH3), 3.34 (2H, t, J=5.2 
Hz, N-CH2CH2-OH), 3.71 (2H, t, J=5.2 Hz, N-CH2CH2OH), 7.18 (1H, dd, J
1
=7.8 Hz, J
2
=7.5 
Hz, ArH), 7.24 (1H, d, J= 8.0 Hz, ArH), 7.53 (1H, dd, J
1
=7.8 Hz, J
2
=7.5 Hz, ArH), 7.92 (1H, 
d, J=8.0 Hz, ArH) ppm. 
13
C NMR c (100 MHz, CDCl3):  35.80 (CH3), 52.41 (CH2), 60.43 (CH2), 119.88 (CH), 
124.71 (CH), 129.36 (qC), 132.04 (CH), 134.07 (CH), 138.18 (qC) ppm. 
HRMS (ESI
+
): found 257.0703 [M+H]
+
, C9H13N4O3S requires 257.0703. 
 
7.1.2.4. Synthesis of 2-{1-[(2-azidophenyl)sulfonyl]piperidin-2-yl}ethan-1-ol. 
 
[Eluent: petroleum ether/ethyl acetate: 2/1, Rf = 0.25] to yield the product as an orange oil (82 
%). 
IR: ʋmax (cm
-1
): 759.9, 863.8, 949.6, 1073.4, 1154.7, 1288.7, 1320.5, 1442.9, 1470.9, 1574.4, 
2097.4, 2867.0, 2941.0, 3537.1. 
1
H NMR: H (400 MHz, CDCl3): 1.11-1.22 (1H, m, CHH), 1.45 (5H, br.s, CHH + 2 x CH2), 
1.49-1.56 (1H, m, HO-CH2CHH), 1.90-1.97 (1H, m, HO-CH2CHH), 2.84 (1H, bs, OH), 2.96 
(1H, m, CH), 3.55-3.58 (1H, m, NCHH), 3.63-3.73 (2H, m, HOCH2), 4.25 (1H, m, NCHH), 
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7.16 (1H, app. td, J
1
=8.3 Hz, J
2
=1.3 Hz, ArH), 7.24 (1H, app. td, J
1
= 8.3 Hz, J
2
=1.3 Hz, 
ArH), 7.51 (1H, app. td, J
1
=8.3 Hz, J
2
=1.3 Hz, ArH), 7.92 (1H, dd, J
1
=8.0 Hz, J
2
=1.6 Hz, 
ArH) ppm. 
13
C NMR c (100 MHz, CDCl3):  18.40 (CH2), 24.86 (CH2), 28.63 (CH2), 32.52 (CH2), 
40.75 (CH2), 49.55 (CH), 58.58 (CH2), 120.00 (CH), 124.68 (CH), 131.24 (CH), 131.35 (qC), 
133.79 (CH), 137.63 (qC) ppm. 
HRMS (ESI
+
): found 311.1167 [M+H]
+
, C13H19N4O3S requires 311.1172. 
 
7.1.2.5. Synthesis of 2-azido-N-ethyl-N-(4-hydroxybutyl)benzenesulfonamide. 
 
 
 [Eluent: petroleum ether/ethyl acetate: 2/1, Rf = 0.24] to yield the product as a brown oil (75 
%). 
IR: ʋmax (cm
-1
): 645.9, 818.5, 906.3, 1031.3, 1058.7, 1155.0, 1288.8, 1324.1, 1443.1, 1471.6, 
1575.4, 2098.4, 2980.2, 3527.0. 
1
H NMR: H (400 MHz, CDCl3): 1.03-1.08 (3H, m, CH3), 1.51-1.62 (4H, m, 
NCH2CH2CH2CH2OH), 2.23-2.33 (1H, m, OH), 3.30-3.34 (4H, m, CH2NCH2), 3.56-3.58 
(2H, m, OCH2), 7.19 (1H, app. td, J
1
=8.0 Hz, J
2
=1.5 Hz, ArH), 7.25 (1H, d, J= 8.0 Hz, ArH), 
7.53 (1H, app. td, J
1
=8.0 Hz, J
2
=1.5 Hz, ArH), 7.91-7.93 (1H, m, ArH) ppm. 
13
C NMR c (100 MHz, CDCl3):  13.98 (CH3), 25.11 (CH2), 29.51 (CH2), 42.25 (CH2), 
47.17 (CH2), 60.07 (CH2), 119.85 (CH), 124.60 (CH), 131.22 (qC), 131.37 (CH), 133.70 
(CH), 137.90 (qC) ppm. 
Chaper 7                                                                                                                                             Experimental 
199 
 
HRMS (ESI
+
): found 299.1166 [M+H]+, C12H19N4O3S requires 299.1172. 
 
 
7.1.2.6. Synthesis of 2-azido-N-benzyl-N-(3-hydroxy propyl)benzenesulfonamide. 
 
 
 
 [Eluent: petroleum ether/ethyl acetate: 2/1, Rf = 0.24] to yield the product as a dark brown oil 
(86 %). 
IR: ʋmax (cm
-1
): 757.9, 819.4, 938.8, 1059.5, 1123.9, 1156.7, 1265.8, 1289.0, 1328.2, 1442.7, 
1471.8, 1495.5, 1574.9, 2101.2, 2877.0,  2947.2, 3542.4. 
1
H NMR: H (400 MHz, CDCl3): 1.52 (2H, p, J=6.0 Hz, NCH2CH2), 2.18 (1H, br.s, OH), 
3.45 (2H, t, J=6.6 Hz, NCH2CH2),  3.66 (2H, m, HO-CH2), 4.51 (2H, br.s, Ph-CH2),  7.23-
7.32 (7H, m, 7 x ArH), 7.61 (1H, td, J
1
=8.0 Hz, J
2
=1.4 Hz, ArH), 8.03 (1H, dd, J
1
=8.0 Hz, 
J
2
=1.4 Hz, ArH) ppm. 
13
C NMR c (100 MHz, CDCl3):  30.73 (CH2), 44.96 (CH2), 52.50 (CH2), 58.75 (CH2), 
119.82 (CH), 124.75 (CH), 127.92 (CH), 128.34 (2 x CH), 128.61 (2 x CH), 130.75 (qC), 
131.73 (CH), 133.98 (CH), 136.64 (qC), 138.11 (qC)   ppm. 
HRMS (ESI
+
): found 347.1166 [M+H]
+
, C16H19N4O3S requires 347.1172. 
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7.1.2.7. Synthesis of {1-[(2-azidophenyl)sulfonyl]piperidin-4-yl}methanol. 
 
 
 [Eluent: petroleum ether/ethyl acetate: 1/1, Rf = 0.22] to yield the product as a brown oil (70 
%). 
IR: ʋmax (cm
-1
):  654.9, 818.1, 934.5, 1035.3, 1087.6, 1157.8, 1266.4, 1307.9, 1328.2, 1443.1, 
1471.6, 1574.1, 2127.6, 2854.5, 2922.0, 3517.0. 
1
H NMR: H (400 MHz, CDCl3): 1.20 (2H, qd, J
1
=16.5 Hz, J
2
=4.1 Hz, CH2CHCH2), 1.42-
1.53 (1H, m, CH2CHCH2), 1.71 (2H, dd, J
1
=12.8 Hz, J
2
=1.8 Hz, CH2CHCH2), 2.58 (2H, td, 
J
1
=12.3 Hz, J
2
=2.2 Hz, CH2NCH2), 2.68 (1H, br.s, OH), 3.38 (2H, d, J=6.4 Hz, CH2NCH2), 
3.81 (2H, d, J=12.3 Hz, HOCH2), 7.18 (1H, ddd, J
1
=8.8 Hz, J
2
=7.8 Hz, J
3
=0.9 Hz, ArH), 7.25 
(1H, d, J= 8.0 Hz, ArH), 7.53 (1H, ddd, J
1
=8.8 Hz, J
2
=7.8 Hz, J
3
=1.3 Hz, ArH), 7.83 (1H, dd, 
J
1
=8.0 Hz, J
2
=1.4 Hz, ArH) ppm. 
13
C NMR c (100 MHz, CDCl3):  28.54 (2 x CH2), 37.96 (CH), 45.95 (2 x CH2), 66.83 
(CH2), 120.04 (CH), 124.67 (CH), 128.98 (qC), 131.57 (CH), 134.01 (CH), 138.19 (qC) ppm. 
HRMS (ESI
+
): found 297.1026 [M+H]
+
, C12H17N4O3S requires 297.1016. 
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7.1.3. Conversion of the alcohols into the aldehydes. 
General experimental: 
 
To solution of  the alcohol (1.0 mmol, 1.0 eq) in anhydrous dichloromethane (10 mL), Dess-
Martin periodinane (466 mg, 1.1 mmol, 1.1 eq) was added at ambient temperature. The 
solution was stirred at ambient temperature under an atmosphere of dry nitrogen for 5 hours. 
The reaction mixture was then quenched with saturated aqueous solutions of NaHCO3 (15 
mL) and Na2SO3 (15 mL). The reaction mixture was filtered under vacuum through a pad of 
celite. The combined organic phase was dried over anhydrous magnesium sulfate, filtered, 
concentrated under reduced pressure and purified by silica chromatography. 
 
7.1.3.1. Synthesis of 1-[(2-azidophenyl)sulfonyl]piperidine-2-carbaldehyde. 
 
(Eluent: petroleum ether/ethylacetate: 3/1, Rf = 0.35) to yield the product as an orange oil (76 
%). 
IR: ʋmax (cm
-1
): 732.4, 856.8, 963.7, 1070.3, 1184.3, 1334.6, 1471.0, 1574.3, 1731.8, 2098.8, 
2859.1, 2944.5. 
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1
H NMR: H (400 MHz, CDCl3): 1.21-1.31 (1H, m, CHH), 1.38-1.51 (1H, m, CHH), 1.56-
1.66 (1H, m, CHH), 1.66-1.76 (2H, m, CH2), 2.27 (1H, dd, J
1
=13.0 Hz, J
2
=1.9 Hz, CHH), 
3.12 (1H, td, J
1
=13.0 Hz, J
2
=2.6 Hz, NCH), 3.86 (1H, d, J=13.5 Hz, NCHH), 4.66 (1H, d, 
J=5.1 Hz, NCHH), 7.25 (1H, dd, J
1
=7.8 Hz, J
2
=7.6 Hz, ArH), 7.32 (1H, d, J=8.0 Hz,  ArH), 
7.60 (1H, app. td, J
1
=7.8 Hz, J
2
=1.3 Hz,  ArH), 8.01 (1H, dd, J
1
=7.8 Hz, J
2
=1.3 Hz, ArH), 
9.66 (1H, s, CHO). 
13
C NMR c (100 MHz, CDCl3): 20.53 (CH2), 24.12 (CH2), 24.84 (CH2), 44.17 (CH2), 62.01 
(CH), 119.95 (CH), 124.62 (CH), 130.76 (qC), 131.25 (CH), 134.00 (CH), 138.12 (qC), 
200.94 (C=O). 
HRMS (ESI
+
): found 317.0680 [M+Na]+, C12H14N4O3SNa requires 317.0679. 
 
7.1.3.2. Synthesis of 2-azido-N-benzyl-N-(2-oxoethyl)benzenesulfonamide. 
 
 
(Eluent: petroleum ether/ethylacetate: 2/1, Rf = 0.23) yielded the product as a white solid (83 
%, m.p.=111-113 
o
C). 
IR: ʋmax (cm
-1
): 795.8, 873.6, 959.2, 1000.0, 1105.7, 1125.9, 1143.8, 1294.3, 1321.0, 1454.2, 
1474.5, 1585.9, 1715.6, 1748.4, 2102.1, 2898.5, 3030.3, 3075.5. 
1
H NMR: H (400 MHz, CDCl3): 4.06 (2H, s, Ph-CH2), 4.54 (2H, s, NCH2), 7.25-7.35 (7H, 
m, 7 x ArH), 7.64 (1H, td, J
1
= 8.0 Hz, J
2
=1.4 Hz, ArH), 8.06 (1H, dd, J
1
=8.0 Hz, J
2
=1.4 Hz, 
ArH), 9.34 (1H, s, CHO) ppm. 
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13
C NMR c (100 MHz, CDCl3):  52.99 (CH2), 59.31 (CH2), 119.92 (CH), 124.78 (CH), 
128.50 (CH), 128.83 (2CH), 128.95 (2CH), 130.18 (qC), 131.67 (CH), 134.32 (CH), 134.89 
(qC), 138.33 (qC), 197.87 (CHO) ppm. 
HRMS (ESI
+
): found 369.0420 [M+K]
+
, C12H14N4O3SK requires 369.0418. 
7.1.3.3. Synthesis of 2-azido-N-methyl-N-(2-oxoethyl)benzenesulfonamide. 
 
 
 (Eluent: petroleum ether/ethylacetate: 2/1, Rf = 0.3) yielded the product as a dark brown oil 
(76 %). 
IR: ʋmax (cm
-1
): 727.7, 886.4, 978.1, 1059.2, 1155.7, 1287.8, 1331.1, 1442.6, 1471.0, 1574.6, 
1731.1, 2100.3, 2945.1. 
1
H NMR: H (400 MHz, CDCl3): 2.88 (3H, s, CH3), 4.17 (2H, s, CH2),  7.20 (1H, ddd, 
J
1
=8.5 Hz, J
2
=7.9 Hz, J
3
=1.2 Hz, ArH), 7.27 (1H, dd, J
1
= 8.0 Hz, J
2
=1.2 Hz, ArH), 7.57 (1H, 
ddd, J
1
=8.5 Hz, J
2
=7.8 Hz, J
3
=1.5 Hz, ArH), 7.92 (1H, dd, J
1
=8.0 Hz, J
2
=1.2 Hz, ArH), 
9.61(1H, s, CHO) ppm. 
13
C NMR c (100 MHz, CDCl3):  36.05 (CH3), 59.53 (CH2), 119.99 (CH), 124.71 (CH), 
129.13 (qC), 131.69 (CH), 134.32 (CH), 138.18 (qC), 197.73 (CHO) ppm. 
HRMS (ESI
+
): found 277.0373 [M+Na]
+
, C9H10N4O3SNa requires 277.0366. 
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7.1.3.4. Synthesis of 2-{1-[(2-azidophenyl)sulfonyl]piperidin-2-yl}acetaldehyde. 
 
(Eluent: petroleum ether/ethylacetate: 2/1, Rf = 0.28) yielded the product as a light yellow oil 
(81 %). 
IR: ʋmax (cm
-1
): 759.5, 818.6, 932.4, 1071.2, 1122.1, 1157.1, 1288.5, 1326.4, 1443.6, 1471.2, 
1574.7, 1721.0, 2099.4, 2863.2, 2941.5. 
1
H NMR: H (400 MHz, CDCl3): 1.14-1.76 (6H, m, 3 x CH2), 2.72-2.84 (2H, m, CH2-CHO), 
3.02-3.09 (1H, m, CH), 3.89 (1H, dd, J
1
=13.5 Hz, J
2
=1.0 Hz, NCHH), 4.66 (1H, q, J=6.2 Hz, 
NCHH), 7.25 (1H, ddd, J
1
=8.8 Hz, J
2
=7.8 Hz, J
3
=1.2 Hz, ArH), 7.31 (1H, dd, J
1
= 8.0 Hz, 
J
2
=1.1 Hz, ArH), 7.60 (1H, ddd, J
1
=8.8 Hz, J
2
=7.8 Hz, J
3
=1.2 Hz, ArH), 8.02 (1H, dd, J
1
=8.0 
Hz, J
2
=1.5 Hz, ArH), 9.62 (1H, t, J=2.0 Hz, CHO) ppm. 
13
C NMR c (100 MHz, CDCl3):  18.39 (CH2), 25.17 (CH2), 28.62 (CH2), 41.40 (CH2), 
44.49 (CH2), 47.76 (CH), 119.92 (CH), 124.58 (CH), 130.98 (qC), 131.36 (CH), 133.88 (CH), 
138.02 (qC), 199.87 (CHO) ppm. 
HRMS (ESI
+
): found 331.0832 [M+Na]
+
, C13H16N4O3SNa requires 331.0835. 
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7.1.3.5. Synthesis of 2-azido-N-ethyl-N-(4-oxobutyl)benzenesulfonamide. 
 
 
(Eluent: petroleum ether/ethylacetate: 3/2, Rf = 0.25) yielded the product as a light yellow oil 
(76 %). 
IR: ʋmax (cm
-1
): 737.3, 818.2, 915.7, 998.2, 1060.1, 1145.3, 1154.8, 1288.5, 1326.5, 1442.6, 
1471.1, 1574.5, 1720.1, 2098.1, 2936.5. 
1
H NMR: H (400 MHz, CDCl3): 1.09 (3H, t, J=7.1 Hz, CH3), 1.89 (2H, app. p, J=7.1 Hz, 
NCH2CH2),  2.57 (2H, t, J=7.1 Hz, CH2-CHO), 3.31-3.42 (4H, m, CH2NCH2), 7.23 (1H, app. 
td, J
1
=8.0 Hz, J
2
=1.0 Hz, ArH), 7.29 (1H, dd, J
1
= 7.9 Hz, J
2
=1.2 Hz, ArH), 7.57 (1H, app. td, 
J
1
=8.0 Hz, J
2
=1.4 Hz, ArH), 7.98 (1H, dd, J
1
=7.9 Hz, J
2
=1.2 Hz, ArH), 9.79 (1H, s, CHO) 
ppm. 
13
C NMR c (100 MHz, CDCl3):  13.89 (CH3), 21.08 (CH2), 40.69 (CH2), 42.43 (CH2), 
49.65 (CH2), 119.79 (CH), 124.66 (CH), 131.11 (qC), 131.59 (CH), 133.76 (CH), 137.95 (qC) 
201.42 (CHO) ppm. 
HRMS (ESI
+
): found 297.1009 [M+H]+, C12H17N4O3S requires 297.1016. 
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7.1.3.6. Synthesis of 2-azido-N-benzyl-N-(3-oxopropyl) benzenesulfonamide. 
 
 
(Eluent: petroleum ether/ethylacetate: 2/1, Rf = 0.3) yielded the product as a light yellow oil 
(77 %). 
IR: ʋmax (cm
-1
): 577.3, 699.5, 726.6, 819.0, 908.2, 1059.1, 1123.6, 1156.4, 1288.2, 1329.8, 
1454.9, 1471.1, 1573.8, 1584.4, 1633.5, 1722.0, 1866.0, 2100.0, 2917.3. 
1
H NMR: H (400 MHz, CDCl3): 2.56 (2H, ddd, J
1
=7.4 Hz, J
2
=7.0 Hz, J
3
=0.8 Hz, 
NCH2CH2), 3.58 (2H, t, J=7.4 Hz, NCH2CH2),  4.53 (2H, s, Ph-CH2),  7.25-7.36 (7H, m, 7 x 
ArH), 7.62 (1H, td, J
1
=8.0 Hz, J
2
=1.4 Hz, ArH), 8.03 (1H, dd, J
1
=8.0 Hz, J
2
=1.4 Hz, ArH), 
9.53 (1H, s, CHO) ppm. 
13
C NMR c (100 MHz, DMSO):  41.68 (CH2), 43.50 (CH2), 53.08 (CH2), 119.88 (CH), 
124.75 (CH), 128.05 (CH), 128.31 (2 x CH), 128.77 (2 x CH), 130.43 (qC), 131.78 (CH), 
134.12 (CH), 136.34 (qC), 138.21 (qC), 200.12 (CHO) ppm. 
HRMS (ESI
+
): found 345.1012 [M+H]
+
, C16H17N4O3S requires 345.1016. 
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7.1.3.7. Synthesis of 1-[(2-azidophenyl)sulfonyl]piperidine-4-carbaldehyde. 
 
(Eluent: petroleum ether/ethylacetate: 1/1, Rf = 0.31) yielded the product as a yellow oil (92 
%). 
IR: ʋmax (cm
-1
): 739.2, 818.4, 929.8, 1042.9, 1068.5, 1124.2, 1158.0, 1265.8, 1288.5, 1325.8, 
1442.7, 1471.3, 1573.6, 1723.0, 2098.6, 2856.3, 2926.8. 
1
H NMR: H (400 MHz, CDCl3): 1.61-1.71 (2H, m, CH2CHCH2), 1.89-1.97 (2H, m, 
CH2CHCH2), 2.30 (1H, septet, J=4.3 Hz, CH2CHCH2), 2.90 (2H, td, J
1
=13.0 Hz, J
2
=3.0 Hz, 
CH2NCH2), 3.61-3.67 (2H, m, CH2NCH2), 7.17 (1H, ddd, J
1
=8.4 Hz, J
2
=7.9 Hz, J
2
=1.0 Hz, 
ArH), 7.23 (1H, dd, J
1
= 8.0 Hz, J
2
=1.3 Hz, ArH), 7.51 (1H, ddd, J
1
=8.4 Hz, J
2
=7.9 Hz, 
J
2
=1.5 Hz, ArH), 7.87 (1H, dd, J
1
=8.0 Hz, J
2
=1.3 Hz, ArH), 9.58 (1H, s, CHO) ppm. 
13
C NMR c (100 MHz, CDCl3):  25.23 (2 x CH2), 44.98 (2 x CH2), 47.04 (CH), 119.95 
(CH), 124.70 (CH), 129.22 (qC), 131.73 (CH), 134.02 (CH), 138.29 (qC), 202.44 (CHO) 
ppm. 
HRMS (ESI
+
): found 295.0856 [M+H]
+
, C12H15N4O3S requires 295.0859. 
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7.1.4. Synthesis of 1,3,4,12a-tetrahydro-2H-benzo[f]pyrido[1,2-
b][1,2,5]thiadiazepin-12(11H)-one 6,6-dioxide. 
 
To a solution of 2-azidobenzyl benzoate (294 mg, 1.0 mmol, 1.0 eq) in anhydrous toluene (10 
mL) was added triphenylphosphine (314 mg, 1.2 mmol, 1.2 eq). The mixture was stirred for 
12 hours at ambient temperature under a nitrogen atmosphere. After completion of the 
reaction, monitored by TLC, the solvent was removed under vacuum. The residue was 
purified by using silica column chromatography [petroleum ether/ethyl acetate: 4/1, Rf = 0.22] 
to yield the product as a yellow- green oil (36 mg, 14 %). 
IR: ʋmax (cm
-1
): 580.7, 752.3, 882.3, 976.6, 1050.6, 1121.6, 1156.5, 1329.3, 1487.9, 1601.4, 
1724.4, 2854.9, 2925.0, 3378.7. 
1
H NMR: H (400 MHz, CDCl3): 1.38-1.43 (1H, m, CHH), 1.77-1.87 (1H, m, CH2), 2.02-
2.10 (1H, m, CHH), 2.41-2.48 (1H, m, CHH), 2.54-2.58 (1H, m, CHH), 3.12-3.19 (1H, m, 
NCHH), 3.57-3.65 (1H, m, NCHH), 5.42 (1H, br.s, NCH), 5.66-5.67 (1H, m, NH), 6.70 (1H, 
d, J=8.5 Hz, ArH), 6.76 (1H, app. td, J
1
=8.2 Hz, J
2
=1.1 Hz, ArH), 7.26 (1H, app. td, J
1
=8.2 
Hz, J
2
=1.1 Hz, ArH), 7.57 (1H, dd, J
1
=8.5 Hz, J
2
=1.0 Hz, ArH) ppm. 
13
C NMR c (100 MHz, CDCl3): 26.25 (CH2), 29.79 (CH2), 39.60 (CH2), 45.10 (CH2), 73.60 
(CH), 115.81 (CH), 118.40 (CH), 119.93 (qC), 125.37 (CH), 133.83 (CH), 140.47 (qC), 
204.82 (C=O) ppm. 
HRMS (ESI
+
): found 266.0716 [M]
+
, C12H14N2O3S requires 266.0725. 
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7.1.5. Synthesis of  3b,4,6,7-tetrahydro-5H-benzo[f]pyrido[1,2-
b][1,2,3]triazolo[5,1-d][1,2,5]thiadiazepine 9,9-dioxide.  
 
 
The aldehyde (80 mg, 1.07 mmol, 1.0 eq) was dissolved in dry methanol (5 mL); potassium 
carbonate (75 mg, 0.54 mmol, 2.0 eq) and the Bestmann-Ohira reagent
236
 (78 μL, 62 mg, 0. 
33 mmol, 1.2 eq) were added and the whole was stirred for 22 hours under nitrogen. The 
reaction was quenched with saturated aqueous ammonium chloride (10 mL), the organic 
phase was separated and the aqueous phase was extracted with dichloromethane (3 x 20 mL). 
The combined organic phases were dried (MgSO4), filtered and concentrated in vacuo to yield 
an orange solid. Purification by silica chromatography (petroleum ether/ethyl acetate: 1/1, Rf 
= 0.2) yielded the product as a pale yellow oil (56 mg, 71 %). 
IR: ʋmax (cm
-1
): 728.3, 907.4, 955.3, 1096.5, 1127.9, 1170.3, 1346.2, 1488.0, 1593.0, 2854.9, 
2926.4. 
1
H NMR: H (400 MHz, CDCl3): 1.33-1.45 (1H, m, CHH), 1.60-1.79 (2H, m, CH2), 1.87-
1.92 (1H, m, CHH), 2.02-2.15 (2H, m, CH2), 2.66 (1H, td, J
1
=11.8 Hz, J
2
=2.6 Hz, NCH), 
3.73 (1H, dd, J
1
=9.7 Hz, J
2
=2.6 Hz, NCHH), 3.86-3.89 (1H, m, NCHH), 7.58 (1H, app. td, 
J
1
=7.6 Hz, J
2
=0.7 Hz, ArH), 7.68 (1H, br.s, ArH), 7.75 (1H, dd, J
1
=7.8 Hz, J
2
=1.1 Hz, ArH), 
7.93 (1H, dd, J
1
=7.8 Hz, J
2
=1.1 Hz,  ArH), 9.97 (1H, d, J=7.6 Hz, ArH). 
13
C NMR c (100 MHz, CDCl3): 23.67 (CH2), 25.07 (CH2), 29.42 (CH2), 48.80 (CH2), 52.25 
(CH), 125.02 (CH), 127.96 (CH), 129.70 (CH), 130.92 (qC), 132.86 (CH), 133.54 (qC), 
134.48 (CH), 136.53 (qC) ppm. 
HRMS (ESI
+
): found 291.0909 [M+H]
+
, C13H15N4O2S requires 291.0910. 
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7.1.6. Synthesis of 5-benzyl-4,5-dihydrobenzo[f][1,2,3]triazolo[5,1-
d][1,2,5]thiadiazepine 6,6-dioxide. 
 
The aldehyde (200 mg, 0.606 mmol, 1.0 eq) was dissolved in dry methanol (5 mL); potassium 
carbonate (167 mg, 1.212 mmol, 2.0 eq) and the Bestmann-Ohira reagent (174 μL, 139 mg, 0. 
727 mmol, 1.2 eq) were added and the whole was stirred for 22 hours under nitrogen. The 
reaction was quenched with saturated aqueous ammonium chloride (10 mL), the organic 
phase was separated and the aqueous phase was extracted with dichloromethane (3 x 20 mL). 
The combined organic phases were dried (MgSO4), filtered and concentrated in vacuo to yield 
an orange solid. Purification by silica chromatography (20 g) (petroleum ether/ethyl acetate: 
1/1, Rf = 0.22) yielded the product as a orange oil (145 mg, 73 %). 
IR: ʋmax (cm
-1
): 697.1, 797.7, 908.5, 1059.1, 1089.9, 1139.7, 1167.7, 1343.9, 1454.0, 1485.7, 
1591.8, 1650.8, 2924.8. 
1
H NMR: H (400 MHz, CDCl3): 4.26 (4H, d, J=7.1 Hz, 2 x CH2), 7.18-7.29 (5H, m, 5 x 
ArH), 7.54 (2H, m, 2 x ArH), 7.72 (1H, td, J
1
=8.2 Hz, J
2
=1.3 Hz, ArH), 8.03 (1H, dd, J
1
= 7.9 
Hz, J
2
=1.5 Hz, ArH), 8.17 (1H, d, J=8.2 Hz, ArH) ppm. 
13
C NMR c (100 MHz, CDCl3):  41.14 (CH2), 54.12 (CH2), 125.03 (CH), 128.36 (CH), 
128.57 (2CH), 128.61 (CH), 129.04 (2CH), 129.18 (CH), 131.63 (qC), 132.85 (qC), 133.05 
(CH), 133.94 (qC), 134.02 (qC), 134.41 (CH) ppm. 
HRMS (ESI
+
): found 327.0905 [M+H]+, C16H15N4O2S requires 327.1091. 
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7.1.7. Synthesis of 5-methyl-4,5-dihydrobenzo[f][1,2,3]triazolo[5,1-
d][1,2,5]thiadiazepine 6,6-dioxide. 
 
The aldehyde (180 mg, 0.708 mmol, 1.0 eq) was dissolved in dry methanol (5 mL); potassium 
carbonate (195 mg, 1.416 mmol, 2.0 eq) and the Bestmann-Ohira reagent (203 μL, 163 mg, 0. 
850 mmol, 1.2 eq) were added and the whole was stirred for 22 hours under nitrogen. The 
reaction was quenched with saturated aqueous ammonium chloride (10 mL), the organic 
phase was separated and the aqueous phase was extracted with dichloromethane (3 x 20 mL). 
The combined organic phases were dried (MgSO4), filtered and concentrated in vacuo to yield 
an orange solid. Purification by silica chromatography (petroleum ether/ethyl acetate: 1/2, Rf 
= 0.24) yielded the product as a pale yellow solid (120 mg, 68 %, m.p.=106-108 
o
C). 
IR: ʋmax (cm
-1
): 727.9, 839.9, 910.8, 978.4, 1104.8, 1137.3, 1165.1, 1230.7, 1344.6, 1459.1, 
1484.7, 1562.9, 2925.2. 
1
H NMR: H (400 MHz, CDCl3): 2.79 (3H, s, CH3), 4.30 (2H, s, CH2), 7.55 (1H, app. td, 
J
1
=7.8 Hz, J
2
= 1.0 Hz, ArH), 7.68 (1H, s, =CH), 7.73 (1H, app. td, J
1
= 7.8 Hz, J
2
=1.4 Hz, 
ArH), 7.96 (1H, dd, J
1
=7.8 Hz, J
2
=1.4 Hz, ArH), 8.09 (1H, dd, J
1
=8.1 Hz, J
2
=0.9 Hz, ArH) 
ppm. 
13
C NMR c (100 MHz, CDCl3):  38.03 (CH3), 43.94 (CH2), 125.04 (CH), 128.74 (CH), 
129.38 (CH), 130.10 (qC), 132.60 (qC), 133.15 (qC), 134.04 (CH), 134.59 (CH) ppm. 
HRMS (ESI
+
): found 251.0612 [M+H]
+
, C10H11N4O2S requires 251.0597. 
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7.1.8. Attempted synthesis of 4,4a,5,6,7,8-hexahydrobenzo[g] pyrido[1,2-
b][1,2,3]triazolo[5,1-e][1,2,6]thiadiazocine 10,10-dioxide. 
 
 
The aldehyde (123 mg, 0.4 mmol, 1.0 eq) was dissolved in dry methanol (5 mL); potassium 
carbonate (110 mg, 0.8 mmol, 2.0 eq) and the Bestmann-Ohira reagent (115μL, 92 mg, 0.48 
mmol, 1.2 eq) were added and the whole was stirred for 22 hours under nitrogen. The reaction 
was quenched with saturated aqueous ammonium chloride (10 mL), the organic phase was 
separated and the aqueous phase was extracted with dichloromethane (3 x 20 mL). The 
combined organic phases were dried (MgSO4), filtered and concentrated in vacuo to yield an 
orange solid. Purification by silica chromatography to give two products: 
First product (281): 1-[(2-azidophenyl)sulfonyl]-2-(prop-2-yn-1-yl) 
piperidine. 
(Petroleum ether/ethyl acetate: 1/1, Rf = 0.21) yielded the product as a light yellow oil 
(80 mg, 66 %). 
IR: ʋmax (cm
-1
): 576.3, 603.7, 647.2, 818.4, 867.8, 905.5, 964.9, 1071.6, 1124.9, 1156.5, 
1265.8, 1327.1, 1444.2, 1471.9, 1575.5, 2099.6, 2125.8, 2943.5, 3307.6. 
1
H NMR: H (400 MHz, CDCl3): 1.16-1.60 (6H, m, 3 x CH2), 1.84 (1H, br.s, CH2CCH), 
1.88-1.93 (1H, m, HCC-CHH), 2.35 (1H, qd, J
1
=16.0 Hz, J
2
=2.6 Hz, HCCCHH), 2.95 (1H, 
td, J
1
=13.8 Hz, J
2
=2.3 Hz, NCH), 3.76 (1H, dd, J
1
=13.9 Hz, J
2
=3.9 Hz, NCHH), 4.15 (H, t, 
J=5.4 Hz, NCHH), 7.14 (1H, dd, J
1
=7.8 Hz, J
2
=7.5 Hz, ArH), 7.21 (1H, app. td, J=7.9 Hz, 
ArH), 7.49 (1H, app. td, J
1
=7.8 Hz, J
2
=1.4 Hz, ArH), 7.91 (1H, dd, J
1
=7.9 Hz, J
2
=1.4 Hz, 
ArH) ppm. 
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13
C NMR c (100 MHz, CDCl3):  18.11 (CH2), 20.05 (CH2), 25.23 (CH2), 26.74 (CH2), 
41.13 (CH2), 51.87 (CH), 70.44 (CH), 80.81 (qC), 119.84 (CH), 124.54 (CH), 131.24 (CH), 
131.34 (qC), 133.68 (CH), 137.99 (qC) ppm. 
HRMS (ESI
+
): found 305.1062 [M+H]
+
, C14H17N4O2S requires 305.1067. 
Second product (283): 2-{[2-(prop-2-yn-1-yl)piperidin-1-yl]sulfonyl}aniline. 
(Petroleum ether/ethyl acetate: 1/2, Rf = 0.21) yielded the product as a yellow oil (20 mg, 
18 %).  
IR: ʋmax (cm
-1
): 839.0, 964.1, 1088.8, 1141.2, 1178.3, 1265.7, 1318.5, 1381.7, 1453.7, 
1567.0, 1616.6, 2129.3, 2884.0, 2980.3, 3305.3, 3376.6, 3483.9. 
1
H NMR: H (400 MHz, CDCl3): 1.14-1.61 (6H, m, 3 x CH2), 1.83-1.97 (1H, m, HCC-
CHH), 2.33.2.39 (1H, m, HCCCHH), 2.53-2.58 (1H, m, NCH), 2.85 (1H, td, J
1
=13.8 Hz, 
J
2
=2.3 Hz, CCH), 3.63 (1H, dd, J
1
=13.9 Hz, J
2
=3.9 Hz, NCHH), 4.13 (H, t, J=5.4 Hz, 
NCHH), 4.92 (2H, sb, NH2), 7.23 (2H, d, J=8.2 Hz, 2 x ArH), 7.74 (2H, d, J=8.2 Hz, 2 x 
ArH) ppm. 
13
C NMR c (100 MHz, CDCl3):  18.09 (CH2), 19.58 (CH2), 24.59 (CH2), 26.19 (CH2), 
40.76 (CH2), 51.66 (CH), 70.51 (CH), 80.99 (qC), 117.35 (CH), 124.55 (CH), 129.90 (CH), 
133.90 (CH), 138.01 (qC), 145.31 (qC) ppm. 
HRMS (ESI
+
): found 278.1089 [M+H]
+
, C14H18N2O2S requires 278.1089. 
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7.1.9. Synthesis of 4,4a,5,6,7,8-hexahydrobenzo[g]pyrido[1,2-b][1,2,3]tria-
zolo[5,1-e][1,2,6]thiadiazocine-10,10-dioxide. 
 
A solution of sodium ascorbate (5 mg, 0.025 mmol, 0.1 eq) and CuSO4.5H2O (1.22 mg, 
0.0049 mmol, 0.02 eq) in water (2 mL) was added to a solution of 1-((2-
azidophenyl)sulfonyl)-2-(prop-2-yn-1-yl)piperidine (75 mg, 0.25 mmol, 1.0 eq) in t-BuOH (2 
mL). The whole was stirred at ambient temperature under nitrogen atmosphere for 48 hours 
and whilst being monitored by TLC. The reaction mixture was diluted with water (10 mL), 
the organic layer was separated and the aqueous layer was extracted with EtOAc (3 x 10 mL). 
The combined organic layers were washed with water (10 mL) and brine (10 mL). The 
organic phase was dried with anhydrous MgSO4, filtered and the solvent removed in vacuo. 
Purified by silica column chromatography [petroleum ether/ethyl acetate: 1/5, Rf = 0.24] to 
yield the product as a light yellow oil (60 mg, 80 %). 
IR: ʋmax (cm
-1
): 772.7, 937.8, 1018.9, 1072.2, 1085.2, 1122.3, 1135.8, 1163.3, 1266.7, 
1297.1, 1343.0, 1357.2, 1455.2, 1488.8, 1589.8, 2856.0, 2928.5. 
1
H NMR: H (400 MHz, CDCl3): 1.18-1.69 (6H, m, 3 x CH2), 1.87-1.96 (1H, m, C=C-
CHH), 2.28 (1H, td, J
1
=12.0 Hz, J
2
=3.1 Hz, C=CCHH), 2.68-2.77 (1H, m, CH), 3.51 (1H, d, 
J=10.3 Hz, NCHH), 4.03-4.12 (1H, m, NCHH), 7.55-7.59 (2H, m, C=CH + ArH), 7.63 (1H, 
d, J=7.8 Hz, ArH), 7.68 (1H, ddd, J
1
=7.8 Hz, J
2
=7.5 Hz, J
3
=2.0 Hz, ArH), 8.03 (1H, d, J=7.8 
Hz, ArH) ppm. 
13
C NMR c (100 MHz, CDCl3):  18.32 (CH2), 23.07 (CH2), 24.79 (CH2), 32.38 (CH2), 
41.22 (CH2), 54.68 (CH), 127.65 (CH), 128.00 (qC), 130.01 (CH), 130.30 (CH), 131.70 (CH), 
132.90 (qC), 133.87 (CH), 133.93 (qC) ppm. 
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HRMS (ESI
+
): found 305.1063 [M+H]
+
, C14H17N4O2S requires 305.1067. 
 
7.1.10. Attempted synthesis of 7-ethyl-4,5,6,7-tetrahydrobenzo[h][1,2,3]tri-
azolo[5,1-f][1,2,7]thiadiazonine 8,8-dioxide. 
 
The aldehyde (200 mg, 0.675 mmol, 1.0 eq) was dissolved in dry methanol (5 mL); potassium 
carbonate (186 mg, 1.35 mmol, 2.0 eq) and the Bestmann-Ohira reagent (194 μL, 155 mg, 
0.81 mmol, 1.2 eq) were added and the whole was stirred for 22 hours under nitrogen. The 
reaction was quenched with saturated aqueous ammonium chloride (10 mL), the organic 
phase was separated and the aqueous phase was extracted with dichloromethane (3 x 20 mL). 
The combined organic phases were dried (MgSO4), filtered and concentrated in vacuo to yield 
an orange solid. Purification by silica chromatography (25 g) (petroleum ether/ethyl acetate: 
1/1, Rf = 0.24) yielded the product as a dark brown oil (137 mg, 70 %). 
IR: ʋmax (cm
-1
): 750.4, 818.3, 936.4, 1002.5, 1063.9, 1155.4, 1264.7, 1327.7, 1443.0, 1471.3, 
1574.9, 2101.1, 2232.0, 2849.3, 2920.2, 3281.9. 
1
H NMR: H (400 MHz, CDCl3): 1.03 (3H, t, J=7.1 Hz, CH3), 1.71 (2H, p, J=7.3 Hz, 
NCH2CH2), 1.87 (1H, bs, C-H),  2.14 (2H, td, J
1
=6.9 Hz, J
2
=2.3 Hz, HCC-CH2), 3.29-3.37 
(4H, m, CH2NCH2),  7.15 (1H, dd, J
1
=7.7 Hz, J
2
=7.6 Hz, ArH), 7.21 (1H, d, J= 7.6 Hz, 
ArH), 7.49 (1H, dd, J
1
=7.6 Hz, J
2
=7.5 Hz, ArH), 7.91 (1H, d, J
1
=7.7 Hz, ArH) ppm. 
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13
C NMR c (100 MHz, CDCl3):  14.01 (CH3), 15.81 (CH2), 27.71 (CH2), 42.67 (CH2), 
46.36 (CH2), 68.98 (C-H), 83.18 (qC), 119.81 (CH), 124.61 (CH), 131.21 (qC), 131.57 (CH), 
133.71 (CH), 137.98 (qC) ppm. 
HRMS (ESI
+
): found 293.1064 [M+H]
+
, C13H17N4O2S requires 293.1067. 
 
7.1.11. Attempted synthesis of 7-ethyl-4,5,6,7-tetrahydrobenzo[h] 
[1,2,3]triazolo[5,1-f][1,2,7]thiadiazonine 8,8-dioxide. 
 
2-Azido-N-ethyl-N-(pent-4-yn-1-yl)benzenesulfonamide (100 mg, 0.34 mmol) in dry 
chloroform (10 mL) was heated at 80 
o
C  under a nitrogen atmosphere for 3 days and 
monitored by TLC which showed no product. The solvent was removed and the remaining 
starting material was added to anhydrous toluene (10 mL). The reaction mixture was heated at 
reflux temperature for 3 days under an atmosphere of dry nitrogen whilst being monitored by 
TLC and concentrated. Purification by silica chromatography (petroleum ether/ ethyl acetate: 
3/1, Rf = 0.23), yielded the product as a brown oil (91 mg, 75%). 
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IR: ʋmax (cm
-1
): 839.6, 909.1, 1086.3, 1139.8, 1319.2, 1453.5, 1483.4, 1616.9, 2156.4, 
2979.9, 3304.1, 3375.7, 3485.8. 
1
H NMR: H (400 MHz, CDCl3): 1.05 (3H, t, J=7.2 Hz, CH3), 1.66-1.73 (2H, m, 
NCH2CH2), 1.87 (1H, t, J=2.6 Hz, C-H),  2.12 (2H, td, J
1
=7.0 Hz, J
2
=2.6 Hz, HCC-CH2), 
3.19-3.24 (4H, m, CH2NCH2), 4.95 (2H, br.s, NH2), 6.63 (1H, d, J=8.0 Hz, ArH), 6.67 (1H, 
d, J= 7.8 Hz, ArH), 7.19 (1H, app. td, J
1
=7.8 Hz, J
2
=1.3 Hz, ArH), 7.54 (1H, dd, J
1
=8.0 Hz, 
J
2
=1.2 Hz, ArH) ppm. 
13
C NMR c (100 MHz, CDCl3):  13.63 (CH3), 15.75 (CH2), 27.39 (CH2), 42.44 (CH2), 
45.83 (CH2), 68.97 (C-H), 83.28 (qC), 117.32 (CH), 117.65 (CH), 121.36 (qC), 129.89 (CH), 
133.87 (CH), 145.69 (qC) ppm. 
HRMS (ESI
+
): found 267.1167 [M+H]
+
, C13H19N2O2S requires 267.1162. 
7.1.12. Attempted synthesis of 5,6-dihydro-4H-4,7-ethanobenzo[h] 
[1,2,3]triazolo[5,1-f][1,2,7]thiadiazonine 8,8-dioxide. 
 
 
The aldehyde (200 mg, 0.68 mmol, 1.0 eq) was dissolved in dry methanol (5 mL); potassium 
carbonate (187 mg, 1.36 mmol, 2.0 eq) and the Bestmann-Ohira reagent (195 μL, 156 mg, 0. 
816 mmol, 1.2 eq) were added and the whole was stirred for 22 hours under nitrogen. The 
reaction was quenched with saturated aqueous ammonium chloride (10 mL), the organic 
phase was separated and the aqueous phase was extracted with dichloromethane (3 x 20 mL). 
The combined organic phases were dried (MgSO4), filtered and concentrated in vacuo to yield 
an orange solid. Purification by silica chromatography gave two products: 
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First product (295): 1-[(2-azidophenyl)sulfonyl]-4-ethynylpiperidine. 
(Petroleum ether/ethyl acetate: 1/2, Rf = 0.24) yielded the product as a light yellow oil 
(125 mg, 64 %). 
IR: ʋmax (cm
-1
):  761.0, 817.6, 936.0, 1039.0, 1068.8, 1123.2, 1265.2, 1309.9, 1325.1, 1443.5, 
1471.6, 1573.9, 1584.7, 2099.1, 2131.0, 2854.4, 2925.5, 3276.0. 
1
H NMR: H (400 MHz, CDCl3): 1.61-1.69 (2H, m, CH2CHCH2), 1.79-1.86 (2H, m, 
CH2CHCH2), 2.03 (1H, br.s, CCH), 2.49-2.54 (1H, m, CH2CHCH2), 3.08-3.14 (2H, m, 
CH2NCH2), 3.41-3.47 (2H, m, CH2NCH2), 7.16 (1H, dd, J
1
=8.0 Hz, J
2
=7.6 Hz, ArH), 7.23 
(1H, d, J= 8.0 Hz, ArH), 7.51 (1H, app. td, J
1
=8.0 Hz, J
2
=1.0 Hz, ArH), 7.87 (1H, d, J=8.0 
Hz, ArH) ppm. 
13
C NMR c (100 MHz, CDCl3):  29.00 (CH), 31.07 (2 x CH2), 44.06 (2 x CH2),  70.23 
(CH), 85.55 (qC), 119.93 (CH), 124.65 (CH), 129.40 (qC), 131.72 (CH), 133.89 (CH), 138.29 
(qC) ppm. 
HRMS (ESI
+
): found 291.0910 [M+H]
+
, C13H15N4O2S requires 291.0910. 
Second product (297): 2-[(4-ethynylpiperidin-1-yl)sulfonyl]aniline. 
(Petroleum ether/ethyl acetate: 1/1, Rf = 0.23) yielded the product as a yellow oil (25 mg, 
14 %). 
IR: ʋmax (cm
-1
): 732.9, 839.7, 928.4, 1039.0, 1087.4, 1113.2, 1142.2, 1248.3, 1320.7, 1338.0, 
1452.3, 1483.3, 1566.4, 1615.6, 2124.0, 2851.6, 2925.7, 3285.3, 3377.1, 3481.5. 
1
H NMR: H (400 MHz, CDCl3): 1.59-1.68 (2H, m, CH2CHCH2), 1.78-1.84 (2H, m, 
CH2CHCH2), 1.99 (1H, d, J=2.3 Hz, CCH), 2.37-2.42 (1H, m, CH2CHCH2), 2.87 (2H, td, 
J
1
=11.7 Hz, J
2
=3.2 Hz, CH2NCH2), 3.32-3.37 (2H, m, CH2NCH2), 4.98 (2H, br.s, NH2), 6.65 
(1H, d, J=7.9 Hz, ArH), 6.68(1H, d, J= 7.9 Hz, ArH), 7.22 (1H, dd, J
1
=7.9 Hz, J
2
=6.7 Hz, 
ArH), 7.48 (1H, d, J=7.9 Hz, ArH) ppm. 
13
C NMR c (100 MHz, CDCl3):  25.94 (CH), 30.66 (2 x CH2), 44.25 (2 x CH2),  70.06 
(CH), 85.59 (qC), 117.20 (CH), 117.66 (CH), 118.00 (qC), 130.24 (CH), 134.17 (CH), 146.23 
(qC) ppm. 
HRMS (ESI
+
): found 265.1004 [M+H]
+
, C13H17N2O2S requires 265.1005. 
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7.1.13. Synthesis of (S)-[1-(2'-azidobenzenesulfonyl)pyrrolidin-2-yl] 
methanol. 
 
2-Azidobenzenesulfonic acid (1.475 g, 7.425 mmol, 2.5 eq) was heated at reflux in a 2M 
solution of (COCl)2 in dichloromethane (7.4 mL, 14.8 mmol, 5.0 eq) with a drop  of DMF  
under an inert atmosphere of nitrogen for 5 hours. The reaction was cooled to room 
temperature before the crude acid chloride was concentrated and the residue was washed with 
dichloromethane (2 x 20 mL) to give the crude sulfonyl chloride as an orange solid. 
A solution of potassium carbonate (1.65 g, 11.88 mmol, 4.0 eq) in water (10 mL) was added 
in one portion to a stirring solution of S-prolinol (300 mg, 2.970 mmol, 1.0 eq) in 
dichloromethane (10 mL). The sulfonyl chloride was dissolved in dichloromethane (5 mL) 
and was added slowly to this solution. The reaction was allowed to stir at room temperature 
for 18 hours before the organic layer was separated and the aqueous layer washed with 
dichloromethane (2 x 20 mL). The combined organic phases were dried (MgSO4), filtered, 
concentrated and purified by silica column chromatography [petroleum ether/ethyl acetate: 
1/10, Rf = 0.2] to yield the product as a yellow oil (600 mg, 72 %). 
IR: ʋmax (cm
-1
): 575.3, 600.1, 649.3, 728.2, 769.4, 820.5, 864.2, 897.4, 997.5, 1018.6, 1064.6, 
1141.8, 1198.1, 1305.1, 1466.5, 1572.5, 1581.5, 2101.4, 2872.4, 2963.4, 3081.6, 3438.7. 
1
H NMR: H (400 MHz, CDCl3): 1.68-1.77 (1H, m, CHH), 1.79-1.88 (1H, m, CHH), 1.90-
2.00 (2H, m, CH2), 2.72 (1H, bs, CH2OH), 3.30-3.49 (1H, m, NCH), 3.52-3.59 (1H, m, 
NCHH), 3.61-3.66 (1H, m, NCHH), 3.70-3.74 (1H, m, HOCHH), 4.02-4.08 (1H, m, 
HOCHH), 7.28 (1H, dd, J
1
=8.1 Hz, J
2
=7.0 Hz, ArH), 7.33 (1H, dd, J= 8.0 Hz, ArH), 7.62 
(1H, ddd, J
1
=8.1 Hz, J
2
=7.0 Hz, J
3
=1.1 Hz, ArH), 8.04 (1H, dd, J=8.0 Hz, J=1.1 Hz, ArH) 
ppm. 
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13
C NMR c (100 MHz, CDCl3): 24.67 (CH2), 29.05 (CH2), 49.52 (CH2), 61.83 (CH), 65.48 
(CH2), 119.91 (CH), 124.80 (CH), 129.04 (qC), 132.59 (CH), 134.21 (CH), 138.20 (qC) ppm. 
HRMS (ESI
+
): found 283.0855 [M+H]
+
, C11H15N5O3S requires 283.0859. 
7.1.14. Synthesis of 2-azidobenzenesulfonamide. 
 
 
To a solution of 2-aminobenzenesulfonamide
237
 ( 5 g, 29 mmol, 1.0 eq) in concentrated HCl 
(45 mL) and water (45 mL) at 0 
o
C, was added, with stirring, a solution  of NaNO2 (2.18 g, 
31.97 mmol, 1.1 eq) in water (10 mL) cooled to 0 
o
C dropwise over 10 minutes and the whole 
stirred for a further hour before a cooled solution of NaN3 (1.89 g, 29 mmol, 1.1 eq)  and 
sodium acetate (60 g) in water (100 mL) was added dropwise over an hour. The precipitate 
formed was filtered by vacuum, washed thoroughly with water (60 mL) and  dried in the oven 
at 80-100 
o
C to give the product as a fawn coloured solid (4.7 g, 82 %). (m.p. =182-184 
o
C, 
Lit. m.p.=176 
o
C
238
). 
IR: ʋmax (cm
-1
): 767.3, 817.7, 884.2, 1064.1, 1080.8, 1155.0, 1282.6, 1331.4, 1446.6, 1555.9, 
1577.9, 2095.6, 3252.7, 3354.1.  
1
H NMR: H (400 MHz, DMSO): 7.30-7.35 (3H, m, NH2+ ArH), 7.54 (1H, d, J= 7.8 Hz, 
ArH), 7.66 (1H, app. td, J
1
= 7.7 Hz, J
2
=1.4 Hz, ArH), 7.83 (1H, dd, J
1
= 7.8 Hz, J
2
= 1.4 Hz, 
ArH) ppm. 
13
C NMR c (100 MHz, DMSO): 121.20 (CH), 125.17 (CH), 128.45 (CH), 133.93 (CH), 
134.23 (qC), 137.36 (qC) ppm. 
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7.1.15. Synthesis of 2-azido-N-(pent-4-en-1-yl)benzenesulfonamide. 
 
 To a solution of 2-azidobenzenesulfonamide (198 mg, 1.0 mmol, 1.0 eq) in CH3CN (10 mL), 
5-bromo-1-pentene (149 mg, 1.0 mmol, 1.0 eq) and pyridine (79 mg, 1.0 mmol, 1.0 eq) were 
added. The mixture was heated at 95 
o
C for 72 hours under a nitrogen atmosphere whilst 
being monitored by TLC. The reaction was diluted with water (10 mL) and the mixture was 
extracted with DCM (3 x 15 mL). The combined organic layer was dried over with anhydrous 
MgSO4, filtered and concentrated. Purification by silica chromatography (eluent: petroleum 
ether/ethyl acetate: 1/1, Rf = 0.3) yielded the product as a light yellow oil (20 mg, 8 %). 
IR: ʋmax (cm
-1
): 731.0, 820.3, 914.7, 1067.1, 1125.3, 1161.5, 1290.8, 1329.0, 1415.2, 1471.4, 
1575.0, 1640.5, 2133.4, 2854.3, 2926.5, 3073.9, 3299.5.  
1
H NMR: H (400 MHz, CDCl3): 1.52 (2H, p, J=7.2 Hz, CH2), 2.00 (2H, q, J=7.0 Hz, CH2), 
2.83 (2H, q, J=6.8 Hz, CH2), 4.88-4.96 (3H, m, N-H, =CH2),  5.59-5.70 (1H, m, =CH), 7.18-
7.24 (2H, m, 2 x ArH), 7.53 (1H, app. td, J
1
= 7.8 Hz, J
2
=1.3 Hz, ArH), 7.91 (1H, dd, J
1
= 7.8 
Hz, J
2
=1.1 Hz, ArH) ppm. 
13
C NMR c (100 MHz, CDCl3): 28.66 (CH2), 30.67 (CH2), 42.79 (CH2), 115.62 (CH2), 
119.36 (CH), 124.91 (CH), 129.92 (qC), 130.76 (CH), 133.96 (CH), 137.19 (CH), 137.46 
(qC) ppm. 
HRMS (ESI
+
): found 289.0730 [M+Na]
+
, C11H14N4O2SNa requires 289.0730. 
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7.1.16. Synthesis of 2-azido-N-(pent-4-en-1-yl)benzenesulfonamide. 
 
To a solution of 2-azidobenzenesulfonamide (198 mg, 1.0 mmol, 1.0 eq) in DMF (10 mL) 
cooled to 0 
o
C, 5-bromo-1-pentene (149 mg, 1.0 mmol, 1.0 eq) and Na2CO3 (212 mg, 2.0 
mmol, 1.0 eq) were added. The mixture was heated at reflux temperature for 72 hours under a 
nitrogen atmosphere whilst being monitored by TLC. The reaction was diluted with NaCl(aq)  
(20 mL) and the mixture was extracted with DCM (3 x 15 mL). The combined organic layer 
was dried over with anhydrous MgSO4, filtered and concentrated. Purification by silica 
chromatography (eluent: petroleum ether/ethyl acetate: 1/1, Rf = 0.3) yielded the product as a 
light yellow oil (8 mg, 3 %), with data identical to that above. 
 
7.1.17. Synthesis of {1-[(2-azidophenyl)sulfonyl]pyrrolidin-2-yl}methanol. 
 
 
To a solution of 2-azido-N-(pent-4-en-1-yl)benzenesulfonamide (20 mg, 0.075 mmol, 1.0 eq) 
and Oxone (35 mg, 0.113 mmol, 1.5 eq) in a 1:1 mixture (5 mL) of acetonitrile  and water  
was added p-toluenesulfonic acid monohydrate (2.9 mg, 0.015 mmol, 0.2 eq). The whole was 
heated at reflux temperature for 12 hours, whilst being monitored by TLC. To this solution, 
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saturated aqueous NaHCO3 solution (15 mL) was added and the product was extracted with 
ethyl acetate (3 x 15 mL). The combined organic layer was washed with brine (15 mL), dried 
over anhydrous MgSO4 and the solvent was removed under vacuum. Purification by silica 
chromatography (eluent: petroleum ether/ethyl acetate: 1/10, Rf = 0.2) yielded the product as 
a yellow oil (20 mg, 95 %). 
IR: ʋmax (cm
-1
): 732.2, 820.0, 1018.6, 1064.6, 1141.8, 1199.8, 1305.1, 1472.0, 1574.6, 
1581.5, 2101.4, 2872.4, 2963.4, 3081.6, 3525.7. 
1
H NMR: H (400 MHz, CDCl3): 1.61-1.68 (1H, m, CHH), 1.72-180 (1H, m, CHH), 1.81-
1.98 (2H, m, CH2), 2.70 (1H, bs, CH2OH), 3.28-3.34 (1H, m, NCH), 3.44-3.50 (1H, m, 
NCHH), 3.53-3.60 (1H, m, NCHH), 3.62-3.66 (1H, m, HOCHH), 3.94-4.00 (1H, m, 
HOCHH), 7.28 (1H, dd, J
1
=8.1 Hz, J
2
=7.0 Hz, ArH), 7.33 (1H, dd, J= 8.0 Hz, ArH), 7.62 
(1H, ddd, J
1
=8.1 Hz, J
2
=7.0 Hz, J
3
=1.1 Hz, ArH), 8.04 (1H, dd, J=8.0 Hz, J=1.1 Hz, ArH) 
ppm. 
13
C NMR c (100 MHz, CDCl3): 24.67 (CH2), 29.06 (CH2), 49.53 (CH2), 61.84 (CH), 65.49 
(CH2), 119.90 (CH), 124.80 (CH), 129.08 (qC), 132.59 (CH), 134.20 (CH), 138.22 (qC) ppm. 
HRMS (ESI
+
): found 305.0674 [M+Na]
+
, C11H14N5O3SNa requires 305.0679. 
 
7.1.18. Synthesis of 2-azido-N-(but-3-en-1-yl)benzenesulfonamide. 
 
2-Azidobenzenesulfonic acid (2.462 g, 12.37 mmol, 2.2 eq) was heated at reflux in a 2M 
solution of (COCl)2 in dichloromethane (14.06 mL, 28.12 mmol, 5.0 eq) with a drop  of DMF  
under an inert atmosphere of nitrogen for 5 hours. The reaction was allowed to reach room 
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temperature before the crude acid chloride was concentrated and the residue was washed with 
dichloromethane (2 x 20 mL) to give the crude sulfonyl chloride as an orange solid. 
A solution of potassium carbonate (3.109 g, 22.50 mmol, 4.0 eq) in water (10 mL) was added 
in one portion to a stirring solution of 4-amino-1-butene (400 mg, 5.624 mmol, 1.0 eq) in 
dichloromethane (10 mL). The sulfonyl chloride was dissolved in dichloromethane (5 mL) 
and was added slowly to this solution. The reaction was allowed to stir at room temperature 
for 18 hours before the organic layer was separated and the aqueous layer washed with 
dichloromethane (2 x 20 mL). The combined organic phases were dried (MgSO4), filtered, 
concentrated and purified by silica column chromatography [petroleum ether/ethyl acetate: 
3/1, Rf = 0.25] to yield the product as a pale yellow oil (1.0 g, 78 %). 
IR: ʋmax (cm
-1
): 756.4, 819.0, 916.1, 1066.1, 1124.3, 1243.8, 1288.4, 1326.9, 1411.6, 1443.7, 
1470.8, 1574.4, 1641.1, 2129.9, 2980.1, 3076.5, 3303.3.  
1
H NMR: H (400 MHz, CDCl3): 2.25 (2H, app. q, J=6.6 Hz, CH2), 2.99 (2H, app. q, J=6.5 
Hz, CH2), 5.00-5.14 (3H, m, NH, =CH2), 5.61-5.72 (1H, m, =CH), 7.28 (1H, d, J=7.7 Hz, 
ArH), 7.32 (1H, d, J= 7.7 Hz, ArH), 7.63 (1H, ddd, J
1
= 7.7 Hz, J
2
=7.0 Hz, J
3
=1.3 Hz, ArH), 
8.00 (1H, d, J= 7.7 Hz, ArH) ppm. 
13
C NMR c (100 MHz, CDCl3): 33.52 (CH2), 42.39 (CH2), 118.04 (CH2), 119.38 (CH), 
124.89 (CH), 129.85 (qC), 130.73 (CH), 133.99 (CH), 134.28 (CH), 137.51 (qC) ppm. 
HRMS (ESI
+
): found 275.0574  [M+Na]
+
, C10H12N4O2SNa requires 275.0573. 
7.1.19. Synthesis of (2-azidophenyl)(2-(hydroxymethyl)pyrrolidin-1-
yl)methanone. 
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2-Azidobenzoic acid (358 mg, 2.2 mmol, 2.2 eq) was heated at reflux in a 2M solution of 
(COCl)2 in dichloromethane (2.5 mL, 5.0 mmol, 5.0 eq) with a drop  of DMF  under an inert 
atmosphere of nitrogen for 5 hours. The reaction was cooled to room temperature before the 
crude acid chloride was concentrated and the residue was washed with dichloromethane (2 x 
20 mL) to give the crude 2-azidobenzoyl chloride as a dark brown solid. 
A solution of potassium carbonate ( 552 mg, 4.0 mmol, 4.0 eq) in water (10 mL) was added in 
one portion to a stirring solution of S-prolinol (101 mg, 1.0 mmol, 1.0 eq) in dichloromethane 
(10 mL). The 2-azidobenzoyl chloride was dissolved in dichloromethane (5 mL) and was 
added slowly to this solution. The reaction was allowed to stir at room temperature for 18 
hours before the organic layer was separated and the aqueous layer washed with 
dichloromethane (2 x 20 mL). The combined organic phases were dried (MgSO4), filtered, 
concentrated and purified by silica column chromatography [petroleum ether/ethyl acetate: 
1/2, Rf = 0.23] to yield the product as a light yellow solid (200 mg, 81 %, m.p.=100-101 
o
C, 
lit. m.p.=98-100 
o
C
120
). 
IR: ʋmax (cm
-1
): 769.2, 945.4, 1032.0, 1083.8, 1169.3, 1210.1, 1290.8, 1454.6, 1597.1, 
2089.8, 2980.8, 3291.6. 
1
H NMR: H (400 MHz, CDCl3): 1.66-1.93 (3H, m, CH2 + CHH), 2.15-2.23 (1H, m, CHH), 
3.23-3.34 (2H, m, N-CH2), 3.72-3.77 (1H, m, HO-CHH), 3.84-3.87 (1H, m, HO-CHH), 4.36 
(1H, dq, J
1
=10.1 Hz, J
2
=2.7 Hz, NCH), 3.83 (1H, bs, OH), 7.10-7.22 (2H, m, 2 x ArH), 7.32 
(1H, dd, J
1
=8.1 Hz, J
2
=1.3 Hz, ArH), 7.45 (1H, app. dt, J
1
=8.1 Hz, J
2
=1.6 Hz, ArH) ppm. 
13
C NMR c (100 MHz, CDCl3): 24.51 (CH2), 28.62 (CH2), 49.64 (CH2), 61.35 (CH), 66.63 
(CH2OH), 118.53 (CH), 125.27 (CH), 127.77 (CH), 129.32 (qC), 130.68 (CH), 136.07 (qC), 
169.05 (C=O) ppm. 
HRMS (ESI
+
): found 247.1185 [M+ H]
+
, C12H15N4O2 requires 247.1190. 
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7.1.20. Synthesis of  2-azido-N-(pent-4-en-1-yl)benzamide 
 
2-Azidobenzenesulfonic acid (717mg, 4.4 mmol, 2.2 eq) was heated at reflux in a 2M solution 
of   (COCl)2 in dichloromethane (5.0 mL, 10.0 mmol, 5.0 eq) with a drop  of DMF  under an 
inert atmosphere of nitrogen for 5 hours. The reaction was cooled to room temperature before 
the crude acid chloride was concentrated and the residue was washed with dichloromethane (2 
x 20 mL) to give the crude 2-azidobenzoyl chloride as a dark brown solid. 
A solution of potassium carbonate (1.104 g, 8.0 mmol, 4.0 eq) in water (10 mL) was added in 
one portion to a stirring solution of 5-amino-1-pentene
188
 (170 mg, 2.0 mmol, 1.0 eq) in 
dichloromethane (10 mL). The 2-azidobenzoyl chloride was dissolved in dichloromethane (5 
mL) and was added slowly to this solution. The reaction was allowed to stir at room 
temperature for 18 hours before the organic layer was separated and the aqueous layer washed 
with dichloromethane (2 x 20 mL). The combined organic phases were dried (MgSO4), 
filtered, concentrated and purified by silica column chromatography [petroleum ether/ethyl 
acetate: 1/4, Rf = 0.25] to yield the product as ayellow oil (330 mg, 72 %). 
IR: ʋmax (cm
-1
): 785.7, 943.8, 993.5, 1164.2, 1293.5, 1444.8, 1480.3, 1536.2, 1577.2 1638.5, 
1712.4, 2124.9, 2863.6, 2930.4, 3075.9, 3293.9. 
1
H NMR: H (400 MHz, CDCl3): 1.66 (2H, p, J=7.2 Hz, -CH2CH2CH2- ), 2.09 (2H, q, J=7.3 
Hz, CH2CH=CH2), 3.37-3.42 (2H, m, NHCH2), 4.92 (1H, dd, J
1
=10.2 Hz, J
2
=1.6 Hz, 
CH=CHH), 4.99 (1H, J
1
= 17.1 Hz, J
2
=1.6 Hz, CH=CHH), 5.70-5.82 (1H, m, CH=CH2), 7.10 
(1H, dd, J
1
=7.8 Hz, J
2
=0.8 Hz, ArH), 7.14 (1H, ddd, J
1
=7.8 Hz, J
2
=7.4 Hz, J
3
=1.6 Hz, ArH), 
7.40 (2H, ddd, J
1
=7.8 Hz, J
2
=7.4 Hz, J
3
=1.6 Hz, 2 x ArH), 8.04 (1H, dd, J
1
= 7.8 Hz, J
2
=1.6 
Hz, NH) ppm. 
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13
C NMR c (100 MHz, CDCl3):  28.64 (CH2), 31.25 (CH2), 39.54 (CH2), 115.22 (=CH2), 
118.37 (CH), 125.17 (CH), 125.26 (qC), 132.17 (CH), 132.19 (CH), 136.82 (qC), 137.79 
(CH), 164.58 (C=O) ppm. 
HRMS (ESI
+
): found 231.1238 [M+H]
+
, C12H15N4O requires 231.1240. 
7.1.21. Attempted synthesis of (2-azidophenyl)(2-(hydroxymethyl)pyrrolid-
in-1-yl)methanone. 
 
 
To a solution of 2-azido-N-(pent-4-en-1-yl)benzamide (100 mg, 0.434mmol, 1.0 eq) and 
Oxone (200 mg, 0.652 mmol, 1.5 eq) in a 1:1 mixture (10 mL) of acetonitrile  and water  was 
added p-toluenesulfonic acid monohydrate (17 mg, 0.087 mmol, 0.2 eq). The whole was 
heated at reflux temperature for 12 hours, whilst being monitored by TLC. To this solution, 
saturated aqueous NaHCO3 solution (15 mL) was added and the product was extracted with 
ethyl acetate (3 x 15 mL). The combined organic layer was washed with brine (15 mL), dried 
over anhydrous MgSO4 and the solvent was removed under vacuum. The residue was purified 
by using silica chromatography (eluent: petroleum ether/ethyl acetate: 1/2, Rf = 0.2) yielded 
the product as a light yellow oil (64 mg, 60 %). 
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IR: ʋmax (cm
-1
): 752.7, 1090.0, 1164.4, 1291.6, 1444.5, 1480.2, 1537.4, 2597.2, 1632.6, 
1712.4, 2125.8, 2928.3, 3360.0. 
1
H NMR: H (400 MHz, CDCl3): 1.50-1.99 (4H, m, 2 x CH2), 3.32-3.56 (4H, m, 2 x CH2), 
3.76-3.83 (2H, m, O-CH), 7.12 (1H, d, J=7.7 Hz, ArH), 7.16 (1H, dd, J
1
= 7.7 Hz, J
2
=7.5 Hz, 
ArH), 7.42 (1H, dd, J
1
=7.8 Hz, J
2
=1.1 Hz, ArH), 7.51 (1H, bs, NH), 8.03 (1H, d, J=7.8 Hz, 
ArH) ppm. 
13
C NMR c (100 MHz, CDCl3): 25.93 (CH2), 32.12 (CH2), 50.20 (CH2), 58.24 (OCH), 
67.04 (OCH2), 71.12 (CH), 118.42 (CH), 125.00 (qC), 125.22 (CH), 132.17 (CH), 132.37 
(CH), 136.92 (qC), 164.94 (C=O) ppm. 
HRMS (ESI
+
): found 326.0375 [M]
+
, C12H14N4O5S requires 326.0378. 
 
7.1.22. Synthesis of [1-(2'-azidobenzenesulfonyl)pyrrolidin-2-yl]carbalde-
hyde. 
 
A 2M solution of oxalyl chloride in dichloromethane (0.94 mL, 1.68 mmol, 1.2 eq) was 
diluted with dichloromethane (5 mL) and cooled to -78 
o
C under nitrogen. DMSO (0.26 mL, 
265 mg, 3.40 mmol, 2.4 eq) in dichloromethane (5 mL) and the alcohol (400 mg, 1.42 mmol, 
1 eq) in dichloromethane (2.5 mL) were added respectively, each over 10 mins. The whole 
was maintained at -78 
o
C for 30 minutes before dropwise addition of triethylamine (1.09 mL, 
0.78 g, 7.09 mmol, 5 eq) and the whole was allowed to reach room temperature. The reaction 
was quenched with a mixture of diethyl ether (5 mL) and water (5 mL). The organic layer was 
separated and the aqueous phase was extracted with dichloromethane (3 x 10 mL). The 
combined organics were dried (MgSO4), filtrered, concentrated and purified on silica (20g) 
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(petroleum ether/ethyl acetate: 3/2, Rf = 0.2) to yield the product as a white solid (383 mg, 96 
%, m.p.=103 - 105 
o
C). 
IR: ʋmax (cm
-1
): 716.5, 771.1, 1079.4, 1150.6, 1323.1, 1434.8, 1468.9, 1572.3, 1731.7, 
2122.2, 2887.6, 2976.8, 3100.5. 
1
H NMR: H (400 MHz, CDCl3): 1.81-1.95 (2H, m, CH2), 2.00-2.09 (1H, m, CHH), 2.14-
2.23 (1H, m, CHH), 3.38-3.44 (1H, m, NCHH), 3.55-3.60 (1H, m, CHH), 4.46-4.49 (1H, m, 
NCH), 7.28 (1H, ddd, J
1
=7.5 Hz, J
2
=7.1 Hz, J
3
=1.5 Hz, ArH), 7.34 (1H, d, J=8.0 Hz,  ArH), 
7.64 (1H, dd, J
1
=7.8 Hz, J
2
=7.5 Hz,  ArH), 8.04 (1H, d, J=8.0 Hz, ArH), 9.7 (1H, s, CHO). 
13
C NMR c (100 MHz, DMSO): 24.99 (CH2), 27.70 (CH2), 48.80 (CH2), 67.08 (CH), 
119.88 (CH), 124.86 (CH), 128.97 (qC), 132.50 (CH), 134.38 (CH), 138.24 (qC), 200.42 
(CH). 
HRMS (ESI
+
): found 281.0697 [M+H]+, C11H13N4O3S requires 281.0703. 
 
7.1.23. Synthesis of (S)-pyrrolo[1,2-b][1,2,3]triazolo[5,1-d][1,2,5] benzothia-
diazepin 8,8-dioxide. 
 
The aldehyde (300 mg, 1.07 mmol, 1 eq) was dissolved in dry methanol (5 mL); potassium 
carbonate (296 mg, 2.14 mmol, 2 eq) and the Bestmann-Ohira reagent (209 μL, 247 mg, 1.29 
mmol, 1.2 eq) were added and the whole was stirred for 22 hours under nitrogen. The reaction 
was quenched with saturated aqueous ammonium chloride (10 mL), the organic phase was 
separated and the aqueous phase was extracted with dichloromethane (3 x 20 mL). The 
combined organic phases were dried (MgSO4), filtered and concentrated in vacuo to yield an 
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orange solid. Purification by silica chromatography (20 g) (petroleum ether/ethyl acetate: 1/3, 
Rf = 0.22) yielded the product as a yellow solid (207 mg, 70 %, m.p.= 208-210 
o
C). 
IR: ʋmax (cm
-1
): 745.8, 809.4, 998.4, 1050.2, 1195.3, 1242.7, 1336.2, 1482.9, 1592.3, 2870.1, 
2991.8, 3108.4. 
1
H NMR: H (400 MHz, CDCl3): 1.53-1.63 (1H, m, CHH), 1.77-1.85 (1H, m, CHH), 1.87-
1.98 (1H, m, CHH), 2.14-2.21 (1H, m, CHH), 2.98-3.04 (1H,m, CHH), 3.54-3.59 (1H, m, 
CHH), 5.06-5.10 (1H, m, NCH), 7.51 (1H, dd, J
1
=7.8 Hz, J
2
=7.6 Hz, ArH), 7.67 (1H, s, 
CHNN), 7.72 (1H, dd, J
1
=7.8 Hz, J
2
=7.6 Hz, ArH), 7.99 (1H, d, J=7.8 Hz, ArH), 8.05 (1H, d, 
J=7.8 Hz, ArH) ppm. 
13
C NMR c (100 MHz, DMSO): 24.42 (CH2), 35.45 (CH2), 49.96 (CH2), 55.09 (CH), 
125.41 (CH), 128.61 (CH), 129.32 (CH), 130.94 (qC),133.54 (qC), 134.03 (CH), 134.37 
(CH), 136.77 (qC) ppm. 
HRMS (ESI
+
): found 277.0754 [M+H]+, C12H13N4O2S requires 277.0754. 
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Chapter 7: 
7-Experimental: Triazolo and Tetrazolobenzothiadiazepines and benzodia-
zepines. 
7.2. The synthesis of Tetrazolobenzothiadiazepines. 
7.2.1. Conversion of the aldehydes into the oximes. 
General experimental: 
 
To a mixture of hydroxylamine hydrochloride (278 mg, 4.0 mmol, 4.0 eq) and sodium acetate 
(492 mg, 6.0 mmol, 6.0 eq) in ethanol (25 mL) was added, at room temperature with vigorous 
stirring, the aldehyde (1.0 mmol, 1.0 eq). The reaction mixture was stirred for 5 hours, filtered 
in vacuo to remove the precipitate and the solvent was evaporated off. The residue was 
extracted with dichloromethane (2 x 15 mL), washed with water (2 x 5 mL) and the combined 
organic layers were dried (MgSO4), filtered in vacuo and the solvent evaporated off and 
purified by silica chromatography. 
 
Chaper 7                                                                                                                                             Experimental 
232 
 
7.2.1.1. Synthesis of 1-[(2-azidophenyl)sulfonyl]piperidine-2-carbaldehyde oxime. 
 
(Eluent: Petroleum ether/ethylacetate: 3/2, Rf = 0.2) yielded the product as a light yellow oil 
(68 %). 
IR: ʋmax (cm
-1
): 753.3, 921.3, 945.1, 1070.3, 1158.1, 1289.9, 1334.2, 1471.5, 1575.0, 2100.3, 
2860.0, 2941.9, 3021.4, 3244.5. 
1
H NMR: H (400 MHz, CDCl3): 1.26 (1H, t, J=7.2 Hz, CHH), 1.36-1.42 (1H, m, CHH), 
1.54-1.61 (1H, m, CHH), 1.66-1.74 (3H, m, CHH + CH2), 2.12 (1H, d, J=12.0 Hz, NCH), 
3.16 (1H, td, J
1
=13.5 Hz, J
2
=2.3 Hz, NCHH), 3.93 (1H, d, J=13.5 Hz, NCHH), 6.84 (1H, d, 
J=5.7 Hz, =CH), 7.21 (1H, dd, J
1
=7.8 Hz, J
2
=7.5 Hz, ArH), 7.28 (1H, d, J=7.8 Hz, ArH), 
7.57 (1H, ddd, J
1
=8.0 Hz, J
2
=7.5 Hz, J
3
=1.4 Hz, ArH), 7.96 (1H, dd, J
1
=8.0 Hz, J
2
= 1.3 Hz, 
ArH), 9.01 (1H, br.s, OH). 
13
C NMR c (100 MHz, CDCl3): 20.73 (CH2), 25.54 (CH2), 28.00 (CH2), 42.83 (CH2), 49.33 
(CH), 119.85 (CH), 124.57 (CH), 130.40 (qC), 131.42 (CH), 134.02 (CH), 138.03 (qC), 
149.71 (CH) ppm. 
HRMS (ESI
+
): found 332.0788 [M+Na]
+
, C12H15N5O3SNa requires 332.0788. 
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7.2.1.2. Synthesis of 2-azido-N-benzyl-N-[2-(hydroxyimino)ethyl] 
benzenesulfonamide. 
 
 (Eluent: Petroleum ether/ethylacetate: 2/1, Rf = 0.25) yielded the product as a white solid (96 
%, m.p.=129-130 
o
C). 
IR: ʋmax (cm
-1
): 763.1, 911.6, 932.5, 1148.0, 1163.0, 1336.5, 1349.3, 1471.5, 2098.5, 3213.7. 
1
H NMR: H (400 MHz, DMSO): 4.05 (2H, d, J=2.4 Hz, N=CH-CH2), 4.54 (2H, br.s, 
NCH2), 6.43 (1H, dd, J
1
=3.7 Hz, J
2
=1.1 Hz, N=CH), 7.22-7.38 (6H, m, 6 x ArH), 7.58 (1H, 
d, J=8.3 Hz, ArH), 7.74 (1H, t, J= 7.7 Hz, ArH), 7.92 (1H, d, J=7.7 Hz, ArH), 11.14 (1H, d, 
J=1.80 Hz, OH) ppm. 
13
C NMR c (100 MHz, DMSO):  46.3 (CH2), 52.54 (CH2), 121.52 (CH), 125.44 (CH), 
128.25 (CH), 128.71 (2CH), 129.06 (2CH), 130.46 (qC), 131.26 (CH), 135.12 (CH), 136.79 
(qC), 138.20 (qC), 147.42 (CH) ppm. 
HRMS (ESI
+
): found 346.0970 [M+H]
+
, C15H16N5O3S requires 346.0968. 
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7.2.1.3. Synthesis of 2-azido-N-[2-(hydroxyimino)ethyl]-N-
methylbenzenesulfonamide. 
 
 
(Eluent: Petroleum ether/ethylacetate: 2/1, Rf = 0.23) yielded the product as a light yellow oil 
(78 %). 
IR: ʋmax (cm
-1
): 724.2, 906.9, 939.9, 1059.0, 1144.6, 1257.7, 1288.2, 1330.8, 1471.6, 1575.1, 
2129.7, 3427.0. 
1
H NMR: H (400 MHz, CDCl3): 2.82 (3H, s, CH3), 4.17 (2H, d, J=4.4 Hz, CH2), 7.17 (1H, 
app. td, J
1
=7.7 Hz, J
2
=1.0 Hz, ArH), 7.23 (1H, ddd, J
1
=8.0 Hz, J
2
=7.7 Hz, J
3
=2.2 Hz, ArH), 
7.31 (1H, t, J= 6.0 Hz, =CH), 7.53 (1H, dd, J
1
=7.7 Hz, J
2
=1.6 Hz, ArH), 7.89 (1H, app. dt, 
J
1
=8.0 Hz, J
2
=1.6 Hz, ArH), 8.77 (1H, br.s, OH) ppm. 
13
C NMR c (100 MHz, CDCl3):  34.53 (CH3), 45.29 (CH2), 119.93 (CH), 124.74 (CH), 
129.11 (qC), 131.82 (CH), 134.26 (CH), 138.24 (qC), 147.22 (CH) ppm. 
HRMS (ESI
+
): found 270.0659 [M+H]
+
, C9H12N5O3S requires 270.0655. 
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7.2.1.4. Synthesis of 2-{1-[(2-azidophenyl)sulfonyl]piperidin-2-yl}acetaldehyde 
oxime. 
 
 
(Eluent: Petroleum ether/ethylacetate: 1/1, Rf = 0.3) yielded the product as a light yellow oil 
(88 %). 
IR: ʋmax (cm
-1
): 725.9, 817.1, 948.1, 1069.3, 1121.3, 1155.6, 1183.0, 1265.4, 1288.3, 1322.5, 
1443.1, 1470.9, 1574.5,  2098.7, 2942.7, 3247.6. 
1
H NMR: H (400 MHz, CDCl3): 1.16-1.66 (6H, m, 3 x CH2), 2.30-2.37 (1H, m, N=CH-
CHH), 2.50-2.62 (1H, m, N=CH-CHH), 3.02 (1H, p, J=12.8 Hz, CH), 3.75-3.81 (1H, m, 
NCHH), 4.13-4.18 (1H, m, NCHH), 6.55 (1H, t, J=5.5 Hz, HO-N=CH), 7.14 (1H, ddd, 
J
1
=8.3 Hz, J
2
=7.9 Hz, J
3
=1.5 Hz, ArH), 7.21 (1H, d, J= 7.9 Hz, ArH), 7.41-7.51 (1H, m, 
ArH), 7.90 (1H, app. qd, J
1
=7.9 Hz, J
2
=1.3 Hz, ArH), 8.75 (1H, br.s, OH) ppm. 
13
C NMR c (100 MHz, CDCl3):  18.26 (CH2), 25.34 (CH2), 27.95 (CH2), 30.32 (CH2), 
41.00 (CH2), 50.46 (CH), 120.00 (CH), 124.43 (CH), 131.04 (CH), 131.28 (qC), 133.71 (CH), 
137.91 (qC), 148.79 (CH) ppm. 
HRMS (ESI
+
): found 324.1120 [M+H]
+
, C13H18N5O3S requires 324.1125. 
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7.2.1.5. Synthesis of 2-azido-N-ethyl-N-[4-(hydroxyimino)butyl] 
benzenesulfonamide. 
 
(Eluent: Petroleum ether/ethylacetate: 3/2, Rf = 0.2) yielded the product as a light yellow oil 
(92 %). 
IR: ʋmax (cm
-1
): 682.1, 818.4, 907.9, 1005.4, 1060.2, 1144.8, 1155.4, 1288.4, 1329.0, 1443.0, 
1471.4, 1575.1, 2098.5, 2936.8, 3446.4. 
1
H NMR: H (400 MHz, CDCl3): 1.03 (3H, p, J=7.0 Hz, CH3), 1.70 (2H, p, J=7.4 Hz, 
NCH2CH2),  2.14 (1H, dd, J
1
=13.5 Hz, J
2
=7.4 Hz, NCH2CHH), 2.27-2.32 (1H, m, 
NCH2CHH), 3.28 (4H, app. p, J=7.4 Hz, CH2NCH2), 7.15 (1H, dd, J
1
=7.8 Hz, J
2
=7.6 Hz, 
ArH), 7.21 (1H, d, J= 7.9 Hz, ArH), 7.34 (1H, t, J=5.7 Hz, N=CH), 7.49 (1H, ddd, J
1
=7.9 Hz, 
J
2
=7.5 Hz, J
3
=1.4 Hz, ArH), 7.91 (1H, d, J=7.8 Hz, ArH), 8.26 (1H, bs, OH) ppm. 
13
C NMR c (100 MHz, CDCl3):  14.00 (CH3), 22.27 (CH2), 25.60 (CH2), 42.51 (CH2), 
46.64 (CH2), 119.82 (CH), 124.61 (CH), 131.15 (qC), 131.53 (CH), 133.74 (CH), 137.97 
(qC), 150.30 (C=N) ppm. 
HRMS (ESI
+
): found 312.1124 [M+H]+, C12H18N5O3S requires 312.1125. 
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7.2.1.6. Synthesis of 2-azido-N-benzyl-N-[3-(hydroxyimino) propyl]benzene-
sulfonamide. 
 
(Eluent: Petroleum ether/ethylacetate: 3/2, Rf = 0.2) yielded the product as a yellow oil (93 
%). 
IR: ʋmax (cm
-1
):  726.3, 819.2, 999.4, 1064.0, 1123.9, 1157.2, 1288.2, 1329.5, 1471.7, 1495.4, 
1575.1, 2101.2, 2923.8, 3258.9. 
1
H NMR: H (400 MHz, CDCl3): 2.47 (2H, app. q, J=6.4 Hz, NCH2CH2), 3.39-3.47 (2H, m, 
NCH2CH2),  4.57 (2H, s, Ph-CH2),  7.02 (1H, t, J=5.9 Hz, N=CH), 7.20-7.33 (7H, m, 7 x 
ArH), 7.58 (1H, td, J
1
=8.0 Hz, J
2
=1.5 Hz, ArH), 8.01 (1H, dq, J
1
=8.0 Hz, J
2
=1.5 Hz, ArH), 
9.41 (1H, br.s, OH) ppm. 
13
C NMR c (100 MHz, CDCl3):  28.58 (CH2), 43.69 (CH2), 51.45 (CH2), 119.95 (CH), 
124.62 (CH), 127.90 (CH), 128.28 (2 x CH), 128.68 (2 x CH), 130.66 (qC), 131.45 (CH), 
134.02 (CH), 136.12 (qC), 138.16 (qC), 148.49 (CH=N)  ppm. 
HRMS (ESI
+
): found 360.1120 [M+H]
+
, C16H18N5O3S requires 360.1125. 
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7.2.1.7. Synthesis of 1-[(2-azidophenyl)sulfonyl]piperidine-4-carbaldehyde oxime. 
 
 (Eluent: Petroleum ether/ethylacetate: 2/1, Rf = 0.2) yielded the product as a white solid (85 
%, m.p.=151-153 
o
C). 
IR: ʋmax (cm
-1
): 770.2, 923.2, 1043.0, 1074.0, 1122.4, 1146.4, 1247.2, 1308.6, 1334.0, 
1437.4, 1471.2, 1584.7, 2097.8, 2849.1, 2933.3, 3255.6. 
1
H NMR: H (400 MHz, CDCl3): 1.43-1.59 (2H, m, CH2CHCH2), 1.76-1.81 (2H, m, 
CH2CHCH2), 2.20-2.29 (1H, m, CH2CHCH2), 2.72 (2H, td, J
1
=12.4 Hz, J
2
=2.6 Hz, 
CH2NCH2), 3.77-3.82 (2H, m, CH2NCH2), 7.17 (1H, ddd, J
1
=8.0 Hz, J
2
=7.6 Hz, J
3
=1.0 Hz, 
ArH), 7.23 (1H, dd, J
1
= 8.0 Hz, J
2
=0.7 Hz, ArH), 7.27 (1H, d, J=5.6 Hz, N=CH), 7.51 (1H, 
ddd, J
1
=7.9 Hz, J
2
=7.6 Hz, J
3
=1.4 Hz, ArH), 7.87 (1H, dd, J
1
=7.9 Hz, J
2
=1.4 Hz, ArH), 9.58 
(1H, s, OH) ppm. 
.
13
C NMR c (100 MHz, CDCl3):  29.12 (2 x CH2), 36.10 (CH), 45.38 (2 x CH2), 119.93 
(CH), 124.67 (CH), 129.29 (qC), 131.77 (CH), 133.94 (CH), 138.32 (qC), 153.69 (CH) ppm. 
HRMS (ESI
+
): found 310.0967 [M+H]
+
, C12H16N5O3S requires 310.0968. 
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7.2.2. Conversion of the oximes into the nitriles. 
General experimental: 
 
To a stirred mixture of diphenylcyclopropenone (19 mg, 0.09 mmol, 5 mol%) and aldoxime 
(289 mg, 0.935 mmol, 1.0 eq) in DCM (10 mL) was added a solution of (COCl)2 (118 mg, 
0.935 mmol, 1.0 eq) in DCM (1.0 mL) by using a syringe pump over 1h and then to this was 
added by slow addition DBU (426 mg, 2.8 mmol, 3.0 eq) in DCM (3 mL). The mixture was 
heated at reflux whilst being monitored by TLC. The reaction mixture was diluted with DCM 
and washed with water (3 x 25 mL). The organic phase was dried with anhydrous MgSO4, 
filtered, concentrated under reduced pressure and purified by silica column chromatography. 
7.2.2.1. Synthesis of 1-[(2-azidophenyl)sulfonyl]piperidine-2-carbonitrile. 
 
 
 [Eluent: petroleum ether/ethyl acetate: 3/1, Rf = 0.3] to yield the product as a dark brown oil 
(86 %). 
IR: ʋmax (cm
-1
): 746.7, 905.9, 1069.4, 1120.5, 1161.1, 1288.9, 1443.3, 1506.6, 1575.4, 
2100.4, 2257.0, 2862.7, 2948.2. 
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1
H NMR: H (400 MHz, CDCl3): 1.46-1.59 (1H, m, CHH), 1.61-1.71 (2H, m, CH2), 1.78-
1.87 (2H, m, CH2), 1.91-1.96 (1H, m, CHH), 2.91 (1H, td, J
1
=13.0 Hz, J
2
= 2.3 Hz, NCHH), 
3.77 (1H, d, J=13.4 Hz, NCHH), 5.09 (1H, br.s, NCH), 7.18 (1H, ddd, J
1
=7.9 Hz, J
2
=7.6 Hz, 
J
3
=1.4 Hz, ArH), 7.25 (1H, d, J=8.0 Hz, ArH), 7.54 (1H, ddd, J
1
=8.0 Hz, J
2
=7.6 Hz, J
3
=1.3 
Hz, ArH), 7.87 (1H, d, J=7.9 Hz, ArH). 
13
C NMR c (100 MHz, CDCl3): 20.01 (CH2), 24.93 (CH2), 29.63 (CH2), 43.49 (CH2), 46.16 
(CH), 116.35 (qC), 120.05 (CH), 124.71 (CH), 128.46 (qC), 131.55 (CH), 134.70 (CH), 
138.65 (qC) ppm. 
HRMS (ESI
+
): found 309.1140 [M+NH4]
+
, C12H17N6O2S requires 309.1128. 
 
7.2.2.2. Synthesis of 2-azido-N-benzyl-N-(cyanomethyl)benzenesulfonamide. 
 
 
[Eluent: petroleum ether/ethyl acetate: 4/1, Rf = 0.23] to yield the product as a light yellow 
solid (84 %, m.p.= 107-109 
o
C). 
IR: ʋmax (cm
-1
): 744.2, 893.2, 924.9, 1067.7, 1096.0, 1123.4, 1206.0, 1290.0, 1325.1, 1471.8, 
1585.3, 2104.9, 2248.8,  2948.6, 2989.9. 
1
H NMR: H (400 MHz, CDCl3): 4.16 (2H, s, CN-CH2), 4.37 (2H, bs, N-CH2), 7.22 (1H, dd, 
J
1
=8.0 Hz, J
2
=7.5 Hz, ArH), 7.26-7.31 (6H, m, 6 x ArH), 7.59 (1H, td, J
1
=8.0 Hz, J
2
=1.4 Hz, 
ArH), 7.97 (1H, dd, J
1
=8.0 Hz, J
2
=1.4 Hz,  ArH) ppm. 
13
C NMR c (100 MHz, CDCl3):  34.88 (CH2), 51.02 (CH2), 114.29 (CN), 119.99 (CH), 
124.87 (CH), 128.77 (3 x CH), 128.84 (qC), 129.11 (2 x CH), 131.80 (CH), 133.53 (qC), 
134.91 (CH), 138.63 (qC) ppm. 
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HRMS (ESI
+
): found 350.0685 [M+Na]+, C15H13N5O2SNa requires 350.0682. 
 
7.2.2.3. Synthesis of 2-azido-N-(cyanomethyl)-N-methylbenzenesulfonamide. 
 
 
 [Eluent: petroleum ether/ethyl acetate: 2/1, Rf = 0.3] to yield the product as a yellow oil (71 
%). 
IR: ʋmax (cm
-1
): 729.4, 819.5, 921.6, 1005.7, 1058.5, 1122.0, 1222.4, 1265.7, 1287.3, 1308.9, 
1333.5, 1442.3, 1471.1, 1574.5, 2125.2, 2261.1, 2927.6. 
1
H NMR: H (400 MHz, CDCl3): 2.85 (3H, s, CH3), 3.37 (2H, s, CH2), 7.20 (1H, dd, J
1
=8.0 
Hz, J
2
=7.7 Hz, ArH), 7.26 (1H, d, J= 8.0 Hz, ArH), 7.57 (1H, ddd, J
1
=8.0 Hz, J
2
=7.8 Hz, 
J
3
=1.2 Hz, ArH), 7.90 (1H, dd, J
1
=8.0 Hz, J
2
=1.2 Hz, ArH) ppm. 
13
C NMR c (100 MHz, CDCl3):  34.61 (CH3), 38.71 (CH2), 114.50 (CN), 119.98 (CH), 
124.81 (CH), 127.98 (qC), 131.93 (CH), 134.87 (CH), 138.56 (qC) ppm. 
HRMS (ESI
+
): found 269.0812 [M+NH4]
+
, C9H13N6O2S requires 269.0815. 
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7.2.2.4. Synthesis of 2-{1-[(2-azidophenyl)sulfonyl]piperidin-2-yl}acetonitrile. 
 
[Eluent: petroleum ether/ethyl acetate: 3/1, Rf= 0.29] to yield the product as a light yellow oil 
(81 %). 
IR: ʋmax (cm
-1
): 818.0, 911.6, 962.1, 988.3, 1070.8, 1118.9, 1209.9, 1287.3, 1328.3, 1443.8, 
1471.1, 1574.6, 2098.5, 2253.7, 2866.0, 2944.9. 
1
H NMR: H (400 MHz, CDCl3): 1.18-1.65 (6H, m, 3 x CH2), 2.59-2.77 (2H, m, CN-CH2), 
2.94 (1H, t, J=13.2 Hz, N-CH), 3.73 (1H, d, J=13.8 Hz, NCHH), 4.34 (1H, bs, NCHH), 7.17 
(1H, ddd, J
1
=7.9 Hz, J
2
=7.4 Hz, J
3
=0.6 Hz, ArH), 7.22-7.24 (1H, m, ArH), 7.53 (1H, ddd, J
1
= 
7.8 Hz, J
2
=7.5, J
3
=1.5 Hz, ArH), 7.90 (1H, d, J
1
=7.8 Hz, J
2
=1.4 Hz, ArH) ppm. 
13
C NMR c (100 MHz, CDCl3):  17.94 (CH2), 19.32 (CH2), 24.78 (CH2), 27.27 (CH2), 
41.97 (CH2), 49.49 (CH), 117.34 (CN), 120.07 (CH), 124.64 (CH), 130.31 (qC), 131.25 (CH), 
134.19 (CH), 138.13 (qC) ppm. 
HRMS (ESI
+
): found 323.1294 [M+NH4]
+
, C13H19N6O2S requires 323.1285. 
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7.2.2.5. Synthesis of 2-azido-N-(3-cyanopropyl)-N-ethylbenzenesulfonamide. 
 
 
 [Eluent: petroleum ether/ethyl acetate: 2/1, Rf = 0.24] to yield the product as a yellow oil (81 
%). 
IR: ʋmax (cm
-1
): 729.0, 818.8, 913.2, 934.2, 1001.5, 1145.9, 1155.4, 1288.2, 1327.9, 1442.8, 
1471.1, 1574.5, 2099.0, 2246.5, 2937.5. 
1
H NMR: H (400 MHz, CDCl3): 1.02 (3H, t, J=7.2 Hz, CH3), 1.89 (2H, app. p, J=7.1 Hz, 
NCH2CH2),  2.37 (2H, t, J=7.1 Hz, CH2-CN), 3.25 (2H, q, J=7.2 Hz, NCH2CH3), 3.40 (2H, t, 
J=6.9 Hz, NCH2CH2), 7.17 (1H, dd, J
1
=7.9 Hz, J
2
=7.5 Hz, ArH), 7.22 (1H, d, J= 8.0 Hz, 
ArH), 7.52 (1H, ddd, J
1
=7.9 Hz, J
2
=7.5 Hz, J
3
=1.4 Hz, ArH), 7.91 (1H, dd, J
1
=8.0 Hz, J
2
= 
1.3 Hz, ArH) ppm. 
13
C NMR c (100 MHz, CDCl3):  13.92 (CH3), 14.56 (CH2), 25.24 (CH2), 42.96 (CH2), 
46.48 (CH2), 119.21 (CN), 119.60 (CH), 124.77 (CH), 130.57 (qC), 131.65 (CH), 134.06 
(CH), 137.96 (qC) ppm. 
HRMS (ESI
+
): found 311.1286 [M+NH4]+, C12H19N6O2S requires 311.1285. 
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7.2.2.6. Synthesis of 2-azido-N-benzyl-N-(2-cyanoethyl) benzenesulfonamide. 
 
 
[Eluent: petroleum ether/ethyl acetate: 2/1, Rf = 0.25] to yield the product as a bronze-
coloured solid (77 %, m.p. = 78 - 80 
o
C). 
IR: ʋmax (cm
-1
):  755.8, 820.1, 945.6, 981.7, 1099.4, 1123.7, 1147.4, 1266.0, 1289.1, 1334.3, 
1471.9, 1495.7, 1584.1, 2102.2, 2250.7, 2929.5, 3031.2, 3066.7. 
1
H NMR: H (400 MHz, CDCl3): 2.30 (2H, t, J=7.3 Hz, NCH2CH2), 3.50 (2H, t, J=7.3 Hz, 
NCH2CH2),  4.45 (2H, s, Ph-CH2), 7.17-7.27 (7H, m, 7 x ArH), 7.55 (1H, td, J
1
=8.0 Hz, 
J
2
=1.4 Hz, ArH), 7.95 (1H, dd, J
1
=8.0 Hz, J
2
=1.2 Hz, ArH) ppm. 
13
C NMR c (100 MHz, CDCl3):  18.08 (CH2), 43.87 (CH2), 52.99 (CH2), 117.34 (CN), 
119.97 (CH), 124.84 (CH), 128.41 (2 x CH), 128.44 (CH), 129.00 (2 x CH), 130.06 (qC), 
131.79 (CH), 134.44 (CH), 135.54 (qC), 138.39 (qC) ppm. 
HRMS (ESI
+
): found 364.0836 [M+Na]
+
, C16H15N5O2SNa requires 364.0839. 
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7.2.2.7. Synthesis of 1-[(2-azidophenyl)sulfonyl]piperidine-4-carbo nitrile. 
 
[Eluent: petroleum ether/ethyl acetate: 2/1, Rf = 0.24] to yield the product as a light yellow oil 
(85 %). 
IR: ʋmax (cm
-1
): 723.8, 908.7, 950.0, 1035.5, 1067.0, 1123.2, 1158.7, 1253.1, 1288.2, 1324.8, 
1341.2, 1443.2, 1471.5, 1574.0, 2098.6, 2254.0, 2969.6. 
1
H NMR: H (400 MHz, CDCl3): 1.81-1.96 (4H, m, CH2CHCH2),  2.77 (1H, septet, J=4.0 
Hz, CH2CHCH2), 3.28-3.38 (4H, m, CH2NCH2), 7.17 (1H, dd, J
1
=7.9 Hz, J
2
=7.5 Hz, ArH), 
7.24 (1H, d, J= 7.9 Hz, ArH), 7.53 (1H, ddd, J
1
=7.9 Hz, J
2
=7.7 Hz, J
3
=1.4 Hz, ArH), 7.86 
(1H, d, J=7.9 Hz, ArH) ppm. 
13
C NMR c (100 MHz, CDCl3):  25.63 (CH), 28.43 (2 x CH2), 43.74 (2 x CH2), 120.06 
(CH), 120.58 (CN), 124.78 (CH), 128.84 (qC), 131.67 (CH), 134.28 (CH), 138.32 (qC) ppm. 
HRMS (ESI
+
): found 292.0857 [M+H]
+
, C12H14N5O2S requires 292.0863. 
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7.2.3. Synthesis of  12,13,14,14a-tetrahydro-11H-benzo[f]pyrido [1,2-
b]tetrazolo[5,1-d][1,2,5]thiadiazepine 9,9-dioxide. 
 
 
1-[(2-Azidophenyl)sulfonyl]piperidine-2-carbonitrile (180 mg, 0.619 mmol) was heated at 
reflux in dry toluene (10 mL) under a nitrogen atmosphere for 65 hours. The solvent was 
removed in vacuo and the crude product was purified by silica chromatography (petroleum 
ether/ ethyl acetate: 1/1, Rf = 0.24), to yield the product as a white solid (122 mg, 68 %, m. 
p.= 179-181 
o
C). 
IR: ʋmax (cm
-1
): 649.0, 1039.2, 1097.0, 1170.0, 1351.3, 1442.5, 1477.4, 1590.8, 1979.9, 
2953.6. 
1
H NMR: H (400 MHz, CDCl3): 1.43-1.50 (1H, m, CHH), 1.66-1.85 (3H, m, CHH + CH2), 
2.24-2.32 (1H, m, CHH), 2.71-2.82 (2H, m, CHH + NCHH), 3.35-3.39 (1H, m, NCHH), 5.23 
(1H, br.s, NCH), 7.67 (1H, dd, J
1
=7.7 Hz, J
2
=7.6 Hz, ArH), 7.84 (1H, ddd, J
1
=8.3 Hz, J
2
=8.0 
Hz, J
3
=0.5 Hz, ArH), 8.16 (1H, d, J=7.7 Hz, ArH), 8.47 (1H, d, J=8.3 Hz, ArH). 
13
C NMR c (100 MHz, CDCl3): 20.62 (CH2), 24.27 (CH2), 28.97 (CH2), 45.37 (CH2), 51.81 
(CH), 124.48 (CH), 129.46 (CH), 129.74 (CH), 130.37 (qC), 130.67 (qC), 134.64 (CH), 
154.24 (qC) ppm. 
HRMS (ESI
+
): found 292.0866 [M+H]
+
, C12H14N5O2S requires 292.0863. 
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7.2.4. Synthesis of  5-benzyl-4,5-dihydrobenzo[f]tetrazolo[5,1-d] 
[1,2,5]thiadiazepine 6,6-dioxide. 
 
2-Azido-N-benzyl-N-(cyanomethyl) benzenesulfonamide (150 mg, 0.459 mmol) was heated 
at reflux in dry toluene (10 mL) under a nitrogen atmosphere for 40 hours. The solvent was 
removed in vacuo and the crude product was purified by silica chromatography (petroleum 
ether/ ethyl acetate: 2/1, Rf = 0.24), to yield the product as a dark yellow (109 mg, 73 %, 
m.p.= 150-152 
o
C). 
IR: ʋmax (cm
-1
): 728.2, 748.5, 905.9, 1066.9, 1093.9, 1138.6, 1171.6, 1356.5, 1448.1, 1480.0, 
1587.6, 3032.2. 
1
H NMR: H (400 MHz, CDCl3): 4.22 (2H, br.s, CH2), 4.99 (2H, br.s, CH2), 7.19-7.21 (2H, 
m, 2 x ArH), 7.28-3.32 (3H, m, 3 x ArH), 7.68 (1H, ddd, J
1
=8.0 Hz, J
2
=7.7 Hz, J
3
=1.3 Hz, 
ArH), 7.84 (1H, ddd, J
1
= 8.5 Hz, J
2
=8.0 Hz, J
3
=1.3 Hz, ArH), 8.22 (1H, dd, J
1
=8.0 Hz, 
J
2
=1.3 Hz, ArH), 8.40 (1H, d, J=8.4 Hz, ArH) ppm. 
13
C NMR c (100 MHz, CDCl3):  43.27 (CH2), 53.25 (CH2), 124.76 (CH), 128.51 (2 x CH), 
128.91 (CH), 129.09 (2 x CH), 129.27 (CH), 129.52 (CH), 130.54 (qC), 131.86 (qC), 133.05 
(qC), 134.71 (CH), 151.75 (qC) ppm. 
HRMS (ESI
+
): found 328.0866 [M+H]
+
, C15H14N5O2S requires 328.0863. 
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7.2.5. Synthesis of  5-methyl-4,5-dihydrobenzo[f]tetrazolo[5,1-
d][1,2,5]thiadiazepine 6,6-dioxide. 
 
 
2-Azido-N-(cyanomethyl)-N-methylbenzenesulfonamide (85 mg, 0.339 mmol) was heated at 
reflux in dry toluene (10 mL) under a nitrogen atmosphere for 72 hours. The solvent was 
removed in vacuo and the crude product was purified by silica chromatography (petroleum 
ether/ ethyl acetate: 1/1, Rf = 0.28), to yield the product as a dark yellow oil (76 mg, 89 %). 
IR: ʋmax (cm
-1
): 758.7, 927.8, 1038.1, 1064.6, 1140.3, 1168.4, 1353.6, 1451.8, 1480.8, 
1588.5, 2925.0, 2980.1. 
1
H NMR: H (400 MHz, CDCl3): 2.77 (3H, s, CH3), 4.66 (2H, s, CH2), 7.59 (1H, ddd, J
1
=7.9 
Hz, J
2
=7.6 Hz, J
3
=1.1 Hz, ArH), 7.78 (1H, ddd, J
1
= 8.3 Hz, J
2
=7.9 Hz, J
3
=1.5 Hz, ArH), 8.07 
(1H, dd, J
1
=7.9 Hz, J
2
=1.5 Hz, ArH), 8.34 (1H, dd, J
1
=8.3 Hz, J
2
=0.9 Hz, ArH) ppm. 
13
C NMR c (100 MHz, CDCl3):  37.08 (CH3), 46.70 (CH2), 124.72 (CH), 129.67 (CH), 
129.90 (CH), 130.19 (qC), 130.46 (qC), 134.86 (CH), 151.72 (qC) ppm. 
HRMS (ESI
+
): found 252.0555 [M+H]
+
, C9H10N5O2S requires 252.0550. 
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7.2.6. Attempted synthesis of 11,12,13,14,14a,15-hexahydrobenzo 
[g]pyrido[1,2-b]tetrazolo[5,1-e][1,2,6]thiadiazocine 9,9-dioxide. 
 
2-{1-[(2-Aminophenyl)sulfonyl]piperidin-2-yl}acetonitrile (100 mg, 0.33 mmol) in dry 
chloroform (7 mL) was heated at 80 
o
C  under a nitrogen atmosphere for 48 hours and 
monitored by TLC which showed no product. The solvent was removed and to the remaining 
starting material was added anhydrous toluene (7 mL). The reaction mixture was heated at 
reflux temperature under a nitrogen atmosphere for 72 hours and monitored by TLC which 
showed no product. The solvent removed and the remaining crude material had dry xylene (7 
mL) added. The reaction mixture was heated at reflux temperature for 3 days under an 
atmosphere of dry nitrogen whilst being monitored by TLC and concentrated. Purification by 
silica chromatography (petroleum ether/ ethyl acetate: 2/1, Rf = 0.23), yielded compound 
(326) as a yellow oil (62 mg, 68%). 
IR: ʋmax (cm
-1
): 867.9, 950.3, 1061.5, 1141.0, 1232.0, 1319.2, 1452.3, 1483.4, 1566.1, 
1617.6, 2856.7, 2926.6, 3374.7, 3475.8. 
1
H NMR: H (400 MHz, CDCl3): 1.20-1.66 (6H, m, 3 x CH2), 2.54-2.73 (2H, m, CN-CH2), 
2.81 (1H, td, J
1
=15.3 Hz, J
2
=2.8 Hz, N-CH), 3.67 (1H, d, J=14.0 Hz, NCHH), 4.29-4.33 (1H, 
m, NCHH), 4.89 (2H, bs, NH2), 6.66 (1H, d, J=8.3 Hz, ArH), 6.70 (1H, ddd, J
1
=8.0 Hz, 
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J
2
=7.7 Hz, J
3
=0.8 Hz, ArH), 7.24 (1H, ddd, J
1
=8.3 Hz, J
2
=8.0 Hz, J
3
=1.4 Hz, ArH), 7.58 (1H, 
dd, J
1
=8.0 Hz, J
2
=1.4 Hz, ArH) ppm. 
13
C NMR c (100 MHz, CDCl3):  18.00 (CH2), 18.55 (CH2), 24.32 (CH2), 26.88 (CH2), 
40.69 (CH2), 49.29 (CH), 117.43 (CN), 117.72 (CH), 117.83 (CH), 121.05 (qC), 129.93 (CH), 
134.39 (CH), 145.36 (qC) ppm. 
HRMS (ESI
+
): found 280.1109 [M+H]
+
, C13H18N3O2S requires 280.1114. 
 
7.2.7. Synthesis of 1-(2'-Azidobenzenesulfonyl)-2-prolin amide. 
 
To 2-azidobenzenesulfonic acid (1.80 g, 9.04 mmol, 2.6 eq) was added a 2M solution of 
thionyl chloride in dichloromethane (12 mL, 24.00 mmol, 6.85 eq) followed by the addition 
of DMF (100 μL). The resultant mixture was heated to reflux for 15 hours under nitrogen at 
80 
o
C. The excess thionyl chloride was removed in vacuo and the residue was washed with 
dichloromethane (2 x 20 mL) to give the crude sulfonyl chloride as an orange solid. 
A solution of potassium carbonate (2.64 g, 19.14 mmol, 5.5 eq) in water (20 mL) was added 
in one portion to S-prolinamide (400 mg, 3.50 mmol, 1 eq) in dichloromethane (20 mL). The 
sulfonyl chloride was dissolved in dichloromethane (5 mL) and was added dropwise to this 
solution. The reaction was allowed to stir at room temperature for 20 hours before the organic 
layer was separated and the aqueous layer washed with DCM (2 x 20 mL). The combined 
organic phases were dried over magnesium sulfate, filtered, concentrated and purified by 
silica column chromatography [petroleum ether/ethyl acetate: 1/10, Rf = 0.2] to yield the 
product as a yellow powder (764 mg, 74 %, m. p.= 139 - 141 
o
C). 
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IR: ʋmax (cm
-1
): 757.5 (m), 1154.3 (m), 1196.6 (s), 1332.2 (m), 1473.2 (s), 1574.1 (m), 
1668.5 (s), 2126.6 (N3), 2952.9 (m), 2977.3 (m), 3153.2 (m), 3447.6 (m). 
1
H NMR: H (400 MHz, CDCl3): 1.71-1.99 (3H, m, CH2+CHH), 2.23-2.30 (1H, m, CHH), 
3.21-3.28 (1H, m, NCHH), 3.38-3.43 (1H, m, NCHH), 4.56-4.59 (1H, m, NCH),  5.68 (1H, 
bs, NHH), 6.83 (1H, bs, NHH),  7.23-7.28 (2H, m, 2 x ArH), 7.57 (1H, dd, J
1
=7.7 Hz, J
2
=7.4 
Hz, ArH), 7.96 (1H, dd, J
1
=8.0 Hz, J
2
= 8.0 Hz, ArH) ppm. 
13
C NMR c (100 MHz, CDCl3): 24.67 (CH2), 30.14 (CH2), 49.10 (CH2), 62.29 (CH), 119.97 
(CH), 124.95 (CH), 127.74 (qC), 133.00 (CH), 134.74 (CH), 138.39 (qC), 174.26 (qC) ppm. 
HRMS (ESI
+
): found 296.0818 [M+H]+, C11H14N5O3S requires 296.0812. 
 
7.2.8. Synthesis of (S)-1-(2'-azidobenzenesulfonyl)pyrrolidine-2-
carbonitrile. 
 
To a solution of the (S)-N-(2-azidobenzenesulfonyl)-2-prolinamide (180 mg, 0.61 mmol) in 
DCM (5 mL) at room temperature  was added pyridine (371 mg, 378 μL, 4.69 mmol, 7.7 eq) 
followed by neat tosyl chloride (755 mg, 3.69 mmol, 6.5 eq). The resultant mixture was 
heated to reflux under a nitrogen atmosphere for 6 hours at 50 
o
C. The solvent was removed 
in vacuo and the crude product purified by column chromatography (petroleum ether/ ethyl 
acetate: 1/1, Rf = 0.35) to yield the product as a brown oil (148 mg, 79 %). 
IR: ʋmax (cm
-1
): 770.2 (s), 1150.5 (m), 1260.8 (m), 1320.2 (m), 1434.8 (m), 1467.2 (m), 
1571.9 (m), 2098.6 (m), 2250.2 (m), 2885.1 (s), 2980.4 (m), 3096.7 (s). 
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1
H NMR: H (400 MHz, CDCl3): 2.03-2.36 (4H, m, 2 x CH2), 3.44-3.51 (1H, m, NCHH), 
3.59-3.64 (1H, m, NCHH), 4.94-4.97 (1H, dd, NCH), 7.29 (H, dd, J
1
=7.8 Hz, J
2
=7.6 Hz, 
ArH), 7.33-7.35 (1H, d, J=7.9 Hz, ArH), 7.66 (1H, dd, J
1
=7.8 Hz, J
2
=7.6 Hz, ArH), 8.04 (1H, 
d, J=7.9 Hz, ArH) ppm. 
13
C NMR c (100 MHz, DMSO): 24.92 (CH2), 32.31 (CH2), 47.82 (CH2), 48.90 (CH), 
118.29 (qC), 119.88 (CH), 124.79 (CH), 129.07 (qC), 131.80 (CH), 134.67 (CH), 138.55 (qC) 
ppm. 
HRMS (ESI
+
): found 278.0710 [M+H]
+
, C11H12N5O2S requires 278.0706. 
 
7.2.9. 11,12,13,13a-tetrahydrobenzo[f]pyrrolo[1,2-b]tetrazolo[5,1-
d][1,2,5]thiadiazepine 9,9-dioxide 
 
(S)-N-(2-azidobenzenesulfonyl)-pyrrolidine-2-carbonitrile (100 mg, 0.361 mmol) was heated 
at reflux in dry toluene (10 mL) under a nitrogen atmosphere for 72 hours. The solvent 
removed in vacuo and the crude product was purified by silica chromatography (petroleum 
ether/ ethyl acetate: 2/1, Rf = 0.3), to yield the product as a white solid (60 mg, 60 %, m. p.= 
179-181 
o
C). 
IR: ʋmax (cm
-1
): 777.4, 829.7, 1175.2, 1359.9, 1455.8, 1485.8, 1588.7, 2878.5, 2980.8, 3080. 
1
H NMR: H (400 MHz, CDCl3): 1.68-1.77 (1H, m, CHH), 1.84-1.93 (1H, m, CHH), 1.94-
2.06 (1H, m, CHH), 2.52-2.58 (1H, m, CHH), 2.93-3.00 (1H, m, CHH), 3.49-3.59 (1H, m, 
CHH), 5.52 (1H, t, J=7.1 Hz, NCH),  7.57 (1H, dd, J
1
=7.8 Hz, J
2
=7.5 Hz, ArH), 7.76 (1H, dd, 
J
1
=7.8 Hz, J
2
=7.5 Hz, ArH), 8.05 (1H, d, J=7.8 Hz, ArH), 8.09 (1H, d, J=7.8 Hz, ArH) ppm. 
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13
C NMR c (100 MHz, DMSO): 24.61 (CH2), 34.64 (CH2), 49.33 (CH2), 56.19 (CH), 
125.20 (CH), 129.38 (CH), 129.75 (CH), 130.82 (qC), 131.16 (qC), 134.61 (CH), 155.50 (qC) 
ppm. 
HRMS (ESI
+
): found 278.0703 [M+H]
+
, C11H12N5O2S requires 278.0706. 
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7.3. Attempted synthesis of Tetrazolobenzothiadiazepines and 
Benzodiazepines. 
7.3.1. Tosylation of the alcohol. 
General experimental: 
 
To a stirred solution the alcohol (1.0 mmol, 1.0 eq) and p-toluenesulfonyl chloride (1.5 mmol, 
1.5 eq) in dichloromethane (10 mL) at 0 
o
C, triethylamine (505 mg, 5.0 mmol, 5.0 eq) was 
added dropwise. The mixture was stirred at room temperature over 5 h whilst being monitored 
by TLC. The reaction mixture was diluted with water (10 mL), the organic layer was 
separated and the aqueous layer was extracted with dichloromethene (3 x 10 mL). The 
combined organic layers were washed with water (2 x 10 mL), with brine (2 x 10 mL). The 
organic layer was dried with anhydrous magnesium sulfate, filtered and the solvent removed 
in vacuo. Purification was by silica chromatography. 
 
7.3.1.1. Synthesis of {1-[(2-azidophenyl)sulfonyl]piperidin-2-yl}methyl 4-
methylbenzenesulfonate. 
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(Eluent: petroleum ether/ethylacetate: 4/1, Rf = 0.23) yielded the product as a yellow oil (98 
%). 
IR: ʋmax (cm
-1
): 725.6, 813.8, 973.7, 1159.2, 1175.8, 1327.2, 1360.5, 1471.4, 1597.5, 2099.0, 
2945.5. 
1
H NMR: H (400 MHz, CDCl3): 1.20-1.34 (2H, m, CH2), 1.47-1.52 (3H, m, CH2), 1.62-
1.69 (1H, m, CHH), 2.34 (3H, br.s, CH3), 2.86 (1H, td, J
1
=13.1 Hz, J
2
=2.1 Hz, NCH), 3.72 
(1H, d, J=13.9 Hz, NCHH), 3.97 (1H, dd, J
1
=9.5 Hz, J
2
=1.3 Hz, NCHH), 4.01-4.05 (1H, m, 
CHH), 4.14 (1H, q, J=5.9 Hz, CHH), 7.10 (1H, td, J
1
=8.0 Hz, J
2
=0.8 Hz, ArH), 7.17 (1H, dd, 
J
1
= 8.0 Hz, J
2
= 0.5 Hz, ArH), 7.22-7.25 (2H, m, 2 x ArH), 7.47 (1H, ddd, J
1
=8.0 Hz, J
2
=7.7 
Hz, J
3
=1.4 Hz, ArH), 7.60 (2H, d, J= 8.3 Hz, 2 x ArH), 7.82 (1H, dd, J
1
=8.0 Hz, J
2
=1.4 Hz, 
ArH) ppm. 
13
C NMR c (100 MHz, CDCl3): 18.24 (CH2), 21.63 (CH3), 24.89 (CH2), 24.92 (CH2), 41.97 
(CH2), 50.58 (CH), 67.09 (CH2), 120.10 (CH), 124.44 (CH), 127.83 (2 x CH), 129.97 (2 x 
CH), 130.70 (qC), 131.05 (CH), 132.44 (qC), 133.89 (CH), 137.94 (qC) 145.12 (qC) ppm. 
HRMS (ESI
+
): found 468.1365 [M+NH4]
+
, C19H26N5O5S2 requires 468.1370. 
 
7.3.1.2. Synthesis of 2-[(2-azido-N-benzylphenyl)sulfonamido]ethyl 4-
methylbenzenesulfonate. 
 
(Eluent: petroleum ether/ethylacetate: 3/1, Rf = 0.22) yielded the product as a light yellow 
solid (98 %, mp.=92-94 
o
C). 
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IR: ʋmax (cm
-1
): 756.4, 816.2, 976.2, 1095.9, 1159.4, 1337.0, 1171.6, 1356.5, 1448.1, 1480.0, 
1587.6, 2129.5, 3032.2. 
1
H NMR: H (400 MHz, CDCl3): 2.47 (3H, br.s, CH3), 3.49-3.54 (2H, m, NCH2 CH2-O), 
3.89 (2H, q, J=6.3 Hz, NCH2CH2O), 4.55 (2H, d, J=14.8 Hz, N-CH2), 7.20-7.34 (9H, m, 9 x 
ArH), 7.57-7.70 (3H, m, 3 x ArH), 8.00 (1H, dd, J
1
=8.0 Hz, J
2
=1.4 Hz, ArH) ppm. 
13
C NMR c (100 MHz, CDCl3):  21.68 (CH3), 45.54 (CH2), 52.65 (CH2), 67.59 (CH2), 
119.99 (CH), 124.62 (CH), 127.88 (2 x CH), 128.45 (2 x CH), 128.76 (2 x CH), 129.92 (2 x 
CH), 130.44 (qC), 131.53 (CH), 132.16 (CH), 132.41 (qC), 134.12 (CH), 135.78 (qC), 138.33 
(qC), 145.06 (qC) ppm. 
HRMS (ESI
+
): found 509.0910 [M+Na]
+
, C22H22N4O5S2Na requires 509.0924. 
7.3.1.3. Synthesis of 2-[(2-azido-N-methylphenyl)sulfonamido]ethyl 4-
methylbenzenesulfonate. 
 
(Eluent: petroleum ether/ethylacetate: 3/2, Rf = 0.25) yielded the product as a yellow oil (88 
%). 
IR: ʋmax (cm
-1
): 723.8, 815.5, 972.7, 1096.1, 1146.7, 1157.2, 1175.5, 1289.0, 1336.3, 1443.5, 
1472.0, 1575.4, 2100.5, 2954.8. 
1
H NMR: H (400 MHz, CDCl3): 2.42 (3H, bs, Ar-CH3), 2.84 (3H, s, N-CH3), 3.56 (2H, t, 
J=5.5 Hz, NCH2CH2O), 4.14 (2H, t, J=5.5 Hz, NCH2CH2O), 7.19 (1H, dd, J
1
=7.9 Hz, J
2
=7.6 
Hz, ArH), 7.26 (1H, d, J=8.0 Hz, ArH), 7.33 (2H, d, J= 8.2 Hz, 2 x ArH), 7.56 (1H, ddd, 
J
1
=7.9 Hz, J
2
=7.6 Hz, J
3
=1.3 Hz, ArH), 7.73 (2H, d, J=8.2 Hz, 2 x ArH), 7.88 (1H, ddd, 
J
1
=7.9 Hz, J
2
= 7.6 Hz, J
3
=1.1 Hz, ArH) ppm. 
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13
C NMR c (100 MHz, CDCl3):  21.65 (CH3), 36.07 (CH3), 49.14 (CH2), 68.82 (CH2), 
119.99 (CH), 124.64 (CH), 127.87 (2 x CH), 129.19 (qC), 130.04 (2 x CH), 131.75 (CH), 
132.42 (qC), 134.19 (CH), 138.09 (qC), 145.22 (qC) ppm. 
HRMS (ESI
+
): found 428.1063 [M+NH4]
+
, C16H22N5O5S2 requires 428.1057. 
 
7.3.1.4. Synthesis of 2-{1-[(2-azidophenyl)sulfonyl]piperidin-2-yl}ethyl4-
methylbenzenesulfonate. 
 
(Eluent: petroleum ether/ethylacetate: 3/1, Rf = 0.24) yielded the product as a light yellow oil 
(84 %). 
IR: ʋmax (cm
-1
): 759.3, 956.1, 1019.4, 1068.7, 1096.1, 1157.0, 1174.2, 1188.2, 1306.1, 
1326.8, 1443.3, 1470.9, 1494.6, 1574.2, 1597.3, 2098.1, 2866.1, 2942.6. 
1
H NMR: H (400 MHz, CDCl3): 1.17-1.55 (6H, m, 3 x CH2), 1.76 (1H, m, O-CH2CHH-), 
1.96-2.08 (1H, m, O-CH2CHH-), 2.36 (3H, bs, CH3), 2.90 (1H, m, CH), 3.74 (1H, dd, 
J
1
=14.2 Hz, J
2
=3.4 Hz, NCHH), 3.82-3.88 (1H, m, NCHH), 3.92-4.04 (2H, m, O-CH2CH2-), 
7.12 (1H, ddd, J
1
=7.9 Hz, J
2
=7.5 Hz, J
3
=0.9 Hz, ArH), 7.19 (1H, dd, J
1
=7.9 Hz, J
2
=0.9 Hz, 
ArH), 7.26 (2H, d, J=8.1 Hz, 2 x ArH), 7.49 (1H, ddd, J
1
=7.9 Hz, J
2
=7.5 Hz, J
3
=1.5 Hz, 
ArH), 7.67 (2H, d, J=8.1, 2 x ArH ), 7.86 (1H, dd, J
1
=7.9 Hz, J
2
=1.5 Hz, ArH) ppm. 
13
C NMR c (100 MHz, CDCl3):  18.34 (CH2), 21.65 (CH3), 25.06 (CH2), 28.26 (CH2), 
29.52 (CH2), 40.89 (CH2), 49.76 (CH), 67.95 (CH2), 119.96 (CH), 124.63 (CH), 127.89 (2 x 
CH), 129.88 (2 x CH), 131.20 (qC), 131.24 (CH), 132.90 (qC), 133.78 (CH), 137.75 (qC), 
144.84 (qC) ppm. 
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HRMS (ESI
+
): found 465.1269 [M+H]
+
, C20H25N4O5S2 requires 465.1261. 
 
7.3.1.5. Synthesis of 4-[(2-azido-N-ethylphenyl)sulfonamido]butyl 4-
methylbenzenesulfonate. 
 
 
(Eluent: petroleum ether/ethylacetate: 2/1, Rf = 0.33) yielded the product as a dark brown oil 
(97 %). 
IR: ʋmax (cm
-1
): 749.2, 816.1, 949.8, 1010.7, 1097.0, 1122.4, 1155.9, 1290.0, 1329.7, 1471.4, 
1574.8, 1597.3, 2129.0, 2979.8. 
1
H NMR: H (400 MHz, CDCl3): 1.06 (3H, t, J=7.2 Hz, CH2CH3), 1.58-1.73 (4H, m, 
NCH2CH2CH2), 2.46 (3H, br.s, Ph-CH3),  3.28-3.36 (4H, m,  CH2-NCH-CH2), 4.04 (2H, t, 
J=6.0 Hz, O-CH2),  7.23 (1H, ddd, J
1
=7.7 Hz, J
2
=7.4 Hz, J
3
=1.2 Hz, ArH), 7.28-7.30 (1H, m, 
ArH), 7.36 (2H, d, J= 8.1 Hz, 2 x ArH), 7.57 (1H, ddd, J
1
=7.7 Hz, J
2
=7.4 Hz, J
3
=1.2 Hz, 
ArH), 7.79 (2H, d, J=8.1 Hz, 2 x ArH), 7.97 (1H, dd, J
1
=8.0 Hz, J
2
=1.4 Hz, ArH) ppm. 
13
C NMR c (100 MHz, CDCl3):  13.89 (CH3), 21.66 (CH3), 24.78 (CH2), 25.97 (CH2), 
42.30 (CH2), 46.72 (CH2), 70.00 (CH2), 119.81 (CH), 124.63 (CH), 127.88 (2 x CH), 129.90 
(2 x CH), 131.19 (qC), 131.52 (CH), 132.97 (qC), 133.73 (CH), 137.94 (qC), 144.84 (qC)   
ppm. 
HRMS (ESI
+
): found 453.1264 [M+H]
+
, C19H25N4O5S2 requires 453.1261. 
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7.3.1.6. Synthesis of 3-[(2-azido-N-benzylphenyl)sulfonamido]propyl 4-methyl-
benzenesulfonate. 
 
(Eluent: petroleum ether/ethylacetate: 2/1, Rf = 0.33) yielded the product as a brown oil (89 
%). 
IR: ʋmax (cm
-1
):  728.0, 814.7, 972.2, 1020.3, 1096.2, 1123.2, 1157.0, 1174.7, 1288.5, 1332.5, 
1471.5, 1494.9, 1597.3, 2128.0, 2979.6. 
1
H NMR: H (400 MHz, CDCl3): 1.71 (2H, p, J=7.3 Hz, NCH2CH2), 2.45 (3H, s, CH3), 3.30 
(2H, t, J=7.3 Hz, NCH2CH2), 3.87 (2H, t, J=6.2 Hz, O-CH2), 4.47 (2H, s, Ph-CH2), 7.21-7.33 
(9H, m, 9 x ArH), 7.60 (1H, d, J=7.9 Hz, ArH), 7.70 (2H, d, J=8.3 Hz, 2 x ArH), 7.99 (1H, 
dd, J
1
=7.9 Hz, J
2
=1.5 Hz, ArH) ppm. 
13
C NMR c (100 MHz, CDCl3):  21.66 (CH3), 28.09 (CH2), 44.64 (CH2), 52.51 (CH2), 
67.84 (CH2), 119.90 (CH), 124.77 (CH), 127.85 (2 x CH), 127.93 (CH), 128.27 (2 x CH), 
128.68 (2 x CH), 129.90 (2 x CH), 130.62 (qC), 131.64 (CH), 132.73 (CH), 134.08 (CH), 
136.29 (qC), 138.08 (qC), 144.92 (qC) ppm. 
HRMS (ESI
+
): found 501.1266 [M+H]
+
, C23H25N4O5S2 requires 501.1261. 
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7.3.1.7. Synthesis of {1-[(2-azidophenyl)sulfonyl]piperidin-4-yl}methyl 4-
methylbenzenesulfonate. 
 
(Eluent: petroleum ether/ethylacetate: 2/1, Rf = 0.30) yielded the product as a brown oil (89 
%). 
IR: ʋmax (cm
-1
): 725.7, 841.9, 909.1, 1065.9, 1173.8, 1188.6, 1287.5, 1308.8, 1353.7, 1443.5, 
1471.4, 1574.0, 2130.6, 2980.0. 
1
H NMR: H (400 MHz, CDCl3): 1.10-1.20 (2H, m, CH2CHCH2), 1.61-1.71 (3H, m, 
CH2CHCH2), 2.35 (3H, s, CH3), 2.54 (2H, td, J
1
=14.0 Hz, J
2
=1.6 Hz, CH2CHCH2), 3.11-3.15 
(4H, m, CH2NCH2),  7.13 (1H, dd, J
1
=7.9 Hz, J
2
=7.4 Hz, ArH), 7.20 (1H, d, J=7.9 Hz, ArH), 
7.26 (2H, d, J=8.2 Hz, 2 x ArH), 7.49 (1H, ddd, J
1
= 7.9 Hz, J
2
=7.5 Hz, J
3
=1.3 Hz, ArH), 7.66 
(2H, d, J=8.2 Hz, 2 x ArH), 7.80 (1H, dd, J
1
=7.9 Hz, J
2
=1.3 Hz, ArH) ppm. 
13
C NMR c (100 MHz, CDCl3):  21.64 (CH3), 28.13 (2 x CH2), 35.11 (CH), 45.46 (2 x 
CH2), 73.61 (CH2), 120.04 (CH), 124.68 (CH), 127.81 (2 x CH), 129.05 (qC), 129.97 (2 x 
CH), 131.59 (CH), 132.61 (CH), 134.05 (qC), 138.19 (qC), 145.05 (qC) ppm. 
HRMS (ESI
+
): found 451.1108 [M+H]
+
, C19H23N4O5S2 requires 451.1104. 
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7.3.2. Attempted Synthesis of 11,12,13,14,14a,15-hexahydrobenzo[g]pyrido-
[1,2-b]tetrazolo[5,1-e][1,2,6]thiadiazocine 9,9-dioxide. 
 
To a stirred solution of the tosylate (450 mg, 1.0 mmol, 1.0 eq) in DMSO (10 mL) was added 
sodium cyanide (98 mg, 2.0 mmol, 2.0 eq) in THF (5 mL). The resultant mixture was heated 
at 70 
o
C under a nitrogen atmosphere for 12 h whilst being monitored by TLC.  The reaction 
was left to cool to room temperature.  The reaction was diluted with water (10 mL) and the 
mixture was extracted with dichloromethane (3 x 20 mL). The combined organic layer was 
dried over anhydrous magnesium sulfate, filtered and concentrated. Purification by silica 
chromatography gave two products:  
Synthesis of 1,3,4,11,12,12a-hexahydro-2H-benzo[f]pyrido[1,2-b][1,2,5]thiadia-
zepine 6,6-dioxide (341). 
[Eluent: petroleum ether/ethylacetate: 2/1, Rf = 0.28) yielded the product as a light 
yellow solid (159 mg, 63 %, m.p.=127-129
 o
C)]. 
IR: ʋmax (cm
-1
): 758.5, 910.7, 959.2, 1074.0, 1153.2, 1247.0, 1314.7, 1477.9, 1595.8, 2855.7, 
2925.9, 2945.7, 3348.1. 
1
H NMR: H (400 MHz, CDCl3): 1.23-1.33 (1H, m, CHH), 1.43-1.51 (1H, m, CHH), 1.52-
1.61 (2H, m, CH2), 1.62-1.69 (1H, m, CHH), 1.71-1.80 (1H,m, CHH), 2.75-2.79 (1H, m, 
NCH), 3.05 (1H, d, J=14.1 Hz, HNCHH), 3.29-3.38 (2H, m, HNCHH + NCHH), 3.99-4.03 
(1H, m, NCHH), 4.47 (1H, br.s, NH), 6.79 (1H, d, J=8.0 Hz, ArH), 6.86 (1H, ddd, J
1
=8.0 Hz, 
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J
2
=7.8 Hz, J
3
=0.8 Hz, ArH), 7.20 (1H, ddd, J
1
=8.0 Hz, J
2
=7.8 Hz, J
3
=1.5 Hz, ArH), 7.69 (1H, 
dd, J
1
=8.0 Hz, J
2
=1.5, ArH) ppm. 
13
C NMR c (100 MHz, CDCl3): 19.88 (CH2), 25.04 (CH2), 28.87 (CH2), 41.77 (CH2), 45.29 
(CH2), 55.76 (CH), 120.44(CH), 121.26(CH), 127.78 (qC), 129.51 (CH), 133.31 (CH), 146.44 
(qC) ppm. 
HRMS (ESI
+
): found 252.0931 [M]
+
, C12H16N2O2S requires 252.0932. 
 
Synthesis of 1,2,3,4,12,12a-hexahydro-11H-benzo[f]pyrido [1,2-b][1,2,5]thiadia-
zepine-11-carbimidoyl cyanide 6,6-dioxide (342). 
[Eluent: petroleum ether/ethylacetate: 2/1, Rf = 0.22)] yielded the product as a light 
yellow solid (95 mg, 31 %, m.p.=167-169 
o
C). 
IR: ʋmax (cm
-1
): 647.8, 960.2, 1073.5, 1158.5, 1315.0, 1475.7, 1606.6, 2252.6  2857.9, 
2946.8, 3346.4. 
1
H NMR: H (400 MHz, CDCl3): 1.55-1.84 (6H, m, 3 x CH2), 2.24-2.29 (1H, m, N-CH), 
3.31 (1H, br.s, N-CHH-CH), 3.44 (1H, d, J=10.7 Hz, N-CHH-CH), 4.29 (1H, d, J=12.4 Hz, 
NCHH), 4.55 (1H, br.s, NCHH), 7.40 (1H, d, J=7.0 Hz, ArH), 7.50 (1H, dd, J
1
=7.2 Hz, 
J
2
=6.6 Hz, ArH), 7.60 (1H, dd, J
1
=7.2 Hz, J
2
=6.6 Hz, ArH), 7.91 (1H, d, J=7.0 Hz, ArH), 
8.22 (1H, br.s, NH) ppm. 
13
C NMR c (100 MHz, CDCl3): 18.60 (CH2), 24.72 (CH2), 27.76 (CH2), 41.01 (CH2), 43.36 
(CH2), 50.68 (CH), 110.36 (CN), 129.74 (CH), 130.50 (CH), 130.71 (CH), 134.19 (CH), 
138.12 (qC), 138.45 (qC) 141.06 (qC) ppm. 
HRMS (ESI
+
): found 304.0998 [M]
+
, C14H16N4O2S requires 304.0994. 
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7.3.3. Attempted synthesis of 6-benzyl-5,6-dihydro-4H-benzo[g] 
tetrazolo[5,1-e][1,2,6]thiadiazocine 7,7-dioxide. 
 
To a stirred solution of the tosylate (300 mg, 0.62 mmol, 1.0 eq) in DMSO (10 mL) was 
added sodium cyanide (61 mg, 1.24 mmol, 2.0 eq) in THF (5 mL). The resultant mixture was 
heated at 70 
o
C under a nitrogen atmosphere for 12 h whilst being monitored by TLC.  The 
reaction was left to cool to room temperature.  The reaction was diluted with water (10 mL) 
and the mixture was extracted with dichloromethane (3 x 20 mL). The combined organic layer 
was dried over anhydrous magnesium sulfate, filtered and concentrated. Purification by silica 
chromatography gave two products: 
2-Benzyl-2,3,4,5-tetrahydrobenzo[f][1,2,5]thiadiazepine 1,1-dioxide (352). 
(Eluent: petroleum ether/ethylacetate: 1/1, Rf = 0.38) yielded the product as a brown oil 
(150 mg, 84 %). 
IR: ʋmax (cm
-1
): 604.4, 697.5, 724.8, 907.4, 1152.8, 1325.7, 1352.9, 1477.4, 1594.0, 2979.8, 
3370.8. 
1
H NMR: H (400 MHz, CDCl3): 3.32 (4H, s, 2 x CH2), 4.19 (2H, 2, CH2), 4.32 (1H, br.s, 
NH), 6.79 (1H, dd, J
1
=8.0 Hz, J
2
=1.0 Hz, ArH), 6.92 (1H, dd, J
1
= 7.8 Hz, J
2
=7.4 Hz, ArH), 
7.18-7.28 (6H, m, 6 x ArH), 7.81 (1H, dd, J
1
=8.0 Hz, J
2
=1.0 Hz, ArH) ppm. 
13
C NMR c (100 MHz, CDCl3):  43.28 (CH2), 48.23 (CH2), 51.48 (CH2), 120.76 (CH), 
120.87 (CH), 127.90 (CH), 128.36 (2 x CH), 128.71 (2 x CH), 128.82 (qC), 129.73 (CH), 
133.26 (CH), 135.93 (qC), 146.10 (qC) ppm. 
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HRMS (ESI
+
): found 289.1007 [M+H]
+
, C15H17N2O2S requires 289.1005. 
2-Benzyl-3,4-dihydrobenzo[f][1,2,5]thiadiaze pine-5(2H)-carbimidoyl cyanide 1,1-
dioxide (353). 
(Eluent: petroleum ether/ethylacetate: 1/1, Rf = 0.19) yielded the product as a light 
yellow oil (18 mg, 9 %). 
IR: ʋmax (cm
-1
): 724.6, 906.4, 1010.6, 1128.2, 1153.6, 1249.4, 1327.3, 1370.8, 1475.5, 
1606.7, 2248.7, 2931.1, 3378.1. 
1
H NMR: H (400 MHz, CDCl3): 1.91 (1H, m, CHH), 3.29 (2H, m, CH2), 3.58 (1H, bs, 
CHH), 4.57 (1H, m, CHH), 4.50 (1H, d, J=14.5 Hz, CHH), 7.17-7.26 (3H, m, 3 x ArH), 7.41 
(1H, d, J=7.5 Hz, ArH), 7.50 (1H, dd, J
1
=7.5 Hz, J
2
=7.3 Hz, ArH), 7.59 (1H, dd, J
1
=7.5 Hz, 
J
2
=7.3 Hz, ArH), 7.78 (2H, d, J=7.5 Hz, 2 x ArH), 7.98 (1H, d, J=7.5 Hz, ArH), 8.20 (1H, sb, 
NH) ppm. 
13
C NMR c (100 MHz, CDCl3):  28.44 (CH2), 50.58 (CH2), 51.46 (CH2), 110.37 (CN), 
120.92 (qC), 127.90 (CH), 128.30 (2 x CH), 128.88 (2 x CH), 129.67 (CH), 129.77 (CH), 
130.88 (CH), 134.18 (CH), 135.03 (qC), 140.87 (qC), 146.20 (qC) ppm. 
HRMS (ESI
+
): found 341.1065 [M+H]
+
, C17H17N4O2S requires 341.1067. 
 
 
7.3.4. Attempted synthesis of 6-methyl-5,6-dihydro-4H-benzo[g] 
tetrazolo[5,1-e][1,2,6]thiadiazocine 7,7-dioxide. 
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To a stirred solution of the tosylate (300 mg, 0.73 mmol, 1.0 eq) in DMSO (10 mL) was 
added sodium cyanide (72 mg, 1.46 mmol, 2.0 eq) in THF (5 mL). The resultant mixture was 
heated at 70 
o
C under a nitrogen atmosphere for 12 h whilst being monitored by TLC.  The 
reaction was left to cool to room temperature.  The reaction was diluted with water (10 mL) 
and the mixture was extracted with dichloromethane (3 x 20 mL). The combined organic layer 
was dried over anhydrous magnesium sulfate, filtered and concentrated. Purification by silica 
chromatography (eluent: petroleum ether/ethylacetate: 1/1, Rf = 0.28) yielded the product as a 
pale yellow (135 mg, 87 %, m.p.=140-142 
o
C).     
IR: ʋmax (cm
-1
): 761.4, 883.8, 911.3, 1028.2, 1045.2, 1130.7, 1148.7, 1251.3, 1316.2, 1369.9, 
1476.9, 1476.9, 1509.2, 1593.2, 2939.7, 3370.5. 
1
H NMR: H (400 MHz, CDCl3): 2.82 (3H, s, CH3), 3.35 (2H, t, J=4.5 Hz, NCH2CH2NH), 
3.56-3.58 (2H, m, NCH2CH2NH), 4.38 (1H, br.s, NH), 6.89 (1H, d, J=8.0 Hz, ArH), 7.01 
(1H, ddd, J
1
= 8.0 Hz, J
2
= 7.7 Hz, J
3
=1.5 Hz, ArH), 7.33 (1H, ddd, J
1
=8.0 Hz, J
2
=7.7 Hz, 
J
3
=1.5 Hz, ArH), 7.85 (1H, dd, J
1
=8.0 Hz, J
2
=1.5 Hz, ArH) ppm. 
13
C NMR c (100 MHz, CDCl3):  35.73 (CH3), 42.64 (CH2), 52.41 (CH2), 120.97 (CH), 
121.10 (CH), 127.72 (qC), 130.33 (CH), 133.35 (CH), 146.02 (qC) ppm. 
HRMS (ESI
+
): found 213.0694 [M+H]
+
, C9H13N2O2S requires 213.0692. 
 
7.3.5. Attempted synthesis of 10,10a,11,12,13,14-hexahydro-9H-benzo[h]-
pyrido[1,2-b]tetrazolo[5,1-f][1,2,7]thiadiazonine 16,16-dioxide. 
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To a stirred solution of the tosylate (250 mg, 0.538 mmol, 1.0 eq) in DMSO (10 mL) was 
added sodium cyanide (53 mg, 1.076 mmol, 2.0 eq) in THF (5 mL). The resultant mixture 
was heated at 70 
o
C under a nitrogen atmosphere for 12 h whilst being monitored by TLC.  
The reaction was left to cool to room temperature.  The reaction was diluted with water (10 
mL) and the mixture was extracted with dichloromethane (3 x 20 mL). The combined organic 
layer was dried over anhydrous magnesium sulfate, filtered and concentrated. Purification by 
silica chromatography gave two products: 
5,6,7,7a,8,9,10,11-Octahydrobenzo[g]pyrido[1,2-b][1,2,6]thiadiazocine 13,13-
dioxide (359). 
(Eluent: petroleum ether/ethylacetate: 2/1, Rf = 0.32) yielded the product as a light 
yellow oil (88 mg, 61 %). 
IR: ʋmax (cm
-1
): 781.9, 854.3, 911.3, 1087.0, 1105.6, 1136.4, 1150.0, 1246.1, 1295.1, 1310.9, 
1331.9, 1463.1, 1488.2, 1595.2, 2864.5, 2938.4, 3365.0. 
1
H NMR: H (400 MHz, CDCl3): 1.15-1.33 (2H, m, CH2), 1.48-1.61 (4H, m, 2 x CH2), 1.76-
1.93 (2H, m, CH2), 2.24-2.31 (1H, m, CHH), 3.24-3.34 (1H, m, HNCHH), 3.23-3.34 (2H, m, 
HNCHH+NCH), 3.40-3.43 (1H, m, NCHH), 4.20 (1H, bs, NCHH), 4.96 (1H, bs, NH), 6.97 
(1H, dd, J
1
=7.9 Hz, J
2
=7.6 Hz, ArH), 7.06 (1H, d, J= 8.0 Hz, ArH), 7.34 (1H, ddd, J
1
=7.9 Hz, 
J
2
=7.6 Hz, J
3
=1.0 Hz, ArH), 7.73 (1H, dd, J
1
=8.0 Hz, J
2
=0.9 Hz, ArH) ppm. 
13
C NMR c (100 MHz, CDCl3):  18.64 (CH2), 25.33 (CH2), 29.00 (CH2), 32.89 (CH2), 
40.31 (CH2), 50.06 (CH2), 52.95 (CH), 121.97 (CH), 125.65 (CH), 129.72 (CH), 132.36 (qC), 
133.40 (CH), 147.08 (qC) ppm. 
HRMS (ESI
+
): found 267.1167 [M+H]
+
, C13H19N2O2S requires 267.1162. 
7,7a,8,9,10,11-Hexahydrobenzo[g]pyrido[1,2-b][1,2,6]thiadiazocine-5(6H)-
carbimidoyl cyanide 13,13-dioxide (360). 
(Eluent: petroleum ether/ethylacetate: 2/1, Rf = 0.2) yielded the product as a yellow oil 
(50 mg, 29 %). 
IR: ʋmax (cm
-1
): 772.1, 872.4, 954.1, 1054.9, 1089.2, 1191.4, 1226.9, 1306.5, 1326.2, 1444.3, 
1474.6, 1584.5, 1607.4, 2255.2, 2857.0, 2930.2, 3314.0. 
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1
H NMR: H (400 MHz, CDCl3): 1.18-1.22 (1H, m, CHH), 1.41-1.66 (4H, m, 2 x CH2), 
1.76-1.85 (1H, m, CHH), 1.90-1.99 (1H, m, CHH), 2.07 (1H, d, J=5.0 Hz, CHH), 2.48 (1H, 
td, J
1
=12.9 Hz, J
2
=4.3 Hz, CHH), 2.91 (1H, bs, CHH), 3.61-3.65 (1H, m, CH), 4.31-4.43 
(2H, m, NCH2), 7.25 (1H, d, J=7.7 Hz, ArH), 7.47 (1H, ddd, J
1
= 7.7 Hz, J
2
=7.5 Hz, J
3
= 0.9 
Hz, ArH), 7.56 (1H, ddd, J
1
=7.7 Hz, J
2
=7.5 Hz, J
3
=1.4 Hz, ArH), 7.99 (1H, dd, J
1
=7.7 Hz, 
J
2
=1.4 Hz, ArH), 8.09 (1H, bs, NH) ppm. 
13
C NMR c (100 MHz, CDCl3):  18.78 (CH2), 25.66 (CH2), 26.10 (CH2), 30.19 (CH2), 
40.72 (CH2), 49.51 (CH2), 50.57 (CH), 110.76 (CN), 129.60 (CH), 130.30 (CH), 130.84 
(CH), 133.80 (CH), 140.51 (qC), 142.13 (qC), 158.19 (C=N) ppm. 
HRMS (ESI
+
): found 319.1228 [M+H]
+
, C15H19N4O2S requires 319.1223. 
7.3.6. Synthesis of 2-ethyl-2,3,4,5,6,7-hexahydrobenzo[h][1,2,7]thiadiazon-
ine 1,1-dioxide. 
 
To a stirred solution of the tosylate (250 mg, 0.553 mmol, 1.0 eq) in DMSO (10 mL) was 
added sodium cyanide (54 mg, 1.11 mmol, 2.0 eq) in THF (5 mL). The resultant mixture was 
heated at 70 
o
C under a nitrogen atmosphere for 12 h whilst being monitored by TLC.  The 
reaction was left to cool to room temperature.  The reaction was diluted with water (10 mL) 
and the mixture was extracted with dichloromethane (3 x 20 mL). The combined organic layer 
was dried over anhydrous magnesium sulfate, filtered and concentrated. Purification by silica 
chromatography (eluent: petroleum ether/ethylacetate: 2/1, Rf = 0.26) yielded the product as a 
yellow oil (85 mg, 60 %). 
IR: ʋmax (cm
-1
): 759.4, 926.4, 978.8, 1020.6, 1085.1, 1146.1, 1187.7, 1266.9, 1322.5, 1376.6, 
1463.6, 1576.0, 1595.1, 2852.2,  2920.7, 3409.9. 
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1
H NMR: H (400 MHz, CDCl3): 1.07-1.18 (3H, m, CH3), 2.06-2.09 (1H, m, NCH2CH2), 
2.24-2.35 (2H, m, HNCH2CH2), 2.88 (2H, q, J=7.0 Hz, HNCH2CH2), 3.36 (2H, t, J=4.6 Hz, 
NCH2CH2), 3.76 (2H, t, J=6.2 Hz, NCH2CH3), 4.79 (1H, bs, NH), 6.84 (1H, dd, J
1
=8.0 Hz, 
J
2
=7.4 Hz, ArH), 7.00 (1H, d, J= 8.0 Hz, ArH), 7.32 (1H, dd, J
1
=8.0 Hz, J
2
=7.4 Hz, ArH), 
7.71 (1H, d, J=8.0 Hz, ArH) ppm.  
13
C NMR c (100 MHz, CDCl3):  14.13 (CH3), 22.70 (CH2), 26.08 (CH2), 29.71 (CH2), 
43.88 (CH2), 48.79 (CH2), 120.01 (CH), 122.12 (CH), 128.93 (CH), 131.80 (qC), 133.25 
(CH), 147.04 (qC) ppm. 
HRMS (ESI
+
): found 255.1165 [M+H]
+
, C12H19N2O2S requires 255.1162. 
 
7.3.7. Attempted synthesis of 7-benzyl-4,5,6,7-tetrahydrobenzo 
[h]tetrazolo[5,1-f][1,2,7]thiadiazonine 8,8-dioxide. 
 
To a stirred solution of the tosylate (350 mg, 0.7 mmol, 1.0 eq) in DMSO (10 mL) was added 
sodium cyanide (69 mg, 1.4 mmol, 2.0 eq) in THF (5 mL). The resultant mixture was heated 
at 70 
o
C under a nitrogen atmosphere for 12 h whilst being monitored by TLC.  The reaction 
was left to cool to room temperature.  The reaction was diluted with water (10 mL) and the 
mixture was extracted with dichloromethane (3 x 20 mL). The combined organic layer was 
dried over anhydrous magnesium sulfate, filtered and concentrated. Purification by silica 
chromatography gave two products: 
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2-Benzyl-3,4,5,6-tetrahydro-2H-benzo[g][1,2,6] thiadiazocine 1,1-dioxide (366). 
(Eluent: petroleum ether/ethylacetate: 2/1, Rf = 0.3) yielded the product as a light yellow 
oil (142 mg, 80 %). 
IR: ʋmax (cm
-1
): 724.5, 860.4, 905.1, 1025.1, 1122.0, 1150.1, 1239.4, 1326.4, 1463.1, 1487.6, 
1595.1, 2934.4, 3368.7. 
1
H NMR: H (400 MHz, CDCl3): 1.48 (2H, br.t, J=3.6 Hz, NCH2CH2),  3.26-3.31 (4H, m, 
NCH2 + HNCH2), 3.89 (2H, s, Ph-CH2), 5.07 (1H, br.s, NH), 6.97 (1H, t, J=7.6 Hz, ArH), 
7.07 (1H, d, J=7.9 Hz, ArH), 7.16-7.23 (5H, m, 5 x ArH), 7.35 (1H, dd, J
1
=7.9 Hz, J
2
=7.4 
Hz, ArH), 7.79 (1H, d, J=7.9 Hz, ArH) ppm
  
13
C NMR c (100 MHz, CDCl3):  25.07 (CH2), 43.58 (CH2), 48.99 (CH2), 49.96 (CH2), 
121.91 (CH), 125.50 (CH), 127.93 (CH), 128.38 (2 x CH), 128.67 (2 x CH), 129.48 (CH), 
132.44 (qC), 133.57 (CH), 135.58 (qC), 147.09 (qC) ppm. 
HRMS (ESI
+
): found 303.1157 [M+H]
+
, C16H19N2O2S requires 303.1162. 
2-Benzyl-2,3,4,5-tetrahydro-6H-benzo[g][1,2,6] thiadiazocine-6-carbonitrile 1,1-
dioxide (367). 
 (Eluent: petroleum ether/ethylacetate: 2/1, Rf = 0.2) yielded the product as a light yellow 
oil (38 mg, 17 %). 
IR: ʋmax (cm
-1
): 793.4, 866.2, 924.1, 1075.8, 1153.6, 1332.7, 1473.7, 1494.9, 1585.0, 2216.5, 
2929.3. 
1
H NMR: H (400 MHz, CDCl3): 1.93 (2H, app. p, J=5.7 Hz, NCH2CH2),  3.60 (2H, t, J=5.6 
Hz, NC-NCH2), 3.67 (2H, t, J=6.0 Hz, NCH2CH2), 4.22 (2H, s, Ph-CH2), 7.22-7.34 (6H, m, 6 
x ArH), 7.39 (1H, ddd, J
1
=8.2 Hz, J
2
=7.9 Hz, J
3
=1.3 Hz, ArH), 7.49 (1H, dd, J
1
=7.9 Hz, 
J
2
=1.1 Hz, ArH), 7.54 (1H, ddd, J
1
=8.3 Hz, J
2
=7.9 Hz, J
3
=1.3 Hz, ArH) ppm
  
13
C NMR c (100 MHz, CDCl3):  23.45 (CH2), 42.26 (CH2), 49.04 (CH2), 54.20 (CH2), 
114.73 (CN), 126.45 (CH), 128.29 (CH), 128.34 (3 x CH), 128.87 (2 x CH), 131.10 (CH), 
133.89 (CH), 134.87 (qC), 136.73 (qC), 138.26 (qC) ppm. 
HRMS (ESI
+
): found 327.1040 [M]
+
, C17H17N3O2S requires 327.1041. 
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7.3.8. Attempted synthesis of 4,5,6,7-tetrahydro-5,8-ethanobenzo 
[i]tetrazolo[5,1-g][1,2,8]thiadiazecine 9,9-dioxide. 
 
To a stirred solution of the tosylate (100 mg, 0.222 mmol, 1.0 eq) in DMSO (10 mL) was 
added sodium cyanide (22 mg, 0.444 mmol, 2.0 eq) in THF (5 mL). The resultant mixture 
was heated at 70 
o
C under a nitrogen atmosphere for 12 h whilst being monitored by TLC.  
The reaction was left to cool to room temperature.  The reaction was diluted with water (10 
mL) and the mixture was extracted with dichloromethane (3 x 20 mL). The combined organic 
layer was dried over anhydrous magnesium sulfate, filtered and concentrated. Purification by 
silica chromatography (eluent: petroleum ether/ethylacetate: 1/1, Rf = 0.32) yielded the 
product as a yellow oil (38 mg, 57 %). 
IR: ʋmax (cm
-1
):  840.0, 886.0, 933.1, 1047.4, 1090.8, 1246.7, 13224.8, 1450.9, 1483.7, 
1564.6, 1617.6, 2247.3, 2852.7, 2923.1, 3378.0, 3476.0. 
1
H NMR: H (400 MHz, CDCl3): 1.35 (1H, qd, J
1
=12.3 Hz, J
2
=4.1 Hz, CH), 1.56-1.67 (2H, 
m, NCH2CH2), 1.78 (2H, d, J=12.7 Hz, NCH2CH2), 2.21 (2H, d, J=6.9 Hz, CH2-CN), 2.44 
(2H, td, J
1
=12.3 Hz, J
2
=2.4 Hz, NCH2CH2), 3.77 (2H, dd, J
1
=10.1 Hz, J
2
=2.1 Hz, NCH2CH2), 
4.95-4.97 (2H, m, NH2), 6.64-6.70 (1H, m, ArH), 7.23 (1H, ddd, J
1
=8.3 Hz, J
2
=8.1 Hz, 
J
3
=1.4 Hz, ArH), 7.48 (1H, dd, J
1
=8.3 Hz, J
2
=1.4 Hz, ArH) ppm. 
13
C NMR c (100 MHz, CDCl3):  23.77 (CH2), 30.74 (2 x CH2), 32.63 (CH), 45.62 (2 x 
CH2), 117.28 (CH), 117.70 (CH), 117.82 (qC), 117.85 (qC), 130.26 (CH), 134.31 (CH), 
146.24 (qC) ppm. 
HRMS (ESI
+
): found 279.1045 [M]
+
, C13H17N3O2S requires 279.1041. 
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7.3.9. Synthesis of (2-azidophenyl)(2-(hydroxymethyl)piperidin-1-
yl)methanone. 
 
2-Azidobenzoic acid
120,239
 (1.075 g, 6.6 mmol, 2.2 eq) was heated at reflux in a 2M solution 
of   (COCl)2 in dichloromethane (7.5 mL, 15.0 mmol, 5.0 eq) with a drop  of DMF  under an 
inert atmosphere of nitrogen for 5 hours. The reaction was allowed to reach room temperature 
before the crude acid chloride was concentrated and the residue was washed with 
dichloromethane (2 x 20 mL) to give the crude 2-azidobenzoyl chloride as a dark brown solid. 
A solution of potassium carbonate (1.656 g, 12.0 mmol, 4.0 eq) in water (10 mL) was added 
in one portion to a stirring solution of 2-piperidinemethanol (345 mg, 3.0 mmol, 1.0 eq) in 
dichloromethane (10 mL). The 2-azidobenzoyl chloride was dissolved in dichloromethane (5 
mL) and was added slowly to this solution. The reaction was allowed to stir at room 
temperature for 18 hours before the organic layer was separated and the aqueous layer washed 
with dichloromethane (2 x 20 mL). The combined organic phases were dried (MgSO4), 
filtered, concentrated and purified by silica column chromatography [petroleum ether/ethyl 
acetate: 5/1, Rf = 0.2] to yield the product as a brown oil (780 mg, 81 %). 
IR: ʋmax (cm
-1
): 872.7, 953.7, 1013.8, 1048.2, 1282.2, 1372.3, 1433.9, 1489.2, 1595.8, 
1607.5, 1715.8, 2124.5, 2869.4, 2938.1, 3053.4, 3377.2. 
1
H NMR: H (400 MHz, CDCl3): 1.42-1.64 (5H, m, 2 x CH2 +CHH), 2.67-2.73 (1H, m, 
CHH), 3.13 (1H, d, J=13.2 Hz, HO-CHH), 3.61-3.72 (3H, m, HO-CHH + NCH + NCHH), 
4.53 (1H, d, J=13.2 Hz, NCHH), 4.81 (1H, br.s, OH), 7.03-7.06 (1H, m, ArH), 7.08-7.11 (1H, 
m, ArH), 7.16-7.22 (1H, m,  ArH), 7.24-7.35 (1H, m, ArH) ppm. 
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13
C NMR c (100 MHz, CDCl3): 19.33 (CH2), 24.68 (CH2), 37.27 (CH2), 43.29 (CH2), 55.98 
(CH), 60.36 (CH2), 118.10 (CH), 125.09 (CH), 128.17 (CH), 128.83 (qC), 130.19 (CH), 
135.93 (qC), 168.07 (C=O) ppm. 
HRMS (ESI
+
): found 261.1346 [M+H]
+
, C13H17N4O2 requires 261.1335. 
 
7.3.10. Synthesis of [1-(2-azidobenzoyl)piperidin-2-yl]methyl 4-methylben-
zenesulfonate. 
 
To a stirred solution the alcohol (300 mg, 1.16 mmol, 1.0 eq) and p-toluenesulfonyl chloride 
(331 mg, 1.74 mmol, 1.5 eq) in dichloromethane (10 mL) at 0 
o
C, triethylamine (586 mg, 5.8 
mmol, 5.0 eq) was added dropwise. The mixture was stirred at room temperature over 5 h 
whilst being monitored by TLC. The reaction mixture was diluted with water (10 mL), the 
organic layer was separated and the aqueous layer was extracted with dichloromethane (3 x 
10 mL). The combined organic layers were washed with water (2 x 10 mL), and brine (2 x 10 
mL). The organic layer was dried with anhydrous magnesium sulfate, filtered and the solvent 
removed in vacuo. Purification by silica chromatography (eluent: petroleum 
ether/ethylacetate: 3/1, Rf = 0.23) yielded the product as a light yellow oil (445 mg, 94 %). 
IR: ʋmax (cm
-1
): 727.6, 908.3, 1076.5, 1147.4, 1124.7, 1247.6, 1293.5, 1445.8, 1486.9, 
1597.0, 1720.8, 2120.5, 2867.2, 2942.7. 
1
H NMR: H (400 MHz, CDCl3): 1.16-1.22 (1H, m, CHH), 1.40-1.49 (4H, m, 2 x CH2), 
1.60-1.65 (1H, m, CHH), 2.26 (3H, br.s, CH3), 3.04 (1H, td, J
1
=14.7 Hz, J
2
=2.2 Hz, NCHH), 
3.71 (1H, dd, J
1
=14.2 Hz, J
2
=4.0 Hz, NCH), 4.21 (1H, app. q, J=5.4 Hz, NCHH), 4.36-4.46 
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(2H, m, OCH2), 7.06-7.13 (4H, m, 2 x ArH), 7.43 (1H, ddd, J
1
=7.9 Hz, J
2
=7.7 Hz, J
3
=1.4 Hz, 
ArH), 7.61 (2H, d, J=8.2 Hz, 2 x ArH), 7.83 (1H, dd, J
1
=7.9 Hz, J
2
=1.4 Hz, ArH) ppm. 
13
C NMR c (100 MHz, CDCl3): 18.90 (CH2), 21.46 (CH3), 24.28 (CH2), 25.19 (CH2), 41.24 
(CH2), 51.07 (CH), 62.01 (CH2), 119.79 (CH), 122.07 (qC), 124.54 (CH), 126.85 (2 x CH), 
129.62 (2 x CH), 132.15 (CH), 133.37 (CH), 138.46 (qC), 140.14 (qC), 142.97 (qC), 164.72 
(C=O) ppm. 
HRMS (ESI
+
): found 437.1234 [M+Na]
+
, C20H22N4O4SNa requires 437.1254. 
 
7.3.11. Attempted synthesis of 11,12,13,14,14a,15-hexahydro-9H-benzo[f]-
pyrido[1,2-a]tetrazolo[5,1-d][1,5]diazocin-9-one. 
 
To a stirred solution of the tosylate (200 mg, 0.483 mmol, 1.0 eq) in DMSO (10 mL) was 
added sodium cyanide (47 mg, 0.966 mmol, 2.0 eq) in THF (5 mL). The resultant mixture 
was heated at 70 
o
C under a nitrogen atmosphere for 12 h whilst being monitored by TLC.  
The reaction was left to cool to room temperature.  The reaction was diluted with water (10 
mL) and the mixture was extracted with dichloromethane (3 x 20 mL). The combined organic 
layer was dried over anhydrous magnesium sulfate, filtered and concentrated. Purification by 
silica chromatography gave two products: 
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 (1-Benzoylpiperidin-2-yl)methyl 4-methylbenzenesulfonate (348): 
[(eluent: Hexane/ethylacetate: 3/1, Rf = 0.24) yielded the product as a light yellow oil (95 
mg, 31 %). 
IR: ʋmax (cm
-1
): 814.5, 907.6, 991.3, 1093.1, 1113.8, 1148.4, 1160.6, 1272.6, 1327.6, 1450.5, 
1600.0, 1719.5, 2854.7, 2925.1. 
1
H NMR: H (400 MHz, CDCl3): 1.18-1.64 (6H, m, 3 x CH2), 2.28 (3H, s, CH3), 3.05 (1H, 
td, J
1
=13.0 Hz, J
2
=1.7 Hz, N-CH), 3.73 (1H, dd, J
1
=14.0 Hz, J
2
=3.5 Hz, N-CHH), 4.22-4.29 
(1H, m, N-CHH), 4.43-4.51 (2H, m, O-CH2), 7.11 (2H, d, J=8.0 Hz, 2 x ArH), 7.36 (2H, t, 
J=7.6 Hz, 2 x ArH), 7.48 (1H, t, J=7.6 Hz, ArH), 7.63 (2H, d, J=8.0 Hz, 2 x ArH), 7.95 (2H, 
d, J=7.6 Hz, 2 x ArH) ppm. 
13
C NMR c (100 MHz, CDCl3): 18.96 (CH2), 21.48 (CH3), 24.42 (CH2), 25.36 (CH2), 41.30 
(CH2), 51.11 (CH), 61.92 (CH2), 126.91 (2 x CH), 128.36 (2 x CH), 129.65 (2 x CH), 129.79 
(2 x CH), 129.82 (qC), 133.07 (CH), 138.44 (qC), 142.99 (qC), 166.36 (C=O) ppm. 
HRMS (ESI
+
): found 396.1242 [M+Na]+, C20H23NO4SNa requires 396.1240. 
 
Piperidin-2-ylmethyl 4-methyl benzenesulfonate (349). 
(eluent: Hexane/ethylacetate: 2/1, Rf =0.2) yielded the product as a orange oil (45 mg, 35 
%). 
IR: ʋmax (cm
-1
): 725.0, 874.2, 987.9, 1092.5, 1153.5, 1186.1, 1303.9, 1325.2, 1446.2, 1597.5, 
2942.1, 3517.9. 
1
H NMR: H (400 MHz, CDCl3): 1.18-1.53 (6H, m, 3 x CH2), 2.17 (1H, bs, NCHH), 2.35 
(3H, s, CH3), 3.02 (1H, t, J=12.7 Hz, NCHH), 3.50 (1H, t, J=5.1 Hz, NCH), 3.70 (1H, bs, 
NH), 7.22 (2H, d, J=7.8 Hz, 2 x ArH), 7.67 (2H, d, J=7.8 Hz, 2 x ArH) ppm. 
13
C NMR c (100 MHz, CDCl3): 19.15 (CH2), 21.53 (CH3), 24.19 (CH2), 24.77 (CH2), 41.41 
(CH2), 54.68 (CH), 60.66 (CH2), 126.99 (2 x CH), 129.79 (2 x CH), 138.10 (qC), 143.28 (qC) 
ppm. 
HRMS (ESI
+
): found 270.1164 [M+H]+, C13H20NO3S requires 270.1158. 
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8. Chapter 8: Experimental for Chapter 4: Reactivity of 2-azidobenzamide. 
8.1. Reactivity of 2-azidobenzamide. 
8.1.1. Reactivity of 2-azidobenzamide with 5-bromo-1-pentene. 
 
 
To a solution of  2-azidobenzamide
240
 (200 mg, 1.23 mmol, 1.0 eq) and sodium carbonate 
(392 mg, 3.70 mmol, 3.0 eq) in extra dry DMSO (10 mL),  5-bromo-1-pentene (368 mg, 2.46 
mmol, 2.0 eq) was added. The whole was heated at 95 
o
C for 48 hours under a nitrogen 
atmosphere and after completion of the reaction, monitored by TLC, the resulting mixture was 
diluted with dichloromethane (30 mL) and washed with 0.1M NaCl and water many times to 
remove the DMSO. The mixture was dried with anhydrous magnesium sulfate, filtered under 
gravity and the solvent was removed under vacuum. The residue was purified by using 
column chromatography to give two products: 
3-(Pent-4-en-1-yl)benzo[d][1,2,3]triazin-4(3H)-one (379). 
 (Eluent: petroleum ether/ethyl acetate: 4/1, Rf = 0.2) yielded the product as a dark 
orange oil (100 mg, 38 %). 
IR: ʋmax (cm
-1
): 559.1, 619.3, 645.5, 686.3, 775.1, 911.3, 968.9, 991.0, 1037.3, 1072.4, 
1183.6, 1274.2, 1294.2, 1333.0, 1463.2, 1579.2, 1607.3, 1640.6, 1679.5, 2856.0, 2929.2, 
3075.6.  
1
H NMR: H (400 MHz, CDCl3):  1.95 (2H, td, J
1
=14.8 Hz, J
2
= 3.6 Hz CH2), 2.12 (2H, q, 
J= 7.1 Hz, CH2), 4.41 (2H, t, J= 7.3 Hz, CH2), 4.92 (1H, d, J= 10.2 Hz, CHH), 5.00 (1H, dd, 
J
1
=17.1 Hz, J
2
=0.8 Hz, CHH), 5.71-5.82 (H, m, CH), 7.72 (1H, dd, J
1
=7.7 Hz, J
2
=7.5 Hz, 
ArH), 7.86 (1H, dd, J
1
=7.7 Hz, J
2
=7.3 Hz, ArH), 8.07 (1H, d, J=7.7 Hz, ArH), 8.27 (1H, d, 
J=7.7 Hz, ArH) ppm. 
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13
C NMR c (100 MHz, CDCl3): 27.93 (CH2), 30.74 (CH2), 49.40 (CH2), 115.58 (CH2), 
119.82 (qC), 125.06 (CH), 128.22 (CH), 132.26 (CH), 134.72 (CH), 137.14 (CH), 144.32 
(qC), 155.52 (C=O) ppm. 
HRMS (ESI
+
): found 215.1059 [M]
+
, C12H13N3O requires 215.1059. 
2-(But-3-en-1-yl)quinazolin-4(3H)-one (380). 
(Eluent: petroleum ether/ethyl acetate: 1/1, Rf = 0.3) yielded the product as a light yellow 
solid (80 mg, 33 %, m.p.: 167-169 
o
C). 
IR: ʋmax (cm
-1
): 766.6, 897.1, 994.0, 1105.3, 1139.6, 1194.7, 1253.1, 1288.4, 1341.5, 1421.1, 
1445.0, 1469.1, 1563.6, 1608.9, 1673.1, 2916.5, 2975.5, 3030.0, 3168.3.  
1
H NMR: H (400 MHz, CDCl3): 2.59 (2H, q, J=7.3 Hz, CH2), 2.84 (2H, t, J= 7.3 Hz, CH2), 
4.97 (1H, d, J=10.1 Hz, =CHH), 5.08 (1H, dd, J
1
= 17.1 Hz, J
2
=1.0 Hz, =CHH), 5.82-5.92 
(1H, m, CH), 7.40 (1H, dd, J
1
=7.8 Hz, J
2
=7.2 Hz, ArH), 7.63 (1H, d, J=8.0 Hz, ArH), 7.70 
(1H, dd, J
1
=8.0 Hz, J
2
=7.1 Hz, ArH), 8.21 (1H, d, J=7.8 Hz, ArH), 12.11 (1H, s, NH) ppm. 
13
C NMR c (100 MHz, CDCl3): 31.31 (CH2), 35.19 (CH2), 116.29 (CH2), 120.53 (qC), 
126.24 (CH), 126.44 (CH), 127.26 (CH), 134.82 (CH), 136.43 (CH), 149.45 (qC), 156.07 
(qC), 164.39 (C=O) ppm. 
HRMS (ESI
+
): found 201.1023 [M+H]
+
, C12H13N2O requires 201.1022 
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8.1.2. Reactivity of 2-azidobenzamide with 1-bromo propane. 
 
 
To a solution of 2-azidobenzamide (200 mg, 1.23 mmol, 1.0 eq) and sodium carbonate (392 
mg, 3.70 mmol, 3.0 eq) in extra dry DMSO (10 mL), 1-bromo propane (304 mg, 2.47 mmol, 
2.0 eq) was added. The whole was heated at 95 
o
C for 48 hours under a nitrogen atmosphere 
and after completion of the reaction, monitored by TLC, the resulting mixture was diluted 
with dichloromethane (30 mL) and washed with 0.1M NaCl and water many times to remove 
the DMSO. The mixture was dried with anhydrous magnesium sulfate, filtered under gravity 
and the solvent was removed under vacuum. The residue was purified by using column 
chromatography to give two products: 
Synthesis of 3-propylbenzo[d][1,2,3]triazin-4(3H)-one (382). 
(Eluent: petroleum ether/ethyl acetate: 4/1, Rf = 0.21) yielded the product as a light 
yellow solid (88 mg, 38 %, m.p.= 49 -51 
o
C). 
IR: ʋmax (cm
-1
): 735.6, 891.3, 976.9, 1015.2, 1024.4, 1142.8, 1174.6, 1226.2, 1281.0, 1293.5, 
1320.3, 1333.6, 1458.0, 1496.7, 1577.7, 1605.6, 1640.6, 2878.9, 2963.5.  
1
H NMR: H (400 MHz, CDCl3): 0.95 (3H, t, J=7.4 Hz, CH3), 1.88 (2H, app. sextet, J= 7.4 
Hz, CH2), 4.37 (2H, t, J= 7.4 Hz, CH2), 7.72 (1H, dd, J
1
=7.9 Hz, J
2
=7.3 Hz, ArH), 7.87 (1H, 
dd, J
1
=8.1 Hz, J
2
=7.5 Hz, ArH), 8.07 (1H, d, J=8.1 Hz, ArH), 8.29 (1H, d, J=7.9 Hz, ArH) 
ppm. 
13
C NMR c (100 MHz, CDCl3): 11.18 (CH3), 22.29 (CH2), 51.44 (CH2), 119.85 (qC), 
125.08 (CH), 128.20 (CH), 132.21 (CH), 134.68 (CH), 144.33 (qC), 155.54 (C=O) ppm. 
HRMS (ESI
+
): found 190.0973 [M+H]
+
, C10H12N3O requires 190.0975. 
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Synthesis of 2-ethylquinazolin-4(3H)-one (383). 
 (Eluent: petroleum ether/ethyl acetate: 1/1, Rf = 0.28) yielded the product as a light 
yellow solid (50 mg, 23 %, m.p.=209-211 
o
C). 
IR: ʋmax (cm
-1
): 771.3, 905.6, 1139.1, 1201.4, 1251.2, 1341.3, 1372.8, 1467.0, 1504.3, 
1607.9, 1619.1, 1674.3, 2852.5, 2922.0, 3043.8, 3163.1.  
1
H NMR: H (400 MHz, CDCl3): 1.17-1.38 (2H, m, CH3), 2.78 (2H, d, J= 6.9 Hz, CH2),  
7.18 (1H, bs, ArH), 7.39 (1H, m, ArH), 7.64-7.68 (2H, m, 2 x ArH), 8.22 (1H, d, J=6.8 Hz, 
ArH),  12.17 (1H, s, NH) ppm. 
13
C NMR c (100 MHz, CDCl3): 11.57 (CH3), 29.71 (CH2), 120.50 (qC), 126.23 (CH), 
126.33 (CH), 127.22 (CH), 134.78 (CH), 149.54 (qC), 156.78 (qC), 164.57 (C=O) ppm. 
HRMS (ESI
+
): found 175.0869 [M+H]
+
, C10H11N2O requires 175.0866. 
 
8.1.3. Reactivity of 2-azidobenzamide with 1-bromobutane. 
 
 
To a solution of 2-azidobenzamide (200 mg, 1.23 mmol, 1.0 eq) and sodium carbonate (392 
mg, 3.70 mmol, 3.0 eq) in extra dry DMSO (10 mL), 1-bromobutane (338 mg, 2.47 mmol, 2.0 
eq) was added. The whole was heated at 95 
o
C for 48 hours under a nitrogen atmosphere and 
after completion of the reaction, monitored by TLC, the resulting mixture was diluted with 
dichloromethane (30 mL) and washed with 0.1M NaCl and water many times to remove the 
DMSO. The mixture was dried with anhydrous magnesium sulfate, filtered under gravity and 
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the solvent was removed under vacuum. The residue was purified by using column 
chromatography to give two products: 
Synthesis of 3-butylbenzo[d][1,2,3]triazin-4(3H)-one (385). 
 (Eluent: petroleum ether/ethyl acetate: 4/1, Rf = 0.2) yielded the product as a light 
yellow oil (92 mg, 37 %). 
IR: ʋmax (cm
-1
):  775.8, 889.4, 966.6, 1032.1, 1163.5, 1293.9, 1319.9, 1379.7, 1428.8, 1463.3, 
1607.1, 1678.4, 2872.9, 2959.5.  
1
H NMR: H (400 MHz, CDCl3): 0.91 (3H, t, J=7.4 Hz, CH3), 1.37 (2H, app. sextet, J= 7.6 
Hz, CH2), 1.86 (2H, app. pentet, J= 7.5 Hz, CH2), 4.40 (2H, t, J= 7.1 Hz, CH2), 7.71 (1H, dd, 
J
1
=7.9 Hz, J
2
=7.5 Hz, HAr), 7.86 (1H, dd, J
1
=7.9 Hz, J
2
=7.5 Hz, HAr), 8.07 (1H, d, J=8.1 
Hz, HAr), 8.28 (1H, d, J=8.1 Hz, HAr) ppm. 
13
C NMR c (100 MHz, CDCl3): 13.66 (CH3), 19.89 (CH2), 30.94 (CH2), 49.67 (CH2), 
119.83 (qC), 125.05 (CH), 128.18 (CH), 132.20 (CH), 134.66 (CH), 144.33 (qC), 155.50 
(C=O) ppm. 
HRMS (ESI
+
): found 204.1127 [M+H]
+
, C11H14N3O requires 204.1131. 
Synshesis of 2-propylquinazolin-4(3H)-one (386). 
 (Eluent: petroleum ether/ethyl acetate: 1/1, Rf = 0.22) yielded the product as a light 
yellow (estimated 20 % ). 
IR: ʋmax (cm
-1
):  752.7, 867.9, 908.0, 1082.4, 1161.3, 1265.4, 1293.3, 1394.8, 1449.9, 1478.8, 
1565.3, 1615.4, 1650.0, 2962.6, 3173.6.  
1
H NMR: H (400 MHz, CDCl3): 0.98 (3H, t, J=7.5 Hz, CH3), 1.69 (2H, app. sextet, J= 7.4 
Hz, CH2), 2.68 (2H, t, J= 7.8 Hz, CH2), 7.37 (1H, dd, J
1
=8.0 Hz, J
2
=7.0 Hz, HAr), 7.61 (1H, 
d, J=8.0 Hz, HAr), 7.68 (1H, dd, J
1
=8.0 Hz, J
2
=7.0 Hz, HAr), 8.17 (1H, d, J=8.0 Hz, HAr), 
11.12 (1H, s, NH) ppm. 
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13
C NMR c (100 MHz, CDCl3): 13.77 (CH3), 18.99 (CH2), 40.47 (CH2), 121.46 (qC), 
122.46 (CH), 125.18 (CH), 127.35 (CH), 132.96 (CH), 149.47 (qC), 157.17 (qC), 164.25 
(C=O) ppm. 
HRMS (ESI
+
): found 189.1023 [M+H]
+
, C11H13N2O requires 189.1022. 
8.1.4. Reactivity of 2-azidobenzamide with 3-bromo-2-methylpropene. 
 
 
 
To a solution of  2-azidobenzamide (200 mg, 1.23 mmol, 1.0 eq) and  sodium carbonate (392 
mg, 3.70 mmol, 3.0 eq) in extra dry DMSO (10 mL),  3-bromo-2-methylpropene (333 mg, 
2.47 mmol, 2.0 eq) was added. The whole was heated at 95 
o
C for 48 hours under a nitrogen 
atmosphere and after completion of the reaction, monitored by TLC, the resulting mixture was 
diluted with dichloromethane (30 mL) and washed with 0.1M NaCl and water many times to 
remove the DMSO. The mixture was dried with anhydrous magnesium sulfate, filtered under 
gravity and the solvent was removed under vacuum. The residue was purified by using 
column chromatography (eluent: petroleum ether/ethyl acetate: 4/1, Rf = 0.21) to yield the 
product as a light orange solid (90 mg, 36 %, m.p.= 69-71 
o
C). 
IR: ʋmax (cm
-1
): 777.9, 917.5, 1009.9, 1089.1, 1153.1, 1223.7, 1275.6, 1296.6, 1332.5, 
1463.2, 1579.9, 1608.9, 1683.8, 2929.6, 2972.6, 3083.4.  
1
H NMR: H (400 MHz, CDCl3): 1.84 (3H, sb, CH3), 4.85 (1H, s, =CHH), 5.00 (H, s, 
=CHH), 5.03 (2H, s, CH2), 7.83 (1H, ddd, J
1
=8.1 Hz, J
2
=8.0 Hz, J
3
=1.1 Hz, HAr), 7.97 (1H, 
ddd, J
1
=8.1 Hz, J
2
=8.0 Hz, J
3
=1.1 Hz, HAr), 8.18 (1H, d, J=8.1 Hz, HAr), 8.38 (1H, dd, 
J
1
=8.1 Hz, J
2
=1.0 Hz, HAr) ppm. 
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13
C NMR c (100 MHz, CDCl3): 20.45 (CH3), 54.77 (CH2), 113.54 (CH2), 119.88 (qC), 
125.22 (CH), 128.33 (CH), 132.38 (CH), 134.84 (CH), 139.51 (qC), 144.29 (qC), 155.43 
(C=O) ppm. 
HRMS (ESI
+
): found 202.0975 [M+H]
+
, C11H12N3O requires 202.0975. 
 
8.1.5. Reactivity of 2-azidobenzamide with bromocyclohexane. 
 
 
To a solution of 2-azidobenzamide (200 mg, 1.23 mmol, 1.0 eq) and sodium carbonate (392 
mg, 3.70 mmol, 3.0 eq) in extra dry DMSO (10 mL), bromocyclohexane (403 mg, 2.47 mmol, 
2.0 eq) was added. The whole was heated at 95 
o
C for 48 hours under a nitrogen atmosphere 
and after completion of the reaction, monitored by TLC, the resulting mixture was diluted 
with dichloromethane (30 mL) and washed with 0.1M NaCl and water many times to remove 
the DMSO. The mixture was dried with anhydrous magnesium sulfate, filtered under gravity 
and the solvent was removed under vacuum. The residue was purified by using column 
chromatography (eluent: petroleum ether/ethyl acetate: 4/1, Rf = 0.23) to yield the product as 
a light yellow solid (85 mg, 30 %, m.p.= 137-139 
o
C). 
IR: ʋmax (cm
-1
):  773.8, 808.5, 905.0, 1064.4, 1164.4, 1160.6, 1180.8, 1220.8, 1267.2, 1292.3, 
1331.2, 1375.5, 1460.4, 1606.6, 1681.1, 2850.9, 2928.3, 3073.4.  
1
H NMR: H (400 MHz, CDCl3): 1.17-1.30 (1H, m, CHH.), 1.39-1.50 (2H, m, CH2), 1.68-
2.72 (1H, m, CHH.), 1.86-2.01 (6H, m, 3 x CH2), 4.96 (1H, p, J=7.6 Hz, CH), 7.70 (1H, dd, 
J
1
=8.0 Hz, J
2
=7.3 Hz, HAr), 7.85 (1H, ddd, J
1
=8.1 Hz, J
2
=8.0 Hz, J
3
=1.1 Hz, HAr), 8.06 (1H, 
d, J=8.0 Hz, HAr), 8.28 (1H, d, J=8.1 Hz, HAr). 
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13
C NMR c (100 MHz, CDCl3): 25.31 (CH2), 25.80 (2 x CH2), 56.64 (2 x CH2), 119.60 
(qC), 123.01 (qC), 125.27 (CH), 128.02 (CH), 132.00 (CH), 134.62 (CH), 143.88 (qC), 
155.12 (C=O) ppm. 
HRMS (ESI
+
): found 230.1285 [M+H]
+
, C13H16N3O requires 230.1288. 
 
8.1.6. Reactivity of 2-azidobenzamide with 4-bromo-1-butene.  
 
 
To a solution of 2-azidobenzamide (200 mg, 1.23 mmol, 1.0 eq) and sodium  carbonate (392 
mg, 3.70 mmol, 3.0 eq) in extra dry DMSO (10 mL), 4-bromo-1-butene (333 mg, 2.47 mmol, 
2.0 eq) was added. The whole was heated at 95 
o
C for 48 hours under a nitrogen atmosphere 
and after completion of the reaction, monitored by TLC, the resulting mixture was diluted 
with dichloromethane (30 mL) and washed with 0.1M NaCl and water many times to remove 
the DMSO. The mixture was dried with anhydrous magnesium sulfate, filtered under gravity 
and the solvent was removed under vacuum. The residue was purified by using column 
chromatography to give two products: 
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Synthesis of 3-(but-3-en-1-yl)benzo[d][1,2,3] triazin-4(3H)-one (392). 
 (Eluent: petroleum ether/ethyl acetate: 4/1, Rf = 0.21) yielded the product as a yellow oil 
(85 mg, 35 %).  
IR: ʋmax (cm
-1
):  777.1, 921.5, 995.5, 1042.6, 1105.2, 1164.7, 1279.5, 1295.5, 1346.1, 1463.4, 
1607.6, 1641.7, 1681.0, 2840.2, 2954.0, 3074.8.  
1
H NMR: H (400 MHz, CDCl3): 2.61 (2H, q, J=7.0 Hz, CH2), 4.47 (2H, t, J= 7.2 Hz, CH2), 
4.99 (2H, td, J
1
= 18.3 Hz, J
2
=2.7 Hz, =CH2), 5.71-5.84 (1H, m, =CH), 7.72 (1H, dd, J
1
=7.7 
Hz, J
2
=7.4 Hz, HAr), 7.86 (1H, ddd, J
1
=8.1 Hz, J
2
=8.0 Hz, J
3
=0.9 Hz, HAr), 8.06 (1H, d, 
J=8.1 Hz, HAr), 8.27 (1H, d, J=7.7 Hz, HAr) ppm. 
13
C NMR c (100 MHz, CDCl3): 33.15 (CH2), 49.03 (CH2), 117.78 (CH2), 119.77 (qC), 
125.07 (CH), 128.24 (CH), 132.27 (CH), 133.97 (CH), 134.73 (CH), 144.27 (qC), 155.50 
(C=O) ppm. 
HRMS (ESI
+
): found 202.0970 [M+H]
+
, C11H12N3O requires 202.0975. 
Synthesis of 2-allylquinazolin-4(3H)-one (393). 
 (Eluent: petroleum ether/ethyl acetate: 1/1, Rf = 0.29) yielded the product as a yellow 
solid (65 mg, 29 %, m.p.= 148-150 
o
C).  
IR: ʋmax (cm
-1
):  682.5, 704.9, 763.7, 813.9, 908.6, 1007.1, 1144.2, 1252.4, 1295.5, 1342.8, 
1468.3, 1562.1, 1606.9, 1658.7, 2924.4, 3062.9, 3182.1.  
1
H NMR: H (400 MHz, CDCl3): 2.08 (3H, dd, J
1
=6.8 Hz, J
2
=1.1 Hz, CH3), 6.40 (1H, dd, 
J
1
=15.9 Hz, J
2
=1.3 Hz, =CH), 7.19-7.26 (1H, m, =CH), 7.47 (1H, dd, J
1
=7.6 Hz, J
2
=7.3 Hz, 
ArH), 7.72 (1H, d, J=7.8 Hz, ArH), 7.78 (1H, dd, J
1
=7.8 Hz, J
2
=7.6 Hz, ArH), 8.30 (1H, d, 
J=7.6 Hz, ArH), 11.98 (1H, s, NH) ppm. 
13
C NMR c (100 MHz, CDCl3): 18.77 (CH3), 120.75 (qC), 125.32 (CH), 126.28 (CH), 
126.36 (CH), 127.51 (CH), 134.83 (CH), 138.47 (CH), 149.67 (qC), 150.89 (qC), 164.12 
(C=O) ppm. 
HRMS (ESI
+
): found 187.0860 [M+H]
+
, C11H11N3O requires 187.0793. 
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8.1.7. Reactivity of 2-azidobenzamide with 2-bromopropane. 
 
To a solution of 2-azidobenzamide (200 mg, 1.23 mmol, 1.0 eq) and sodium carbonate (392 
mg, 3.70 mmol, 3.0 eq) in extra dry DMSO (10 mL), 2-bromopropane (301 mg, 2.47 mmol, 
2.0 eq) was added. The whole was heated at 95 
o
C for 48 hours under a nitrogen atmosphere 
and after completion of the reaction, monitored by TLC, the resulting mixture was diluted 
with dichloromethane (30 mL) and washed with 0.1M NaCl and water many times to remove 
the DMSO. The mixture was dried with anhydrous magnesium sulfate, filtered under gravity 
and the solvent was removed under vacuum. The residue was purified by using column 
chromatography (eluent: petroleum ether/ethyl acetate: 4/1, Rf = 0.23) to yield the product as 
a light yellow solid (80 mg, 34 %, m.p.=47-49 
o
C).  
IR: ʋmax (cm
-1
):  776.9, 850.2, 900.5, 965.8, 1016.2, 1131.3, 1195.1, 1266.3, 1290.1, 1338.4, 
1386.1, 1461.6, 1494.2, 1608.3, 1676.5, 2874.9, 2976.1.  
1
H NMR: H (400 MHz, CDCl3): 1.60 (6H, d, J=6.8 Hz, 2 x CH3), 5.45 (1H, sp, J= 6.7 Hz, 
CH), 7.79 (1H, dd, J
1
=7.8 Hz, J
2
=7.5 Hz, HAr), 7.94 (1H, dd, J
1
=7.8 Hz, J
2
=7.5 Hz, HAr), 
8.15 (1H, d, J=8.1 Hz, HAr), 8.36 (1H, d, J=8.1 Hz, HAr) ppm. 
13
C NMR c (100 MHz, CDCl3): 21.61 (2 x CH3), 49.53 (CH), 119.61 (qC), 125.20 (CH), 
128.05 (CH), 132.07 (CH), 134.66 (CH), 144.00 (qC), 155.09 (C=O) ppm. 
HRMS (ESI
+
): found 190.0970 [M+H]
+
, C10H12N3O requires 190.0975. 
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8.1.8. Reactivity of 2-azidobenzamide with benzyl bromide. 
 
 
To a solution of 2-azidobenzamide (200 mg, 1.23 mmol, 1.0 eq) and sodium carbonate (392 
mg, 3.70 mmol, 3.0 eq) in extra dry DMSO (10 mL), benzyl bromide (422 mg, 2.47 mmol, 
2.0 eq) was added. The whole was heated at 95 
o
C for 48 hours under a nitrogen atmosphere 
and after completion of the reaction, monitored by TLC, the resulting mixture was diluted 
with dichloromethane (30 mL) and washed with 0.1M NaCl and water many times to remove 
the DMSO. The mixture was dried with anhydrous magnesium sulfate, filtered under gravity 
and the solvent was removed under vacuum. The residue was purified by using column 
chromatography (eluent: petroleum ether/ethyl acetate: 4/1, Rf = 0.2) to yield the product as a 
yellow solid (95 mg, 33 %, m.p.= 110-112 
o
C).  
IR: ʋmax (cm
-1
):  777.7, 910.3, 976.6, 1002.8, 1048.8, 1086.2, 1178.6, 1204.7, 1295.1, 1349.4, 
1454.0, 1492.3, 1580.8, 1605.4, 1681.8, 3032.5, 3062.5.  
1
H NMR: H (400 MHz, CDCl3): 5.65 (2H, s, CH2), 7.29-7.38 (3H, m, 3 x HAr), 7.55 (2H, 
d, J=6.9 Hz, 2 x HAr), 7.79 (1H, dd, J
1
=7.7 Hz, J
2
=7.3 Hz, HAr), 7.94 (1H, dd, J
1
=8.0 Hz, 
J
2
=7.3 Hz, HAr), 8.16 (1H, d, J=8.0 Hz, HAr), 8.35 (1H, d, J=7.7 Hz, HAr) ppm. 
13
C NMR c (100 MHz, CDCl3): 53.39 (CH2), 120.10 (qC), 125.18 (qC), 128.23 (CH), 
128.33 (CH), 128.73 (2 x CH), 128.87 (2 x CH), 132.36 (CH), 134.82 (CH), 135.76 (qC), 
144.34 (qC), 155.39 (C=O) ppm. 
HRMS (ESI
+
): found 238.0977 [M+H]
+
, C14H12N3O requires 238.0975. 
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8.1.9. Reactivity of 2-azidobenzamide with bromodiphenylmethane. 
 
 
To a solution of 2-azidobenzamide (200 mg, 1.23 mmol, 1.0 eq) and sodium carbonate (392 
mg, 3.70 mmol, 3.0 eq) in extra dry DMSO (10 mL), bromodiphenylmethane (610 mg, 2.47 
mmol, 2.0 eq) was added. The whole was heated at 95 
o
C for 48 hours under a nitrogen 
atmosphere and after completion of the reaction, monitored by TLC, the resulting mixture was 
diluted with dichloromethane (30 mL) and washed with 0.1M NaCl and water many times to 
remove the DMSO. The mixture was dried with anhydrous magnesium sulfate, filtered under 
gravity and the solvent was removed under vacuum. The residue was purified by using 
column chromatography (eluent: petroleum ether/ethyl acetate: 4/1, Rf = 0.23) to yield the 
product as a white solid (76 mg, 84 %, m.p.=49-51 
o
C, lit. m.p.=48-50 
o
C
241
). 
IR: ʋmax (cm
-1
):  637.7, 648.0, 696.1, 726.7, 905.1, 1028.1, 1176.4, 1276.5, 1446.9, 1598.5, 
1655.5, 3059.9.  
1
H NMR: H (400 MHz, CDCl3):  7.50 (4H, dd, J
1
= 7.5 Hz, J
2
=7.4, 4 x ArH), 7.61 (2H, t, 
J=7.5 Hz, 2 x ArH), 7.83 (4H, dd, J
1
=7.5 Hz, J
2
=1.3 Hz, 4 x ArH) ppm. 
13
C NMR c (100 MHz, CDCl3): 128.30 (4 x CH), 130.08 (4 x CH), 132.45 (2 x CH), 137.60 
(2 x qC), 196.79 (C=O) ppm. 
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HRMS (ESI
+
): found 183.0803 [M+H]
+
, C13H11O requires 183.0804. 
8.1.10. Reactivity of 2-azidobenzamide with triphenylmethyl bromide. 
 
 
To a solution of 2-azidobenzamide (200 mg, 1.23 mmol, 1.0 eq) and sodium carbonate (392 
mg, 3.70 mmol, 3.0 eq) in extra dry DMSO (10 mL), triphenylmethyl bromide (797 mg, 2.47 
mmol, 2.0 eq) was added. The whole was heated at 95 
o
C for 48 hours under a nitrogen 
atmosphere and after completion of the reaction, monitored by TLC, the resulting mixture was 
diluted with dichloromethane (30 mL) and washed with 0.1M NaCl and water many times to 
remove the DMSO. The mixture was dried with anhydrous magnesium sulfate, filtered under 
gravity and the solvent was removed under vacuum. The residue was purified by using 
column chromatography (eluent: petroleum ether/ethyl acetate: 4/1, Rf = 0.24) to yield the 
product as a white solid (561 mg, 88 %, m.p.=163-164 
o
C, lit. m.p.=48-50 
o
C
242
). 
IR: ʋmax (cm
-1
):  637.3, 695.5, 756.2, 889.7, 910.2, 1008.9, 1156.3, 1328.1, 1444.2, 1596.7, 
3060.0, 3462.3.  
1
H NMR: H (400 MHz, CDCl3):  2.73 (1H, s, OH), 7.15-7.24 (15 H, m, 15 x ArH) ppm. 
13
C NMR c (100 MHz, CDCl3): 82.06 (C-OH), 127.29 (3 x CH), 127.96 (12 x CH), 146.88 
(3 x qC) ppm. 
HRMS (ESI
+
): found 242.1095 [M-H2O]
+
, C19H14 requires 242.1096. 
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8.1.11. Reactivity of 2-azidobenzamide with 2-bromo-2-methylpropane. 
 
 
To a solution of 2-azidobenzamide (200 mg, 1.23 mmol, 1.0 eq) and sodium carbonate (392 
mg, 3.70 mmol, 3.0 eq) in extra dry DMSO (10 mL), 2-bromo-2-methylpropane (338 mg, 
2.47 mmol, 2.0 eq) was added. The whole was heated at 95 
o
C for 48 hours under a nitrogen 
atmosphere and after completion of the reaction, monitored by TLC, the resulting mixture was 
diluted with dichloromethane (30 mL) and washed with 0.1M NaCl and water many times to 
remove the DMSO. The mixture was dried with anhydrous magnesium sulfate, filtered under 
gravity and the solvent was removed under vacuum. The residue was purified by using 
column chromatography (eluent: petroleum ether/ethyl acetate: 4/1, Rf = 0.21) to yield the 
product as a light yellow oil (50 mg, 20 %).  
IR: ʋmax (cm
-1
):  776.5, 893.8, 917.9, 970.4, 1086.3, 1180.6, 1293.9, 1463.0, 1493.9, 1580.7, 
1608.3, 1686.5, 2920.8, 3082.0.  
1
H NMR: H (400 MHz, CDCl3): 2.26 (3H, s, CH3), 4.92 (1H, s, C=CHH), 4.94 (1H, s, 
C=CHH), 5.41 (2H, s, NCH2), 7.74 (1H, dd, J
1
=7.0 Hz, J
2
=6.7 Hz, ArH), 7.86-7.91 (1H, m, 
ArH), 8.10 (1H, d, J=8.0 Hz, ArH), 8.30 (1H, dd, J
1
=8.0 Hz, J
2
=2.4 Hz,  ArH) ppm. 
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13
C NMR c (100 MHz, CDCl3): 20.45 (CH3), 52.92 (CH2), 113.54 (=CH2), 119.88 (qC), 
125.22 (CH), 128.38 (CH), 132.39 (CH), 134.85 (CH), 139.51 (qC), 144.23 (qC), 155.11 
(C=O) ppm. 
HRMS (ESI
+
): found 202.0982 [M+H]
+
, C11H12N3O requires 202.0975. 
8.1.12. Reactivity of 2-azidobenzamide with 1-bromobutane. 
 
 
2-Azidobenzamide (98 mg, 0.60 mmol, 1.0 eq), commercial KOH (50 mg, 0.90 mmol, 1.5 eq) 
and TBAB (58 mg, 0.18 mmol, 0.3 eq) were mixed and stirred for 15 minutes at room 
temperature and then 1-bromobutane (102 mg, 81 µL, 0.75 mmol, 1.25 eq) was added. The 
mixture was heated at 80 
o
C in an oil bath for 15 minutes. The crude mixture was diluted with 
water (10 mL), and then was extracted with dichloromethane (3 x 10 mL). The organic layer 
was dried with anhydrous magnesium sulfate, filtered and the solvent removed in vacuo. 
Purification by silica chromatography (eluent: petroleum ether/ethylacetate: 2/1, Rf = 0.25) 
yielded the product as a yellow oil (115 mg, 70 %). 
IR: ʋmax (cm
-1
): 751.8, 940.2, 1081.2, 1117.5, 1200.7, 1288.8, 1424.6, 1443.7, 1577.3, 
1598.2, 1632.8, 2091.1, 2872.6, 2931.6, 2957.3. 
1
H NMR: H (400 MHz, CDCl3): 0.68 (3H, t, J=7.3 Hz, CH3), 0.90 (3H, t, J=7.3 Hz, CH3), 
1.04 (2H, app. sextet, J=7.3 Hz, CH2), 1.29-1.38 (4H, m, 2 x CH2), 1.57 (2H, app. pentet, 
J=7.6 Hz, CH2), 2.96-2.98 (2H, m, CH2), 3.29 (1H, br.s, CHH), 3.54 (1H, br.s, CHH), 7.06-
7.10 (2H, m, 2 x ArH), 7.14 (1H, dd, J
1
=7.5 Hz, J
2
=1.4 Hz, ArH), 7.31 (1H, ddd, J
1
=8.2 Hz, 
J
2
=8.0 Hz, J
3
=1.4 Hz, ArH) ppm. 
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13
C NMR c (100 MHz, CDCl3): 13.56 (CH3), 13.93 (CH3), 19.70 (CH2), 20.25 (CH2), 29.51 
(CH2), 30.55 (CH2), 44.22 (CH2), 48.18 (CH2), 118.41 (CH), 124.93 (CH), 127.87 (CH), 
129.44 (qC), 129.95 (CH), 136.17 (qC), 168.19 (C=O) ppm. 
HRMS (ESI
+
): found 275.1860 [M+H]
+
, C15H23N4O requires 275.1866. 
8.1.13. Reactivity of 2-azido-N,N-dibutylbenzamide. 
 
 
To a solution of 2-azido-N,N-dibutylbenzamide (98 mg, 0.358 mmol, 1.0 eq) and sodium 
carbonate (114 mg, 1.07 mmol, 3.0 eq) in extra dry DMSO (8 mL), 2-bromopropane (88 mg, 
67 µL, 0.716 mmol, 2.0 eq) was added. The whole was heated at 95 
o
C for 48 hours under a 
nitrogen atmosphere and after completion of the reaction, monitored by TLC which showed 
no product. The reaction mixture was heated at 120 
o
C for 48 hours and after completion of 
the reaction, monitored by TLC, the resulting mixture was diluted with dichloromethane (30 
mL) and washed with 0.1M NaCl and water many times to remove the DMSO. The mixture 
was dried with anhydrous magnesium sulfate, filtered under gravity and the solvent was 
removed under vacuum. The residue was purified by using column chromatography (eluent: 
petroleum ether/ethyl acetate: 2/1, Rf = 0.21) to yield the product as a yellow oil (55 mg, 63 
%). 
IR: ʋmax (cm
-1
): 750.2, 908.5, 1027.9, 1153.0, 1169.0, 1321.9, 1463.6, 1509.3, 1579.7, 
1610.1, 2871.6, 2929.9, 1956.7, 3284.2.  
1
H NMR: H (400 MHz, CDCl3): 0.84 (6H, app. pentet, J=7.2 Hz, 2 x CH3), 1.15-1.24 (1H, 
m, CHH), 1.29-1.36 (3H, m, CH2 + CHH), 1.50-1.59 (3H, m, CH2 + CHH), 1.74-1.84 (1H, m, 
CHH), 2.72-2.79 (1H, m, CH), 4.00-4.07 (1H, m, NH), 4.48-4.50 (2H, m, CH2), 6.55 (1H, d, 
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J=8.0 Hz, ArH), 6.75 (1H, ddd, J
1
=7.8 Hz, J
2
=7.6 Hz, J
3
=1.2 Hz, ArH), 7.16-7.20 (1H, m, 
ArH), 7.81 (1H, dd, J
1
=7.8 Hz, J
2
=1.2 Hz, ArH) ppm. 
13
C NMR c (100 MHz, CDCl3): 13.68 (CH3), 13.89 (CH3), 18.64 (CH2), 20.15 (CH2), 30.48 
(CH2), 35.48 (CH2), 44.88 (CH2), 69.25 (CH), 114.81 (CH), 117.14 (qC), 118.41 (CH), 
128.41 (CH), 133.06 (CH), 145.06 (qC), 162.34 (C=O) ppm. 
HRMS (ESI
+
): found 247.1802 [M+H]
+
, C13H16N3O requires 247.1805. 
 
 
 
8.2. Reactivity of o-Azidobenzaldoxime and 2-azidobenzaldehyde. 
8.2.1. Synthesis of 3,4-bis(2-azidophenyl)-1,2,5-oxadiazole 2-oxide. 
 
 
To a solution of N-chlorosuccinimide (403 mg, 3.03 mmol, 1.01 eq) in anhydrous DCM (15 
mL) and pyridine (0.1 mL) was added o-azidobenzaldoxime (486 mg, 3 mmol, 1.0 eq). The 
reaction mixture was stirred at room temperature for 48 hours. The solvent was removed in 
vacuo and the crude product was purified by flash column chromatography (petroleum 
ether/ethylacetate: 5/1, Rf=0.24) to yield the product (750 mg, 78 % yield) as a deep brown 
oil. 
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IR: ʋmax (cm
-1
): 748.2, 830.9, 961.7, 1080.7, 1130.6, 1291.6, 1417.7, 1499.1, 1575.5, 1592.8, 
2091.3, 2980.3, 3063.8. 
1
H NMR: H (400 MHz, CDCl3): 7.06 (1H, d, J=8.1 Hz, ArH), 7.09-7.14 (2H, m, 2 x ArH), 
7.18 (1H, d, J=7.7 Hz, ArH), 7.27 (1H, dd, J
1
=7.7 Hz, J
2
=1.1 Hz, ArH), 7.38-7.50 (3H, m, 3 
x ArH) ppm. 
13
C NMR c (100 MHz, CDCl3): 113.61 (qC), 115.23 (qC), 118.79 (qC), 118.83 (qC), 
118.90 (CH), 118.96 (CH), 125.21 (CH), 125.27 (CH), 130.88 (CH), 130.99 (CH), 132.12 
(CH), 132.30 (CH), 138.54 (qC), 139.28 (qC) ppm. 
HRMS (ESI
+
): found 265.0717 [M-2N2+H]
+
, C14H9N4O requires 265.0720. 
 
8.2.2. Synthesis of 1-azido-2-ethynylbenzene. 
 
 
The aldehyde (638 mg, 4.34 mmol, 1.0 eq) was dissolved in dry methanol (5 mL); potassium 
carbonate (1.197 mg, 8.68 mmol, 2.0 eq) and the Bestmann-Ohira reagent (1.17 mL, 1.0 mg, 
5.21 mmol, 1.2 eq) were added and the whole was stirred for 24 hours under nitrogen. The 
reaction was quenched with saturated aqueous ammonium chloride (25 mL), the organic 
phase was separated and the aqueous phase was extracted with dichloromethane (3 x 30 mL). 
The combined organic phases were dried (MgSO4), filtered and concentrated in vacuo to yield 
an orange solid. Purification by silica chromatography (petroleum ether/ethyl acetate: 1/50, Rf 
= 0.2) yielded the product as a brown oil (559 mg, 90 %). 
IR: ʋmax (cm
-1
): 751.1, 823.2, 943.0, 1089.3, 1163.2, 1273.4, 1295.0, 1439.7, 1483.9, 1571.7, 
1594.8, 2102.8, 2925.3, 3290.5.  
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1
H NMR: H (400 MHz, CDCl3): 3.30 (1H, s, CH), 6.99-7.06 (2H, m, 2 x ArH), 7.29 (1H, 
dd, J
1
=7.5 Hz, J
2
=7.4 Hz, ArH), 7.39 (1H, d, J=7.5 Hz, ArH) ppm. 
13
C NMR c (100 MHz, CDCl3): 79.33 (CH), 82.88 (qC), 114.05 (CH), 118.50 (qC), 124.62 
(CH), 130.13 (CH), 134.28 (CH), 141.71 (qC) ppm. 
HRMS (ESI
+
): found 286.0958 [2M]
+
, C16H10N6 requires 286.0967. 
The data is identical to that reported in the literature.
223 
8.2.3. Synthesis of 2-azidobenzonitrile. 
 
 
To a stirred mixture of diphenylcyclopropenone (62 mg, 0.3 mmol, 5 mol%)  and aldoxime 
(972 mg, 6.0 mmol, 1.0 eq) in DCM (10 mL) was added a solution of (COCl)2 (756 mg, 6.0 
mmol, 1.0 eq) in DCM (1.0 mL) by using a syringe pump over 1h and then was added by 
slow addition DBU (2.736 mg, 18.0 mmol, 3.0 eq) in DCM (3 mL). The mixture was heated 
at reflux whilst being monitored by TLC. The reaction mixture was diluted with DCM and 
washed by water (3 x 40 mL). The organic phase was dried with anhydrous MgSO4, filtered, 
concentrated under reduced pressure and purified by silica column chromatography 
[petroleum ether/ethyl acetate: 10/1, Rf = 0.24] to yield the product as a yellow solid (750 mg, 
87 %, m.p. = 54 - 55 
o
C, lit. m.p. = 52 - 53 
o
C)
213
. 
IR: ʋmax (cm
-1
): 755.4, 823.6, 950.4, 1035.7, 1147.5, 1166.9, 1250.5, 1277.1, 1293.4, 1306.2, 
1445.8, 1485.7, 1575.9, 1594.2, 2109.8, 2227.9, 3068.2.  
1
H NMR: H (400 MHz, CDCl3): 7.24 (1H, dd, J
1
=7.8 Hz, J
2
=7.6 Hz, ArH), 7.29 (1H, d, J= 
8.8 Hz, ArH), 7.62-7.66 (2H, m, 2 x ArH) ppm. 
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13
C NMR c (100 MHz, CDCl3): 104.22 (CN), 115.59 (qC), 118.80 (CH), 125.00 (CH), 
133.95 (CH), 134.03 (CH), 143.44 (qC) ppm. 
HRMS (ESI
+
): found 233.0790 [2M-2N2+H]
+
, C14H9N4 requires 233.0822. 
 
8.2.4. Synthesis of benzo[e]benzo[5,6][1,2,3]triazino[2,1-a][1,2,3]triazine. 
 
A solution of sodium ascorbate (17.2 mg, 0.069 mmol, 0.1 eq) and CuSO4.5H2O (2.73 mg, 
0.0123 mmol, 0.02 eq) in water (2 mL) was added to a solution of 2-azidobenzonitrile (100 
mg, 0.69 mmol, 1.0 eq) in t-BuOH (2 mL). The whole was stirred at ambient temperature 
under a nitrogen atmosphere for 48 hours. The reaction mixture was diluted with water (10 
mL), the organic layer was separated and the aqueous layer was extracted with EtOAc (3 x 10 
mL). The combined organic layers were washed with water (10 mL) and brine (10 mL). The 
organic phase was dried with anhydrous MgSO4, filtered and the solvent removed in vacuo. 
The crude product was purified by silica column chromatography [petroleum ether/ethyl 
acetate: 2/1]. The product was tentatively  assigned as light yellow oil (17 mg, 10 %) . 
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IR: ʋmax (cm
-1
): 766.5, 980.5, 1093.3, 1190.2, 1338.4, 1448.7, 1494.4, 1575.3, 1616.7, 
1650.9, 2855.6, 2923.6, 3024.4, 3057.9.  
1
H NMR: H (400 MHz, CDCl3): 6.29 (1H, m, ArH), 6.62 (1H, d, J= 8.5.0 Hz, ArH), 6.69 
(1H, d, J=7.5 Hz,  ArH), 7.02 (1H, m, ArH), 7.22-7.41 (3H, m, 3 x ArH), 7.53-7.55 (2H, m, 2 
x ArH), 7.67 (1H, d, J=7.5 Hz, ArH) ppm. 
13
C NMR c (100 MHz, CDCl3): 125.43 (CH), 126.71 (CH), 128.30 (CH), 128.36 (CH), 
128.86 (qC), 128.88 (qC), 128.98 (CH), 129.09 (CH), 130.42 (CH), 130.52 (CH), 134.81 
(qC), 135.46 (qC), 143.39 (CH), 143.56 (CH) ppm. 
HRMS (ESI
+
): found 234.1045 [M]
+
, C14H10N4 requires 234.0905. 
8.2.5. Synthesis of 2-azido-N'-hydroxybenzimidamide.  
 
 
Sodium carbonate (599 mg, 5.65 mmol, 1.1 eq) in small portions was added to hydroxylamine 
hydrochloride (393 mg, 5.65 mmol, 1.1 eq) in water (30 mL). To the solution 2-
azidobenzonitrile (740 mg, 5.14 mmol, 1.0 eq) in ethanol (30 mL) was added. The whole was 
heated at reflux temperature for 24 hours. The reaction mixture was extracted with CH2Cl2 (3 
x 40 mL). The combined organic layer was dried over MgSO4, filtered and concentrated 
under reduced pressure. Purification by silica chromatography (eluent: petroleum 
ether/ethylacetate: 1/1, Rf = 0.18) yielded the product as an orange solid (610 mg, 67 %, 
m.p.=110-112 
o
C). 
IR: ʋmax (cm
-1
): 757.6, 834.3, 934.1, 1028.3, 1082.0, 1164.7, 1290.7, 1379.1, 1446.4, 1497.7, 
1575.5, 1637.3, 2121.5, 2807.9, 3062.9, 3151.7, 3371.0, 3483.3.  
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1
H NMR: H (400 MHz, CDCl3): 4.97 (1H, s, NHH), 5.22 (1H, s, NHH), 7.19 (1H, dd, J
1
= 
7.8 Hz, J
2
=7.6 Hz, ArH), 7.36-7.46 (2H, m, 2 x ArH), 7.63 (1H, ddd, J
1
=7.2 Hz, J
2
=7.0 Hz, 
J
3
=1.4 Hz, ArH), 9.40 (1H, br.s, OH) ppm. 
13
C NMR c (100 MHz, CDCl3): 118.81 (CH), 123.96 (qC), 125.65 (CH), 128.65 (CH), 
130.44 (CH), 137.62 (qC), 151.23 (C=N) ppm. 
HRMS (ESI
+
): found 178.0719 [M+H]
+
, C7H8N5O requires 178.0723. 
 
8.2.6. Synthesis of ethyl 3-(2-azidophenyl)-1,2,4-oxadiazole-5-carboxylate. 
 
 
To a solution of ethyl 2-chloro-2-oxoacetate (202 mg, 1.49 mmol, 1.2 eq) in THF (10 mL), 
(Z)-2-azido-N'-hydroxybenzimidamide (220 mg, 1.24 mmol, 1.0 eq) was added. The mixture 
was heated at reflux temperature for 24 hours, whilst being monitored by TLC. The solvent 
was distilled off under vacuum and the residue was purified by silica chromatography to give 
two products: 
Ethyl 3-(2-azidophenyl)-1,2,4-oxadiazole-5-carboxylate (427). 
[(eluent: petroleum ether/ethyl acetate: 3/1, Rf = 0.25) yielded the product as a yellow oil 
(300 mg, 93 %)]. 
IR: ʋmax (cm
-1
): 748.2, 816.3, 909.3, 1018.9, 1165.0, 1186.7, 1262.3, 1372.7, 1429.4, 1478.7, 
1588.1, 1748.0, 2097.1, 2987.0, 3065.3.  
1
H NMR: H (400 MHz, CDCl3): 1.50 (3H, t, J=7.1 Hz, CH3), 4.58 (2H, q, J=7.1 Hz, CH2), 
7.29 (1H, ddd, J
1
=7.8 Hz, J
2
=7.6 Hz, J
3
=1.2 Hz, ArH), 7.35 (1H, d, J= 8.1 Hz, ArH), 7.59 
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(1H, ddd, J
1
= 8.1 Hz, J
2
=7.9 Hz, J
3
=1.5 Hz, ArH), 8.04 (1H, dd, J
1
= 7.8 Hz, J
2
=1.2 Hz,  ArH) 
ppm. 
13
C NMR c (100 MHz, CDCl3): 14.05 (CH3), 64.03 (CH2), 117.23 (qC), 119.96 (CH), 
124.96 (CH), 131.80 (CH), 132.71 (CH), 139.19 (qC), 154.11 (C=N), 166.06 (C=N), 167.52 
(C=O) ppm. 
HRMS (ESI
+
): found 282.0600 [M+Na]
+
, C11H9N5O3Na requires 282.0598. 
Ethyl 3-(2-(2-ethoxy-2-oxoacetamido)phenyl)-1,2,4-oxadiazole-5-carboxylate 
(428). 
 (Eluent: petroleum ether/ethyl acetate: 3/1, Rf = 0.16) yielded the product as a yellow oil 
(20 mg, 5 %). 
IR: ʋmax (cm
-1
): 753.6, 846.8, 938.1, 1018.9, 1177.0, 1204.1, 1278.9, 1369.5, 1433.6, 1504.0, 
1546.8, 1583.0, 1597.0, 1610.7, 1711.5, 1753.7, 2993.0, 3253.1.  
1
H NMR: H (400 MHz, CDCl3): 1.38 (3H, t, J=7.1 Hz, CH3), 1.43 (3H, t, J=7.1 Hz, CH3), 
4.39 (2H, q, J=7.1 Hz, CH2), 4.52 (2H, q, J=7.1 Hz, CH2), 7.24 (1H, dd, J
1
=8.0 Hz, J
2
=7.5 
Hz, ArH), 7.53 (1H, dd, J
1
= 8.2 Hz, J
2
=7.5 Hz, ArH), 8.23 (1H, dd, J
1
= 8.0 Hz, J
2
=0.9 Hz, 
ArH), 8.68 (1H, d, J= 8.2 Hz, ArH), 11.51 (1H, s, NH) ppm. 
13
C NMR c (100 MHz, CDCl3): 14.00 (CH3), 14.04 (CH3), 63.73 (CH2), 64.27 (CH2), 
114.00 (qC), 121.18 (CH), 125.02 (CH), 130.09 (CH), 133.18 (CH), 136.34 (qC), 153.74 
(C=O), 154.80 (C=N), 160.38 (C=O), 165.91 (qC), 168.33 (C=O) ppm. 
HRMS (ESI
+
): found 356.0844 [M+Na]
+
, C15H15N3O6Na requires 356.0853. 
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8.2.7. Reactivity of ethyl 3-(2-azidophenyl)-1,2,4-oxadiazole-5-carboxylate. 
 
 
 
To a solution of ethyl 3-(2-azidophenyl)-1,2,4-oxadiazole-5-carboxylate (180 mg, 0.695 
mmol, 1.0 eq)  in anhydrous toluene (10 mL) was added triphenylphosphine (218 mg, 0.834 
mmol, 1.2 eq). The whole was stirred for 6 hours at ambient temperature under a nitrogen 
atmosphere and after completion of the reaction, monitored by TLC, the mixture was heated 
at reflux temperature for 24 hours under a nitrogen atmosphere. The solvent was removed 
under vacuum and the residue was purified by using silica column chromatography 
[petroleum ether/ethyl acetate: 1/1, Rf = 0.2] to yield the product as a light yellow solid (100 
mg, 61 %, m.p=214-216 
o
C). 
IR: ʋmax (cm
-1
): 797.1, 832.5, 944.5, 1024.7, 1116.8, 1156.3, 1203.3, 1253.9, 1294.3, 1368.7, 
1470.8, 1503.0, 1581.5, 1619.4, 1651.3, 1701.8, 1732.1, 2978.9, 3001.1, 3044.7, 3158.5, 
3376.7. 
1
H NMR: H (400 MHz, DMSO): 1.34 (3H, t, J=7.0 Hz, OCH2CH3), 4.33 (2H, q, J=7.0 Hz, 
OCH2CH3), 7.10 (1H, m, ArH), 7.37 (1H, dd, J
1
=8.0 Hz, J
2
= 7.5 Hz, ArH), 7.50 (1H, d, 
J=8.0 Hz, ArH), 7.69 (1H, d, J= 7.0 Hz, ArH), 11.19 (1H, s, NH), 12.94 (1H, s, NH) ppm. 
13
C NMR c (100 MHz, DMSO): 14.30 (CH3), 62.82 (CH2), 110.81 (CH), 116.91 (qC), 
120.48 (CH), 121.72 (CH), 127.01 (CH), 138.64 (qC), 141.40 (qC), 156.89 (C=O), 160.97 
(C=O) ppm. 
HRMS (ESI
+
): found 233.0799 [M]
+
, C11H11N3O3 requires 233.0800. 
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8.2.8. Synthesis of dimethyl 1-{2-[5-(ethoxycarbonyl)-1,2,4-oxadiazol-
3-yl]phenyl}-1H-1,2,3-triazole-4,5-dicarboxylate.  
 
 
To a solution of ethyl 3-(2-azidophenyl)-1,2,4-oxadiazole-5-carboxylate (150 mg, 0.58 mmol, 
1.0 eq) in dry toluene (10 mL) was added dimethylacetylene dicarboxylate (791 mg, 0.637 
mmol, 1.1 eq). The mixture was heated at reflux under nitrogen for 24 hours whilst being 
monitored by TLC. The solvent was distilled of under vacuum and the mixture was purified 
by using silica chromatography [petroleum ether/ethyl acetate: 1/1, Rf = 0.22] to give the 
product as a brown solid (175 mg, 75 %, m.p.=117-119 
o
C). 
IR: ʋmax (cm
-1
): 776.2, 826.0, 913.4, 1018.8, 1100.7, 1191.9, 1288.9, 1360.2, 1448.0, 1491.5, 
1524.9, 1565.8, 1590.7, 1608.7, 1731.8, 2955.4, 2985.7. 
1
H NMR: H (400 MHz, CDCl3): 1.43 (3H, t, J=7.1 Hz, OCH2CH3), 3.76 (3H, s, OCH3), 
4.02 (3H, s, OCH3), 4.50 (2H, q, J=7.1 Hz, OCH2CH3), 7.57 (1H, dd, J
1
=7.7 Hz, J
2
= 1.9 Hz, 
ArH), 7.73-7.80 (2H, m, 2 x ArH), 8.36 (1H, dd, J
1
= 7.1 Hz, J
2
=1.6 Hz,  ArH) ppm. 
13
C NMR c (100 MHz, CDCl3): 13.90 (CH3), 52.78 (CH3), 53.39 (CH3), 64.01 (CH2), 
123.73 (qC), 128.80 (CH), 130.72 (CH), 131.61 (CH), 132.29 (CH), 132.93 (qC), 134.00 
(qC), 139.31 (qC), 153.62 (qC), 158.16 (qC), 160.30 (qC), 166.37 (qC), 166.43 (qC) ppm. 
HRMS (ESI
+
): found 402.0975 [M+H]
+
, C17H16N5O7 requires 402.1044. 
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8.2.9. Attempted Synthesis of 3,5-bis(2-azidophenyl)-1,2,4-oxadiazole. 
 
 
To a solution of the acid chloride (150 mg, 0.84 mmol, 1.0 eq) in THF (10 mL), was added 
(Z)-2-azido-N'-hydroxybenzimidamide (168 mg, 0.93 mmol, 1.1 eq) followed by additon of 
pyridine (150 µL, 1.86 mmol, 1.1 eq). The mixture was heated at reflux for 24 hours, whilst 
being monitored by TLC. The solvent was distilled off under vacuum and the residue was 
purified by using silica chromatography [petroleum ether/ethyl acetate: 1/2, Rf = 0.20] to give 
the product (433) as a brown oil (120 mg, 44 %). 
IR: ʋmax (cm
-1
): 748.2, 909.6, 1043.1, 1116.5, 1241.8, 1446.2, 1482.9, 1576.9, 1596.4, 
1620.4, 1721.8, 2118.3, 2979.2, 3072.1, 3341.7, 3465.7. 
1
H NMR: H (400 MHz, CDCl3): 5.90 (2H, bs, NH2), 7.15-7.22 (2H, m, 2 x ArH), 7.25 (2H, 
dd, J
1
=8.0 Hz, J
2
=6.7 Hz, 2 x ArH), 7.47 (1H, dd, J
1
=7.7 Hz, J
2
=7.5 Hz, ArH), 7.57 (1H, dd, 
J
1
=7.7 Hz, J
2
= 7.5 Hz, ArH), 7.77 (1H, d, J=7.5 Hz, ArH), 8.00 (1H, d, J= 7.5 Hz,  ArH) 
ppm. 
13
C NMR c (100 MHz, CDCl3): 118.71 (CH), 119.25 (CH), 121.85 (qC), 122.11 (qC), 
124.91 (CH), 125.04 (CH), 131.21 (CH), 131.89 (CH), 132.77 (CH), 133.45 (CH), 138.10 
(qC), 139.27 (qC), 156.49 (C=N), 163.26 (C=O) ppm. 
HRMS (ESI
+
): found 323.0990 [M+H]
+
, C14H11N8O2 requires 323.0999. 
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8.2.10. Synthesis of 3,5-bis(2-azidophenyl)-1,2,4-oxadiazole. 
 
 
To a solution of ((benzoyloxy)amino)(phenyl)methanamine (80 mg, 0.248 mmol, 1.0 eq) in 
THF (10 mL), tetrabutylammonium fluoride (1 M in THF, 248 µL, 0.248 mmol, 1.0 eq) was 
added dropwise. The mixture was stirred at room temperature for 72 h whilst being monitored 
by TLC. The reaction mixture was diluted with water, the organic layer was separated and the 
aqueous layer was extracted with ethylacetate (3 x 10 mL). The combined organic layers were 
washed with water and brine. The organic layer was dried with anhydrous (MgSO4), filtered 
and the solvent removed in vacuo. Purification by silica chromatography (eluent: petroleum 
ether/ethylacetate: 3/2, Rf = 0.2) yielded the product as a light yellow oil (68 mg, 90 %). 
IR: ʋmax (cm
-1
): 710.0, 886.9, 1141.6, 1290.0, 1352.0, 1467.5, 1487.1, 1578.2, 1591.7,  
2082.9, 3091.2. 
1
H NMR: H (400 MHz, CDCl3): 7.19-7.24 (2H, m, 2 x ArH), 7.27 (2H, m, 2 x ArH), 7.48 
(1H, ddd, J
1
=8.4 Hz, J
2
=8.3 Hz, J
3
=1.3 Hz, ArH), 7.55 (1H, ddd, J
1
=8.4 Hz, J
2
= 8.3 Hz, 
J
3
=1.2 Hz, ArH), 7.99 (1H, dd, J
1
=7.8 Hz, J
2
=1.2 Hz, ArH), 8.06 (1H, dd, J
1
= 7.8 Hz, J
2
=1.2 
Hz,  ArH) ppm. 
13
C NMR c (100 MHz, CDCl3): 115.78 (qC), 118.54 (qC), 119.36 (CH), 119.82 (CH), 
124.95 (CH), 125.03 (CH), 131.75 (CH), 131.78 (CH), 132.12 (CH), 133.69 (CH), 138.98 
(qC), 139.72 (qC), 166.83 (C=N), 173.38 (C=N) ppm. 
HRMS (ESI
+
): found 305.0894 [M+H]
+
, C14H9N8O requires 305.0894. 
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8.2.11. Synthesis of tetramethyl 1,1'-[(1,2,4-oxadiazole-3,5-diyl)bis(2,1-
phenylene)]bis(1H-1,2,3-triazole-4,5-dicarboxylate). 
 
 
To a solution of 3,5-bis(2-azidophenyl)-1,2,4-oxadiazole (65 mg, 0.21 mmol, 1.0 eq) in dry 
toluene (10 mL) was added dimethylacetylene dicarboxylate ( 66 mg, 0.47 mmol, 2.2 eq). The 
mixture was heated at reflux under nitrogen for 24 hours and whilst being monitored by TLC. 
The solvent was distilled under vacuum and the mixture was purified by using silica 
chromatography [petroleum ether/ethyl acetate: 5/3, Rf = 0.22] to give the product as a yellow 
oil (125 mg, 95 %). 
IR: ʋmax (cm
-1
): 724.0, 825.7, 907.9, 1004.0, 1079.7, 1204.3, 1290.4, 1349.0, 1491.5, 1562.1, 
1592.8, 1608.7, 1731.5,  2955.1. 
1
H NMR: H (400 MHz, CDCl3): 3.64 (6H, bs, 2 x CH3), 3.94 (3H, s, CH3), 3.98 (3H, s, 
CH3), 7.42 (1H, d, J
1
=7.8 Hz, ArH), 7.53 (1H, d, J=7.2 Hz, ArH), 7.62 (1H, d, J
1
=7.8 Hz, 
ArH), 7.68-7.75 (2H, m, 2 x ArH), 7.87 (1H, d, J=7.8 Hz, ArH), 8.12 (1H, d, J
1
= 7.2 Hz, 
ArH) ppm. 
13
C NMR c (100 MHz, CDCl3): 52.79 (CH3), 52.95 (CH3), 53.38 (CH3), 53.45 (CH3), 
121.14 (qC), 123.99 (qC), 128.60 (CH), 129.07 (CH), 130.40 (CH), 130.64 (CH), 131.56 
(CH), 131.78 (CH), 131.85 (CH), 132.74 (qC), 133.04 (qC), 133.58 (CH), 133.71 (qC), 
134.11 (qC), 139.22 (qC), 139.57 (qC), 157.88 (C=O), 158.06 (C=O), 160.38 (C=O), 160.44 
(C=O), 165.65 (C=N), 171.56 (C=N) ppm. 
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HRMS (ESI
+
): found 589.1422 [M+H]
+
, C26H21N8O9 requires 589.1426. 
 
8.2.12. Synthesis of 3,3'-bis(2-azidophenyl)-5,5'-bi(1,2,4-oxadiazole). 
 
 
To a solution of oxalyl chloride (86 mg, 0.678 mmol, 1.2 eq) in DCM (10 mL), was added 
(Z)-2-azido-N'-hydroxybenzimidamide (100 mg, 0.565 mmol, 1.0 eq) followed by the 
addition of pyridine (100 µL). The mixture was stirred at room temperature for 24 hours, 
whilst being monitored by TLC. The solvent was distilled off under vacuum and the residue 
was purified by silica chromatography [eluent: petroleum ether/ethyl acetate: 5/1, Rf = 0.2] 
yielded the desired product (426) as a partially pure sample (light yellow oil, 168 mg, 80 %). 
 
IR: ʋmax (cm
-1
): 752.7, 1107.6, 1166.9, 1293.8, 1446.3, 1471.0, 1510.0, 1576.9, 1594.8,  
2111.7. 
1
H NMR: H (400 MHz, CDCl3): 7.14 (2H, dd, J
1
=7.9 Hz, J
2
= 7.7 Hz, 2 x ArH), 7.17-7.20 
(2H, m, 2 x ArH), 7.53 (2H, ddd, J
1
=7.7 Hz, J
2
= 7.5 Hz, J
3
=1.5 Hz, 2 x ArH), 7.93 (2H, dd, 
J
1
=7.7 Hz, J
2
=1.5 Hz, 2 x ArH) ppm. 
13
C NMR c (100 MHz, CDCl3): 118.81 (2 x CH), 125.02 (2 x CH), 133.91 (2 x CH), 134.08 
(2 x CH), 138.93 (2 x qC), 143.37 (2 x qC), 164.28 (2 x qC (C-C)), 165.76 (2 x qC (C=N)) 
ppm. 
HRMS (ESI
+
): found 395.0727 [M+Na]
+
, C16H8N10O2Na requires 395.0724. 
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8. Experimental: 3. Reactivity of 2-azidobenzenesulfonic acid and 2-
azidobenzoic acid. 
8.3.1. Synthesis of o-azido benzene sulfonyl chloride 
 
 
2-Azidobenzene sulfonic acid (2.0 g, 10.054 mmol, 2.2 eq) was heated to reflux in a 2M 
solution of (COCl)2 in dichloromethane (11.85 mL, 22.85 mmol, 5 eq) with a drop  of DMF  
under an inert atmosphere of nitrogen for 5 hours. The reaction was cooled to room 
temperature before the crude acid chloride was concentrated and the residue was washed with 
dichloromethane (2 x 20 mL) to give the crude sulfonyl chloride in as an orange solid (1.91 g, 
87 %).
186,231
 
IR: ʋmax (cm
-1
): 728.4, 763.4, 1057.3, 1124.3, 1148.2, 1170.3, 1270.0, 1287.3, 1367.3, 
1470.6, 1581.0, 2101.9, 2940.7, 3098.3. 
1
H NMR: H (400 MHz, DMSO): 7.13 (1H, dd, J
1
=7.6 Hz, J
2
=7.4 Hz, ArH), 7.21 (1H, 
d, J= 7.7 Hz, ArH), 7.39 (1H, ddd, J
1
=7.6 Hz, J
2
=7.5 Hz, J
3
=1.4 Hz, ArH), 7.76 (1H, dd, 
J
1
=7.7 Hz, J
2
=1.4 Hz, ArH) ppm. 
13
C NMR c (100 MHz, DMSO): 120.95 (CH), 124.68 (CH), 129.01 (CH), 130.84 
(CH), 136.47 (qC), 138.93 (qC) ppm. 
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8.3.2. Synthesis of 2-azidobenzyl 2-azidobenzenesulfonate. 
 
 
To 2-azidobenzene sulfonic acid (1.194 g, 6.0 mmol, 2.0 eq) was added a 2M solution of 
oxalyl chloride in dichloromethane (7.5 mL, 15.0 mmol, 5.0 eq) followed by the addition of 
DMF (100 μL). The whole was heated to reflux for 15 hours under nitrogen. The excess 
oxalyl chloride was removed in vacuo and the residue was washed with dichloromethane (3 x 
10 mL) to give the crude sulfonyl chloride as an orange solid. 
Pyridine (241 μL, 237 mg, 3.0 mmol, 1.0 eq ) was added dropwise to a stirring solution of 2-
azidobenzyl alcohol (447 mg, 3.0 mmol, 1.0 eq) in DCM (10 mL). The sulfonyl chloride was 
dissolved in dichloromethane (5 mL) and was added dropwise to this solution followed by 
addition a drop of DMF. The mixture was heated to reflux under a nitrogen atmosphere for 48 
hours whilst being monitored by TLC. The solvent was removed under vacuum and the 
mixture was purified by using column chromatography (eluent: methanol/ethyl acetate: 1/2, 
Rf = 0.4) yielded the product as a deep brown solid (750 mg, 76 %, m.p.=168-170 
o
C). 
IR: ʋmax (cm
-1
):  762.3, 876.3, 978.8, 1025.1, 1088.6, 1105.0, 1195.2, 1280.7, 1438.6, 1472.4, 
1493.7, 1575.7, 2125.7.  
1
H NMR: H (400 MHz, DMSO): 4.72 (2H, s, CH2), 7.12-7.21 (2H, m, 2 x ArH), 7.24 (1H, 
dd, J
1
= 8.0 Hz, J
2
=1.0 Hz, ArH), 7.29 (1H, dd, J
1
=8.0 Hz, J
2
=1.0 Hz, ArH), 7.37-7.43 (3H, 
m, 3 x ArH), 7.77 (1H, dd, J
1
=7.7 Hz, J
2
=1.6 Hz, ArH) ppm. 
13
C NMR c (100 MHz, DMSO): 63.28 (CH2), 118.75 (CH), 120.65 (CH), 124.66 (CH), 
125.29 (CH), 128.99 (CH), 129.30 (qC), 129.41 (CH), 129.62 (CH), 130.91 (CH), 136.48 
(qC), 137.24 (qC), 138.76 (qC) ppm. 
HRMS (ESI
+
): found 353.0427 [M+Na]
+
, C13H10N6O3SNa requires 353.0427. 
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8.3.3. Synthesis of 2-[(triphenyl-λ5-phosphanylidene)amino]benzyl 2-
[(triphenyl-λ5-phosphanylidene)amino]benzenesulfonate. 
 
 
To a solution of 2-azidobenzyl 2-azidobenzenesulfonate (330 mg, 1.0 mmol, 1.0 eq) in 
anhydrous toluene (10 mL), triphenylphosphine (524 mg, 2.0 mmol, 2.0 eq) was added. The 
mixture was stirred for 12 hours at ambient temperature under a nitrogen atmosphere. After 
completion of the reaction, monitored by TLC, the solvent was removed under vacuum. The 
residue was purified by using silica column chromatography with [methanol /ethyl acetate = 
1/3, Rf= 0.23 as eluent] to give a brown solid as the product (570 mg, 71 %, m.p.=101-103 
o
C). 
IR: ʋmax (cm
-1
):  540.7, 691.8, 905.3, 1013.9, 1111.0, 1180.7, 1336.5, 1450.4, 1479.1, 1586.5, 
3055.2.  
1
H NMR: H (400 MHz, CDCl3): 5.15 (2H, bs, CH2), 6.32-6.43 (4H, m, 4 x ArH), 6.61-6.92 
(5H, m, 5 x ArH), 7.33-7.10 (21H, m, 21 x ArH), 8.01-8.10 (8H, m, 8 x ArH) ppm. 
13
C NMR c (100 MHz, CDCl3): 26.73 (CH2) 119.27 (qC), 121.27 (CH), 128.53 (4 x CH), 
128.60 (4 x CH), 128.65 (3 x CH), 128.80 (4 x CH), 128.92 (3 x CH), 129.33 (qC), 129.47 
(CH), 129.99 (CH), 130.11 (CH), 130.33 (2 x qC), 130.81 (qC) 132.04 (3 x CH), 132.32 
(CH), 132.42 (CH), 133.07 (qC), 133.66 (3 x CH), 133.85 (3 x CH), 134.02 (CH), 134.11 (3 x 
CH), 134.86 (CH), 137.12 (2 x qC), 137.22 (qC), 150.90 (qC) ppm. 
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8.3.4. Synthesis of  2-azidobenzoyl chloride243 
 
 
2-Azidobenzoic acide (1.63 g, 10.00 mmol, 1.0 eq) was heated to reflux in a 2M solution of   
(COCl)2 in dichloromethane (10.35 mL, 20.70 mmol, 2.7 eq) with a drop  of DMF  under an 
inert atmosphere of nitrogen for 5 hours. The reaction was cooled to room temperature before 
the crude acid chloride was concentrated and the residue was washed with dichloromethane (2 
x 20 mL) to give the crude sulfonyl chloride in as an orange solid (1.5 g, 82 %). 
IR: ʋmax (cm
-1
): 761.3, 866.8, 1190.6, 1277.2, 1311.0, 1446.3, 1475.3, 1572.1, 1777.7, 
2123.2. 
1
H NMR: H (400 MHz, CDCl3): 7.27-7.33 (2H, m, 2 x ArH), 7.66 (1H, ddd, J
1
=8.2 Hz, 
J
2
=8.0 Hz, J
3
=1.2 Hz, ArH), 8.15 (1H, dd, J
1
=8.0 Hz, J
2
=0.9 Hz, ArH) ppm. 
13
C NMR c (100 MHz, CDCl3): 119.83 (CH), 124.70 (CH), 124.83 (qC), 134.42 (CH), 
135.39 (CH), 140.73 (qC), 164.10 (C=O) ppm. 
8.3.5. Synthesis of 2-azidobenzyl benzoate. 
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To a stirring solution of 2-azidobenzyl alcohol (500 mg, 3.35 mmol, 2.0 eq) in DCM (10 mL) 
was added pyridine (135 μL, 132 mg, 1.67 mmol, 1.0 eq ) dropwise. The benzoyl chloride 
(235 mg, 1.677 mmol, 1.0 eq) was added dropwise to this solution followed by addition of a 
drop of DMF. The mixture was heated to reflux under a nitrogen atmosphere for 48 hours 
whilst being monitored by TLC. The solvent was removed under vacuum and the mixture was 
purified by using column chromatography (eluent: petrolum ether/ethyl acetate: 2/1, Rf = 
0.23) tpyield the product as a yellow oil (650 mg, 77%). 
IR: ʋmax (cm
-1
):  748.5, 870.1, 990.7, 1041.3, 1122.1, 1173.7, 1269.9, 1372.7, 1450.2, 1584.2, 
1719.5, 2117.6, 2980.1.  
1
H NMR: H (400 MHz, CDCl3): 5.37 (2H, s, CH2), 7.19 (1H, t, J=7.6 Hz, ArH), 7.23 (1H, 
d, J= 8.0 Hz, ArH), 7.40-7.50 (4H, m, 4 x ArH), 7.59 (1H, dd, J
1
=7.6 Hz, J
2
=7.3 Hz, ArH), 
8.10 (2H, d, J=7.6 Hz, 2 x ArH), ppm. 
13
C NMR c (100 MHz, CDCl3): 62.26 (CH2), 118.24 (CH), 124.48 (CH), 127.23 (qC), 
128.41 (2 x CH), 129.69 (CH), 129.74 (2 x CH), 130.07 (qC), 130.19 (CH), 133.08 (CH), 
138.57 (qC), 166.35 (C=O) ppm. 
HRMS (ESI
+
): found 276.0742 [M+Na]
+
, C14H11N3O2Na requires 276.0743. 
 
8.3.6. Synthesis of 2-[(triphenyl-λ5-phosphanylidene)amino]benzyl benzoate. 
 
 
To a solution of 2-azidobenzyl benzoate (200 mg, 0.790 mmol, 1.0 eq) in anhydrous toluene 
(10 mL) was added triphenylphosphine (248 mg, 0.949 mmol, 1.2 eq). The mixture was 
stirred for 12 hours at ambient temperature under a nitrogen atmosphere. After completion of 
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the reaction, monitored by TLC, the solvent was removed under vacuum. The residue was 
purified by using column chromatography [petroleum ether/ethyl acetate: 2/1, Rf = 0.19] to 
yield the product as a pale yellow solid (290 mg, 75 %, m.p.=159-161 
o
C). 
IR: ʋmax (cm
-1
):  753.2, 925.2, 1022.4, 1104.9, 1298.6, 1345.0, 1439.4, 1454.0, 1480.8, 
1595.3, 1650.4, 1696.8, 1715.9, 2941.3, 3064.1, 2980.1.  
1
H NMR: H (400 MHz, CDCl3): 5.65 (2H, s, CH2), 6.39 (1H, d, J=7.9 Hz, ArH), 6.59 (1H, 
t, J=7.6 Hz, ArH), 6.79 (1H, t, J=7.6 Hz, ArH), 7.24-7.33 (8H, m, 8 x ArH), 7.38-7.45 (4H, 
m, 4 x ArH), 7.65 (3H, d, J=7.8 Hz, 3 x ArH), 7.67 (3H, d, J=7.8 Hz, 3 x ArH), 7.96 (2H, d, 
J=7.9 Hz, 2 x ArH) ppm. 
13
C NMR c (100 MHz, CDCl3): 65.69 (CH2), 117.11 (CH), 121.04 (CH), 128.18 (2 x CH), 
128.35 (CH), 128.57 (3 x CH), 128.60 (qC), 128.69 (3 x CH), 129.00 (CH), 129.69 (2 x CH), 
129.90 (3 x qC), 130.98 (qC), 131.69 (3 x CH), 132.50 (4 x CH), 132.60 (3 x CH), 149.80 
(qC), 167.02 (C=O) ppm. 
HRMS (ESI
+
): found 488.1777 [M+H]
+
, C32H27NO2P requires 488.1774. 
 
8.3.7. Synthesis of 2-phenyl-4H-benzo[d][1,3]oxazine. 
 
2-[(Triphenyl-λ5-phosphanylidene)amino]benzyl benzoate (100 mg, 0.205 mmol) was added 
to dry xylene (10 mL). The mixture was heated at reflux temperature for 24 hours under a 
nitrogen atmosphere, and monitored by TLC. The solvent was distilled under vacuum. The 
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residue was purified by using column chromatography [petroleum ether/ethyl acetate: 4/1, Rf 
= 0.22] to yield the product as a dark yellow oil (40 mg, 93 %). 
IR: ʋmax (cm
-1
):  771.3, 873.2, 930.4, 1000.3, 1109.6, 1227.6, 1246.4, 1315.8, 1379.8, 1490.1, 
1567.8, 1593.9, 1612.5, 2868.0, 3039.5.  
1
H NMR: H (400 MHz, CDCl3): 5.41 (2H, s, CH2), 7.04 (1H, d, J=7.4 Hz, ArH), 7.21 (1H, 
td, J
1
=7.3 Hz, J
2
=2.1 Hz, ArH), 7.33 (2H, dd, J
1
=7.5 Hz, J
2
=6.7 Hz, 2 x ArH), 7.47 (2H, dd, 
J
1
=7.8 Hz, J
2
=7.8 Hz, 2 x ArH), 7.52 (1H, t, J=7.2 Hz, ArH), 8.17 (2H, d, J=7.3 Hz, 2 x ArH) 
ppm. 
13
C NMR c (100 MHz, CDCl3): 66.44 (CH2), 122.33 (qC), 123.75 (CH), 124.67 (CH), 
126.48 (CH), 128.02 (2 x CH), 128.27 (2 x CH), 129.02 (CH), 131.46 (CH), 132.39 (qC), 
139.72 (qC), 157.71 (C=N) ppm. 
HRMS (ESI
+
): found 210.0916 [M+H]
+
, C14H12NO  requires 210.0913. 
8.3.8. Synthesis of 2-aminobenzyl benzoate. 
 
To a solution of 2-azidobenzyl benzoate (253 mg, 1 mmol, 1.0 eq) in anhydrous toluene (10 
mL) was added tributylphosphine (244 mg, 1.2 mmol, 1.2 eq). The mixture was stirred for 12 
hours at ambient temperature under a nitrogen atmosphere. After completion of the reaction, 
monitored by TLC, the solvent was removed under vacuum. The residue was purified by 
using column chromatography [petroleum ether/ethyl acetate: 3/1, Rf = 0.22] to yield the 
product as a yellow oil (136  mg, 60 %). 
IR: ʋmax (cm
-1
):  782.1, 927.7, 996.8, 1025.3, 1068.9, 1105.9, 1266.0, 1314.0, 1451.1, 1496.1, 
1584.0, 1602.7, 1705.1, 3063.5, 3376.9.  
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1
H NMR: H (400 MHz, CDCl3): 4.70 (2H, bs, NH2), 5.38 (2H, s, CH2), 6.76 (1H, d, J=8.0 
Hz, ArH), 6.82 (1H, dd, J
1
=7.8 Hz, J
2
=7.6 Hz, ArH), 7.21 (1H, dd, J
1
=7.8 Hz, J
2
=1.4 Hz, 
ArH), 7.33 (1H, d, J=7.7 Hz, ArH), 7.45 (2H, dd, J
1
=7.7 Hz, J
2
=7.6 Hz, 2 x ArH), 7.58 (1H, 
t, J=7.5 Hz, ArH), 7.94-8.15 (2H, m, 2 x ArH) ppm. 
13
C NMR c (100 MHz, CDCl3): 64.86 (CH2), 116.28 (CH), 118.50 (CH), 120.27 (qC), 
128.45 (2 x CH), 129.74 (2 x CH),  129.97 (qC), 130.19 (CH), 131.54 (CH), 133.19 (CH), 
145.98 (qC), 166.86 (C=O) ppm. 
The data is identical to that reported in the literature.
244
 
8.3.9. Reactivity of 2-azidobenzyl benzoate. 
 
 
To a solution of  2-azidobenzyl benzoate (150 mg, 0.592 mmol, 1.0 eq)  in anhydrous toluene 
(10 mL) was added tributylphosphine (145 mg, 0.711 mmol, 1.2 eq). The whole was stirred 
for 6 hours at ambient temperature under a nitrogen atmosphere and after completion of the 
reaction, monitored by TLC, the mixture was heated at reflux temperature for 24 hours under 
a nitrogen atmosphere. The solvent was removed under vacuum and the residue was purified 
by using silica column chromatography to give two products: 
2-Phenyl-4H-benzo[d][1,3]oxazine (481). 
[Petroleum ether/ethyl acetate: 3/1, Rf = 0.3] to yield the product as a pale green oil (86 
mg, 69 %), data as reported above. 
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2-Benzamidobenzyl benzoate (484). 
 [Petroleum ether/ethyl acetate: 3/1, Rf = 0.21] to yield the product as a light yellow (40 
mg, 24 %, m.p.=128-130 
o
C). 
IR: ʋmax (cm
-1
): 606.6, 673.3, 753.1, 822.6, 934.3, 1070.8, 1110.9, 1243.9, 1379.3, 1448.9, 
1514.8, 1585.8, 1600.9, 1667.7, 1696.1, 2980.6, 3060.7, 3317.1. 
1
H NMR: H (400 MHz, CDCl3): 5.31 (2H, s, CH2), 7.13 (1H, t, J=7.5 Hz, ArH), 7.33-7.38 
(3H, m, 3 x ArH), 7.40-7.44 (3H, m, 3 x ArH), 7.49 (2H, dd, J
1
=7.0 Hz, J
2
=6.4 Hz, 2 x ArH), 
7.97-8.02 (5H, m, 5 x ArH), 9.69 (1H, bs, NH) ppm. 
13
C NMR c (100 MHz, CDCl3): 66.12 (CH2), 124.71 (CH), 125.24 (CH), 126.84 (qC), 
127.45 (2 x CH), 128.53 (2 x CH), 128.73 (2 x CH), 129.39 (qC), 129.88 (2 x CH), 130.01 
(CH), 131.75 (CH), 131.91 (CH), 133.60 (CH), 134.60 (qC), 136.86 (qC), 165.82 (C=O), 
167.47 (C=O) ppm. 
HRMS (ESI
+
): found 331.1205 [M]
+
, C19H15N4O2 requires 331.1195. 
 
8.3.10. Synthesis of 2-azidobenzyl 2-azidobenzoate. 
 
 
To 2-azidobenzoic acid (800 mg, 4.9 mmol, 2.0 eq) was added a 2M solution of oxalyl 
chloride in dichloromethane (6.15 mL, 12.3 mmol, 5.0 eq) followed by the addition of DMF 
(100 μL). The whole was heated to reflux for 15 hours under nitrogen. The excess oxalyl 
chloride was removed in vacuo and the residue was washed with dichloromethane (3 x 10 
mL) to give the crude sulfonyl chloride as an orange solid. 
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Pyridine (198 μL, 194 mg, 2.46 mmol, 1.0 eq ) was added dropwise to a stirring solution of 2-
azidobenzyl alcohol (366 mg, 2.46 mmol, 1.0 eq) in DCM (10 mL). The sulfonyl chloride was 
dissolved in dichloromethane (5 mL) and was added dropwise to this solution followed by the 
addition of a drop of DMF. The mixture was heated to reflux under a nitrogen atmosphere for 
48 hours whilst being monitored by TLC. The solvent was removed under vacuum and the 
mixture was purified by using column chromatography (eluent: petroleum ether/ethyl acetate: 
10/1, Rf = 0.3) which yielded the product as a brown oil (536 mg, 74 %, m.p.=154-156 
o
C ). 
IR: ʋmax (cm
-1
): 886.7, 992.3, 1072.8, 1129.3, 1231.6, 1366.4, 1446.0, 1484.8, 1594.1, 
1729.9, 2092.8, 2930.2, 3031.7.  
1
H NMR: H (400 MHz, CDCl3): 5.35 (2H, s, CH2), 7.14-7.27 (4H, m, 4 x ArH), 7.41 (1H, 
dd, J
1
= 7.8 Hz, J
2
=7.5 Hz, ArH), 7.51 (1H, d, J=8.7 Hz, ArH), 7.56 (1H, dd, J
1
=8.0 Hz, 
J
2
=1.2 Hz, ArH), 7.91 (1H, d, J=7.8 Hz, ArH) ppm. 
13
C NMR c (100 MHz, CDCl3): 62.63 (CH2), 118.25 (CH), 119.85 (CH), 122.36 (qC), 
124.48 (CH), 124.86 (CH), 126.91 (qC), 129.80 (CH), 130.47 (CH), 131.95 (CH), 133.35 
(CH), 138.64 (qC), 140.25 (qC), 164.90 (C=O) ppm. 
HRMS (ESI
+
): found 317.0764 [M+Na]
+
, C14H10N6O2Na requires 317.0757. 
8.3.11. Synthesis of 2-[(triphenyl-λ5-phosphanylidene)amino]benzyl 2-
[(triphenyl-λ5-phosphanylidene)amino]benzoate. 
 
 
To a solution of 2-azidobenzyl 2-azidobenzoate (100 mg, 0.34 mmol, 1.0 eq) in anhydrous 
toluene (10 mL), triphenylphosphine (178 mg, 0.68 mmol, 2.0 eq) was added. The mixture 
was stirred for 12 hours at ambient temperature under a nitrogen atmosphere. After 
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completion of the reaction, monitored by TLC, the solvent was removed under vacuum. The 
residue was purified by using column chromatography (eluent: petroleum ether/ethyl acetate: 
2/1, Rf = 0.21) yielded the product as a light yellow oil (130 mg, 50 %). 
IR: ʋmax (cm
-1
):  926.2, 1023.4, 1052.8, 1107.1, 1183.3, 1242.7, 1341.3, 1451.8, 1481.9, 
1592.8, 1615.7, 1684.0, 2852.8, 2926.3, 3056.7, 3369.8, 3473.7.  
1
H NMR: H (400 MHz, CDCl3): 5.72 (4H, bs, NH2 + CH2), 6.51 (1H, d, J=7.9 Hz, ArH), 
6.56 (1H, t, J=7.5 Hz, ArH), 6.62 (1H, d, J=8.0 Hz, ArH), 6.70 (1H, t, J=7.5 Hz, ArH) 6.90 
(1H, t, J=7.5 Hz, ArH), 7.23 (1H, t, J=7.5 Hz, ArH), 7.39 (1H, d, J=7.2 Hz, ArH), 7.44-7.47 
(6H, m, 6 x ArH), 7.51-7.55 (3H, m, 3 x ArH), 7.78 (6H, m, 6 x ArH), 7.93 (1H, d, J=8.0 Hz, 
ArH) ppm. 
13
C NMR c (100 MHz, CDCl3): 65.14 (CH2), 111.76 (qC), 116.13 (CH), 116.54 (CH), 
117.03 (CH), 120.98 (CH), 124.34 (CH), 128.57 (3 x CH), 128.69 (3 x CH), 129.13 (CH), 
129.95 (qC), 130.17 (qC), 130.79 (qC), 131.66 (3 x CH), 131.73 (CH), 131.78 (qC), 132.50 (3 
x CH), 132.60 (3 x CH), 133.67 (CH),  149.92 (qC), 150.21 (qC), 168.52 (C=O) ppm. 
HRMS (ESI
+
): found 503.1883 [M+H]
+
, C14H10N6O2Na requires 503.1884. 
 
8.3.12. Synthesis of (Z)-8-ethoxy-5,16-dihydro-6H-dibenzo[c,J][1]oxa 
[5,9]diazacyclododecine-6,14(7H)-dione. 
 
 
Chaper 8                                                                                                                                            Experimental 
315 
 
To a solution of 2-((triphenyl-λ5-phosphanylidene)amino)benzyl 2-((triphenyl-λ5-
phosphanylidene)amino)benzoate (105 mg, 0.138 mmol, 1.0 eq) in anhydrous toluene (10 
mL) was added diethyl malonate (26 mg, 0.165 mmol, 1.2 eq). The whole was heated for 24 
hours at reflux under a nitrogen atmosphere, whilst being monitored by TLC. The solvent was 
removed under vacuum. The residue was purified by using column chromatography (eluent: 
petroleum ether/ethyl acetate: 3/1, Rf = 0.25) which yielded the product as a light yellow oil 
(30 mg, 65 %). 
IR: ʋmax (cm
-1
):  762.5, 950.8, 1030.9, 1072.7, 1162.1, 1237.9, 1262.0, 1378.9, 1446.2, 
1460.9, 1574.1, 1600.7, 1650.5, 1692.5, 1737.6, 2927.8, 2979.8.  
1
H NMR: H (400 MHz, CDCl3): 1.20 (3H, t, J=7.2 Hz, OCH2CH3), 3.50 (2H, s, CH2-C=O), 
4.17 (2H, q, J=7.2 Hz, OCH2CH3), 5.34 (2H, s, OCH2), 6.97 (1H, d, J=7.4 Hz, ArH), 7.04 
(1H, dd, J=7.6 Hz, J
2
=7.5 Hz, ArH), 7.14-7.22 (2H, m, 2 x ArH), 7.27 (1H, dd, J=7.4 Hz, 
J
2
=7.3 Hz, ArH), 7.41 (1H, dd, J=7.6 Hz, J
2
=7.5 Hz, ArH), 7.95 (1H, d, J=7.6 Hz, ArH), 8.64 
(1H, d, J=8.0 Hz, ArH), 13.27 (1H, bs, HN) ppm. 
13
C NMR c (100 MHz, CDCl3): 14.15 (CH3), 45.74 (CH2), 61.63 (CH2), 66.48 (CH2), 
116.82 (qC), 120.40 (CH), 121.72 (qC), 122.74 (CH), 124.01 (CH), 124.12 (CH), 127.23 
(CH), 128.94 (CH), 129.23 (CH), 132.85 (CH), 137.85 (qC), 140.19 (qC),  158.17 (C=N), 
163.94 (C=O), 167.46 (C=O) ppm. 
HRMS (ESI
+
): found 338.1278 [M]
+
, C19H18N2O4 requires 338.1267. 
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8.3.13. Synthesis of 2-{[(3-(diphenylphosphoryl)propyl)diphenyl-λ5-phosph-
anylidene]amino}benzyl 2-aminobenzoate. 
 
  
To a solution of 2-azidobenzyl 2-azidobenzoate (100 mg, 0.34 mmol, 1.0 eq) in anhydrous 
toluene (10 mL), 1,3-bis(diphenylphosphanyl)propane (280 mg, 0.34 mmol, 1.0 eq) was 
added. The mixture was stirred for 12 hours at ambient temperature under a nitrogen 
atmosphere. After completion of the reaction, monitored by TLC, the solvent was removed 
under vacuum. The residue was purified by using slica column chromatography (eluent: 
petroleum ether/ethyl acetate: 2/1, Rf = 0.23) which yielded the product as a pale yellow oil 
(92 mg, 41 %). 
IR: ʋmax (cm
-1
): 729.3, 907.9, 1024.1, 1107.9, 1291.1, 1371.6, 1435.7, 1481.4, 1591.5, 
1614.8, 1682.1, 2853.9, 2924.2, 3056.5, 3367.5, 3471.3.  
1
H NMR: H (400 MHz, CDCl3): 1.93 (2H, t, J=7.3 Hz, O=PCH2CH2CH2), 2.08-2.24 (2H, 
m, O=PCH2CH2CH2), 2.55-2.69 (2H, m, O=PCH2CH2CH2), 5.50 (2H, s, OCH2), 5.56 (2H, 
bs, NH2), 6.26 (1H, t, J=7.0 Hz, ArH), 6.46 (1H, m, ArH), 6.53 (1H, t, J=7.9 Hz, ArH), 6.59 
(1H, t, J=7.0 Hz, ArH), 6.81 (1H. bs, ArH), 7.12-7.21 (7H, m, 7 x ArH), 7.27-7.47 (11H, m, 
11 x ArH), 7.63-7.67 (4H, m, 4 x ArH), 7.81 (1H, d, J=7.9 Hz, ArH) ppm. 
13
C NMR c (100 MHz, CDCl3): 15.05 (CH2), 18.27 (CH2), 29.72 (CH2), 64.93 (CH2), 
111.63 (qC), 116.58 (2 x CH), 116.71 (CH), 120.56 (CH), 128.37-129.07 (m, 11 x CH), 
130.63 (2 x CH), 130.77 (2 x qC), 131.43 (2 x CH), 131.52 (3 x CH), 131.63 (2 x CH), 
131.67 (CH), 132.11 (qC), 132.54 (CH), 132.73 (CH), 133.08 (qC), 133.65 (CH), 138.02 (2 x 
qC), 150.23 (qC), 168.37 (C=O) ppm. 
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HRMS (ESI
+
): found 652.2437 [M]
+
, C41H38N2O3P2 requires 652.2409. 
 
9. Chapter 9: Experimental for chapter 5: Attempted synthesis of 
circumdatin and fuligocandin analogues. 
9.1. Synthesis of the 10,10-dioxo-2,3,3a,5-tetrahydro-1H-pyrrolo[1,2-
b][1,2,5]benzothiadiazepin-4-one. 
9.1.1. Synthesis of methoxycarbonyl-1-(2'- azidobenzenesulfonyl) 
pyrrolidine. 
 
2-Azidobenzenesulfonic acid (603 mg, 3.030 mmol, 2.5 eq) was heated at reflux at 80 
o
C in a 
2M solution of   thionyl chloride in dichloromethane (3.03 mL, 6.06 mmol, 5.0 eq) with a 
drop of DMF under an inert atmosphere of nitrogen for 5 hours. The reaction was allowed to 
reach room temperature before the crude acid chloride was concentrated and the residue was 
washed with dichloromethane (2 x 10 mL) to give the crude sulfonyl chloride as an orange 
solid. 
A solution of potassium carbonate (919 mg, 6.66 mmol, 5.5 eq) in water (20 mL) was added 
in one portion to L-proline methyl ester (200 mg, 1.212 mmol, 1.0 eq) in dichloromethane (20 
mL). The sulfonyl chloride was dissolved in dichloromethane (5 mL) and was added dropwise 
to this solution. The reaction was allowed to stir at room temperature for 20 hours before the 
organic layer was separated and the aqueous layer washed with dichloromethane (2 x 10 mL). 
The combined organic phases were dried (MgSO4), filtered, concentrated and purified by 
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silica column chromatography [petroleum ether/ethyl acetate: 3/1, Rf= 0.23] to yield the 
product as a yellow oil (300 mg, 58 %). 
IR: ʋmax (cm
-1
): 759.7, 1019.9, 1079.9, 1155.5, 1285.8, 1335.8, 1471.1, 1736.7, 2119.7, 
2883.1, 2980.4. 
1
H NMR: H (400 MHz, CDCl3): 1.79-1.88 (1H, m, CHH), 1.91-2.04 (2H, m, CH2), 2.08-
2.18 (1H, m, CHH), 3.34-3.40 (1H, m, CHH), 3.56-3.61 (4H, m, CH3 + CH), 4.62 (1H, dd, 
J
1
=8.5 Hz, J
2
=3.0 Hz, NCH), 7.16 (H, dd, J
1
=7.6 Hz, J
2
=7.7 Hz, ArH), 7.21 (H, d, J=8.0 Hz, 
ArH) 7.51 (1H, ddd, J
1
=7.7 Hz, J
2
=7.6 Hz, J
3
=1.3 Hz, ArH), 7.93 (1H, dd, J=8.0 Hz, J=1.8 
Hz, ArH) ppm. 
13
C NMR c (100 MHz, DMSO): 24.70 (CH2), 31.02 (CH2), 48.35 (CH2), 52.33 (CH), 60.41 
(CH), 119.70 (CH), 124.57 (CH), 130.23 (qC), 131.75 (CH), 133.19 (CH), 138.19 (qC), 
172.65 (C=O) ppm. 
HRMS (ESI
+
): found 333.0630 [M+Na]
+
, C12H14N4O4S requires 333.0628. 
9.1.2. 2-Methoxycarbonyl-1-(2'-aminobenzenesulfonyl)pyrrolidine. 
 
 
To a solution of the azido ester (426 mg, 1.37 mmol, 1.0 eq) in dry THF was added 
triphenylphosphine (PPh3) (360 mg, 1.37 mmol, 1.0 eq) and the mixture was stirred for 24 
hours at room temperature. After completion of the reaction, monitored by TLC, water (10 
mL) was added. The mixture was heated at reflux overnight. 
The solvent was distilled under vacuum and the mixture was purified by using silica column 
chromatography (petroleum ether/ethylacetate: 2/1, Rf = 0.25) to give the product as a light 
yellow in 390 mg and 64 % yield, m.p=121-122 
o
C (lit. m.p = 118-119 
o
C
245
). 
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IR: ʋmax(cm
-1
): 752.1, 997.2, 1086.8, 1137.3, 1276.9, 1433.7, 1486.2, 1620.7, 1724.1, 2900.5, 
2951.9, 3370.4, 3474.2. 
1
H NMR: H (400 MHz, CDCl3): 1.82-1.91 (1H, m, CHH), 1.93-2.07 (2H, m, CH2), 2.15-
2.24 (1H, m, CHH), 3.39 (2H, t, J=6.9 Hz, CH2), 3.73  (3H, s, CH3), 4.52 (1H, dd, J
1
=8.7 Hz, 
J
2
=4.3 Hz, NCH),  5.24 (2H, s, NH2), 6.74 (2H, dd, J
1
=8.5 Hz, J
2
=8.3 Hz, 2 x ArH), 7.31 
(1H, ddd, J
1
=8.5 Hz, J
2
=8.3 Hz, J
3
=1.1 Hz, ArH), 7.71 (1H, dd, J
1
=8.5 Hz, J
2
=0.9 Hz, ArH) 
ppm. 
13
C NMR c (100 MHz, DMSO): 24.86 (CH2), 31.02 (CH2), 48.60 (CH2), 52.51 (CH), 59.48 
(CH), 116.89 (CH), 117.56 (CH), 119.11 (qC), 130.23 (CH), 134.50 (CH), 146.40 (qC), 
173.03 (C=O) ppm. 
HRMS (ESI
+
): found 285.0905 [M+H]
+
, C12H17N2SO4 requires 285.0904. 
 
9.1.3. 2-Methoxycarbonyl-1-(2'-aminobenzenesulfonyl)pyrrolidine. 
 
 
To a solution of the azido ester (425) (426 mg, 1.37 mmol, 1.0 eq) in dry THF (10 mL) was 
added triphenylphosphine (PPh3) (360 mg, 1.37 mmol, 1.0 eq) and the mixture was stirred for 
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24 hours at room temperature. After completion of the reaction, monitored by TLC, water (10 
mL) was added. The mixture was heated at reflux overnight. 
The solvent was removed under vacuum and the mixture was purified by using silica column 
chromatography (petroleum ether/ethyl acetate: 2/1, Rf = 0.2) to give the product which was 
identical to that isolated above (100 mg, 25 %, m.p.=121-122 
o
C, lit. m.p = 118-119 
o
C
245
). 
9.1.4. 2-Methoxycarbonyl-1-(2'-aminobenzenesulfonyl)pyrrolidine.  
 
To a solution of the azido ester (426 mg, 1.37 mmol, 1.0 eq) in dry THF (10 mL) was added 
tributyl phosphine (279 mg, 1.37 mmol, 1.0 eq) and the mixture was stirred for 24 hours at 
room  temperature. After completion of the reaction, monitored by TLC, water (10 mL) was 
added. The mixture was heated at reflux overnight. 
The solvent was distilled under vacuum and the mixture was purified by using column 
chromatography with (petroleum ether/ethyl acetate: 2/1, Rf = 0.2) to give two products. 
Methyl[(2-aminophenyl)sulfonyl] prolinate (442).   
[yellow solid (150 mg, 39 %)], data as reported above. 
11-Methoxy-1,2,3,11a-tetrahydrobenzo[f]pyrrolo[1,2-b][1,2,5]thiadiazepine 5,5-
dioxide (443). 
[white oil, 200 mg, 54 %] 
IR: ʋmax (cm
-1
): 761.0, 952.7, 1069.4, 1128.1, 1160,5, 1335.6, 1372.6, 1434.2, 1588.9, 
1673.5, 2866.1, 2969.0, 3334.5. 
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1
H NMR: H (400 MHz, CDCl3): 1.62-1.71 (1H, m, CHH), 1.76-1.95 (1H, m, CH2), 2.21-
2.30 (1H, m, CHH), 2.80-2.86 (1H, m, CHH), 3.27-3.32 (1H, m, CHH), 3.71  (3H, s, CH3), 
4.50  (1H, t, J=7.0 Hz, NCH), 7.02 (1H, dd, J
1
=7.7 Hz, J
2
=7.5 Hz, ArH), 7.12 (1H, d, J=7.9 
Hz, ArH), 7.39 (1H, dd, J
1
=7.7 Hz, J
2
=7.5 Hz, ArH), 7.69 (1H, d, J=7.9 Hz, ArH) ppm. 
13
C NMR c (100 MHz, DMSO): 24.53 (CH2), 31.85 (CH2), 48.88 (CH2), 53.80 (CH), 63.75 
(CH3), 123.47 (CH), 128.13 (CH), 128.26 (CH), 131.69 (qCH), 133.73 (CH), 140.48 (qC), 
164.49 (qC) ppm. 
 
9.1.5. 2-Methoxycarbonyl-1-(2'-aminobenzenesulfonyl)pyrrolidine. 
 
 
To a solution of compound (428) (200 mg, 0.75 mmol, 1.0 eq) in THF (10 mL) was added 
water (10 mL) and the solution was stirred at room temperature for 24 hours. After 
completion of the reaction, monitored by TLC, the solvent was removed under vacuum and 
the mixture was purified by using column chromatography with (petroleum ether/ethyl 
acetate: 2/1, Rf = 0.2) which gave the product (190 mg, 90 %), identical in all respects to that 
isolated above. 
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9.1.6. Synthesis of 2-Methoxycarbonyl-1-(2'-nitrobenzenesulfonyl) pyrro-
lidine. 
 
 
A solution of potassium carbonate (4.27 g, 31.00 mmol, 5.5 eq) in water (10 mL) was added 
in one portion to a stirred solution of L-proline methyl ester (930 mg, 5.63 mmol, 1.0 eq) in 
DCM (10 mL). The sulfonyl chloride (3.23 g, 14.65 mmol, 2.6 eq) dissolved in DCM (5 mL) 
was added dropwise to this solution and the whole was stirred for 18 hours. The organic layer 
was separated and the aqueous layer was extracted with DCM (3 x 10 mL). The combined 
organic phases were dried (MgSO4), filtered, concentrated and purified by silica column 
chromatography (ethyl acetate/ hexane: 1/2, Rf = 0.2) to give the product as a colorless oil 
(1.800 g, 84 %, lit. m.p = 86-88 
o
C
245
) 
IR: ʋmax (cm
-1
): 741.8, 851.8, 1021.9, 1081.9, 1126.5, 1158.7, 1201.0, 1343.3, 1437.4, 
1540.6, 1589.6, 1741.9, 2955.8, 3098.4. 
1
H NMR: H (400 MHz, CDCl3): 1.95-2.18 (3H, m, CH2 + CHH), 2.23-2.33 (1H, m, CHH), 
3.53-3.59 (1H, m, CHH), 3.62-3.67 (1H, m, CHH), 3.68  (3H, s, CH3), 4.61  (1H, dd, J
1
=5.5 
Hz, J
2
=3.0 Hz, NCH), 7.64-7.67 (1H, m, ArH), 7.71 (2H, m, 2 x ArH), 8.12 (1H, m, ArH) 
ppm. 
13
C NMR c (100 MHz, DMSO): 24.55 (CH2), 30.96 (CH2), 48.51 (CH2), 52.45 (CH), 60.91 
(CH), 124.06 (CH), 131.07 (CH), 131.66 (CH), 132.85 (qC), 133.56 (CH), 148.08 (qC), 
172.31 (C=O) ppm. 
HRMS (ESI
+
): found 315.0643 [M+H]
+
, C12H15N2SO6 requires 315.0645. 
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9.1.7. Synthesis of 2-Methoxycarbonyl-1-(2'-aminobenzenesulfonyl) pyrro-
lidine. 
 
 
To a solution of the nitroester (1.8 g, 5.73 mmol, 1.0 eq) in glacial acetic acid (25 mL), iron 
powder (1.6 g, 28.662 mmol, 5.0 eq) was added over 30 minutes. The reaction mixture was 
stirred and heated at 60 
o
C for 2 hours. Removal of the solvent gave a gummy residue which 
was extracted with ethyl acetate (4 x 30 mL). The organic extracts were combined, washed 
with sodium bicarbonate, brine and dried. Concentration in vacuo afforded the aminoester as a 
yellow solid (1.19 g, 74 %), identical to that isolated previously. 
9.1.8. Synthesis of 10,10-dioxo-2,3,3a,5-tetrahydro-1H-pyrrolo[1,2-b][1,2,5]-
benzothiadiazepin-4-one. 
 
 
A mixture of the aminoester (177 mg, 0.58 mmol, 1.0 eq), 2-hydroxypyridine (56 mg, 0.58 
mmol, 1.0 eq), and diphenyl ethyl ether (10 mL) was heated at 205 
o
C while monitoring via 
TLC overnight. On cooling the crude reaction mixture was poured over n-hexane (10 mL) and 
allowed to stand for 10 min. The clear supernatant was discarded and the solid was dissolved 
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in CHCl3 and purified on a silica column to afford the cyclised compound as a brown solid 
(100 mg, 63 %. m.p.= 291-292 
o
C, lit. m.p.=292-293 
o
C
233
). 
 IR: ʋmax (cm
-1
): 755.4, 1007.2, 1078.4, 1191.5, 1341.8, 1384.2, 1478.5, 1583.2, 1661.4, 
2891.7, 2933.1, 2985.4, 3063.3, 3204.1. 
1
H NMR: H (400 MHz, CDCl3): 1.82-1.92 (1H, m, CHH), 1.95-2.07 (1H, m, CHH), 2.19-
2.27 (1H, m, CHH), 2.46-2.55 (1H, m, CHH), 3.00-3.06 (1H, m, CHH), 3.42-3.54 (1H, m, 
CHH), 4.65 (1H, dd, J
1
=7.9 Hz, J
2
=5.9 Hz, NCH),  7.18 (1H, d, J=8.0 Hz, ArH), 7.22 (1H, 
dd, J
1
=7.8 Hz, J
2
=7.6 Hz, ArH), 7.53 (1H, ddd, J
1
=7.8 Hz, J
2
=7.6 Hz, J
3
=1.4 Hz, ArH), 7.91 
(1H, dd, J
1
=8.0 Hz, J
2
=1.3 Hz, ArH), 9.20 (1H, s, NH) ppm. 
13
C NMR c (100 MHz, DMSO): 24.64 (CH2), 32.47 (CH2), 58.47 (CH2), 63.65 (CH), 
121.58 (CH), 123.78 (CH), 129.03 (CH), 129.39 (qC), 134.10 (CH), 134.54 (qC), 174.91 
(C=O) ppm. 
HRMS (ESI
+
): found 253.0639 [M+H]
+
, C11H13N2SO3 requires 253.0641. 
9.1.9. 1-(2-Nitrobenzenesulfonyl)pyrrolidine-2-carboxylic acid. 
 
2-Azidobenzenesulfonyl chloride (2.0 g, 9.02 mmol, 1.0 eq) was added portionwise over a 
period of 5 min to a well stirred and ice-cooled solution of pyrrolidine methyl ester (1.494 g, 
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9.024 mmol, 1.0 eq) in 3N sodium hydroxide (7 mL). 30 mins of vigorous stirring resulted in 
a clear yellow solution which was acidified with concentrated HCl dropwise and then 
extracted into ethyl acetate (3 x 15 mL). The organic extracts were combined, dried and 
evaporated to give as a pale yellow oil (2.066 g, 76 %) in excellent purity that was directly 
carried forward without further purification. 
IR: ʋmax (cm
-1
): 568.5, 601.1, 726.4, 909.1, 1125.2, 1159.5, 1348.2, 1540.5, 1716.6, 2980.6, 
3275.3. 
1
H NMR: H (400 MHz, CDCl3): 1.89-1.97 (2H, m, CH2), 2.05-2.13 (1H, m, CHH), 2.18-
2.27 (1H, m, CHH), 3.44 (1H, app. q, J
1
=7.4 Hz, CHH), 3.55-3.60 (1H, m, CHH), 4.53 (1H, 
dd, J
1
=8.6 Hz, J
2
=2.9, CH), 7.56-7.58 (1H, m, ArH), 7.62-7.67 (2H, m, 2 x ArH), 8.01 (1H, 
dd, J
1
=8.7 Hz, J
2
=1.7 Hz ArH), 9.13 (1H, s, OH) ppm. 
13
C NMR c (100 MHz, DMSO): 24.48 (CH2), 30.96 (CH2), 48.47 (CH2), 60.69 (CH), 
124.16 (CH), 131.0478 (CH), 131.83 (CH), 132.38 (qC), 133.84 (CH), 148.03 (qC), 177.40 
(C=O) ppm. 
The data is identical to that reported in the literature
233
. 
9.1.10. 1-(2-Nitrobenzenesulfonyl)pyrrolidine-2-carboxylic acid. 
 
2-Nitrobenzenesulfonyl chloride (2.00 g, 9.00 mmol, 1.0 eq) was added portionwise over a 
period of 5 min to a well stirred and ice-cooled solution of pyrrolidine-2-carboxylic acid (1.04 
g, 9.024 mmol, 1.0 eq) in 3N sodium hydroxide (7 mL). 30 min of vigorous stirring resulted 
in a clear yellow solution which was acidified with conc. HCl dropwise and then extracted 
into ethyl acetate (3 x 15 mL). The organic extracts were combined, dried and evaporated to 
Chaper 9                                                                                                                                           Experimental 
326 
 
give as a pale yellow oil (2.30 g) in 85 % yield and excellent purity which was directly carried 
forward without any purification. The data obtained was identical to that obtained above. 
 
9.1.11. 1-(2-Aminobenzenesulfonyl)pyrrolidine-2-carboxylic acid. 
 
 
To a solution of the nitroester (2.0 g, 6.67 mmol, 1.0 eq) in glacial acetic acid (25 mL), iron 
powder (1.86 g, 33.34 mmol, 5.0 eq) was added over 30 minutes. The reaction mixture was 
stirred and heated at 60 
o
C for 2 hours. Removal of the solvent gave a gummy residue which 
was extracted with ethyl acetate (4 x 30 mL). The organic extracts were combined, washed 
with sodium bicarbonate, brine and dried. Concentration in vacuo afforded the amino acid as 
a yellow oil (1.45 g, 76 %). 
IR: ʋmax (cm
-1
): 756.1, 1141.6, 1319.6, 1453.5, 1483.7, 1616.8, 1727.7, 2980.1, 3375.9, 
3469.9. 
1
H NMR: H (400 MHz, CDCl3): 1.75-1.93 (2H, m, CH2), 2.07-2.16 (2H, m, CH2), 3.31 
(2H, dd, J
1
=7.6 Hz, J
2
=1.7 Hz, CH2), 3.55-3.60 (1H, m, CHH), 4.46 (1H, dd, J
1
=7.9 Hz, 
J
2
=5.1 Hz, CH), 6.63-6.72 (2H, m, 2 x ArH), 7.12 (3H, bs, NH2 + OH), 7.26 (1H, ddd, J
1
=8.0 
Hz, J
2
=7.8 Hz, J
3
=1.5 Hz ArH), 7.63 (1H, dd, J
1
=8.0 Hz, J
2
=1.5 Hz, ArH) ppm. 
13
C NMR c (100 MHz, DMSO): 24.85 (CH2), 30.92 (CH2), 48.83 (CH2), 59.69 (CH), 
117.44 (CH), 117.95 (CH), 118.95 (qC), 130.38 (CH), 134.81 (CH), 146.31 (qC), 176.93 
(C=O) ppm. 
HRMS (ESI
+
): found 271.0753 [M+H]+, C11H15N2SO4 requires 271.0747. 
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9.1.12. 10,10-Dioxo-2,3,3a,5-tetrahydro-1H-pyrrolo[1,2-b][1,2,5] benzothia-
diazepin-4-one. 
 
 
DCC (1.297 g, 0.629 mmol) dissolved in dichloromethane (3 mL) was added to a solution of 
compound (433) (1.7 g, 0.629 mol, 1.0 eq) in dichloromethane (6 mL) at 0 
o
C, and the 
mixture was stirred at ambient temperature overnight. After filtration through Celtite, the 
organic phase was washed with 2 M HCl (10 mL), saturated aqueous NaHCO3 (10 mL), and 
water (10 mL). The organic phase was dried (MgSO4) and concentrated under reduced 
pressure to afford a solid residue, which was purified by flash silica chromatography 
(petroleum ether/ethyl acetate: 1/1, Rf = 0.23) to give the title compound (1.00 g, 63 %, m.p.= 
291-292 
o
C) as a white solid, lit. m.p.292-293 
o
C
233
.  
IR: ʋmax (cm
-1
): 755.4, 1007.2, 1078.4, 1191.5, 1341.8, 1384.2, 1478.5, 1583.2, 1661.4, 
2891.7, 2933.1, 2985.4, 3063.3, 3204.1. 
1
H NMR: H (400 MHz, CDCl3): 1.82-1.92 (1H, m, CHH), 1.95-2.07 (1H, m, CHH), 2.19-
2.27 (1H, m, CHH),2.46-2.55 (1H, m, CHH), 3.00-3.06 (1H, m, CHH), 3.49-3.54 (1H, m, 
CHH), 4.65 (1H, dd, J
1
=7.9 Hz, J
2
=5.9 Hz, NCH),  7.18 (1H, d, J=8.0 Hz, ArH), 7.22 (1H, 
dd, J
1
=7.8 Hz, J
2
=7.6 Hz, ArH), 7.53 (1H, ddd, J
1
=7.8 Hz, J
2
=7.6 Hz, J
3
=1.4 Hz, ArH), 7.91 
(1H, dd, J
1
=8.0 Hz, J
2
=1.3 Hz, ArH), 9.20 (1H, s, NH) ppm. 
13
C NMR c (100 MHz, DMSO): 24.64 (CH2), 32.47 (CH2), 58.47 (CH2), 63.65 (CH), 
121.58 (CH), 123.78 (CH), 129.03 (CH), 129.39 (qC), 134.10 (CH), 134.54 (qC), 174.91 
(C=O) ppm. 
HRMS (ESI
+
): found 253.0639 [M+H]+, C11H13N2SO3 requires 253.0641. 
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9.2. Attempted Synthesis of fuligocandin Analogues. 
9.2.1. 10,10-Dioxo-2,3,3a,5-tetrahydro-1H-pyrrolo[1,2-b][1,2,5] benzothia-
diazepine-4-thione. 
 
 
Lawesson's reagent (404 mg, 1.0 mmol, 0.5 eq) was added to a MeCN solution (25 mL) of 
compound (441) (504 mg, 2.0 mmol, 1.0 eq) and the mixture was heated to reflux at 60 
o
C for 
3h  during which time a yellow precipitate was formed. The reaction mixture was allowed to 
stand at room temperature overnight. The product was vacuum-filtered and washed with a 
small amount of cold MeCN and purified by silica column chromatography [petroleum ether/ 
ethyl acetate: 2/1, Rf = 0.23] to yield the product as a yellow solid (50 mg, 9 %, m.p: 262-264 
o
C (lit. m.p: 268-270 
o
C
143
)). 
IR: ʋmax (cm
-1
): 580.90, 697.40, 751.10, 1004.80, 1051.30, 1169.90, 1339.80, 1384.00, 
1470.60, 1529.10, 1589.00, 2868.60, 2922.50, 2955.80, 3150.20. 
1
H NMR: H (400 MHz, CDCl3): 1.70-2.19 (1H, m, CHH), 1.95-2.07 (1H, m, CHH), 2.30-
2.41 (1H, m, CHH), 2.50 (1H, s, CHH), 2.87-2.93 (1H, m, CHH), 3.32-3.47 (1H, m, CHH), 
4.80 (1H, t, J=7.5 Hz, NCH),  7.39 (1H, dd, J
1
=7.6 Hz, J
2
=7.5 Hz, ArH), 7.44 (1H, d, J=7.9 
Hz, ArH), 7.72 (1H, ddd, J
1
=7.6 Hz, J
2
=7.5 Hz, J
3
=1.2 Hz, ArH), 7.77 (1H, d, J=7.9 Hz, 
ArH), 12.35 (1H, s, NH) ppm. 
13
C NMR c (100 MHz, DMSO): 24.15 (CH2), 35.18 (CH2), 49.79 (CH2), 70.81 (CH), 
124.00 (CH), 125.77 (CH), 128.27 (CH), 130.68 (qC), 134.94 (CH), 135.25 (qC), 206.32 
(C=S) ppm. 
HRMS (ESI
+
): found 269.0403 [M+H]
+
, C11H13O2N2S2  requires 269.0413 
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9.2.2. 10,10-Dioxo-2,3,3a,5-tetrahydro-1H-pyrrolo[1,2-b][1,2,5]-
benzothiadiazepine-4-thione. 
 
 
Lawesson's reagent (404 mg, 1.0 mmol, 0.5 eq) in one portion was added to a solution of 
compound (441) (504 mg, 2.0 mmol, 1 eq) in a dry THF (30 mL) at room temperature, under 
a nitrogen atmosphere, with stirring.  The mixture was stirred 1hour at room temperature after 
which time all solid had dissolved to give a clear for yellow solution. The reaction mixture 
was heated at reflux for a further hour (monitored for completion by TLC). Upon cooling to 
room temperature the solution was concentrated and purified using flash silica column 
chromatography [Eluent: petroleum ether/ ethyl acetate: 2/1, Rf = 0.23] to yield the product as 
a yellow solid (60 mg, 11%, m.p: 262-264 
o
C). The data was identical to that obtained above.  
9.2.3. 10,10-Dioxo-2,3,3a,5-tetrahydro-1H-pyrrolo[1,2-b][1,2,5]benzothia-
diazepine-4-thione. 
 
 
The P2S5-py2 reagent (230 mg, 0.6 mmol) was added to a MeCN solution (25 mL) of 
compound (426) (504 mg, 2.0 mmol) and the mixture was heated at reflux for 3h  during 
which time a yellow precipitate was formed.
246
 The reaction mixture was left at room 
temperature overnight in order to precipitate fully. The product was filtered and washed with 
a small amount of cold MeCN and purified by silica column chromatography [petroleum 
Chaper 9                                                                                                                                           Experimental 
330 
 
ether/ ethyl acetate: 2/1, Rf = 0.23] to yield the product as a yellow solid (100 mg, 19 %, m.p: 
262-264 
o
C), identical to that isolated above. 
9.2.4. 10,10-Dioxo-2,3,3a,5-tetrahydro-1H-pyrrolo[1,2-b][1,2,5]benzothia-
diazepine-4-thione. 
 
 
To a toluene solution (25 mL) of compound (441) (504 mg, 2.0 mmol, 1.0 eq) was added  
Lawesson’s Reagent (404 mg, 1.0 mmol, 0.5 eq)  and the mixture was heated to 60 oC for 3h  
during which time a yellow precipitate was formed. The reaction mixture was allowed to 
stand at room temperature overnight in order to precipitate fully. The product was vacuum-
filtered and washed with a small amount of cold MeCN and purified by silica column 
chromatography [petroleum ether/ ethyl acetate: 2/1, Rf = 0.23] to yield the product as a 
yellow solid (60 mg, 11 %, m.p.= 262-264 
o
C) with data identical to that given above. 
 
9.2.5. 1-(2-Nitrophenylsulfonyl)-indole-3-carbaldehyde. 
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A dichloromethane suspension (12 mL) of indole-3-carbaldehyde (0.9 g, 6.2 mmol, 1.0 eq), 
DMAP (0.061 g, 0.5 mmol, 0.08 eq), and triethylamine (1.3 mL, 9.3 mmol, 1.5 eq) was 
stirred for 10 min at  room temperature, and then 2-nitrophenylsulfonyl chloride (1.5 g, 6.82 
mmol, 1.1 eq) in 12 mL of dichloromethane was added dropwise over 10 min. The reaction 
mixture was allowed to stir at room temperature overnight and thereafter quenched with 30 
mL of aq. HCl (5 %). The organic phase was separated, and the aqueous phase was extracted 
several times with dichloromethane. The combined dichloromethane phases were dried with 
MgSO4 and flushed through a short silica plug. Evaporation of the yellow filtrate in vacuo 
gave the product (2.0 g, 98 %, m.p.=132-134 
o
C) as a beige solid. 
IR: ʋmax (cm
-1
): 747.8, 778.5, 969.6, 1117.9, 1182.7, 1372.0, 1388.3, 1439.5, 1541.1, 1583.4, 
1675.6, 2840.0, 2912.1, 3147.5. 
1
H NMR: H (400 MHz, CDCl3): 7.43-7.53 (2H, m, 2 x ArH), 7.86 (1H, dd, J
1
=7.0 Hz, 
J
2
=2.0 Hz, ArH), 7.96 (1H, ddd, J
1
=7.8 Hz, J
2
=1.2 Hz, ArH), 8.05 (1H, td, J
1
=7.7 Hz, J
2
=1.3 
Hz, ArH), 8.17-8.22 (2H, m, ArH), 8.33 (1H, dd, J
1
=8.0 Hz, J
2
=1.3 Hz, ArH), 8.82 (1H, s, 
HC=O) ppm. 
13
C NMR c (100 MHz, DMSO): 113.60 (CH), 121.82 (qC), 122.56 (CH), 125.98 (CH), 
126.98 (qC), 126.13 (qC), 126.42 (CH), 127.01 (CH), 128.83 (qC), 131.54 (CH), 134.32 (CH) 
134.76 (qC), 137.86 (CH), 139.68 (CH), 147.73 (CH), 187.65 (C=O) ppm. 
HRMS (ESI
+
): found 329.0237 [M-H]
+
, C15H8O3N4S  requires 329.0231. 
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9.2.6. 1-(2-Nitrophenylsulfonyl)-indole-3-carbaldehyde. 
 
 
A dichloromethane suspension (12 mL) of indole-3-carbaldehyde (0.9 g, 6.2 mmol, 1.0 eq), 
DMAP (0.061 g, 0.5 mmol, 0.08 eq), and triethylamine (1.3 mL, 9.3 mmol, 1.5 eq) was 
stirred for 10 min at  room temperature, and then 4-nitrophenylsulfonyl chloride (1.5 g, 6.82 
mmol, 1.1 eq) in 12 mL of dichloromethane was added dropwise over 10 min. The reaction 
mixture was allowed to stir at room temperature overnight and thereafter quenched with 30 
mL of aq. HCl (5 %). The phases were separated, and the aqueous phase was extracted several 
times with dichloromethane. The combined dichloromethane phases were dried with MgSO4 
and flushed through a short silica plug. Evaporation of the light yellow filtrate in vacuo gave 
the product as a beige solid (1.2 g, 59 %, m.p.= 159-161
o
C, lit. m.p=160 
o
C
143
). 
IR: ʋmax (cm
-1
): 778.5, 969.6, 1117.9, 1182.7, 1372.0, 1388.3, 1439.5, 1541.1, 1583.4, 
1675.6, 2840.0, 2912.1, 3147.5. 
1
H NMR: H (400 MHz, CDCl3): 7.43-7.53 (2H, m, 2 x ArH), 7.86 (1H, dd, J
1
=7.0 Hz, 
J=2.0 Hz, ArH), 7.96 (1H, ddd, J
1
=7.8 Hz, J
2
=7.7 Hz, J
3
=1.3 Hz, ArH), 8.05 (1H, ddd, J
1
=7.8 
Hz, J
2
=7.7 Hz, J
3
=1.3 Hz, ArH), 8.17-8.22 (2H, m, 2 x ArH), 8.33 (1H, dd, J
1
=8.0 Hz, J
2
=1.3 
Hz, ArH), 8.82 (1H, s, HC=O) ppm. 
13
C NMR c (100 MHz, DMSO): 113.60 (CH), 121.82 (qC), 122.56 (CH), 125.98 (CH), 
126.98 (qC), 126.13 (qC), 126.42 (CH), 127.01 (CH), 128.83 (qC), 131.54ppm. (CH), 134.32 
(CH) 134.76 (qC), 137.86 (CH), 139.68 (CH), 147.73 (CH), 187.65 (C=O) ppm. 
HRMS (ESI
+
): found 331.0381 [M+H]
+
, C15H11O5N2S  requires 331.0383. 
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IV. Conclusions. 
In conclusion for the first project (Chapter 2) of this PhD the aims have been partially 
achieved. We have been successful in applying a series of multi-component reactions (MCR) 
to aldehydes incorporating the azide functional group. Some of the reactions investigated with 
o-azidobenzaldehyde gave the desired MCR and a new product with an azide but the azide did 
not react with the nitrile. Some of the reactions resulted in the attempted MCR stopping after 
one reaction between just two of the components. Some of these, however, had azides and 
nitriles in them which did react to form tetrazoles, a previously unreported process with these 
starting materials. 
In conclusion for the second project (Chapter 3) of this thesis the aims have been achieved. 
We have been successful in the preparation of tetra- and triazolo-analogues of the 
pyrrolobenzothiadiazepines and benzothiadiazepines. However, some of the attempted 
reactions resulted in products that did not react the azide moiety with the nitriles or alkynes, 
and ring-size appeared to be an important factor.  
In conclusion for the third project (Chapter 4.1) of this PhD the aims have been achieved.  We 
have been successful in making new products from azides. The 2-azidobenzamide with alkyl 
bromides gave mixtures of benzotriazinones and quinazolinones. Some of the alkyl bromides 
with 2-azidobenzamide gave just benzotriazinones and some of the alkyl bromides did not 
react. The benzotriazinones did not react with diphenylcyclopropenone to produce new 
compounds. 
In conclusion for the fourth project (Chapter 4.2) of this thesis the aims have been achieved. 
We have been successful in the preparation of 1,2,4-oxadiazole analogues. 1,3-Dipolar 
cycloaddition  of 2-azido-N'-hydroxybenzimidamide with the acid chlorides, ethyl 2-chloro-2-
oxoacetate and  oxalyl chloride gave new 1,2,4-oxadazole analogues. The 1,2,4-oxadiazoles 
reacted with dimethylacetylene dicarboxylate  (DMAD) to produce new compounds. This 
process should be more thoroughly investigated in future.  
In conclusion for the fifth project (Chapter 4.3) of this thesis significant progress has been 
made. We have been successful in the preparation of a 6H-1,3-oxazine. We have been 
successful in synthesising diazides as starting materials but these did not react to form the 
desired products, with the exception of the synthesis of one macrocycle. 
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In conclusion for the final project (Chapter 5) of this thesis the aims have not been achieved. 
We have not been successful in developing a synthetic route for sulfonamide analogues 
circumdatin or fuligocandin, but we have shown that this appears not to be a valid route. 
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V. Future work 
1. N-((phenylcarbamoyl)(phenyl)methyl)-N-(2-acetylphenyl)-2-azidobenzamide 
derivative. 
In the future 2-azidobenzoic acid will be synthesized which will be useful for the future study 
of azide-containing MCRs in which the azide can hopefully undergo post-MCR modification. 
It is hoped that 2-azidobenzoic acid will not undergo the condensation reaction that the 2-
azidobenzaldehyde underwent. It is clear from the MCR work that 2-azidobenzaldehyde / 
nitrile reactions are a problem due to the cycloaddition occurring before the MCR and 
stopping the MCR.  
 
For example, 2-azidobenzoic acid will be studied for the reaction shown below, in which it 
could be attempted to react the azide present in compound (480) after MCR in an aza-Wittig 
reaction
247
. 
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1. Synthesis of  Sulfonamide Analogues of the Circumdatins. 
 
All attempts to reacted the amide (441) with 2-azidobenzoyl chloride or 2-
azidobenzenesulfonyl chloride and provide precursors for circumdatin analogue synthesis 
were not successful. However, it was thought that compound (482) might be prepared by 
adapting a procedure in the literature
248
. The proposed reaction is shown below: 
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